CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: vitamin E
Accession: CHEBI:33234
browse the term
Definition: Any member of a group of fat-soluble chromanols that exhibit biological activity against vitamin E deficiency. The vitamers in this class consists of a chroman-6-ol core which is substituted at position 2 by a methyl group and (also at position 2) either a saturated or a triply-unsaturated hydrocarbon chain consisting of three isoprenoid units. The major function of vitamin E is to act as a natural antioxidant by scavenging free radicals and molecular oxygen.
Synonyms: related_synonym: vitamin E vitamer; vitamin E vitamers; vitamins E
alt_id: MESH:D014810
xref_mesh: MESH:D024502
xref: MetaCyc:Vitamin-E; PMID:33684201; PMID:33847203; PMID:33896432; PMID:34277234; PMID:34278890; PMID:7898412; PMID:7901680; Wikipedia:Vitamin_E
G
Aamp
angio-associated, migratory cell protein
increases expression
ISO
Vitamin E results in increased expression of AAMP mRNA
CTD
PMID:19244175
NCBI chr 9:75,863,382...75,869,188
Ensembl chr 9:75,863,389...75,868,547
G
Aass
aminoadipate-semialdehyde synthase
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of AASS mRNA Vitamin E results in decreased expression of AASS mRNA
CTD
PMID:19244175
NCBI chr 4:52,572,146...52,628,811
Ensembl chr 4:51,606,462...51,663,136
G
Abcb11
ATP binding cassette subfamily B member 11
decreases expression
ISO
Vitamin E results in decreased expression of ABCB11 mRNA
CTD
PMID:34767876
NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:54,017,127...54,112,730
G
Abcc2
ATP binding cassette subfamily C member 2
multiple interactions
EXP
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of ABCC2 mRNA
CTD
PMID:11444866
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:242,664,657...242,723,238
G
Abhd14a
abhydrolase domain containing 14A
decreases expression
ISO
Vitamin E results in decreased expression of ABHD14A mRNA
CTD
PMID:19244175
NCBI chr 8:107,079,139...107,089,004
Ensembl chr 8:107,079,144...107,086,985
G
Abhd2
abhydrolase domain containing 2, acylglycerol lipase
decreases expression increases expression
ISO
Vitamin E results in decreased expression of ABHD2 mRNA Vitamin E results in increased expression of ABHD2 mRNA
CTD
PMID:19244175
NCBI chr 1:142,626,748...142,707,892
Ensembl chr 1:133,217,375...133,299,061
G
Abhd4
abhydrolase domain containing 4, N-acyl phospholipase B
increases expression
ISO
Vitamin E results in increased expression of ABHD4 mRNA
CTD
PMID:19244175
NCBI chr15:31,674,090...31,686,051
Ensembl chr15:27,704,113...27,716,966
G
Acaa2
acetyl-CoA acyltransferase 2
increases expression
ISO
Vitamin E results in increased expression of ACAA2 mRNA
CTD
PMID:19244175
NCBI chr18:70,620,310...70,648,417
Ensembl chr18:68,345,012...68,373,249
G
Acads
acyl-CoA dehydrogenase short chain
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of ACADS mRNA Vitamin E results in increased expression of ACADS mRNA
CTD
PMID:19244175
NCBI chr12:47,154,259...47,163,580
Ensembl chr12:41,493,626...41,502,898
G
Ache
acetylcholinesterase
multiple interactions
ISO EXP
[Resveratrol co-treated with Ascorbic Acid co-treated with Thioctic Acid co-treated with Vitamin E] results in increased activity of ACHE protein; Hexachlorocyclohexane inhibits the reaction [[Resveratrol co-treated with Ascorbic Acid co-treated with Thioctic Acid co-treated with Vitamin E] results in increased activity of ACHE protein] [Zinc co-treated with Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [sodium arsenite results in increased activity of ACHE protein]; Vitamin E inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased activity of ACHE protein]; Vitamin E inhibits the reaction [Scopolamine results in decreased activity of ACHE protein]
CTD
PMID:11814146 PMID:20663516 PMID:23619517 PMID:29233033
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651
G
Aco2
aconitase 2
increases expression
ISO
Vitamin E results in increased expression of ACO2 mRNA
CTD
PMID:19244175
NCBI chr 7:115,265,816...115,308,931
Ensembl chr 7:113,385,646...113,428,261
G
Acot2
acyl-CoA thioesterase 2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ACOT2 mRNA Vitamin E results in increased expression of ACOT2 mRNA
CTD
PMID:19244175
NCBI chr 6:109,341,426...109,352,818
Ensembl chr 6:103,611,544...103,619,245
G
Acp1
acid phosphatase 1
decreases expression
ISO
Vitamin E results in decreased expression of ACP1 mRNA
CTD
PMID:19244175
NCBI chr 6:47,506,380...47,522,021
Ensembl chr 6:47,506,380...47,522,021
G
Acta2
actin alpha 2, smooth muscle
decreases expression
ISO
Vitamin E results in decreased expression of ACTA2 mRNA
CTD
PMID:19244175
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:231,746,548...231,759,554
G
Actb
actin, beta
increases expression
ISO
Vitamin E results in increased expression of ACTB mRNA
CTD
PMID:19244175
NCBI chr12:16,776,664...16,779,634
Ensembl chr12:11,663,109...11,672,877
G
Actn4
actinin alpha 4
increases expression
ISO
Vitamin E results in increased expression of ACTN4 mRNA
CTD
PMID:19244175
NCBI chr 1:93,310,294...93,379,369
Ensembl chr 1:84,182,788...84,251,847
G
Actr1a
actin related protein 1A
increases expression
ISO
Vitamin E results in increased expression of ACTR1A mRNA
CTD
PMID:19244175
NCBI chr 1:255,179,241...255,199,009
Ensembl chr 1:245,237,826...245,256,495
G
Actr1b
actin related protein 1B
increases expression
ISO
Vitamin E results in increased expression of ACTR1B mRNA
CTD
PMID:19244175
NCBI chr 9:38,928,819...38,938,483
Ensembl chr 9:38,929,912...38,938,507
G
Acvr2a
activin A receptor type 2A
decreases expression
ISO
Vitamin E results in decreased expression of ACVR2A mRNA
CTD
PMID:19244175
NCBI chr 3:33,204,961...33,292,673
Ensembl chr 3:33,205,523...33,289,968
G
Acvr2b
activin A receptor type 2B
decreases expression
EXP
Vitamin E results in decreased expression of SCGB2A2 mRNA
CTD
PMID:15084515
NCBI chr 8:119,138,901...119,178,477
Ensembl chr 8:119,138,812...119,170,458
G
Adam17
ADAM metallopeptidase domain 17
decreases expression
ISO
Vitamin E results in decreased expression of ADAM17 mRNA
CTD
PMID:19244175
NCBI chr 6:46,601,583...46,663,690
Ensembl chr 6:40,872,856...40,920,639
G
Adamts5
ADAM metallopeptidase with thrombospondin type 1 motif, 5
decreases expression
ISO
Vitamin E results in decreased expression of ADAMTS5 mRNA
CTD
PMID:19244175
NCBI chr11:38,486,945...38,533,516
Ensembl chr11:25,000,637...25,047,205
G
Adap1
ArfGAP with dual PH domains 1
increases expression
ISO
Vitamin E results in increased expression of ADAP1 mRNA
CTD
PMID:19244175
NCBI chr12:20,438,091...20,489,961
Ensembl chr12:15,324,209...15,380,831
G
Adarb1
adenosine deaminase, RNA-specific, B1
decreases expression
ISO
Vitamin E results in decreased expression of ADARB1 mRNA
CTD
PMID:19244175
NCBI chr20:11,222,171...11,350,416
Ensembl chr20:11,222,583...11,350,852
G
Adcy2
adenylate cyclase 2
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ADCY2 mRNA
CTD
PMID:19244175
NCBI chr 1:36,204,054...36,650,645
Ensembl chr 1:34,375,895...34,822,236
G
Adcy6
adenylate cyclase 6
increases expression
ISO
Vitamin E results in increased expression of ADCY6 mRNA
CTD
PMID:19244175
NCBI chr 7:131,621,860...131,642,923
Ensembl chr 7:129,742,838...129,763,754
G
Add1
adducin 1
increases expression
ISO
Vitamin E results in increased expression of ADD1 mRNA
CTD
PMID:19244175
NCBI chr14:80,333,242...80,401,641
Ensembl chr14:76,108,654...76,167,182
G
Add3
adducin 3
decreases expression
ISO
Vitamin E results in decreased expression of ADD3 mRNA
CTD
PMID:19244175
NCBI chr 1:252,147,341...252,255,126
Ensembl chr 1:252,147,386...252,255,124
G
Adgrb1
adhesion G protein-coupled receptor B1
increases expression
ISO
Vitamin E results in increased expression of ADGRB1 mRNA
CTD
PMID:19244175
NCBI chr 7:108,293,681...108,365,892
Ensembl chr 7:106,404,958...106,476,902
G
Adh7
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide
decreases expression
ISO
Vitamin E results in decreased expression of ADH7 mRNA
CTD
PMID:19244175
NCBI chr 2:229,422,125...229,436,584
Ensembl chr 2:226,741,788...226,763,182
G
Adipoq
adiponectin, C1Q and collagen domain containing
multiple interactions
EXP
Vitamin E inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ mRNA]; Vitamin E inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ protein]
CTD
PMID:20404018
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
G
Adissp
adipose secreted signaling protein
increases expression multiple interactions
ISO
Vitamin E results in increased expression of ADISSP mRNA [Selenium co-treated with Vitamin E] results in decreased expression of ADISSP mRNA
CTD
PMID:19244175
NCBI chr 3:118,364,730...118,378,881
Ensembl chr 3:118,362,363...118,378,838
G
Adra2c
adrenoceptor alpha 2C
increases expression
ISO
Vitamin E results in increased expression of ADRA2C mRNA
CTD
PMID:19244175
NCBI chr14:79,695,514...79,697,476
Ensembl chr14:75,471,143...75,472,846
G
Adrm1
ADRM1 26S proteasome ubiquitin receptor
increases expression
ISO
Vitamin E results in increased expression of ADRM1 mRNA
CTD
PMID:19244175
NCBI chr 3:187,643,043...187,647,805
Ensembl chr 3:167,265,296...167,270,195
G
Aebp1
AE binding protein 1
increases expression
ISO
Vitamin E results in increased expression of AEBP1 mRNA
CTD
PMID:19244175
NCBI chr14:80,738,800...80,748,878
Ensembl chr14:80,738,892...80,748,877
G
Aen
apoptosis enhancing nuclease
increases expression
ISO
Vitamin E results in increased expression of AEN mRNA
CTD
PMID:19244175
NCBI chr 1:142,224,499...142,233,902
Ensembl chr 1:132,815,142...132,824,523
G
Agpat2
1-acylglycerol-3-phosphate O-acyltransferase 2
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of AGPAT2 mRNA
CTD
PMID:19244175
NCBI chr 3:29,814,924...29,826,569
Ensembl chr 3:9,416,843...9,428,371
G
Agrn
agrin
decreases expression
ISO
Vitamin E results in decreased expression of AGRN mRNA
CTD
PMID:19244175
NCBI chr 5:172,031,528...172,064,429
Ensembl chr 5:166,749,310...166,786,003
G
Agtpbp1
ATP/GTP binding carboxypeptidase 1
decreases expression
ISO
Vitamin E results in decreased expression of AGTPBP1 mRNA
CTD
PMID:19244175
NCBI chr17:5,120,540...5,238,874
Ensembl chr17:5,120,609...5,238,869
G
Ahnak
AHNAK nucleoprotein
increases expression
ISO
Vitamin E results in increased expression of AHNAK mRNA
CTD
PMID:19244175
NCBI chr 1:215,311,289...215,400,010
Ensembl chr 1:205,882,273...205,970,926
G
Ahnak2
AHNAK nucleoprotein 2
increases expression
ISO
Vitamin E results in increased expression of AHNAK2 mRNA
CTD
PMID:19244175
NCBI chr 6:131,830,668...131,876,311
Ensembl chr 6:131,831,454...131,854,463
G
Ahr
aryl hydrocarbon receptor
decreases expression
ISO
Vitamin E results in decreased expression of AHR mRNA
CTD
PMID:19244175
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
G
Ahsa1
activator of Hsp90 ATPase activity 1
increases expression
ISO
Vitamin E results in increased expression of AHSA1 mRNA
CTD
PMID:19244175
NCBI chr 6:106,913,296...106,921,347
Ensembl chr 6:106,913,530...106,921,345
G
Aimp1
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of AIMP1 mRNA Vitamin E results in decreased expression of AIMP1 mRNA
CTD
PMID:19244175
NCBI chr 2:223,825,930...223,849,477
Ensembl chr 2:221,151,904...221,175,728
G
Ak1
adenylate kinase 1
increases expression
ISO
Vitamin E results in increased expression of AK1 mRNA
CTD
PMID:19244175
NCBI chr 3:36,310,113...36,320,760
Ensembl chr 3:15,912,485...15,923,041
G
Ak3
adenylate kinase 3
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of AK3 mRNA
CTD
PMID:19244175
NCBI chr 1:236,151,012...236,178,689
Ensembl chr 1:226,739,318...226,764,625
G
Akap13
A-kinase anchoring protein 13
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of AKAP13 mRNA Vitamin E results in decreased expression of AKAP13 mRNA
CTD
PMID:19244175
NCBI chr 1:138,722,445...139,029,401
Ensembl chr 1:129,314,402...129,619,646
G
Akr1b1
aldo-keto reductase family 1 member B1
increases expression
ISO
Vitamin E results in increased expression of AKR1B1 mRNA
CTD
PMID:19244175
NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:62,932,031...62,946,157
G
Akr1b10
aldo-keto reductase family 1 member B10
increases expression
ISO
Vitamin E results in increased expression of AKR1B10 mRNA
CTD
PMID:34767876
NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:63,040,169...63,053,852
G
Akr1c2
aldo-keto reductase family 1, member C2
increases expression
ISO
Vitamin E results in increased expression of AKR1C2 mRNA
CTD
PMID:19244175
NCBI chr17:70,669,684...70,717,935
Ensembl chr17:65,759,788...65,775,764
G
Akt1
AKT serine/threonine kinase 1
increases expression multiple interactions
ISO EXP
Vitamin E results in increased expression of AKT1 mRNA [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in decreased phosphorylation of AKT1 protein]
CTD
PMID:19244175 PMID:21911000
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Alad
aminolevulinate dehydratase
multiple interactions
EXP
Vitamin E inhibits the reaction [lead acetate results in decreased activity of ALAD protein]
CTD
PMID:2604901
NCBI chr 5:80,977,562...80,987,901
Ensembl chr 5:75,961,993...75,972,474
G
Alb
albumin
multiple interactions
ISO EXP
Vitamin E inhibits the reaction [Ethanol results in decreased expression of ALB protein] [Quercetin co-treated with Vitamin E] inhibits the reaction [Cyclosporine results in decreased expression of ALB protein]; Vitamin E inhibits the reaction [Cyclosporine results in decreased expression of ALB protein] Vitamin E inhibits the reaction [Oleic Acid results in decreased secretion of ALB protein]
CTD
PMID:17927767 PMID:21086752 PMID:23348005
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
G
Aldh6a1
aldehyde dehydrogenase 6 family, member A1
decreases expression
ISO
Vitamin E results in decreased expression of ALDH6A1 mRNA
CTD
PMID:19244175
NCBI chr 6:109,809,092...109,829,725
Ensembl chr 6:104,077,979...104,098,656
G
Aldoa
aldolase, fructose-bisphosphate A
increases expression
ISO
Vitamin E results in increased expression of ALDOA mRNA
CTD
PMID:19244175
NCBI chr 1:190,832,820...190,838,021
Ensembl chr 1:181,402,275...181,406,182
G
Alg3
ALG3, alpha-1,3- mannosyltransferase
increases expression
ISO
Vitamin E results in increased expression of ALG3 mRNA
CTD
PMID:19244175
NCBI chr11:80,300,487...80,306,014
Ensembl chr11:80,300,498...80,307,912
G
Alg9
ALG9, alpha-1,2-mannosyltransferase
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ALG9 mRNA
CTD
PMID:19244175
NCBI chr 8:51,117,057...51,188,790
Ensembl chr 8:51,119,365...51,182,261
G
Alkbh1
alkB homolog 1, histone H2A dioxygenase
decreases expression
ISO
Vitamin E results in decreased expression of ALKBH1 mRNA
CTD
PMID:19244175
NCBI chr 6:112,799,234...112,819,708
Ensembl chr 6:107,068,475...107,088,759
G
Alox5
arachidonate 5-lipoxygenase
decreases activity multiple interactions
ISO EXP
Vitamin E results in decreased activity of ALOX5 protein [Vitamin E co-treated with Selenium] results in decreased expression of ALOX5 mRNA; [Vitamin E co-treated with Selenium] results in decreased expression of ALOX5 protein
CTD
PMID:11325678 PMID:12200813 PMID:22223226
NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:149,531,515...149,578,743
G
Alpl
alkaline phosphatase, biomineralization associated
multiple interactions
EXP
Vitamin E inhibits the reaction [Doxorubicin results in decreased activity of ALPL protein]; Vitamin E inhibits the reaction [Hexachlorobenzene results in increased activity of ALPL protein]; Vitamin E inhibits the reaction [Tramadol results in increased expression of ALPL protein]
CTD
PMID:30064338 PMID:31618080 PMID:32810592
NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:149,951,409...150,006,446
G
Ambra1
autophagy and beclin 1 regulator 1
increases expression
ISO
Vitamin E results in increased expression of AMBRA1 mRNA
CTD
PMID:19244175
NCBI chr 3:98,156,626...98,345,876
Ensembl chr 3:77,700,936...77,890,221
G
Anapc15
anaphase promoting complex subunit 15
increases expression
ISO
Vitamin E results in increased expression of ANAPC15 mRNA
CTD
PMID:19244175
NCBI chr 1:165,650,478...165,678,004
Ensembl chr 1:156,262,841...156,268,145
G
Andpro
androgen regulated protein
decreases expression
EXP
Vitamin E results in decreased expression of ANDPRO mRNA
CTD
PMID:15084515
NCBI chr 3:157,171,739...157,178,262
Ensembl chr 3:136,718,602...136,724,966
G
Angpt1
angiopoietin 1
decreases expression
ISO
Vitamin E results in decreased expression of ANGPT1 mRNA
CTD
PMID:19244175
NCBI chr 7:75,415,959...75,668,696
Ensembl chr 7:73,531,486...73,784,067
G
Ank3
ankyrin 3
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of ANK3 mRNA Vitamin E results in decreased expression of ANK3 mRNA
CTD
PMID:19244175
NCBI chr20:18,602,267...19,225,831
Ensembl chr20:18,602,786...19,086,300
G
Ankrd12
ankyrin repeat domain 12
decreases expression
ISO
Vitamin E results in decreased expression of ANKRD12 mRNA
CTD
PMID:19244175
NCBI chr 9:105,583,273...105,687,957
Ensembl chr 9:105,584,065...105,687,911
G
Anp32b
acidic nuclear phosphoprotein 32 family member B
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of ANP32B mRNA Vitamin E results in decreased expression of ANP32B mRNA
CTD
PMID:19244175
NCBI chr 5:65,538,872...65,561,305
Ensembl chr 5:60,743,443...60,765,717
G
Anxa6
annexin A6
increases expression
ISO
Vitamin E results in increased expression of ANXA6 mRNA
CTD
PMID:19244175
NCBI chr10:39,602,106...39,657,183
Ensembl chr10:39,097,109...39,156,433
G
Ap1m2
adaptor related protein complex 1 subunit mu 2
increases expression
ISO
Vitamin E results in increased expression of AP1M2 mRNA
CTD
PMID:19244175
NCBI chr 8:28,114,748...28,132,767
Ensembl chr 8:19,838,580...19,856,482
G
Ap2a2
adaptor related protein complex 2 subunit alpha 2
increases expression
ISO
Vitamin E results in increased expression of AP2A2 mRNA
CTD
PMID:19244175
NCBI chr 1:206,081,856...206,155,146
Ensembl chr 1:196,652,337...196,725,603
G
Ap2m1
adaptor related protein complex 2 subunit mu 1
increases expression
ISO
Vitamin E results in increased expression of AP2M1 mRNA
CTD
PMID:19244175
NCBI chr11:93,859,690...93,868,600
Ensembl chr11:80,328,041...80,364,140
G
Ap2s1
adaptor related protein complex 2 subunit sigma 1
increases expression
ISO
Vitamin E results in increased expression of AP2S1 mRNA
CTD
PMID:19244175
NCBI chr 1:86,545,601...86,557,007
Ensembl chr 1:77,417,477...77,428,905
G
Ap3s2
adaptor related protein complex 3 subunit sigma 2
increases expression
ISO
Vitamin E results in increased expression of AP3S2 mRNA
CTD
PMID:19244175
NCBI chr 1:143,228,131...143,268,573
Ensembl chr 1:133,818,825...133,859,322
G
Apbb2
amyloid beta precursor protein binding family B member 2
decreases expression
ISO
Vitamin E results in decreased expression of APBB2 mRNA
CTD
PMID:19244175
NCBI chr14:41,557,918...41,878,622
Ensembl chr14:41,557,972...41,877,495
G
Apex1
apurinic/apyrimidinic endodeoxyribonuclease 1
increases expression
ISO
Vitamin E results in increased expression of APEX1 mRNA
CTD
PMID:19244175
NCBI chr15:26,618,146...26,620,330
Ensembl chr15:24,144,362...24,146,785
G
Aplp2
amyloid beta precursor like protein 2
increases expression
ISO
Vitamin E results in increased expression of APLP2 mRNA
CTD
PMID:19244175
NCBI chr 8:37,857,407...37,920,487
Ensembl chr 8:29,599,230...29,661,855
G
Apoa1
apolipoprotein A1
increases expression
ISO
Vitamin E results in increased expression of APOA1 protein
CTD
PMID:18458655
NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:46,527,144...46,529,035
G
Apob
apolipoprotein B
multiple interactions
ISO
[Eicosapentaenoic Acid co-treated with Docosahexaenoic Acids co-treated with Oleic Acid co-treated with Folic Acid co-treated with Vitamin B 6 co-treated with Vitamin E] results in decreased expression of APOB protein; Vitamin E promotes the reaction [Flavonoids inhibits the reaction [Copper results in increased oxidation of APOB protein]]; Vitamin E promotes the reaction [Quercetin inhibits the reaction [Copper results in increased oxidation of APOB protein]]
CTD
PMID:17237316 PMID:17475462
NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:30,844,368...30,892,497
G
Apoe
apolipoprotein E
multiple interactions
ISO
Vitamin E inhibits the reaction [APOE mutant form results in increased abundance of 8,12-iso-isoprostane F2alpha-VI]
CTD
PMID:16303615
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:79,353,916...79,357,932
G
Apom
apolipoprotein M
increases expression
ISO
Vitamin E results in increased expression of APOM mRNA
CTD
PMID:19244175
NCBI chr20:3,695,618...3,698,218
Ensembl chr20:3,688,413...3,693,550
G
App
amyloid beta precursor protein
decreases expression multiple interactions
ISO EXP
Vitamin E results in decreased expression of APP mRNA Vitamin E inhibits the reaction [APP protein modified form promotes the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of NOS2 protein]]; Vitamin E inhibits the reaction [APP protein results in increased activity of CASP3] Vitamin E inhibits the reaction [Aluminum results in increased cleavage of APP protein]
CTD
PMID:12039845 PMID:12117551 PMID:15223066 PMID:19244175
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561
G
Appbp2
amyloid beta precursor protein binding protein 2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of APPBP2 mRNA Vitamin E results in increased expression of APPBP2 mRNA
CTD
PMID:19244175
NCBI chr10:70,555,212...70,597,267
Ensembl chr10:70,057,774...70,099,835
G
Aqp1
aquaporin 1
increases expression
ISO
Vitamin E results in increased expression of AQP1 mRNA
CTD
PMID:19244175
NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:84,482,512...84,494,690
G
Aqp3
aquaporin 3 (Gill blood group)
increases expression multiple interactions
ISO
Vitamin E results in increased expression of AQP3 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of AQP3 mRNA
CTD
PMID:19244175
NCBI chr 5:61,035,165...61,040,683
Ensembl chr 5:56,239,201...56,244,720
G
Aqp4
aquaporin 4
multiple interactions
EXP ISO
Vitamin E inhibits the reaction [manganese(III) acetate dihydrate results in increased expression of AQP4 protein] Vitamin E inhibits the reaction [[ferrous chloride results in increased abundance of Iron] which results in increased expression of AQP4 protein]
CTD
PMID:20648640 PMID:30914277
NCBI chr18:6,782,389...6,799,034
Ensembl chr18:6,507,903...6,524,856
G
Araf
A-Raf proto-oncogene, serine/threonine kinase
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ARAF mRNA
CTD
PMID:19244175
NCBI chr X:1,227,392...1,292,356
Ensembl chr X:1,227,392...1,239,073
G
Arf3
ARF GTPase 3
increases expression
ISO
Vitamin E results in increased expression of ARF3 mRNA
CTD
PMID:19244175
NCBI chr 7:131,765,039...131,792,075
Ensembl chr 7:129,886,082...129,912,002
G
Arf5
ARF GTPase 5
increases expression
ISO
Vitamin E results in increased expression of ARF5 mRNA
CTD
PMID:19244175
NCBI chr 4:58,003,919...58,006,898
Ensembl chr 4:57,038,521...57,041,441
G
Arhgap10
Rho GTPase activating protein 10
increases expression
ISO
Vitamin E results in increased expression of ARHGAP10 mRNA
CTD
PMID:19244175
NCBI chr19:30,448,572...30,710,315
Ensembl chr19:30,448,637...30,710,313
G
Arhgap8
Rho GTPase activating protein 8
increases expression
ISO
Vitamin E results in increased expression of ARHGAP8 mRNA
CTD
PMID:19244175
NCBI chr 7:115,842,223...115,902,094
Ensembl chr 7:115,850,654...115,902,093
G
Arhgdia
Rho GDP dissociation inhibitor alpha
increases expression
ISO
Vitamin E results in increased expression of ARHGDIA mRNA
CTD
PMID:19244175
NCBI chr10:106,352,858...106,356,347
Ensembl chr10:105,854,533...105,858,023
G
Arih1
ariadne RBR E3 ubiquitin protein ligase 1
decreases expression
ISO
Vitamin E results in decreased expression of ARIH1 mRNA
CTD
PMID:19244175
NCBI chr 8:68,673,199...68,775,648
Ensembl chr 8:59,777,379...59,880,245
G
Arl4d
ARF like GTPase 4D
increases expression
ISO
Vitamin E results in increased expression of ARL4D mRNA
CTD
PMID:19244175
NCBI chr10:87,092,276...87,103,079
Ensembl chr10:86,595,661...86,602,836
G
Arl6ip4
ARF like GTPase 6 interacting protein 4
increases expression
ISO
Vitamin E results in increased expression of ARL6IP4 mRNA
CTD
PMID:19244175
NCBI chr12:38,140,566...38,142,711
Ensembl chr12:32,479,625...32,481,799
G
Arpc1a
actin related protein 2/3 complex, subunit 1A
increases expression
ISO
Vitamin E results in increased expression of ARPC1A mRNA
CTD
PMID:19244175
NCBI chr12:9,502,496...9,525,304
Ensembl chr12:9,502,501...9,525,330
G
Arpc4
actin related protein 2/3 complex, subunit 4
increases expression
ISO
Vitamin E results in increased expression of ARPC4 mRNA
CTD
PMID:19244175
NCBI chr 4:148,077,799...148,088,427
Ensembl chr 4:146,522,176...146,532,785
G
Asap3
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3
increases expression
ISO
Vitamin E results in increased expression of ASAP3 mRNA
CTD
PMID:19244175
NCBI chr 5:148,433,382...148,476,027
Ensembl chr 5:148,433,494...148,474,073
G
Asb1
ankyrin repeat and SOCS box-containing 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ASB1 mRNA Vitamin E results in increased expression of ASB1 mRNA
CTD
PMID:19244175
NCBI chr 9:99,566,852...99,588,321
Ensembl chr 9:92,120,306...92,136,376
G
Asxl1
ASXL transcriptional regulator 1
decreases expression
ISO
Vitamin E results in decreased expression of ASXL1 mRNA
CTD
PMID:19244175
NCBI chr 3:162,273,828...162,341,742
Ensembl chr 3:141,813,433...141,881,538
G
Atf2
activating transcription factor 2
increases phosphorylation
ISO
Vitamin E results in increased phosphorylation of ATF2 protein
CTD
PMID:11522656
NCBI chr 3:79,125,814...79,202,896
Ensembl chr 3:58,718,332...58,795,236
G
Atf3
activating transcription factor 3
decreases expression
ISO
Vitamin E results in decreased expression of ATF3 mRNA
CTD
PMID:19244175
NCBI chr13:105,274,103...105,331,653
Ensembl chr13:102,751,321...102,764,631
G
Atf5
activating transcription factor 5
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ATF5 mRNA Vitamin E results in increased expression of ATF5 mRNA
CTD
PMID:19244175
NCBI chr 1:104,432,094...104,437,611
Ensembl chr 1:95,295,610...95,299,707
G
Atg12
autophagy related 12
decreases expression
ISO
Vitamin E results in decreased expression of ATG12 mRNA
CTD
PMID:19244175
NCBI chr18:41,638,841...41,649,311
Ensembl chr18:39,452,191...39,462,418
G
Atg5
autophagy related 5
multiple interactions
EXP
Vitamin E inhibits the reaction [Doxorubicin results in increased expression of ATG5 mRNA]
CTD
PMID:38997059
NCBI chr20:49,380,835...49,471,826
Ensembl chr20:47,798,290...47,889,209
G
Atmin
ATM interactor
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ATMIN mRNA Vitamin E results in decreased expression of ATMIN mRNA
CTD
PMID:19244175
NCBI chr19:44,996,506...45,013,606
Ensembl chr19:44,996,356...45,013,605
G
Atox1
antioxidant 1 copper chaperone
increases expression
ISO
Vitamin E results in increased expression of ATOX1 mRNA
CTD
PMID:19244175
NCBI chr10:39,564,855...39,579,892
Ensembl chr10:39,564,857...39,579,950
G
Atp5f1b
ATP synthase F1 subunit beta
increases expression
ISO
Vitamin E results in increased expression of ATP5F1B mRNA
CTD
PMID:19244175
NCBI chr 7:1,100,058...1,106,461
Ensembl chr 7:515,460...567,273
G
Atp5f1c
ATP synthase F1 subunit gamma
decreases expression
ISO
Vitamin E results in decreased expression of ATP5F1C mRNA
CTD
PMID:19244175
NCBI chr17:73,333,584...73,355,872
Ensembl chr17:68,423,909...68,608,367
G
Atp5me
ATP synthase membrane subunit e
decreases expression
ISO
Vitamin E results in decreased expression of ATP5ME mRNA
CTD
PMID:19244175
NCBI chr14:1,319,868...1,320,996
Ensembl chr14:1,319,868...1,321,013
G
Atp6ap2
ATPase H+ transporting accessory protein 2
decreases expression
ISO
Vitamin E results in decreased expression of ATP6AP2 mRNA
CTD
PMID:19244175
NCBI chr X:12,856,708...12,883,670
Ensembl chr X:10,183,068...10,210,918
G
Atp6v0d1
ATPase H+ transporting V0 subunit D1
increases expression
ISO
Vitamin E results in increased expression of ATP6V0D1 mRNA
CTD
PMID:19244175
NCBI chr19:50,313,268...50,357,248
Ensembl chr19:33,403,355...33,447,450
G
Atp6v1c1
ATPase H+ transporting V1 subunit C1
decreases expression
ISO
Vitamin E results in decreased expression of ATP6V1C1 mRNA
CTD
PMID:19244175
NCBI chr 7:69,834,464...69,872,278
Ensembl chr 7:69,834,463...69,872,278
G
Atp8b1
ATPase phospholipid transporting 8B1
decreases expression
ISO
Vitamin E results in decreased expression of ATP8B1 mRNA
CTD
PMID:19244175
NCBI chr18:60,286,605...60,427,862
Ensembl chr18:58,018,268...58,157,396
G
Atrx
ATRX, chromatin remodeler
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of ATRX mRNA [Selenium co-treated with Vitamin E] results in decreased expression of ATRX mRNA
CTD
PMID:19244175
NCBI chr X:74,916,548...75,062,880
Ensembl chr X:70,850,981...70,997,330
G
Atxn3
ataxin 3
decreases expression
ISO
Vitamin E results in decreased expression of ATXN3 mRNA
CTD
PMID:19244175
NCBI chr 6:126,837,107...126,872,919
Ensembl chr 6:121,074,448...121,107,902
G
Atxn7
ataxin 7
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of ATXN7 mRNA Vitamin E results in decreased expression of ATXN7 mRNA
CTD
PMID:19244175
NCBI chr15:11,117,360...11,262,818
Ensembl chr15:11,118,886...11,263,106
G
Auts2
activator of transcription and developmental regulator AUTS2
decreases expression
ISO
Vitamin E results in decreased expression of AUTS2 mRNA
CTD
PMID:19244175
NCBI chr12:24,104,187...25,194,123
Ensembl chr12:24,104,192...25,194,416
G
Axl
Axl receptor tyrosine kinase
decreases expression
ISO
Vitamin E results in decreased expression of AXL mRNA
CTD
PMID:19244175
NCBI chr 1:90,392,864...90,424,123
Ensembl chr 1:81,265,088...81,296,265
G
Baat
bile acid CoA:amino acid N-acyltransferase
increases expression
EXP
Vitamin E results in increased expression of BAAT mRNA
CTD
PMID:28923436
NCBI chr 5:68,647,166...68,656,137
Ensembl chr 5:63,850,705...63,860,685
G
Babam1
BRISC and BRCA1 A complex member 1
increases expression
ISO
Vitamin E results in increased expression of BABAM1 mRNA
CTD
PMID:19244175
NCBI chr16:18,102,885...18,108,916
Ensembl chr16:18,068,884...18,074,923
G
Babam2
BRISC and BRCA1 A complex member 2
increases expression
ISO
Vitamin E results in increased expression of BABAM2 mRNA
CTD
PMID:19244175
NCBI chr 6:30,089,065...30,467,508
Ensembl chr 6:24,369,022...24,833,951
G
Bag5
BAG cochaperone 5
decreases expression
ISO
Vitamin E results in decreased expression of BAG5 mRNA
CTD
PMID:19244175
NCBI chr 6:130,768,467...130,772,122
Ensembl chr 6:130,768,141...130,772,970
G
Bag6
BAG cochaperone 6
increases expression
ISO
Vitamin E results in increased expression of BAG6 mRNA
CTD
PMID:19244175
NCBI chr20:3,680,607...3,693,329
Ensembl chr20:3,675,938...3,688,657
G
Banf1
barrier to autointegration nuclear assembly factor 1
increases expression
ISO
Vitamin E results in increased expression of BANF1 mRNA
CTD
PMID:19244175
NCBI chr 1:212,101,523...212,103,568
Ensembl chr 1:202,671,305...202,674,188
G
Bap1
BRCA1 associated deubiquitinase 1
increases expression
ISO
Vitamin E results in increased expression of BAP1 mRNA
CTD
PMID:19244175
NCBI chr16:6,453,126...6,461,952
Ensembl chr16:6,446,709...6,455,535
G
Bard1
BRCA1 associated RING domain 1
decreases expression
ISO
Vitamin E results in decreased expression of BARD1 mRNA
CTD
PMID:19244175
NCBI chr 9:80,069,960...80,144,167
Ensembl chr 9:72,623,155...72,694,265
G
Batf
basic leucine zipper ATF-like transcription factor
increases expression
ISO
Vitamin E results in increased expression of BATF mRNA
CTD
PMID:19244175
NCBI chr 6:111,084,717...111,107,052
Ensembl chr 6:105,353,715...105,376,051
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions affects expression increases expression
ISO EXP
Vitamin E inhibits the reaction [bioallethrin results in increased expression of BAX protein]; Vitamin E inhibits the reaction [cinnamaldehyde results in increased expression of BAX protein]; Vitamin E inhibits the reaction [Curcumin results in decreased expression of BAX protein]; Vitamin E inhibits the reaction [phenethyl isothiocyanate results in increased expression of BAX protein] [Vitamin E co-treated with Folic Acid] affects the expression of BAX protein; Vitamin E inhibits the reaction [Diazinon results in increased expression of BAX mRNA]; Vitamin E inhibits the reaction [Diazinon results in increased expression of BAX protein]; Vitamin E inhibits the reaction [Nanotubes, Carbon results in increased expression of BAX protein] Vitamin E affects the expression of BAX protein Vitamin E results in increased expression of BAX protein
CTD
PMID:11166918 PMID:15566391 PMID:16054126 PMID:16933212 PMID:22020378 PMID:23523949 PMID:27353299 PMID:30935902 PMID:35511042 More...
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Baz1a
bromodomain adjacent to zinc finger domain, 1A
decreases expression
ISO
Vitamin E results in decreased expression of BAZ1A mRNA
CTD
PMID:19244175
NCBI chr 6:78,124,872...78,247,672
Ensembl chr 6:72,389,703...72,512,459
G
Baz1b
bromodomain adjacent to zinc finger domain, 1B
increases expression
ISO
Vitamin E results in increased expression of BAZ1B mRNA
CTD
PMID:19244175
NCBI chr12:27,068,541...27,126,511
Ensembl chr12:21,431,985...21,490,426
G
Bbx
BBX high mobility group box domain containing
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of BBX mRNA Vitamin E results in decreased expression of BBX mRNA
CTD
PMID:19244175
NCBI chr11:50,381,249...50,628,934
Ensembl chr11:50,381,247...50,623,251
G
Bcap31
B-cell receptor-associated protein 31
increases expression
ISO
Vitamin E results in increased expression of BCAP31 mRNA
CTD
PMID:19244175
NCBI chr X:156,548,911...156,581,002
Ensembl chr X:151,397,576...151,428,506
G
Bche
butyrylcholinesterase
multiple interactions
ISO
[Resveratrol co-treated with Ascorbic Acid co-treated with Thioctic Acid co-treated with Vitamin E] results in increased activity of BCHE protein; Hexachlorocyclohexane inhibits the reaction [[Resveratrol co-treated with Ascorbic Acid co-treated with Thioctic Acid co-treated with Vitamin E] results in increased activity of BCHE protein]
CTD
PMID:20663516
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:158,307,584...158,401,148
G
Bcl11a
BCL11 transcription factor A
decreases expression
ISO
Vitamin E results in decreased expression of BCL11A mRNA
CTD
PMID:19244175
NCBI chr14:102,230,147...102,325,289
Ensembl chr14:98,030,461...98,124,180
G
Bcl2
BCL2, apoptosis regulator
multiple interactions increases expression
ISO EXP
[Vitamin E co-treated with Curcumin] results in decreased expression of BCL2 protein; Vitamin E inhibits the reaction [cinnamaldehyde results in decreased expression of BCL2 protein] Vitamin E results in increased expression of BCL2 mRNA [Vitamin E co-treated with Folic Acid] affects the expression of BCL2 protein; Vitamin E inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA]; Vitamin E inhibits the reaction [Nanotubes, Carbon results in decreased expression of BCL2 protein]
CTD
PMID:15566391 PMID:16933212 PMID:22020378 PMID:27353299 PMID:30935902 PMID:32810592 PMID:38997059 More...
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
multiple interactions increases expression
EXP ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of BCL2L1 mRNA Vitamin E results in increased expression of BCL2L1 mRNA
CTD
PMID:11444866 PMID:19244175
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Bcl6
BCL6, transcription repressor
decreases expression
ISO
Vitamin E results in decreased expression of BCL6 mRNA
CTD
PMID:19244175
NCBI chr11:90,358,753...90,382,049
Ensembl chr11:76,854,090...76,877,389
G
Bclaf1
BCL2-associated transcription factor 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of BCLAF1 mRNA Vitamin E results in decreased expression of BCLAF1 mRNA
CTD
PMID:19244175
NCBI chr 1:16,904,572...16,937,106
Ensembl chr 1:15,070,894...15,148,832
G
Bco1
beta-carotene oxygenase 1
multiple interactions
EXP
Vitamin E inhibits the reaction [Oxidants inhibits the reaction [BCO1 protein results in increased oxidation of beta Carotene]]
CTD
PMID:9526112
NCBI chr19:62,058,061...62,094,923
Ensembl chr19:45,149,265...45,186,101
G
Becn1
beclin 1
multiple interactions decreases expression
EXP
Vitamin E inhibits the reaction [Pilocarpine results in increased expression of BECN1 mRNA]; Vitamin E inhibits the reaction [Pilocarpine results in increased expression of BECN1 protein] Vitamin E results in decreased expression of BECN1 protein
CTD
PMID:19138675
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742
G
Bglap
bone gamma-carboxyglutamate protein
multiple interactions
EXP
Vitamin E inhibits the reaction [Doxorubicin results in increased expression of BGLAP protein]
CTD
PMID:32810592
NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:173,838,518...173,839,495
G
Bicd1
BICD cargo adaptor 1
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of BICD1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of BICD1 mRNA
CTD
PMID:19244175
NCBI chr 4:184,208,891...184,362,840
Ensembl chr 4:182,479,071...182,627,434
G
Bicd2
BICD cargo adaptor 2
decreases expression
ISO
Vitamin E results in decreased expression of BICD2 mRNA
CTD
PMID:19244175
NCBI chr17:15,449,011...15,511,423
Ensembl chr17:15,259,773...15,304,889
G
Bin1
bridging integrator 1
increases expression
ISO
Vitamin E results in increased expression of BIN1 mRNA
CTD
PMID:19244175
NCBI chr18:24,009,731...24,067,267
Ensembl chr18:24,009,653...24,067,263
G
Birc2
baculoviral IAP repeat-containing 2
multiple interactions
EXP ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of BIRC2 mRNA Vitamin E inhibits the reaction [cinnamaldehyde results in decreased expression of BIRC2 protein]
CTD
PMID:11444866 PMID:15566391
NCBI chr 8:13,253,697...13,273,672
Ensembl chr 8:4,968,842...4,988,732
G
Birc3
baculoviral IAP repeat-containing 3
multiple interactions
ISO
Vitamin E inhibits the reaction [cinnamaldehyde results in decreased expression of BIRC3 protein]
CTD
PMID:15566391
NCBI chr 8:13,285,702...13,313,329
Ensembl chr 8:5,000,845...5,015,802
G
Birc5
baculoviral IAP repeat-containing 5
multiple interactions
ISO
Vitamin E inhibits the reaction [Benzo(a)pyrene results in decreased expression of BIRC5 protein]
CTD
PMID:24664296
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,073,408...103,081,380
G
Bles03
basophilic leukemia expressed protein BLES03
increases expression
ISO
Vitamin E results in increased expression of C11ORF68 mRNA
CTD
PMID:19244175
NCBI chr 1:212,163,892...212,166,146
Ensembl chr 1:202,734,555...202,736,804
G
Bltp2
bridge-like lipid transfer protein family member 2
increases expression
ISO
Vitamin E results in increased expression of BLTP2 mRNA
CTD
PMID:19244175
NCBI chr10:63,155,999...63,185,213
Ensembl chr10:63,156,044...63,191,141
G
Bltp3b
bridge-like lipid transfer protein family member 3B
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of BLTP3B mRNA Vitamin E results in decreased expression of BLTP3B mRNA
CTD
PMID:19244175
NCBI chr 7:26,068,948...26,149,033
Ensembl chr 7:24,181,644...24,261,720
G
Blvra
biliverdin reductase A
increases expression
ISO
Vitamin E results in increased expression of BLVRA mRNA
CTD
PMID:19244175
NCBI chr 3:114,340,778...114,366,048
Ensembl chr 3:114,340,838...114,366,033
G
Bmp2k
BMP-2 inducible kinase
decreases expression
ISO
Vitamin E results in decreased expression of BMP2K mRNA
CTD
PMID:19244175
NCBI chr14:12,481,194...12,579,411
Ensembl chr14:12,484,729...12,579,134
G
Bmp4
bone morphogenetic protein 4
increases expression
ISO
Vitamin E results in increased expression of BMP4 mRNA
CTD
PMID:19244175
NCBI chr15:22,098,191...22,113,145
Ensembl chr15:19,618,542...19,623,306
G
Bptf
bromodomain PHD finger transcription factor
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of BPTF mRNA Vitamin E results in decreased expression of BPTF mRNA
CTD
PMID:19244175
NCBI chr10:92,480,007...92,582,485
Ensembl chr10:91,982,758...92,082,769
G
Brd2
bromodomain containing 2
multiple interactions decreases expression increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of BRD2 mRNA Vitamin E results in decreased expression of BRD2 mRNA Vitamin E results in increased expression of BRD2 mRNA
CTD
PMID:19244175
NCBI chr20:4,728,282...4,737,286
Ensembl chr20:4,728,151...4,735,388
G
Brf2
BRF2 general transcription factor 3B subunit
increases expression
ISO
Vitamin E results in increased expression of BRF2 mRNA
CTD
PMID:19244175
NCBI chr16:64,928,334...64,933,057
Ensembl chr16:64,928,300...64,933,059
G
Brms1
BRMS1, transcriptional repressor and anoikis regulator
increases expression
ISO
Vitamin E results in increased expression of BRMS1 mRNA
CTD
PMID:19244175
NCBI chr 1:211,775,142...211,784,411
Ensembl chr 1:202,345,704...202,355,028
G
Bscl2
BSCL2 lipid droplet biogenesis associated, seipin
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of BSCL2 mRNA Vitamin E results in increased expression of BSCL2 mRNA
CTD
PMID:19244175
NCBI chr 1:215,160,764...215,172,540
Ensembl chr 1:205,733,872...205,743,421
G
Bst2
bone marrow stromal cell antigen 2
increases expression
ISO
Vitamin E results in increased expression of BST2 mRNA
CTD
PMID:19244175
NCBI chr16:18,216,605...18,220,979
Ensembl chr16:18,217,407...18,220,979
G
C1s
complement C1s
increases expression
ISO
Vitamin E results in increased expression of C1S mRNA
CTD
PMID:19244175
NCBI chr 4:159,116,549...159,128,736
Ensembl chr 4:157,430,117...157,442,303
G
C4h2orf42
similar to human chromosome 2 open reading frame 42
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of C2ORF42 mRNA Vitamin E results in decreased expression of C2ORF42 mRNA
CTD
PMID:19244175
NCBI chr 4:118,887,688...118,916,808
Ensembl chr 4:118,888,112...118,916,936
G
C5h1orf216
similar to human chromosome 1 open reading frame 216
increases expression
ISO
Vitamin E results in increased expression of C1ORF216 mRNA
CTD
PMID:19244175
NCBI chr 5:138,900,045...138,905,267
Ensembl chr 5:138,900,581...138,905,273
G
C5h1orf50
similar to human chromosome 1 open reading frame 50
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of C1ORF50 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of C1ORF50 mRNA
CTD
PMID:19244175
NCBI chr 5:132,837,135...132,841,744
Ensembl chr 5:132,836,506...132,841,762
G
C7h8orf33
similar to human chromosome 8 open reading frame 33
increases expression
ISO
Vitamin E results in increased expression of C8ORF33 mRNA
CTD
PMID:19244175
NCBI chr 7:108,682,122...108,684,372
Ensembl chr 7:108,682,176...108,684,358
G
Caap1
caspase activity and apoptosis inhibitor 1
decreases expression
ISO
Vitamin E results in decreased expression of CAAP1 mRNA
CTD
PMID:19244175
NCBI chr 5:109,313,253...109,414,323
Ensembl chr 5:109,361,912...109,414,314
G
Cab39
calcium binding protein 39
increases expression
ISO
Vitamin E results in increased expression of MO25 mRNA
CTD
PMID:19244175
NCBI chr 9:93,911,099...93,972,542
Ensembl chr 9:86,463,095...86,524,544
G
Cald1
caldesmon 1
decreases expression
ISO
Vitamin E results in decreased expression of CALD1 mRNA
CTD
PMID:19244175
NCBI chr 4:64,232,906...64,414,085
Ensembl chr 4:63,265,942...63,446,932
G
Calm3
calmodulin 3
increases expression
ISO
Vitamin E results in increased expression of CALM3 mRNA
CTD
PMID:19244175
NCBI chr 1:86,718,761...86,725,869
Ensembl chr 1:77,589,230...77,592,207
G
Calr
calreticulin
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CALR mRNA Vitamin E results in decreased expression of CALR mRNA
CTD
PMID:19244175
NCBI chr19:40,213,367...40,218,262
Ensembl chr19:23,308,351...23,313,414
G
Calu
calumenin
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CALU mRNA Vitamin E results in increased expression of CALU mRNA
CTD
PMID:19244175
NCBI chr 4:58,914,456...58,941,957
Ensembl chr 4:57,948,997...57,976,593
G
Camk2b
calcium/calmodulin-dependent protein kinase II beta
increases expression
ISO
Vitamin E results in increased expression of CAMK2B mRNA
CTD
PMID:19244175
NCBI chr14:85,059,166...85,148,121
Ensembl chr14:80,845,238...80,933,994
G
Camk2g
calcium/calmodulin-dependent protein kinase II gamma
decreases expression
ISO
Vitamin E results in decreased expression of CAMK2G mRNA
CTD
PMID:19244175
NCBI chr15:3,553,238...3,612,310
Ensembl chr15:3,504,085...3,563,050
G
Cap1
cyclase associated actin cytoskeleton regulatory protein 1
increases expression
ISO
Vitamin E results in increased expression of CAP1 mRNA
CTD
PMID:19244175
NCBI chr 5:140,427,265...140,507,678
Ensembl chr 5:135,142,112...135,168,769
G
Capg
capping actin protein, gelsolin like
increases expression
ISO
Vitamin E results in increased expression of CAPG mRNA
CTD
PMID:19244175
NCBI chr 4:106,152,912...106,170,010
Ensembl chr 4:104,594,753...104,611,856
G
Capn7
calpain 7
decreases expression
ISO
Vitamin E results in decreased expression of CAPN7 mRNA
CTD
PMID:19244175
NCBI chr16:6,545,630...6,581,908
Ensembl chr16:6,545,731...6,581,905
G
Capns1
calpain, small subunit 1
increases expression
ISO
Vitamin E results in increased expression of CAPNS1 mRNA
CTD
PMID:19244175
NCBI chr 1:94,572,083...94,582,332
Ensembl chr 1:85,444,608...85,454,795
G
Caprin2
caprin family member 2
decreases expression
ISO
Vitamin E results in decreased expression of CAPRIN2 mRNA
CTD
PMID:19244175
NCBI chr 4:183,537,935...183,592,162
Ensembl chr 4:181,806,575...181,860,830
G
Capzb
capping actin protein of muscle Z-line subunit beta
increases expression
ISO
Vitamin E results in increased expression of CAPZB mRNA
CTD
PMID:19244175
NCBI chr 5:156,718,619...156,818,623
Ensembl chr 5:151,434,871...151,535,409
G
Car3
carbonic anhydrase 3
multiple interactions
EXP
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of CA3 mRNA
CTD
PMID:11444866
NCBI chr 2:88,491,666...88,501,299
Ensembl chr 2:86,770,420...86,784,280
G
Casc3
CASC3 exon junction complex subunit
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of MLN51 mRNA Vitamin E results in increased expression of MLN51 mRNA
CTD
PMID:19244175
NCBI chr10:83,769,014...83,788,966
Ensembl chr10:83,769,001...83,788,966
G
Casp3
caspase 3
multiple interactions increases expression
ISO EXP
Vitamin E inhibits the reaction [bioallethrin results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [cinnamaldehyde results in increased activity of CASP3 protein]; Vitamin E inhibits the reaction [Curcumin results in decreased expression of CASP3 protein]; Vitamin E inhibits the reaction [osimertinib results in increased expression of CASP3 protein modified form]; Vitamin E inhibits the reaction [phenethyl isothiocyanate results in increased activity of CASP3 protein] Vitamin E results in increased expression of CASP3 mRNA Vitamin E inhibits the reaction [titanium dioxide results in increased activity of CASP3 protein] [Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Dichlorvos results in increased activity of CASP3 protein]; [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of CASP3 mRNA]; Vitamin E inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [Acrylamide results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [APP protein results in increased activity of CASP3]; Vitamin E inhibits the reaction [Diazinon results in increased activity of CASP3 protein]; Vitamin E inhibits the reaction [Diazinon results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [Diazinon results in increased expression of CASP3 protein modified form]; Vitamin E inhibits the reaction [Doxorubicin results in decreased expression of CASP3 mRNA]; Vitamin E inhibits the reaction [Doxorubicin results in increased expression of CASP3 protein]; Vitamin E inhibits the reaction [Nanotubes, Carbon results in increased activity of CASP3 protein]; Vitamin E inhibits the reaction [Tramadol results in increased expression of CASP3 protein]
CTD
PMID:12117551 PMID:15566391 PMID:16054126 PMID:16973328 PMID:21628957 PMID:21873648 PMID:22020378 PMID:23523949 PMID:27353299 PMID:28237877 PMID:30626778 PMID:30935902 PMID:31618080 PMID:32810592 PMID:35511042 PMID:38043637 PMID:38997059 More...
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
increases expression multiple interactions
ISO EXP
Vitamin E results in increased expression of CASP9 mRNA Vitamin E inhibits the reaction [bioallethrin results in increased cleavage of CASP9 protein] [Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Dichlorvos results in increased activity of CASP9 protein]; [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of CASP9 mRNA]; Vitamin E inhibits the reaction [Diazinon results in increased cleavage of CASP9 protein]
CTD
PMID:16973328 PMID:19244175 PMID:21628957 PMID:27353299 PMID:35511042
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
multiple interactions increases expression decreases activity affects expression
ISO EXP
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Air Pollutants, Occupational affects the expression of CAT protein]; [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Malathion results in increased activity of CAT protein]; [Ascorbic Acid co-treated with Vitamin E] results in increased expression of CAT mRNA; Vitamin E inhibits the reaction [Aluminum results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Dimethoate results in increased activity of CAT protein]; Vitamin E inhibits the reaction [Malathion results in increased activity of CAT protein]; Vitamin E inhibits the reaction [Oleic Acid results in decreased activity of CAT protein] Vitamin E results in increased expression of CAT protein [Curcumin co-treated with Vitamin E] inhibits the reaction [Thyroxine results in decreased expression of CAT mRNA]; [Selenium co-treated with Vitamin E] inhibits the reaction [Malathion results in decreased activity of CAT protein]; [Vitamin E co-treated with coenzyme Q10] inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein]; [Vitamin E co-treated with coenzyme Q10] results in increased activity of CAT protein; [Vitamin E co-treated with Curcumin] inhibits the reaction [Thyroxine results in decreased activity of CAT protein]; [Vitamin E co-treated with Quercetin] inhibits the reaction [Cyclosporine results in decreased activity of CAT protein]; [Vitamin E co-treated with Sodium Selenite] inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]; [Vitamin E inhibits the reaction [Nanotubes, Carbon results in decreased activity of CAT protein]] which affects the abundance of Reactive Oxygen Species; [Zinc co-treated with Vitamin E co-treated with Ascorbic Acid co-treated with sodium arsenite] results in increased activity of CAT protein; Ginkgo biloba extract promotes the reaction [Vitamin E inhibits the reaction [endotoxin, Escherichia coli results in decreased activity of CAT protein]]; Vitamin E inhibits the reaction [Atrazine results in increased activity of CAT protein]; Vitamin E inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Cadmium results in increased activity of CAT protein]; Vitamin E inhibits the reaction [Carbofuran results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [chromium hexavalent ion results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Cyclosporine results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Dimethoate results in increased activity of CAT protein]; Vitamin E inhibits the reaction [endotoxin, Escherichia coli results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Food Additives affects the activity of CAT protein]; Vitamin E inhibits the reaction [Formaldehyde results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Hexachlorobenzene results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Malathion results in increased activity of CAT protein]; Vitamin E inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Methoxychlor results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Nanotubes, Carbon results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Petroleum results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Potassium Dichromate results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Tetrachlorodibenzodioxin results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Thyroxine results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Thyroxine results in decreased expression of CAT protein]; Vitamin E promotes the reaction [Ginkgo biloba extract inhibits the reaction [endotoxin, Escherichia coli results in decreased activity of CAT protein]] Vitamin E results in decreased activity of CAT protein [Vitamin E co-treated with coenzyme Q10] inhibits the reaction [sodium arsenite results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Ethanol results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [fipronil results in decreased activity of CAT protein] Vitamin E affects the expression of CAT protein
CTD
PMID:11597945 PMID:11834209 PMID:11955947 PMID:12355564 PMID:14535831 PMID:15669049 PMID:15820619 PMID:16144695 PMID:16298753 PMID:16758767 PMID:16937016 PMID:17262218 PMID:17383094 PMID:17709913 PMID:17927767 PMID:18655177 PMID:19914224 PMID:19958828 PMID:20077558 PMID:20079796 PMID:20136348 PMID:20535553 PMID:21086752 PMID:21628957 PMID:21736874 PMID:21787585 PMID:22020378 PMID:22207723 PMID:23348005 PMID:23369933 PMID:23619517 PMID:24865641 PMID:25046308 PMID:25721553 PMID:29948670 PMID:30064338 More...
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Cav1
caveolin 1
multiple interactions
ISO
Vitamin E inhibits the reaction [Hydrogen Peroxide results in increased expression of CAV1 protein] Vitamin E inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased phosphorylation of CAV1 protein]
CTD
PMID:12134086 PMID:35349355
NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:45,634,918...45,673,705
G
Cavin1
caveolae associated protein 1
multiple interactions increases expression
ISO
Vitamin E inhibits the reaction [Hydrogen Peroxide results in increased expression of CAVIN1 protein] Vitamin E results in increased expression of CAVIN1 mRNA
CTD
PMID:19244175 PMID:21705337
NCBI chr10:86,384,401...86,398,240
Ensembl chr10:85,889,036...85,896,120
G
Cavin3
caveolae associated protein 3
increases expression
ISO
Vitamin E results in increased expression of CAVIN3 mRNA
CTD
PMID:19244175
NCBI chr 1:169,238,384...169,239,973
Ensembl chr 1:159,826,549...159,828,161
G
Cblb
Cbl proto-oncogene B
decreases expression
ISO
Vitamin E results in decreased expression of CBLB mRNA
CTD
PMID:19244175
NCBI chr11:62,058,829...62,225,904
Ensembl chr11:48,592,703...48,756,839
G
Cbx5
chromobox 5
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CBX5 mRNA Vitamin E results in decreased expression of CBX5 mRNA
CTD
PMID:19244175
NCBI chr 7:136,203,827...136,254,575
Ensembl chr 7:134,331,335...134,375,022
G
Cbx6
chromobox 6
increases expression
ISO
Vitamin E results in increased expression of CBX6 mRNA
CTD
PMID:19244175
NCBI chr 7:113,253,364...113,263,413
Ensembl chr 7:111,372,980...111,383,091
G
Cbx7
chromobox 7
increases expression
ISO
Vitamin E results in increased expression of CBX7 mRNA
CTD
PMID:19244175
NCBI chr 7:113,341,030...113,358,716
Ensembl chr 7:111,460,656...111,477,973
G
Cby1
chibby 1, beta catenin antagonist
increases expression
ISO
Vitamin E results in increased expression of CBY1 mRNA
CTD
PMID:19244175
NCBI chr 7:113,097,220...113,103,831
G
Ccdc85b
coiled-coil domain containing 85B
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of DIPA mRNA Vitamin E results in increased expression of DIPA mRNA
CTD
PMID:19244175
NCBI chr 1:212,192,979...212,193,994
Ensembl chr 1:202,763,631...202,764,703
G
Cchcr1
coiled-coil alpha-helical rod protein 1
increases expression
ISO
Vitamin E results in increased expression of CCHCR1 mRNA
CTD
PMID:19244175
NCBI chr20:3,210,383...3,223,187
Ensembl chr20:3,205,676...3,218,308
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions increases expression
ISO
alpha-Tocopherol inhibits the reaction [Vitamin E deficiency results in increased expression of CCL2 protein]; Quercetin inhibits the reaction [Vitamin E deficiency results in increased expression of CCL2 protein]
CTD
PMID:19735175
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccl5
C-C motif chemokine ligand 5
multiple interactions
ISO
[Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3,4-dihydroxyphenylethanol] results in decreased expression of CCL5 mRNA
CTD
PMID:16797527
NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,322,829...68,327,377
G
Ccnd1
cyclin D1
increases expression multiple interactions affects expression
ISO EXP
Vitamin E results in increased expression of CCND1 mRNA Vitamin E inhibits the reaction [Curcumin results in decreased expression of CCND1 protein] Vitamin E affects the expression of CCND1 mRNA; Vitamin E affects the expression of CCND1 protein [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of CCND1 mRNA
CTD
PMID:11444866 PMID:16298738 PMID:19244175 PMID:30935902
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
G
Ccnd2
cyclin D2
increases expression
ISO
Vitamin E results in increased expression of CCND2 mRNA
CTD
PMID:19244175
NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:159,962,363...159,989,495
G
Ccnd3
cyclin D3
affects expression
EXP
Vitamin E affects the expression of CCND3 mRNA
CTD
PMID:15370891
NCBI chr 9:20,891,696...20,987,199
Ensembl chr 9:13,394,169...13,489,371
G
Ccne1
cyclin E1
affects expression
EXP
Vitamin E affects the expression of CCNE1 mRNA
CTD
PMID:16298738
NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:90,781,949...90,791,101
G
Ccnl1
cyclin L1
decreases expression
ISO
Vitamin E results in decreased expression of CCNL1 mRNA
CTD
PMID:19244175
NCBI chr 2:150,184,865...150,199,524
Ensembl chr 2:150,184,798...150,197,368
G
Ccpg1
cell cycle progression 1
decreases expression
ISO
Vitamin E results in decreased expression of CPR8 mRNA
CTD
PMID:19244175
NCBI chr 8:82,600,677...82,633,082
Ensembl chr 8:73,719,955...73,752,430
G
Ccs
copper chaperone for superoxide dismutase
increases expression
ISO
Vitamin E results in increased expression of CCS mRNA
CTD
PMID:19244175
NCBI chr 1:211,543,192...211,564,354
Ensembl chr 1:202,113,804...202,134,915
G
Cd2bp2
Cd2 (cytoplasmic tail) binding protein 2
increases expression
ISO
Vitamin E results in increased expression of CD2BP2 mRNA
CTD
PMID:19244175
NCBI chr 1:191,239,899...191,244,395
Ensembl chr 1:181,809,406...181,813,448
G
Cd44
CD44 molecule
decreases expression
ISO
Vitamin E results in decreased expression of CD44 mRNA
CTD
PMID:19244175
NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:89,157,058...89,244,620
G
Cd63
Cd63 molecule
increases expression
ISO
Vitamin E results in increased expression of CD63 mRNA
CTD
PMID:19244175
NCBI chr 7:1,909,538...1,924,937
Ensembl chr 7:1,325,103...1,399,178
G
Cd86
CD86 molecule
multiple interactions
ISO
Vitamin E inhibits the reaction [Dinitrochlorobenzene results in increased expression of CD86 protein]; Vitamin E inhibits the reaction [Ethylmercuric Chloride results in increased expression of CD86 protein]; Vitamin E inhibits the reaction [Thimerosal results in increased expression of CD86 protein]
CTD
PMID:20457211
NCBI chr11:77,647,565...77,706,178
Ensembl chr11:64,163,828...64,200,818
G
Cd99
CD99 molecule (Xg blood group)
increases expression
ISO
Vitamin E results in increased expression of CD99 mRNA
CTD
PMID:19244175
NCBI chr20:54,418,239...54,422,882
G
Cdc14b
cell division cycle 14B
decreases expression
ISO
Vitamin E results in decreased expression of CDC14B mRNA
CTD
PMID:19244175
NCBI chr17:850,272...938,972
Ensembl chr17:844,685...933,235
G
Cdc16
cell division cycle 16
decreases expression
ISO
Vitamin E results in decreased expression of CDC16 mRNA
CTD
PMID:19244175
NCBI chr16:82,475,234...82,498,797
Ensembl chr16:75,773,028...75,796,550
G
Cdc25b
cell division cycle 25B
increases expression
ISO
Vitamin E results in increased expression of CDC25B mRNA
CTD
PMID:19244175
NCBI chr 3:138,860,148...138,870,287
Ensembl chr 3:118,407,128...118,417,272
G
Cdc27
cell division cycle 27
decreases expression
ISO
Vitamin E results in decreased expression of CDC27 mRNA
CTD
PMID:19244175
NCBI chr10:89,400,720...89,449,816
Ensembl chr10:89,400,940...89,449,736
G
Cdc42bpa
CDC42 binding protein kinase alpha
multiple interactions increases expression decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CDC42BPA mRNA Vitamin E results in increased expression of CDC42BPA mRNA Vitamin E results in decreased expression of CDC42BPA mRNA
CTD
PMID:19244175
NCBI chr13:94,215,359...94,435,681
Ensembl chr13:91,684,007...91,903,732
G
Cdh2
cadherin 2
multiple interactions
EXP
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of CDH2 protein]
CTD
PMID:29940330
NCBI chr18:8,051,097...8,265,288
Ensembl chr18:7,776,704...7,990,167
G
Cdh3
cadherin 3
increases expression
ISO
Vitamin E results in increased expression of CDH3 mRNA
CTD
PMID:19244175
NCBI chr19:51,303,414...51,353,900
Ensembl chr19:34,393,727...34,444,084
G
Cdk10
cyclin-dependent kinase 10
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CDK10 mRNA
CTD
PMID:19244175
NCBI chr19:51,260,012...51,273,009
Ensembl chr19:51,261,356...51,269,078
G
Cdk13
cyclin-dependent kinase 13
decreases expression
ISO
Vitamin E results in decreased expression of CDK13 mRNA
CTD
PMID:19244175
NCBI chr17:51,945,975...52,040,218
Ensembl chr17:47,251,163...47,341,721
G
Cdk4
cyclin-dependent kinase 4
increases expression
ISO
Vitamin E results in increased expression of CDK4 mRNA
CTD
PMID:19244175
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:62,883,105...62,942,403
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
affects expression multiple interactions
EXP ISO
Vitamin E affects the expression of CDKN1A mRNA Vitamin E inhibits the reaction [Curcumin results in decreased expression of CDKN1A protein]
CTD
PMID:16298738 PMID:30935902
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
increases expression
ISO
Vitamin E results in increased expression of CDKN1B protein
CTD
PMID:12352461
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:167,760,181...167,764,982
G
Cds1
CDP-diacylglycerol synthase 1
decreases expression
ISO
Vitamin E results in decreased expression of CDS1 mRNA
CTD
PMID:19244175
NCBI chr14:7,820,328...7,882,943
Ensembl chr14:7,820,351...7,882,681
G
Cebpa
CCAAT/enhancer binding protein alpha
multiple interactions
ISO
Vitamin E inhibits the reaction [Ethanol results in decreased activity of CEBPA protein]; Vitamin E inhibits the reaction [Ethanol results in decreased expression of CEBPA protein]
CTD
PMID:16737972
NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:87,759,433...87,762,412
G
Cebpb
CCAAT/enhancer binding protein beta
increases response to substance
ISO
CEBPB results in increased susceptibility to Vitamin E
CTD
PMID:9359698
NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:156,397,052...156,399,473
G
Cep164
centrosomal protein 164
increases expression
ISO
Vitamin E results in increased expression of CEP164 mRNA
CTD
PMID:19244175
NCBI chr 8:46,070,901...46,134,511
Ensembl chr 8:46,071,076...46,134,336
G
Cep170
centrosomal protein 170
decreases expression
ISO
Vitamin E results in decreased expression of CEP170 mRNA
CTD
PMID:19244175
NCBI chr13:88,669,672...88,754,011
Ensembl chr13:88,670,358...88,732,226
G
Cep290
centrosomal protein 290
decreases expression
ISO
Vitamin E results in decreased expression of CEP290 mRNA
CTD
PMID:19244175
NCBI chr 7:37,196,765...37,285,955
Ensembl chr 7:35,310,199...35,399,392
G
Cep350
centrosomal protein 350
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of CEP350 mRNA Vitamin E results in decreased expression of CEP350 mRNA
CTD
PMID:19244175
NCBI chr13:68,023,327...68,164,478
Ensembl chr13:68,026,891...68,165,214
G
Cep57
centrosomal protein 57
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CEP57 mRNA Vitamin E results in decreased expression of CEP57 mRNA
CTD
PMID:19244175
NCBI chr 8:10,669,588...10,689,257
Ensembl chr 8:10,669,590...10,689,249
G
Cep97
centrosomal protein 97
decreases expression
ISO
Vitamin E results in decreased expression of CEP97 mRNA
CTD
PMID:19244175
NCBI chr11:58,152,561...58,187,174
Ensembl chr11:44,683,506...44,711,471
G
Cerk
ceramide kinase
increases expression
ISO
Vitamin E results in increased expression of CERK mRNA
CTD
PMID:19244175
NCBI chr 7:117,225,855...117,269,436
Ensembl chr 7:117,225,855...117,268,759
G
Cert1
ceramide transporter 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of CERT1 mRNA Vitamin E results in decreased expression of CERT1 mRNA
CTD
PMID:19244175
NCBI chr 2:29,617,202...29,721,734
Ensembl chr 2:27,882,555...27,987,074
G
Ces1d
carboxylesterase 1D
increases expression
ISO
Vitamin E results in increased expression of CES1 mRNA
CTD
PMID:19244175
NCBI chr19:30,046,494...30,085,039
Ensembl chr19:13,796,623...13,912,035
G
Cflar
CASP8 and FADD-like apoptosis regulator
increases expression
ISO
Vitamin E results in increased expression of CFLAR mRNA
CTD
PMID:19244175
NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:60,185,452...60,237,034
G
Chd1
chromodomain helicase DNA binding protein 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CHD1 mRNA Vitamin E results in decreased expression of CHD1 mRNA
CTD
PMID:19244175
NCBI chr 1:56,661,743...56,729,119
Ensembl chr 1:56,664,054...56,728,125
G
Chordc1
cysteine and histidine rich domain containing 1
decreases expression
ISO
Vitamin E results in decreased expression of CHORDC1 mRNA
CTD
PMID:19244175
NCBI chr 8:23,650,721...23,674,786
Ensembl chr 8:15,374,471...15,399,162
G
Chpf
chondroitin polymerizing factor
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CHPF mRNA
CTD
PMID:19244175
NCBI chr 9:76,963,178...76,967,878
Ensembl chr 9:76,963,184...76,967,878
G
Chst3
carbohydrate sulfotransferase 3
increases expression
ISO
Vitamin E results in increased expression of CHST3 mRNA
CTD
PMID:19244175
NCBI chr20:28,114,386...28,152,046
Ensembl chr20:28,114,404...28,121,807
G
Chst6
carbohydrate sulfotransferase 6
increases expression
ISO
Vitamin E results in increased expression of CHST6 mRNA
CTD
PMID:19244175
NCBI chr19:56,769,991...56,790,276
Ensembl chr19:39,860,501...39,881,064
G
Ciao2b
cytosolic iron-sulfur assembly component 2B
increases expression
ISO
Vitamin E results in increased expression of CIAO2B mRNA
CTD
PMID:19244175
NCBI chr19:344,194...346,068
Ensembl chr19:344,203...346,068
G
Cib2
calcium and integrin binding family member 2
increases expression
ISO
Vitamin E results in increased expression of CIB2 mRNA
CTD
PMID:19244175
NCBI chr 8:63,826,410...63,843,301
G
Cirbp
cold inducible RNA binding protein
increases expression
ISO
Vitamin E results in increased expression of CIRBP mRNA
CTD
PMID:19244175
NCBI chr 7:9,533,857...9,538,899
Ensembl chr 7:9,424,178...9,538,818
G
Ckap2
cytoskeleton associated protein 2
decreases expression
ISO
Vitamin E results in decreased expression of CKAP2 mRNA
CTD
PMID:19244175
NCBI chr16:76,542,114...76,567,297
Ensembl chr16:69,839,630...69,864,913
G
Ckb
creatine kinase B
increases expression
ISO
Vitamin E results in increased expression of CKB mRNA
CTD
PMID:19244175
NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:130,729,423...130,732,315
G
Ckm
creatine kinase, M-type
multiple interactions
EXP
Vitamin E inhibits the reaction [Diazinon results in increased activity of CKM protein]
CTD
PMID:23523949
NCBI chr 1:88,189,382...88,199,717
Ensembl chr 1:79,061,456...79,071,720
G
Clcc1
chloride channel CLIC-like 1
decreases expression
ISO
Vitamin E results in decreased expression of CLCC1 mRNA
CTD
PMID:19244175
NCBI chr 2:198,984,455...199,015,015
Ensembl chr 2:196,296,393...196,326,913
G
Clcn3
chloride voltage-gated channel 3
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of CLCN3 mRNA Vitamin E results in decreased expression of CLCN3 mRNA
CTD
PMID:19244175
NCBI chr16:34,138,004...34,210,984
Ensembl chr16:29,127,419...29,200,119
G
Cldn4
claudin 4
multiple interactions
EXP
Vitamin E inhibits the reaction [phoxim results in decreased expression of CLDN4 mRNA]
CTD
PMID:30003487
NCBI chr12:27,388,160...27,389,958
Ensembl chr12:21,751,331...21,753,436
G
Clec3b
C-type lectin domain family 3, member B
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of TNA mRNA Vitamin E results in increased expression of TNA mRNA
CTD
PMID:19244175
NCBI chr 8:131,687,575...131,693,292
Ensembl chr 8:122,810,149...122,815,835
G
Clic1
chloride intracellular channel 1
increases expression
ISO
Vitamin E results in increased expression of CLIC1 mRNA
CTD
PMID:19244175
NCBI chr20:3,769,522...3,778,367
Ensembl chr20:3,761,461...3,773,712
G
Clip1
CAP-GLY domain containing linker protein 1
decreases expression
ISO
Vitamin E results in decreased expression of CLIP1 mRNA
CTD
PMID:19244175
NCBI chr12:38,571,533...38,678,779
Ensembl chr12:32,910,977...33,017,884
G
Cln3
CLN3 lysosomal/endosomal transmembrane protein, battenin
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of CLN3 mRNA Vitamin E results in increased expression of CLN3 mRNA
CTD
PMID:19244175
NCBI chr 1:190,586,649...190,600,034
Ensembl chr 1:181,156,073...181,167,434
G
Cltb
clathrin, light chain B
increases expression
ISO
Vitamin E results in increased expression of CLTB mRNA
CTD
PMID:19244175
NCBI chr17:10,006,416...10,024,278
Ensembl chr17:10,001,513...10,019,169
G
Clu
clusterin
multiple interactions increases expression
EXP ISO
Vitamin E inhibits the reaction [Estradiol results in increased expression of CLU protein] Vitamin E results in increased expression of CLU mRNA
CTD
PMID:9037392 PMID:19244175
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:40,174,617...40,200,315
G
Cmtr1
cap methyltransferase 1
increases expression
ISO
Vitamin E results in increased expression of CMTR1 mRNA
CTD
PMID:19244175
NCBI chr20:7,722,729...7,782,579
Ensembl chr20:7,709,713...7,766,302
G
Cngb1
cyclic nucleotide gated channel subunit beta 1
decreases expression
ISO
Vitamin E results in decreased expression of CNGB1 mRNA
CTD
PMID:19244175
NCBI chr19:9,732,646...9,798,864
Ensembl chr19:9,726,595...9,791,173
G
Cnn1
calponin 1
increases expression
ISO
Vitamin E results in increased expression of CNN1 mRNA
CTD
PMID:19244175
NCBI chr 8:20,632,434...20,641,097
Ensembl chr 8:20,632,338...20,641,098
G
Cnpy2
canopy FGF signaling regulator 2
decreases expression
ISO
Vitamin E results in decreased expression of CNPY2 mRNA
CTD
PMID:19244175
NCBI chr 7:748,877...754,352
Ensembl chr 7:749,008...755,519
G
Cnpy3
canopy FGF signaling regulator 3
increases expression
ISO
Vitamin E results in increased expression of CNPY3 mRNA
CTD
PMID:19244175
NCBI chr 9:21,731,088...21,745,448
Ensembl chr 9:14,233,428...14,247,831
G
Cog4
component of oligomeric golgi complex 4
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of COG4 mRNA
CTD
PMID:19244175
NCBI chr19:55,729,854...55,763,902
Ensembl chr19:38,820,501...38,854,796
G
Col18a1
collagen type XVIII alpha 1 chain
increases expression
ISO
Vitamin E results in increased expression of COL18A1 mRNA
CTD
PMID:19244175
NCBI chr20:11,473,645...11,582,111
Ensembl chr20:11,474,104...11,582,593
G
Col1a1
collagen type I alpha 1 chain
multiple interactions
EXP
[silybin co-treated with Phosphatidylcholines co-treated with Vitamin E] inhibits the reaction [Dimethylnitrosamine results in increased expression of COL1A1 mRNA]
CTD
PMID:16169303
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:79,883,622...79,900,624
G
Col1a2
collagen type I alpha 2 chain
multiple interactions
ISO
Vitamin E inhibits the reaction [CYP2E1 protein results in increased expression of COL1A2 mRNA]
CTD
PMID:10498651
NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:32,563,381...32,598,867
G
Col4a1
collagen type IV alpha 1 chain
increases expression
ISO
Vitamin E results in increased expression of COL4A1 mRNA
CTD
PMID:19244175
NCBI chr16:84,885,597...84,996,482
Ensembl chr16:78,183,533...78,294,412
G
Col4a3
collagen type IV alpha 3 chain
decreases expression
ISO
Vitamin E results in decreased expression of COL4A3 mRNA
CTD
PMID:19244175
NCBI chr 9:91,323,990...91,453,088
Ensembl chr 9:83,875,561...84,001,895
G
Col6a2
collagen type VI alpha 2 chain
increases expression
ISO
Vitamin E results in increased expression of COL6A2 mRNA
CTD
PMID:19244175
NCBI chr20:12,021,182...12,048,932
Ensembl chr20:12,021,767...12,057,564
G
Col6a3
collagen type VI alpha 3 chain
increases expression
ISO
Vitamin E results in increased expression of COL6A3 mRNA
CTD
PMID:19244175
NCBI chr 9:98,809,171...98,887,060
Ensembl chr 9:91,361,583...91,439,471
G
Colgalt2
collagen beta(1-O)galactosyltransferase 2
increases expression
ISO
Vitamin E results in increased expression of COLGALT2 mRNA
CTD
PMID:19244175
NCBI chr13:67,073,551...67,178,194
Ensembl chr13:64,523,658...64,627,549
G
Commd3
COMM domain containing 3
decreases expression
ISO
Vitamin E results in decreased expression of COMMD3 mRNA
CTD
PMID:19244175
NCBI chr17:81,327,444...81,331,191
Ensembl chr17:81,327,405...81,331,177
G
Cope
COPI coat complex subunit epsilon
increases expression
ISO
Vitamin E results in increased expression of COPE mRNA
CTD
PMID:19244175
NCBI chr16:19,148,832...19,159,052
Ensembl chr16:19,114,871...19,128,907
G
Cops6
COP9 signalosome subunit 6
increases expression
ISO
Vitamin E results in increased expression of COPS6 mRNA
CTD
PMID:19244175
NCBI chr12:17,038,979...17,041,818
Ensembl chr12:17,038,979...17,046,371
G
Copz2
COPI coat complex subunit zeta 2
increases expression
ISO
Vitamin E results in increased expression of COPZ2 mRNA
CTD
PMID:19244175
NCBI chr10:82,328,888...82,341,959
Ensembl chr10:81,832,418...81,845,514
G
Coq9
coenzyme Q9
increases expression
ISO
Vitamin E results in increased expression of COQ9 mRNA
CTD
PMID:19244175
NCBI chr19:10,172,943...10,185,960
Ensembl chr19:10,166,951...10,179,949
G
Cox6a1
cytochrome c oxidase subunit 6A1
decreases expression
ISO
Vitamin E results in decreased expression of COX6A1 mRNA
CTD
PMID:19244175
NCBI chr12:46,922,709...46,925,762
Ensembl chr12:41,261,967...41,265,041
G
Cpm
carboxypeptidase M
decreases expression
ISO
Vitamin E results in decreased expression of CPM mRNA
CTD
PMID:19244175
NCBI chr 7:55,111,599...55,172,114
Ensembl chr 7:53,225,696...53,286,220
G
Cpne1
copine 1
increases expression
ISO
Vitamin E results in increased expression of CPNE1 mRNA
CTD
PMID:19244175
NCBI chr 3:165,047,615...165,089,994
Ensembl chr 3:144,588,995...144,598,636
G
Cpsf1
cleavage and polyadenylation specific factor 1
increases expression
ISO
Vitamin E results in increased expression of CPSF1 mRNA
CTD
PMID:19244175
NCBI chr 7:108,319,429...108,330,018
Ensembl chr 7:108,319,434...108,329,934
G
Cr1l
complement C3b/C4b receptor 1 like
multiple interactions
ISO
Vitamin E inhibits the reaction [Endosulfan results in decreased expression of CR1L mRNA]
CTD
PMID:23208437
NCBI chr13:106,606,952...106,660,442
Ensembl chr13:106,574,858...106,660,445
G
Cr2
complement C3d receptor 2
multiple interactions
ISO
Vitamin E inhibits the reaction [Endosulfan results in decreased expression of CR2 mRNA]; Vitamin E inhibits the reaction [Endosulfan results in decreased expression of CR2 protein]
CTD
PMID:23208437
NCBI chr13:109,207,034...109,244,980
Ensembl chr13:106,685,413...106,716,235
G
Creb1
cAMP responsive element binding protein 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CREB1 mRNA Vitamin E results in decreased expression of CREB1 mRNA
CTD
PMID:19244175
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Creb3
cAMP responsive element binding protein 3
increases expression
ISO
Vitamin E results in increased expression of CREB3 mRNA
CTD
PMID:19244175
NCBI chr 5:62,613,652...62,619,019
Ensembl chr 5:57,817,832...57,824,390
G
Crebbp
CREB binding protein
decreases expression
ISO
Vitamin E results in decreased expression of CREBBP mRNA
CTD
PMID:19244175
NCBI chr10:11,842,307...11,968,266
Ensembl chr10:11,335,953...11,461,888
G
Crp
C-reactive protein
multiple interactions decreases expression
ISO
[Eicosapentaenoic Acid co-treated with Docosahexaenoic Acids co-treated with Oleic Acid co-treated with Folic Acid co-treated with Vitamin B 6 co-treated with Vitamin E] results in decreased expression of CRP protein; [Vitamin E co-treated with Ascorbic Acid co-treated with Folic Acid co-treated with Riboflavin co-treated with Vitamin B 6 co-treated with Vitamin B 12] results in decreased expression of CRP protein; [Vitamin E co-treated with Ascorbic Acid] results in decreased expression of CRP protein Vitamin E inhibits the reaction [titanium dioxide results in increased expression of CRP protein] Vitamin E results in decreased expression of CRP protein
CTD
PMID:16517955 PMID:17237316 PMID:20370442 PMID:30626778
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:85,124,977...85,175,178
G
Crybg2
crystallin beta-gamma domain containing 2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of CRYBG2 mRNA Vitamin E results in increased expression of CRYBG2 mRNA
CTD
PMID:19244175
NCBI chr 5:146,286,406...146,318,417
Ensembl chr 5:146,286,925...146,323,666
G
Csnk1a1
casein kinase 1, alpha 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CSNK1A1 mRNA Vitamin E results in decreased expression of CSNK1A1 mRNA
CTD
PMID:19244175
NCBI chr18:57,285,156...57,320,540
Ensembl chr18:55,017,055...55,049,271
G
Csnk1d
casein kinase 1, delta
decreases expression
ISO
Vitamin E results in decreased expression of CSNK1D mRNA
CTD
PMID:19244175
NCBI chr10:106,713,497...106,754,953
Ensembl chr10:106,221,992...106,256,614
G
Csnk1e
casein kinase 1, epsilon
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CSNK1E mRNA
CTD
PMID:19244175
NCBI chr 7:112,863,726...112,887,338
Ensembl chr 7:110,983,318...111,006,794
G
Csnk1g2
casein kinase 1, gamma 2
decreases expression
ISO
Vitamin E results in decreased expression of CSNK1G2 mRNA
CTD
PMID:19244175
NCBI chr 7:9,076,739...9,095,082
Ensembl chr 7:9,076,740...9,095,052
G
Csnk1g3
casein kinase 1, gamma 3
decreases expression
ISO
Vitamin E results in decreased expression of CSNK1G3 mRNA
CTD
PMID:19244175
NCBI chr18:47,299,547...47,386,538
Ensembl chr18:47,299,579...47,386,535
G
Csnk2a1
casein kinase 2 alpha 1
decreases expression
ISO
Vitamin E results in decreased expression of CSNK2A1 mRNA
CTD
PMID:19244175
NCBI chr 3:161,170,295...161,217,073
Ensembl chr 3:140,709,991...140,756,696
G
Csnk2b
casein kinase 2 beta
increases expression
ISO
Vitamin E results in increased expression of CSNK2B mRNA
CTD
PMID:19244175
NCBI chr20:3,704,833...3,709,999
Ensembl chr20:3,698,733...3,707,133
G
Cspg4
chondroitin sulfate proteoglycan 4
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of CSPG4 mRNA Vitamin E results in increased expression of CSPG4 mRNA
CTD
PMID:19244175
NCBI chr 8:66,160,942...66,195,987
Ensembl chr 8:57,264,962...57,300,010
G
Cspp1
centrosome and spindle pole associated protein 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of CSPP1 mRNA Vitamin E results in decreased expression of CSPP1 mRNA
CTD
PMID:19244175
NCBI chr 5:13,860,072...13,975,299
Ensembl chr 5:9,077,161...9,193,377
G
Csrp1
cysteine and glycine-rich protein 1
increases expression
ISO
Vitamin E results in increased expression of CSRP1 mRNA
CTD
PMID:19244175
NCBI chr13:47,158,171...47,179,388
Ensembl chr13:47,167,789...47,179,384
G
Cst3
cystatin C
increases expression
ISO
Vitamin E results in increased expression of CST3 mRNA
CTD
PMID:19244175
NCBI chr 3:156,790,061...156,794,116
Ensembl chr 3:136,336,920...136,340,822
G
Ctbp1
C-terminal binding protein 1
decreases expression
ISO
Vitamin E results in decreased expression of CTBP1 mRNA
CTD
PMID:19244175
NCBI chr14:81,679,956...81,707,331
Ensembl chr14:77,455,696...77,482,821
G
Ctbp2
C-terminal binding protein 2
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CTBP2 mRNA Vitamin E results in decreased expression of CTBP2 mRNA
CTD
PMID:19244175
NCBI chr 1:197,208,536...197,348,802
Ensembl chr 1:187,782,682...187,920,222
G
Ctdnep1
CTD nuclear envelope phosphatase 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CTDNEP1 mRNA Vitamin E results in increased expression of CTDNEP1 mRNA
CTD
PMID:19244175
NCBI chr10:55,203,047...55,212,469
Ensembl chr10:54,704,148...54,713,781
G
Ctdspl
CTD small phosphatase like
increases expression
ISO
Vitamin E results in increased expression of CTDSPL mRNA
CTD
PMID:19244175
NCBI chr 8:118,642,729...118,767,238
Ensembl chr 8:118,642,672...118,767,117
G
Ctf1
cardiotrophin 1
decreases expression
ISO
Vitamin E results in decreased expression of CTF1 protein
CTD
PMID:16507596
NCBI chr 1:191,758,512...191,771,259
Ensembl chr 1:182,328,090...182,333,335
G
Ctnnb1
catenin beta 1
multiple interactions
EXP ISO
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of and affects the localization of CTNNB1 protein]; [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of CTNNB1 protein] Vitamin E inhibits the reaction [Curcumin results in decreased expression of CTNNB1 protein]
CTD
PMID:29940330 PMID:30935902
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
G
Ctnnbl1
catenin, beta like 1
increases expression
ISO
Vitamin E results in increased expression of CTNNBL1 mRNA
CTD
PMID:19244175
NCBI chr 3:166,807,899...166,968,932
Ensembl chr 3:146,387,889...146,548,987
G
Cttn
cortactin
decreases expression
ISO
Vitamin E results in decreased expression of CTTN mRNA
CTD
PMID:19244175
NCBI chr 1:209,029,048...209,064,577
Ensembl chr 1:199,599,710...199,635,164
G
Cuedc2
CUE domain containing 2
increases expression
ISO
Vitamin E results in increased expression of CUEDC2 mRNA
CTD
PMID:19244175
NCBI chr 1:245,192,057...245,200,594
Ensembl chr 1:245,192,063...245,200,339
G
Cul3
cullin 3
decreases expression
ISO
Vitamin E results in decreased expression of CUL3 mRNA
CTD
PMID:19244175
NCBI chr 9:89,040,987...89,118,775
Ensembl chr 9:81,592,641...81,670,462
G
Cul4a
cullin 4A
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CUL4A mRNA Vitamin E results in increased expression of CUL4A mRNA
CTD
PMID:19244175
NCBI chr16:83,086,688...83,124,503
Ensembl chr16:76,384,546...76,422,330
G
Cutc
cutC copper transporter
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of CUTC mRNA Vitamin E results in decreased expression of CUTC mRNA
CTD
PMID:19244175
NCBI chr 1:242,622,281...242,637,048
Ensembl chr 1:242,622,276...242,637,047
G
Cux1
cut-like homeobox 1
decreases expression
ISO
Vitamin E results in decreased expression of CUX1 mRNA
CTD
PMID:19244175
NCBI chr12:25,728,393...26,062,497
Ensembl chr12:20,107,311...20,425,866 Ensembl chr 4:20,107,311...20,425,866
G
Cwh43
cell wall biogenesis 43 C-terminal homolog
decreases expression
ISO
Vitamin E results in decreased expression of CWH43 mRNA
CTD
PMID:19244175
NCBI chr14:35,108,328...35,154,578
Ensembl chr14:34,754,289...34,800,814
G
Cxcr1
C-X-C motif chemokine receptor 1
increases expression
ISO
Vitamin E results in increased expression of CXCR1 mRNA
CTD
PMID:19244175
NCBI chr 9:83,216,040...83,220,225
Ensembl chr 9:75,766,770...75,771,084
G
Cyba
cytochrome b-245 alpha chain
decreases expression
ISO
Vitamin E results in decreased expression of CYBA mRNA
CTD
PMID:15571180
NCBI chr19:67,396,143...67,404,214
Ensembl chr19:50,487,597...50,495,721
G
Cycs
cytochrome c, somatic
multiple interactions
ISO EXP
Vitamin E inhibits the reaction [cinnamaldehyde affects the localization of CYCS protein]; Vitamin E inhibits the reaction [phenethyl isothiocyanate affects the localization of CYCS protein] Vitamin E inhibits the reaction [Diazinon affects the localization of CYCS protein]
CTD
PMID:15566391 PMID:16054126 PMID:23523949
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Cyfip1
cytoplasmic FMR1 interacting protein 1
increases expression
ISO
Vitamin E results in increased expression of CYFIP1 mRNA
CTD
PMID:19244175
NCBI chr 1:115,842,754...115,935,163
Ensembl chr 1:106,711,016...106,799,386
G
Cyp11a1
cytochrome P450, family 11, subfamily a, polypeptide 1
multiple interactions
EXP
Vitamin E inhibits the reaction [acetamiprid results in decreased expression of CYP11A mRNA]; Vitamin E inhibits the reaction [acetamiprid results in decreased expression of CYP11A protein]; Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of CYP11A1 protein]; Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of CYP11A1 mRNA]
CTD
PMID:16298753 PMID:17280759 PMID:28395332
NCBI chr 8:67,318,665...67,330,196
Ensembl chr 8:58,404,669...58,434,338
G
Cyp11b3
cytochrome P450, family 11, subfamily b, polypeptide 3
multiple interactions decreases expression
EXP
Vitamin E inhibits the reaction [adrenocorticotropin zinc results in decreased expression of CYP11B2 mRNA]; Vitamin E promotes the reaction [adrenocorticotropin zinc results in decreased activity of CYP11B2 protein] Vitamin E results in decreased expression of CYP11B2 mRNA
CTD
PMID:10822027 PMID:28923436
NCBI chr 7:108,689,319...108,694,808
Ensembl chr 7:106,808,559...106,814,048
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
decreases expression multiple interactions
EXP
Vitamin E results in decreased expression of CYP19A1 mRNA Vitamin E inhibits the reaction [Doxorubicin results in decreased expression of CYP19A1 mRNA]
CTD
PMID:15084515 PMID:32810592
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:54,553,165...54,580,758
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
EXP
Vitamin E results in increased expression of CYP1A1 mRNA
CTD
PMID:28923436
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
affects expression
EXP
Vitamin E inhibits the reaction [nitroglycerine decreases Cyp1a2 protein expression in rat heart]
RGD
PMID:16520233
RGD:401900296
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions
ISO EXP
Vitamin E inhibits the reaction [[CYP2E1 protein co-treated with Paraquat] results in increased expression of KLF6 protein]; Vitamin E inhibits the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; Vitamin E inhibits the reaction [Arachidonic Acid promotes the reaction [CYP2E1 protein results in increased expression of KLF6 mRNA]]; Vitamin E inhibits the reaction [CYP2E1 protein promotes the reaction [Arachidonic Acid results in increased expression of KLF6 mRNA alternative form]]; Vitamin E inhibits the reaction [CYP2E1 protein results in increased expression of COL1A2 mRNA] Vitamin E inhibits the reaction [decamethrin results in increased expression of CYP2E1 mRNA]
CTD
PMID:10498651 PMID:22486562 PMID:25439240
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
decreases expression
ISO
Vitamin E results in decreased expression of CYP3A4 mRNA
CTD
PMID:19244175
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
decreases expression
ISO
Vitamin E results in decreased expression of CYP3A5 mRNA
CTD
PMID:19244175
NCBI chr12:21,919,955...21,960,160
Ensembl chr12:16,806,207...16,846,422
G
Daam1
dishevelled associated activator of morphogenesis 1
decreases expression
ISO
Vitamin E results in decreased expression of DAAM1 mRNA
CTD
PMID:19244175
NCBI chr 6:90,389,544...90,550,114
Ensembl chr 6:90,389,688...90,550,114
G
Daam2
dishevelled associated activator of morphogenesis 2
increases expression
ISO
Vitamin E results in increased expression of DAAM2 mRNA
CTD
PMID:19244175
NCBI chr 9:11,428,913...11,546,982
Ensembl chr 9:11,428,724...11,545,497
G
Dact1
dishevelled-binding antagonist of beta-catenin 1
decreases expression
ISO
Vitamin E results in decreased expression of DACT1 mRNA
CTD
PMID:19244175
NCBI chr 6:95,526,645...95,538,625
Ensembl chr 6:89,790,644...89,817,906
G
Dad1
defender against cell death 1
multiple interactions
EXP
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of DAD1 mRNA
CTD
PMID:11444866
NCBI chr15:31,647,326...31,667,159
Ensembl chr15:27,677,268...27,697,347
G
Dapk3
death-associated protein kinase 3
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of DAPK3 mRNA Vitamin E results in increased expression of DAPK3 mRNA
CTD
PMID:19244175
NCBI chr 7:9,174,903...9,183,272
Ensembl chr 7:8,524,183...8,532,558
G
Dcaf8
DDB1 and CUL4 associated factor 8
increases expression
ISO
Vitamin E results in increased expression of DCAF8 mRNA
CTD
PMID:19244175
NCBI chr13:87,141,940...87,199,859
Ensembl chr13:84,610,248...84,669,726
G
Dcn
decorin
increases expression
ISO
Vitamin E results in increased expression of DCN mRNA
CTD
PMID:19244175
NCBI chr 7:34,167,973...34,208,004
Ensembl chr 7:32,281,252...32,321,270
G
Dctn3
dynactin subunit 3
increases expression
ISO
Vitamin E results in increased expression of DCTN3 mRNA
CTD
PMID:19244175
NCBI chr 5:61,676,950...61,684,958
Ensembl chr 5:56,881,085...56,889,102
G
Ddah2
DDAH family member 2, ADMA-independent
increases expression
ISO
Vitamin E results in increased expression of DDAH2 mRNA
CTD
PMID:19244175
NCBI chr20:3,766,115...3,769,161
Ensembl chr20:3,761,465...3,764,511
G
Ddost
dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit
increases expression
ISO
Vitamin E results in increased expression of DDOST mRNA
CTD
PMID:19244175
NCBI chr 5:150,522,297...150,529,413
Ensembl chr 5:150,522,242...150,529,413
G
Ddx17
DEAD-box helicase 17
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of DDX17 mRNA Vitamin E results in decreased expression of DDX17 mRNA
CTD
PMID:19244175
NCBI chr 7:112,971,522...112,989,747
Ensembl chr 7:111,089,445...111,109,193
G
Ddx18
DEAD-box helicase 18
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of DDX18 mRNA Vitamin E results in decreased expression of DDX18 mRNA
CTD
PMID:19244175
NCBI chr13:32,729,697...32,743,161
Ensembl chr13:32,729,700...32,743,161
G
Ddx24
DEAD-box helicase 24
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of DDX24 mRNA Vitamin E results in decreased expression of DDX24 mRNA
CTD
PMID:19244175
NCBI chr 6:128,329,554...128,346,818
Ensembl chr 6:122,564,767...122,581,927
G
Ddx39b
DExD-box helicase 39B
increases expression decreases expression
ISO
Vitamin E results in increased expression of DDX39B mRNA Vitamin E results in decreased expression of DDX39B mRNA
CTD
PMID:19244175
NCBI chr20:3,577,200...3,589,651
Ensembl chr20:3,572,056...3,584,996
G
Ddx41
DEAD-box helicase 41
increases expression multiple interactions
ISO
Vitamin E results in increased expression of DDX41 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of DDX41 mRNA
CTD
PMID:19244175
NCBI chr17:9,108,030...9,113,562
Ensembl chr17:9,103,010...9,108,415
G
Dedd
death effector domain-containing
increases expression
ISO
Vitamin E results in increased expression of DEDD mRNA
CTD
PMID:19244175
NCBI chr13:86,286,341...86,301,789
Ensembl chr13:83,756,108...83,769,332
G
Dennd1b
DENN domain containing 1B
decreases expression
ISO
Vitamin E results in decreased expression of DENND1B mRNA
CTD
PMID:19244175
NCBI chr13:50,545,324...50,772,922
Ensembl chr13:50,545,836...50,770,601
G
Dennd2b
DENN domain containing 2B
increases expression
ISO
Vitamin E results in increased expression of DENND2B mRNA
CTD
PMID:19244175
NCBI chr 1:163,544,075...163,734,736
Ensembl chr 1:163,544,074...163,694,680
G
Dennd2d
DENN domain containing 2D
decreases expression
ISO
Vitamin E results in decreased expression of DENND2D mRNA
CTD
PMID:19244175
NCBI chr 2:193,973,231...193,992,275
Ensembl chr 2:193,973,231...193,992,270
G
Dennd4a
DENN domain containing 4A
decreases expression
ISO
Vitamin E results in decreased expression of DENND4A mRNA
CTD
PMID:19244175
NCBI chr 8:74,218,131...74,331,543
Ensembl chr 8:65,322,941...65,436,330
G
Dennd5a
DENN domain containing 5A
increases expression
ISO
Vitamin E results in increased expression of DENND5A mRNA
CTD
PMID:19244175
NCBI chr 1:173,362,959...173,428,973
Ensembl chr 1:163,928,183...163,994,316
G
Des
desmin
increases expression
ISO
Vitamin E results in increased expression of DES mRNA
CTD
PMID:19244175
NCBI chr 9:84,299,626...84,307,344
Ensembl chr 9:76,850,982...76,858,699
G
Dgcr8
DGCR8 microprocessor complex subunit
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of DGCR8 mRNA
CTD
PMID:19244175
NCBI chr11:96,208,959...96,241,560
Ensembl chr11:82,704,729...82,737,242
G
Dhcr7
7-dehydrocholesterol reductase
affects expression
EXP
Vitamin E affects the expression of DHCR7 mRNA
CTD
PMID:15370891
NCBI chr 1:208,444,434...208,460,408
Ensembl chr 1:199,015,081...199,031,055
G
Dhodh
dihydroorotate dehydrogenase
decreases expression
ISO
Vitamin E results in decreased expression of DHODH mRNA
CTD
PMID:19244175
NCBI chr19:54,460,636...54,483,049
Ensembl chr19:37,558,177...37,591,654
G
Dhps
deoxyhypusine synthase
increases expression multiple interactions
ISO
Vitamin E results in increased expression of DHPS mRNA [Selenium co-treated with Vitamin E] results in increased expression of DHPS mRNA
CTD
PMID:19244175
NCBI chr19:39,987,328...39,991,418
Ensembl chr19:23,082,448...23,086,881
G
Dhrs1
dehydrogenase/reductase 1
increases expression
ISO
Vitamin E results in increased expression of DHRS1 mRNA
CTD
PMID:19244175
NCBI chr15:33,206,449...33,213,776
Ensembl chr15:29,236,522...29,243,838
G
Dhrs4
dehydrogenase/reductase 4
increases expression
ISO
Vitamin E results in increased expression of DHRS4 mRNA
CTD
PMID:19244175
NCBI chr15:32,924,482...32,948,103
Ensembl chr15:28,966,553...28,978,127
G
Dhx9
DExH-box helicase 9
decreases expression
ISO
Vitamin E results in decreased expression of DHX9 mRNA
CTD
PMID:19244175
NCBI chr13:68,152,813...68,189,580
Ensembl chr13:65,602,323...65,639,069
G
Diablo
diablo, IAP-binding mitochondrial protein
multiple interactions
ISO
Vitamin E inhibits the reaction [cinnamaldehyde affects the localization of DIABLO protein]; Vitamin E inhibits the reaction [phenethyl isothiocyanate affects the localization of DIABLO protein]
CTD
PMID:15566391 PMID:16054126
NCBI chr12:38,716,668...38,731,285
Ensembl chr12:33,055,263...33,070,387
G
Dicer1
dicer 1 ribonuclease III
decreases expression
ISO
Vitamin E results in decreased expression of DICER1 mRNA
CTD
PMID:19244175
NCBI chr 6:129,392,298...129,457,252
Ensembl chr 6:123,631,250...123,693,965
G
Dio2
iodothyronine deiodinase 2
increases expression
ISO
Vitamin E results in increased expression of DIO2 mRNA
CTD
PMID:19244175
NCBI chr 6:115,396,308...115,410,594
Ensembl chr 6:109,665,523...109,679,809
G
Dlst
dihydrolipoamide S-succinyltransferase
increases expression
ISO
Vitamin E results in increased expression of DLST mRNA
CTD
PMID:19244175
NCBI chr 6:104,758,511...104,783,296
Ensembl chr 6:104,758,631...104,783,296
G
Dmtf1
cyclin D binding myb-like transcription factor 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of DMTF1 mRNA Vitamin E results in decreased expression of DMTF1 mRNA
CTD
PMID:19244175
NCBI chr 4:24,909,937...24,950,786
Ensembl chr 4:24,910,534...24,950,967
G
Dnaja3
DnaJ heat shock protein family (Hsp40) member A3
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of DNAJA3 mRNA Vitamin E results in decreased expression of DNAJA3 mRNA
CTD
PMID:19244175
NCBI chr10:11,361,168...11,386,599
Ensembl chr10:10,854,732...10,880,161
G
Dnajb4
DnaJ heat shock protein family (Hsp40) member B4
decreases expression
ISO
Vitamin E results in decreased expression of DNAJB4 mRNA
CTD
PMID:19244175
NCBI chr 2:243,790,296...243,819,042
Ensembl chr 2:241,130,340...241,159,089
G
Dnajc2
DnaJ heat shock protein family (Hsp40) member C2
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of DNAJC2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of DNAJC2 mRNA
CTD
PMID:19244175
NCBI chr 4:14,162,490...14,189,662
Ensembl chr 4:13,270,191...13,297,431
G
Dnajc3
DnaJ heat shock protein family (Hsp40) member C3
decreases expression
ISO
Vitamin E results in decreased expression of DNAJC3 mRNA
CTD
PMID:19244175
NCBI chr15:102,432,667...102,475,643
Ensembl chr15:96,025,624...96,065,181
G
Dnajc7
DnaJ heat shock protein family (Hsp40) member C7
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of DNAJC7 mRNA Vitamin E results in increased expression of DNAJC7 mRNA
CTD
PMID:19244175
NCBI chr10:85,518,637...85,555,079
Ensembl chr10:85,518,621...85,555,575
G
Dnmt1
DNA methyltransferase 1
increases expression
ISO
Vitamin E results in increased expression of DNMT1 mRNA
CTD
PMID:29854080
NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:19,440,611...19,486,659
G
Dnmt3a
DNA methyltransferase 3 alpha
decreases expression
ISO
Vitamin E results in decreased expression of DNMT3A mRNA
CTD
PMID:19244175
NCBI chr 6:32,507,316...32,621,678
Ensembl chr 6:26,822,609...26,896,687
G
Dnph1
2'-deoxynucleoside 5'-phosphate N-hydrolase 1
increases expression
ISO
Vitamin E results in increased expression of DNPH1 mRNA
CTD
PMID:19244175
NCBI chr 9:21,978,894...21,981,631
Ensembl chr 9:14,481,066...14,484,022
G
Dock1
dedicator of cyto-kinesis 1
decreases expression
ISO
Vitamin E results in decreased expression of DOCK1 mRNA
CTD
PMID:19244175
NCBI chr 1:198,897,021...199,413,636
Ensembl chr 1:189,467,143...189,983,768
G
Dohh
deoxyhypusine hydroxylase
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of DOHH mRNA Vitamin E results in increased expression of DOHH mRNA
CTD
PMID:19244175
NCBI chr 7:8,321,466...8,326,305
Ensembl chr 7:8,321,466...8,326,289
G
Dok1
docking protein 1
increases expression
ISO
Vitamin E results in increased expression of DOK1 mRNA
CTD
PMID:19244175
NCBI chr 4:117,095,171...117,098,251
Ensembl chr 4:115,537,462...115,540,465
G
Dpt
dermatopontin
increases expression
ISO
Vitamin E results in increased expression of DPT mRNA
CTD
PMID:19244175
NCBI chr13:79,656,341...79,684,759
Ensembl chr13:77,123,115...77,151,639
G
Dpysl3
dihydropyrimidinase-like 3
increases expression
ISO
Vitamin E results in increased expression of DPYSL3 mRNA
CTD
PMID:19244175
NCBI chr18:35,374,427...35,480,228
Ensembl chr18:35,377,181...35,480,157
G
Dr1
down-regulator of transcription 1
decreases expression
ISO
Vitamin E results in decreased expression of DR1 mRNA
CTD
PMID:19244175
NCBI chr14:1,458,223...1,469,578
Ensembl chr14:1,458,223...1,469,638
G
Drg2
developmentally regulated GTP binding protein 2
increases expression
ISO
Vitamin E results in increased expression of DRG2 mRNA
CTD
PMID:19244175
NCBI chr10:45,255,512...45,269,971
Ensembl chr10:45,255,507...45,269,969
G
Dsc2
desmocollin 2
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of DSC2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of DSC2 mRNA
CTD
PMID:19244175
NCBI chr18:11,725,466...11,757,591
Ensembl chr18:11,450,390...11,482,392
G
Dxo
decapping exoribonuclease
increases expression
ISO
Vitamin E results in increased expression of DXO mRNA
CTD
PMID:19244175
NCBI chr20:3,993,322...3,995,484
Ensembl chr20:3,993,327...3,995,494
G
Dync1h1
dynein cytoplasmic 1 heavy chain 1
increases expression
ISO
Vitamin E results in increased expression of DYNC1H1 mRNA
CTD
PMID:19244175
NCBI chr 6:135,436,375...135,502,117
Ensembl chr 6:129,609,397...129,680,883
G
E2f6
E2F transcription factor 6
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of E2F6 mRNA Vitamin E results in decreased expression of E2F6 mRNA
CTD
PMID:19244175
NCBI chr 6:39,592,224...39,608,685
Ensembl chr 6:39,592,228...39,608,683
G
Echdc2
enoyl CoA hydratase domain containing 2
decreases expression
ISO
Vitamin E results in decreased expression of ECHDC2 mRNA
CTD
PMID:19244175
NCBI chr 5:128,144,241...128,163,611
Ensembl chr 5:122,916,134...122,934,859
G
Ecsit
ECSIT signaling integrator
increases expression multiple interactions
ISO
Vitamin E results in increased expression of ECSIT mRNA [Selenium co-treated with Vitamin E] results in increased expression of ECSIT mRNA
CTD
PMID:19244175
NCBI chr 8:28,881,594...28,894,443
Ensembl chr 8:20,605,583...20,618,390
G
Eda
ectodysplasin-A
decreases expression
ISO
Vitamin E results in decreased expression of EDA mRNA
CTD
PMID:19244175
NCBI chr X:69,118,577...69,520,274
Ensembl chr X:65,078,673...65,480,172
G
Edem3
ER degradation enhancing alpha-mannosidase like protein 3
decreases expression
ISO
Vitamin E results in decreased expression of EDEM3 mRNA
CTD
PMID:19244175
NCBI chr13:63,858,282...63,920,538
Ensembl chr13:63,858,716...63,920,523
G
Edf1
endothelial differentiation-related factor 1
increases expression
ISO
Vitamin E results in increased expression of EDF1 mRNA
CTD
PMID:19244175
NCBI chr 3:28,764,906...28,779,499
Ensembl chr 3:8,366,613...8,381,363
G
Ednra
endothelin receptor type A
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of EDNRA mRNA Vitamin E results in decreased expression of EDNRA mRNA
CTD
PMID:19244175
NCBI chr19:47,137,360...47,207,961
Ensembl chr19:30,233,571...30,297,049
G
Eef1a2
eukaryotic translation elongation factor 1 alpha 2
increases expression multiple interactions
ISO
Vitamin E results in increased expression of EEF1A2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of EEF1A2 mRNA
CTD
PMID:19244175
NCBI chr 3:188,643,455...188,652,633
Ensembl chr 3:168,195,357...168,275,071
G
Eef1d
eukaryotic translation elongation factor 1 delta
increases expression
ISO
Vitamin E results in increased expression of EEF1D mRNA
CTD
PMID:19244175
NCBI chr 7:109,462,645...109,478,021
Ensembl chr 7:107,581,930...107,608,799
G
Eef2
eukaryotic translation elongation factor 2
multiple interactions increases expression
EXP
Vitamin E analog inhibits the reaction [cumene hydroperoxide results in decreased expression of EEF2 protein] Vitamin E analog results in increased expression of EEF2 protein
CTD
PMID:17510559
NCBI chr 7:9,183,836...9,196,255
Ensembl chr 7:8,533,116...8,559,183
G
Efcab14
EF-hand calcium binding domain 14
increases expression
ISO
Vitamin E results in increased expression of EFCAB14 mRNA
CTD
PMID:19244175
NCBI chr 5:129,218,139...129,258,628
Ensembl chr 5:129,218,424...129,258,625
G
Efemp2
EGF containing fibulin extracellular matrix protein 2
increases expression
ISO
Vitamin E results in increased expression of EFEMP2 mRNA
CTD
PMID:19244175
NCBI chr 1:212,211,057...212,218,739
Ensembl chr 1:202,781,665...202,789,414
G
Efhc1
EF-hand domain containing 1
decreases expression
ISO
Vitamin E results in decreased expression of EFHC1 mRNA
CTD
PMID:19244175
NCBI chr 9:23,375,815...23,414,283
Ensembl chr 9:23,375,840...23,414,283
G
Efhd2
EF-hand domain family, member D2
increases expression
ISO
Vitamin E results in increased expression of EFHD2 mRNA
CTD
PMID:19244175
NCBI chr 5:159,443,959...159,459,993
Ensembl chr 5:154,160,946...154,176,980
G
Egfr
epidermal growth factor receptor
decreases expression
ISO
Vitamin E results in decreased expression of EGFR mRNA
CTD
PMID:19244175
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:91,177,067...91,344,382
G
Egln2
egl-9 family hypoxia-inducible factor 2
increases expression
ISO
Vitamin E results in increased expression of EGLN2 mRNA
CTD
PMID:19244175
NCBI chr 1:91,579,205...91,586,985
Ensembl chr 1:82,451,555...82,459,751
G
Egr1
early growth response 1
decreases expression multiple interactions
ISO EXP
Vitamin E results in decreased expression of EGR1 mRNA [Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of EGR1 mRNA
CTD
PMID:11444866 PMID:19244175
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,462,981...26,466,766
G
Ehbp1
EH domain binding protein 1
decreases expression
ISO
Vitamin E results in decreased expression of EHBP1 mRNA
CTD
PMID:19244175
NCBI chr14:96,093,327...96,380,502
Ensembl chr14:96,093,327...96,345,332
G
Ehd2
EH-domain containing 2
increases expression
ISO
Vitamin E results in increased expression of EHD2 mRNA
CTD
PMID:19244175
NCBI chr 1:85,767,757...85,786,974
Ensembl chr 1:76,637,482...76,658,783
G
Eif2ak2
eukaryotic translation initiation factor 2-alpha kinase 2
decreases expression
ISO
Vitamin E results in decreased expression of EIF2AK2 mRNA
CTD
PMID:19244175
NCBI chr 6:21,941,147...21,977,115
Ensembl chr 6:16,188,979...16,224,971
G
Eif2b2
eukaryotic translation initiation factor 2B subunit beta
increases expression
ISO
Vitamin E results in increased expression of EIF2B2 mRNA
CTD
PMID:19244175
NCBI chr 6:104,866,926...104,873,351
Ensembl chr 6:104,866,753...104,873,353
G
Eif3a
eukaryotic translation initiation factor 3, subunit A
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of EIF3A mRNA Vitamin E results in decreased expression of EIF3A mRNA
CTD
PMID:19244175
NCBI chr 1:269,888,730...269,925,785
Ensembl chr 1:259,902,680...259,932,976
G
Eif3b
eukaryotic translation initiation factor 3, subunit B
increases expression
ISO
Vitamin E results in increased expression of EIF3B mRNA
CTD
PMID:19244175
NCBI chr12:19,310,308...19,334,768
Ensembl chr12:14,196,403...14,220,886
G
Eif3k
eukaryotic translation initiation factor 3, subunit K
increases expression
ISO
Vitamin E results in increased expression of EIF3K mRNA
CTD
PMID:19244175
NCBI chr 1:84,260,127...84,270,051
Ensembl chr 1:84,259,673...84,270,302
G
Eif4a1
eukaryotic translation initiation factor 4A1
increases expression
ISO
Vitamin E results in increased expression of EIF4A1 mRNA
CTD
PMID:19244175
NCBI chr10:54,883,093...54,888,602
Ensembl chr10:54,384,347...54,389,858
G
Eif4ebp2
eukaryotic translation initiation factor 4E binding protein 2
increases expression
ISO
Vitamin E results in increased expression of EIF4EBP2 mRNA
CTD
PMID:19244175
NCBI chr20:29,379,444...29,400,110
Ensembl chr20:29,382,668...29,399,946
G
Eif4g1
eukaryotic translation initiation factor 4 gamma 1
multiple interactions increases expression decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of EIF4G1 mRNA Vitamin E results in increased expression of EIF4G1 mRNA Vitamin E results in decreased expression of EIF4G1 mRNA
CTD
PMID:19244175
NCBI chr11:93,726,322...93,746,387
Ensembl chr11:80,221,919...80,241,941
G
Eif5
eukaryotic translation initiation factor 5
decreases expression
ISO
Vitamin E results in decreased expression of EIF5 mRNA
CTD
PMID:19244175
NCBI chr 6:130,589,162...130,597,656
Ensembl chr 6:130,589,143...130,597,656
G
Eif5a
eukaryotic translation initiation factor 5A
multiple interactions increases expression decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of EIF5A mRNA Vitamin E results in increased expression of EIF5A mRNA Vitamin E results in decreased expression of EIF5A mRNA
CTD
PMID:19244175
NCBI chr10:55,138,821...55,143,272
Ensembl chr10:54,640,024...54,644,656
G
Eif5b
eukaryotic translation initiation factor 5B
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of IF2 mRNA Vitamin E results in decreased expression of IF2 mRNA
CTD
PMID:19244175
NCBI chr 9:47,718,706...47,773,289
Ensembl chr 9:40,222,898...40,277,482
G
Eif6
eukaryotic translation initiation factor 6
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of EIF6 mRNA Vitamin E results in increased expression of EIF6 mRNA
CTD
PMID:19244175
NCBI chr 3:144,325,038...144,331,396
Ensembl chr 3:144,325,036...144,331,401
G
Elf1
E74 like ETS transcription factor 1
decreases expression
ISO
Vitamin E results in decreased expression of ELF1 mRNA
CTD
PMID:19244175
NCBI chr15:61,354,026...61,395,762
Ensembl chr15:54,865,616...54,986,699
G
Elk1
ETS transcription factor ELK1
increases phosphorylation
ISO
Vitamin E results in increased phosphorylation of ELK1 protein
CTD
PMID:11522656
NCBI chr X:3,692,367...3,709,252
Ensembl chr X:1,139,756...1,155,713
G
Eloa
elongin A
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of ELOA mRNA Vitamin E results in decreased expression of ELOA mRNA
CTD
PMID:19244175
NCBI chr 5:153,513,246...153,530,819
Ensembl chr 5:148,231,596...148,246,765
G
Emc6
ER membrane protein complex subunit 6
increases expression
ISO
Vitamin E results in increased expression of EMC6 mRNA
CTD
PMID:19244175
NCBI chr10:57,794,072...57,795,671
Ensembl chr10:57,793,685...57,796,217
G
Emc9
ER membrane protein complex subunit 9
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of EMC9 mRNA Vitamin E results in increased expression of EMC9 mRNA
CTD
PMID:19244175
NCBI chr15:33,041,840...33,046,056
Ensembl chr15:29,071,883...29,076,098
G
Emilin1
elastin microfibril interfacer 1
increases expression
ISO
Vitamin E results in increased expression of EMILIN1 mRNA
CTD
PMID:19244175
NCBI chr 6:31,175,919...31,183,657
Ensembl chr 6:25,445,298...25,463,698
G
Eml2
EMAP like 2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of EML2 mRNA Vitamin E results in increased expression of EML2 mRNA
CTD
PMID:19244175
NCBI chr 1:87,955,924...87,987,366
Ensembl chr 1:78,828,080...78,859,341
G
Emp3
epithelial membrane protein 3
increases expression
ISO
Vitamin E results in increased expression of EMP3 mRNA
CTD
PMID:19244175
NCBI chr 1:96,388,651...96,391,946
Ensembl chr 1:96,388,652...96,391,988
G
Emsy
EMSY transcriptional repressor, BRCA2 interacting
decreases expression
ISO
Vitamin E results in decreased expression of EMSY mRNA
CTD
PMID:19244175
NCBI chr 1:152,881,485...152,960,420
Ensembl chr 1:152,883,992...152,953,528
G
Endog
endonuclease G
increases expression
ISO
Vitamin E results in increased expression of ENDOG mRNA
CTD
PMID:19244175
NCBI chr 3:33,846,935...33,849,531
Ensembl chr 3:13,449,086...13,451,932
G
Eno1
enolase 1
increases expression
ISO
Vitamin E results in increased expression of ENO1 mRNA
CTD
PMID:19244175
NCBI chr 5:166,002,867...166,014,252
Ensembl chr 5:160,719,951...160,731,336 Ensembl chr 3:160,719,951...160,731,336
G
Eno2
enolase 2
increases expression
ISO
Vitamin E results in increased expression of ENO2 mRNA
CTD
PMID:19244175
NCBI chr 4:159,258,371...159,267,220
Ensembl chr 4:157,572,088...157,580,980
G
Entpd1
ectonucleoside triphosphate diphosphohydrolase 1
increases expression
ISO
Vitamin E results in increased expression of ENTPD1 mRNA
CTD
PMID:19244175
NCBI chr 1:249,374,810...249,502,310
Ensembl chr 1:239,425,430...239,552,317
G
Entpd5
ectonucleoside triphosphate diphosphohydrolase 5
decreases expression
ISO
Vitamin E results in decreased expression of ENTPD5 mRNA
CTD
PMID:19244175
NCBI chr 6:109,750,210...109,786,376
Ensembl chr 6:104,019,185...104,055,530
G
Epb41l2
erythrocyte membrane protein band 4.1-like 2
increases expression
ISO
Vitamin E results in increased expression of EPB41L2 mRNA
CTD
PMID:19244175
NCBI chr 1:19,863,010...20,037,795
Ensembl chr 1:19,863,009...20,037,721
G
Epn2
epsin 2
increases expression
ISO
Vitamin E results in increased expression of EPN2 mRNA
CTD
PMID:19244175
NCBI chr10:46,697,238...46,759,128
Ensembl chr10:46,197,785...46,259,642
G
Erbb2
erb-b2 receptor tyrosine kinase 2
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ERBB2 mRNA
CTD
PMID:19244175
NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,411,313...83,435,078
G
Ercc1
ERCC excision repair 1, endonuclease non-catalytic subunit
increases expression
ISO
Vitamin E results in increased expression of ERCC1 mRNA
CTD
PMID:19244175
NCBI chr 1:88,099,308...88,135,966
Ensembl chr 1:78,996,390...79,007,963
G
Ercc3
ERCC excision repair 3, TFIIH core complex helicase subunit
increases expression
ISO
Vitamin E results in increased expression of ERCC3 mRNA
CTD
PMID:19244175
NCBI chr18:23,883,613...23,914,326
Ensembl chr18:23,883,580...23,914,329
G
Esr1
estrogen receptor 1
multiple interactions affects expression
EXP
Vitamin E affects the reaction [Doxorubicin affects the expression of ESR1 mRNA] Vitamin E affects the expression of ESR1 mRNA
CTD
PMID:32810592
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
G
Esrp2
epithelial splicing regulatory protein 2
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of ESRP2 mRNA [Selenium co-treated with Vitamin E] results in increased expression of ESRP2 mRNA
CTD
PMID:19244175
NCBI chr19:34,034,559...34,041,726
Ensembl chr19:34,034,559...34,041,726
G
Ess2
ess-2 splicing factor homolog
increases expression
ISO
Vitamin E results in increased expression of ESS2 mRNA
CTD
PMID:19244175
NCBI chr11:83,075,893...83,085,849
Ensembl chr11:83,075,925...83,084,846
G
Ets2
ETS proto-oncogene 2, transcription factor
decreases expression
ISO
Vitamin E results in decreased expression of ETS2 mRNA
CTD
PMID:19244175
NCBI chr11:48,491,057...48,507,843
Ensembl chr11:35,021,596...35,038,319
G
Evi5
ecotropic viral integration site 5
decreases expression
ISO
Vitamin E results in decreased expression of EVI5 mRNA
CTD
PMID:19244175
NCBI chr14:1,875,601...2,021,678
Ensembl chr14:1,875,647...2,021,678
G
Evl
Enah/Vasp-like
increases expression
ISO
Vitamin E results in increased expression of EVL mRNA
CTD
PMID:19244175
NCBI chr 6:133,238,547...133,358,730
Ensembl chr 6:127,474,543...127,594,344
G
Ewsr1
EWS RNA-binding protein 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of EWSR1 mRNA Vitamin E results in increased expression of EWSR1 mRNA
CTD
PMID:19244175
NCBI chr14:84,179,413...84,208,149
Ensembl chr14:79,965,368...79,994,544
G
Exoc3
exocyst complex component 3
increases expression
ISO
Vitamin E results in increased expression of SEC6 mRNA
CTD
PMID:19244175
NCBI chr 1:30,919,871...30,950,624
Ensembl chr 1:29,091,294...29,122,045
G
Exosc4
exosome component 4
increases expression
ISO
Vitamin E results in increased expression of EXOSC4 mRNA
CTD
PMID:19244175
NCBI chr 7:108,047,831...108,050,573
Ensembl chr 7:108,047,831...108,050,573
G
Ext1
exostosin glycosyltransferase 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of EXT1 mRNA Vitamin E results in increased expression of EXT1 mRNA
CTD
PMID:19244175
NCBI chr 7:86,265,651...86,544,488
Ensembl chr 7:84,375,784...84,655,357
G
Eya2
EYA transcriptional coactivator and phosphatase 2
increases expression
ISO
Vitamin E results in increased expression of EYA2 mRNA
CTD
PMID:19244175
NCBI chr 3:174,754,772...174,938,035
Ensembl chr 3:154,335,400...154,518,793
G
Ezh1
enhancer of zeste 1 polycomb repressive complex 2 subunit
increases expression
ISO
Vitamin E results in increased expression of EZH1 mRNA
CTD
PMID:19244175
NCBI chr10:86,626,307...86,662,257
Ensembl chr10:86,126,015...86,161,921
G
Ezr
ezrin
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of EZR mRNA [Selenium co-treated with Vitamin E] results in decreased expression of EZR mRNA
CTD
PMID:19244175
NCBI chr 1:49,373,033...49,416,573
Ensembl chr 1:46,967,658...47,011,505
G
F10
coagulation factor X
increases expression
ISO
Vitamin E results in increased expression of F10 mRNA
CTD
PMID:19244175
NCBI chr16:83,170,973...83,190,280
Ensembl chr16:76,468,838...76,488,141
G
F2
coagulation factor II, thrombin
multiple interactions
ISO
Vitamin E results in decreased expression of and results in decreased activity of F2 protein
CTD
PMID:10216089
NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:77,596,198...77,609,486
G
F2r
coagulation factor II (thrombin) receptor
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of F2R mRNA [Selenium co-treated with Vitamin E] results in increased expression of F2R mRNA
CTD
PMID:19244175
NCBI chr 2:28,604,066...28,620,579
Ensembl chr 2:26,868,404...26,885,870
G
F3
coagulation factor III, tissue factor
multiple interactions
ISO
Vitamin E inhibits the reaction [Copper results in increased activity of F3 protein]; Vitamin E inhibits the reaction [Norepinephrine results in increased expression of F3 mRNA]; Vitamin E results in decreased expression of and results in decreased activity of F3 protein
CTD
PMID:7600656 PMID:10216089 PMID:23114885
NCBI chr 2:212,511,675...212,523,375
Ensembl chr 2:209,826,959...209,838,668
G
Fabp3
fatty acid binding protein 3
increases expression
ISO
Vitamin E results in increased expression of FABP3 mRNA
CTD
PMID:19244175
NCBI chr 5:147,936,027...147,942,870
Ensembl chr 5:142,651,956...142,658,718
G
Faim
Fas apoptotic inhibitory molecule
increases expression
ISO
Vitamin E results in increased expression of FAIM mRNA
CTD
PMID:19244175
NCBI chr 8:99,543,877...99,569,499
Ensembl chr 8:99,542,405...99,560,562
G
Fam107a
family with sequence similarity 107, member A
increases expression
ISO
Vitamin E results in increased expression of FAM107A mRNA
CTD
PMID:19244175
NCBI chr15:19,038,726...19,060,644
Ensembl chr15:16,607,205...16,630,396
G
Fam111a
FAM111 trypsin like peptidase A
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of FAM111A mRNA [Selenium co-treated with Vitamin E] results in decreased expression of FAM111A mRNA
CTD
PMID:19244175
NCBI chr 1:219,065,542...219,081,213
Ensembl chr 1:209,640,953...209,656,547
G
Fam149a
family with sequence similarity 149, member A
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of FAM149A mRNA Vitamin E results in decreased expression of FAM149A mRNA
CTD
PMID:19244175
NCBI chr16:53,587,841...53,647,072
Ensembl chr16:46,854,635...46,912,066
G
Fam174c
family with sequence similarity 174 member C
decreases expression
ISO
Vitamin E results in decreased expression of FAM174C mRNA
CTD
PMID:19244175
NCBI chr 7:9,531,995...9,533,705
G
Fam222b
family with sequence similarity 222, member B
decreases expression
ISO
Vitamin E results in decreased expression of FAM222B mRNA
CTD
PMID:19244175
NCBI chr10:62,986,571...63,052,350
Ensembl chr10:62,986,571...63,052,350
G
Fam3a
FAM3 metabolism regulating signaling molecule A
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of FAM3A mRNA
CTD
PMID:19244175
NCBI chr X:157,317,993...157,326,640
Ensembl chr X:152,165,535...152,175,362
G
Fam53b
family with sequence similarity 53, member B
increases expression
ISO
Vitamin E results in increased expression of FAM53B mRNA
CTD
PMID:19244175
NCBI chr 1:196,930,170...197,021,290
Ensembl chr 1:187,500,066...187,591,186
G
Fam89b
family with sequence similarity 89, member B
increases expression
ISO
Vitamin E results in increased expression of FAM89B mRNA
CTD
PMID:19244175
NCBI chr 1:212,445,101...212,447,164
Ensembl chr 1:203,015,773...203,017,367
G
Farsa
phenylalanyl-tRNA synthetase subunit alpha
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of FARSA mRNA Vitamin E results in increased expression of FARSA mRNA
CTD
PMID:19244175
NCBI chr19:40,196,255...40,205,830
Ensembl chr19:23,268,869...23,300,980
G
Fastkd3
FAST kinase domains 3
decreases expression
ISO
Vitamin E results in decreased expression of FASTKD3 mRNA
CTD
PMID:19244175
NCBI chr 1:34,858,342...34,866,988
Ensembl chr 1:34,858,219...34,866,973
G
Fat4
FAT atypical cadherin 4
decreases expression
ISO
Vitamin E results in decreased expression of FAT4 mRNA
CTD
PMID:19244175
NCBI chr 2:123,855,289...123,984,716
Ensembl chr 2:121,927,942...122,056,707
G
Fbln1
fibulin 1
increases expression
ISO
Vitamin E results in increased expression of FBLN1 mRNA
CTD
PMID:19244175
NCBI chr 7:118,190,347...118,269,965
Ensembl chr 7:116,310,582...116,390,075
G
Fbxl7
F-box and leucine-rich repeat protein 7
increases expression
ISO
Vitamin E results in increased expression of FBXL7 mRNA
CTD
PMID:19244175
NCBI chr 2:78,870,236...79,239,697
Ensembl chr 2:77,140,826...77,509,223
G
Fbxo17
F-box protein 17
increases expression
ISO
Vitamin E results in increased expression of FBXO17 mRNA
CTD
PMID:19244175
NCBI chr 1:84,002,276...84,024,455
Ensembl chr 1:84,002,267...84,024,453
G
Fbxo28
F-box protein 28
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of FBXO28 mRNA
CTD
PMID:19244175
NCBI chr13:93,995,993...94,021,464
Ensembl chr13:93,995,996...94,021,464
G
Fbxo31
F-box protein 31
increases expression
ISO
Vitamin E results in increased expression of FBXO31 mRNA
CTD
PMID:19244175
NCBI chr19:66,533,437...66,564,674
Ensembl chr19:49,627,686...49,656,010
G
Fbxw2
F-box and WD repeat domain containing 2
increases expression
ISO
Vitamin E results in increased expression of FBXW2 mRNA
CTD
PMID:19244175
NCBI chr 3:18,088,859...18,114,387
Ensembl chr 3:18,088,865...18,114,381
G
Fech
ferrochelatase
decreases expression
ISO
Vitamin E results in decreased expression of FECH mRNA
CTD
PMID:19244175
NCBI chr18:60,215,325...60,248,525
Ensembl chr18:57,945,122...57,979,348
G
Fermt1
FERM domain containing kindlin 1
decreases expression
ISO
Vitamin E results in decreased expression of FERMT1 mRNA
CTD
PMID:19244175
NCBI chr 3:140,624,434...140,666,419
Ensembl chr 3:120,171,561...120,213,555
G
Ferry3
FERRY endosomal RAB5 effector complex subunit 3
decreases expression
ISO
Vitamin E results in decreased expression of FERRY3 mRNA
CTD
PMID:19244175
NCBI chr 4:161,458,942...161,494,213
Ensembl chr 4:159,772,786...159,806,382
G
Fgg
fibrinogen gamma chain
multiple interactions
EXP
[Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of FGG mRNA
CTD
PMID:11444866
NCBI chr 2:170,652,929...170,660,372
Ensembl chr 2:168,355,013...168,362,322
G
Fibp
FGF1 intracellular binding protein
increases expression
ISO
Vitamin E results in increased expression of FIBP mRNA
CTD
PMID:19244175
NCBI chr 1:212,197,216...212,201,732
Ensembl chr 1:202,768,078...202,772,399
G
Fig4
FIG4 phosphoinositide 5-phosphatase
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of FIG4 mRNA Vitamin E results in decreased expression of FIG4 mRNA
CTD
PMID:19244175
NCBI chr20:46,183,225...46,306,686
Ensembl chr20:44,600,603...44,723,844
G
Fis1
fission, mitochondrial 1
increases expression
ISO
Vitamin E results in increased expression of FIS1 mRNA
CTD
PMID:19244175
NCBI chr12:25,345,239...25,360,135
Ensembl chr12:19,708,558...19,723,377
G
Fkbp1a
FKBP prolyl isomerase 1A
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of FKBP1A mRNA Vitamin E results in increased expression of FKBP1A mRNA
CTD
PMID:19244175
NCBI chr 3:160,500,748...160,520,492
Ensembl chr 3:140,040,278...140,060,743
G
Flii
FLII, actin remodeling protein
increases expression
ISO
Vitamin E results in increased expression of FLII mRNA
CTD
PMID:19244175
NCBI chr10:45,394,032...45,408,051
Ensembl chr10:45,394,032...45,407,970
G
Flna
filamin A
increases expression
ISO
Vitamin E results in increased expression of FLNA mRNA
CTD
PMID:19244175
NCBI chr X:157,159,051...157,185,559
Ensembl chr X:152,007,758...152,031,052
G
Flot1
flotillin 1
increases expression
ISO
Vitamin E results in increased expression of FLOT1 mRNA
CTD
PMID:19244175
NCBI chr20:2,922,662...2,932,906
Ensembl chr20:2,917,137...2,927,978
G
Flrt3
fibronectin leucine rich transmembrane protein 3
decreases expression
ISO
Vitamin E results in decreased expression of FLRT3 mRNA
CTD
PMID:19244175
NCBI chr 3:148,448,115...148,461,458
Ensembl chr 3:127,994,226...128,007,841
G
Fmo5
flavin containing dimethylaniline monoxygenase 5
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of FMO5 mRNA Vitamin E results in decreased expression of FMO5 mRNA
CTD
PMID:19244175
NCBI chr 2:187,885,741...187,938,468
Ensembl chr 2:185,222,204...185,249,693
G
Fnbp1
formin binding protein 1
decreases expression
ISO
Vitamin E results in decreased expression of FNBP1 mRNA
CTD
PMID:19244175
NCBI chr 3:34,706,814...34,826,770
Ensembl chr 3:14,309,640...14,424,881
G
Fnbp4
formin binding protein 4
decreases expression
ISO
Vitamin E results in decreased expression of FNBP4 mRNA
CTD
PMID:19244175
NCBI chr 3:76,733,012...76,763,077
Ensembl chr 3:76,733,027...76,763,079
G
Folh1
folate hydrolase 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of FOLH1 mRNA Vitamin E results in decreased expression of FOLH1 mRNA
CTD
PMID:19244175
NCBI chr 1:140,428,101...140,501,563
Ensembl chr 1:140,428,101...140,501,379
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
Vitamin E promotes the reaction [Alcohols results in increased expression of FOS mRNA]
CTD
PMID:18814483
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Foxa2
forkhead box A2
multiple interactions
EXP ISO
Vitamin E inhibits the reaction [nitrofen results in decreased expression of FOXA2 protein] Vitamin E inhibits the reaction [nitrofen results in decreased expression of FOXA2 mRNA]
CTD
PMID:16490937 PMID:16863852
NCBI chr 3:155,923,305...155,927,508
Ensembl chr 3:135,470,131...135,474,326
G
Foxe1
forkhead box E1
decreases expression
ISO
Vitamin E results in decreased expression of FOXE1 mRNA
CTD
PMID:19244175
NCBI chr 5:65,425,630...65,428,438
Ensembl chr 5:60,630,027...60,632,835
G
Foxf2
forkhead box F2
decreases expression
ISO
Vitamin E results in decreased expression of FOXF2 mRNA
CTD
PMID:19244175
NCBI chr17:33,044,446...33,051,259
Ensembl chr17:32,836,777...32,842,176
G
Foxm1
forkhead box M1
decreases expression
ISO
Vitamin E results in decreased expression of FOXM1 mRNA
CTD
PMID:19244175
NCBI chr 4:163,325,628...163,338,100
Ensembl chr 4:161,638,816...161,650,684
G
Foxo1
forkhead box O1
decreases expression
ISO
Vitamin E results in decreased expression of FOXO1 mRNA
CTD
PMID:19244175
NCBI chr 2:138,462,974...138,541,420
Ensembl chr 2:136,312,168...136,387,790
G
Frat1
FRAT regulator of WNT signaling pathway 1
increases expression
ISO
Vitamin E results in increased expression of FRAT1 mRNA
CTD
PMID:19244175
NCBI chr 1:250,587,641...250,590,189
Ensembl chr 1:240,638,296...240,640,945
G
Fshb
follicle stimulating hormone subunit beta
multiple interactions
EXP
Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of FSHB protein]; Vitamin E inhibits the reaction [chromium hexavalent ion results in increased expression of FSHB protein]; Vitamin E inhibits the reaction [cypermethrin results in decreased expression of FSHB protein]; Vitamin E inhibits the reaction [Petroleum results in increased expression of FSHB protein]; Vitamin E inhibits the reaction [Potassium Dichromate results in increased expression of FSHB protein]
CTD
PMID:17280759 PMID:20079796 PMID:24759048 PMID:25046308
NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:93,548,560...93,552,370
G
Fst
follistatin
increases expression
ISO
Vitamin E results in increased expression of FST mRNA
CTD
PMID:19244175
NCBI chr 2:47,856,345...47,863,670
Ensembl chr 2:46,123,439...46,130,571
G
Ftsj1
FtsJ RNA 2'-O-methyltransferase 1
decreases expression
ISO
Vitamin E results in decreased expression of FTSJ1 mRNA
CTD
PMID:19244175
NCBI chr X:14,243,684...14,256,555
Ensembl chr X:14,244,050...14,252,030
G
Fus
Fus RNA binding protein
increases expression
ISO
Vitamin E results in increased expression of FUS mRNA
CTD
PMID:19244175
NCBI chr 1:192,007,011...192,020,887
Ensembl chr 1:182,576,545...182,590,414
G
Fxr1
FMR1 autosomal homolog 1
decreases expression
ISO
Vitamin E results in decreased expression of FXR1 mRNA
CTD
PMID:19244175
NCBI chr 2:118,812,287...118,865,813
Ensembl chr 2:116,884,248...116,937,590
G
Fxr2
FMR1 autosomal homolog 2
increases expression
ISO
Vitamin E results in increased expression of FXR2 mRNA
CTD
PMID:19244175
NCBI chr10:54,350,577...54,370,964
Ensembl chr10:54,350,131...54,370,964
G
Fxyd6
FXYD domain-containing ion transport regulator 6
increases expression
ISO
Vitamin E results in increased expression of FXYD6 mRNA
CTD
PMID:19244175
NCBI chr 8:54,575,578...54,602,715
Ensembl chr 8:45,678,885...45,705,958
G
Fzr1
fizzy and cell division cycle 20 related 1
increases expression multiple interactions
ISO
Vitamin E results in increased expression of FZR1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of FZR1 mRNA
CTD
PMID:19244175
NCBI chr 7:8,982,765...8,994,689
Ensembl chr 7:8,332,029...8,343,952
G
G0s2
G0/G1switch 2
increases expression
ISO
Vitamin E results in increased expression of G0S2 mRNA
CTD
PMID:19244175
NCBI chr13:107,335,036...107,335,948
Ensembl chr13:104,806,156...104,807,451
G
G6pd
glucose-6-phosphate dehydrogenase
multiple interactions
ISO EXP
Vitamin E inhibits the reaction [sodium arsenite results in decreased activity of G6PD protein] Vitamin E inhibits the reaction [Atrazine results in decreased activity of G6PD protein]
CTD
PMID:19635623 PMID:20136348
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:152,201,098...152,220,801
G
Gab2
GRB2-associated binding protein 2
increases expression
ISO
Vitamin E results in increased expression of GAB2 mRNA
CTD
PMID:19244175
NCBI chr 1:160,841,066...161,036,940
Ensembl chr 1:151,429,695...151,625,031
G
Gabpb2
GA binding protein transcription factor subunit beta 2
decreases expression
ISO
Vitamin E results in decreased expression of GABPB2 mRNA
CTD
PMID:19244175
NCBI chr 2:182,755,304...182,795,368
Ensembl chr 2:182,761,359...182,795,109
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of GADD45A mRNA Vitamin E results in decreased expression of GADD45A mRNA
CTD
PMID:19244175
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:96,154,789...96,157,115
G
Gak
cyclin G associated kinase
decreases expression
ISO
Vitamin E results in decreased expression of GAK mRNA
CTD
PMID:19244175
NCBI chr14:1,089,853...1,164,098
Ensembl chr14:1,089,866...1,216,398
G
Galnt1
polypeptide N-acetylgalactosaminyltransferase 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of GALNT1 mRNA Vitamin E results in decreased expression of GALNT1 mRNA
CTD
PMID:19244175
NCBI chr18:15,763,697...15,843,598
Ensembl chr18:15,489,020...15,568,245
G
Galnt10
polypeptide N-acetylgalactosaminyltransferase 10
decreases expression
ISO
Vitamin E results in decreased expression of GALNT10 mRNA
CTD
PMID:19244175
NCBI chr10:42,321,691...42,468,087
Ensembl chr10:41,820,158...41,967,013
G
Galnt3
polypeptide N-acetylgalactosaminyltransferase 3
decreases expression
ISO
Vitamin E results in decreased expression of GALNT3 mRNA
CTD
PMID:19244175
NCBI chr 3:71,150,559...71,187,321
Ensembl chr 3:50,742,512...50,766,268
G
Galr3
galanin receptor 3
increases expression
ISO
Vitamin E results in increased expression of GALR3 mRNA
CTD
PMID:19244175
NCBI chr 7:112,483,183...112,496,359
Ensembl chr 7:110,605,226...110,607,685
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
increases expression
ISO
Vitamin E results in increased expression of GAPDH mRNA
CTD
PMID:19244175
NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:157,962,343...157,966,235
G
Gas8
growth arrest specific 8
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of GAS8 mRNA Vitamin E results in increased expression of GAS8 mRNA
CTD
PMID:19244175
NCBI chr19:68,461,280...68,480,810
Ensembl chr19:51,552,816...51,572,305
G
Gata4
GATA binding protein 4
affects expression
EXP
Vitamin E affects the expression of GATA4 mRNA
CTD
PMID:15370891
NCBI chr15:41,635,572...41,707,252
Ensembl chr15:37,459,601...37,505,636
G
Gatad1
GATA zinc finger domain containing 1
decreases expression
ISO
Vitamin E results in decreased expression of GATAD1 mRNA
CTD
PMID:19244175
NCBI chr 4:31,462,251...31,473,827
Ensembl chr 4:30,507,538...30,519,107
G
Gatd3a
glutamine amidotransferase class 1 domain containing 3A
increases expression
ISO
Vitamin E results in increased expression of GATD3 mRNA
CTD
PMID:19244175
NCBI chr20:10,514,793...10,522,894
Ensembl chr20:10,514,744...10,522,885
G
Gbp1
guanylate binding protein 1
decreases expression
ISO
Vitamin E results in decreased expression of GBP1 mRNA
CTD
PMID:19244175
NCBI chr 2:234,071,366...234,106,012
Ensembl chr 2:231,398,163...231,432,131 Ensembl chr 2:231,398,163...231,432,131
G
Gcfc2
GC-rich sequence DNA-binding factor 2
decreases expression
ISO
Vitamin E results in decreased expression of GCFC2 mRNA
CTD
PMID:19244175
NCBI chr 4:114,481,613...114,519,268
Ensembl chr 4:114,481,607...114,519,962
G
Gclc
glutamate-cysteine ligase, catalytic subunit
multiple interactions affects expression
ISO EXP
Vitamin E inhibits the reaction [Alcohols results in increased expression of GCLC mRNA] [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of GCLC mRNA; Vitamin E affects the reaction [[REL binds to GCLC promoter] which affects the expression of GCLC mRNA] Vitamin E affects the expression of GCLC mRNA; Vitamin E affects the expression of GCLC protein
CTD
PMID:11444866 PMID:16298738 PMID:18814483
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
multiple interactions affects expression
EXP
Vitamin E affects the reaction [[REL binds to GCLM promoter] which affects the expression of GCLM mRNA] Vitamin E affects the expression of GCLM mRNA
CTD
PMID:16298738 PMID:20447326
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:210,347,482...210,367,535
G
Gdap1l1
ganglioside-induced differentiation-associated protein 1-like 1
decreases expression
ISO
Vitamin E results in decreased expression of GDAP1L1 mRNA
CTD
PMID:19244175
NCBI chr 3:152,110,225...152,129,693
Ensembl chr 3:152,110,253...152,128,711
G
Gdi1
GDP dissociation inhibitor 1
increases expression
ISO
Vitamin E results in increased expression of GDI1 mRNA
CTD
PMID:19244175
NCBI chr X:157,238,900...157,245,562
Ensembl chr X:152,087,444...152,094,272
G
Gfap
glial fibrillary acidic protein
multiple interactions
EXP
Vitamin E inhibits the reaction [Aluminum results in increased expression of GFAP protein]
CTD
PMID:16545059
NCBI chr10:88,352,987...88,361,661
Ensembl chr10:87,852,890...87,861,589
G
Gfod1
Gfo/Idh/MocA-like oxidoreductase domain containing 1
increases expression
ISO
Vitamin E results in increased expression of GFOD1 mRNA
CTD
PMID:19244175
NCBI chr17:21,400,142...21,504,972
Ensembl chr17:21,399,479...21,499,938
G
Gfus
GDP-L-fucose synthase
increases expression
ISO
Vitamin E results in increased expression of GFUS mRNA
CTD
PMID:19244175
NCBI chr 7:109,492,808...109,497,719
Ensembl chr 7:107,612,094...107,616,948
G
Ggps1
geranylgeranyl diphosphate synthase 1
decreases expression
ISO
Vitamin E results in decreased expression of GGPS1 mRNA
CTD
PMID:19244175
NCBI chr17:55,958,750...55,982,762
Ensembl chr17:51,263,263...51,276,220
G
Ggt1
gamma-glutamyltransferase 1
multiple interactions
ISO EXP
[Selenium co-treated with Vitamin E] results in increased expression of GGT1 mRNA Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of GGT1 protein]
CTD
PMID:16298753 PMID:19244175
NCBI chr20:13,074,141...13,103,551
Ensembl chr20:13,074,700...13,108,442
G
Gigyf2
GRB10 interacting GYF protein 2
decreases expression
ISO
Vitamin E results in decreased expression of GIGYF2 mRNA
CTD
PMID:19244175
NCBI chr 9:95,449,143...95,574,927
Ensembl chr 9:88,001,301...88,125,715
G
Gimap5
GTPase, IMAP family member 5
increases expression
ISO
Vitamin E results in increased expression of GIMAP5 mRNA
CTD
PMID:19244175
NCBI chr 4:79,025,151...79,031,917
Ensembl chr 4:77,687,564...77,703,086
G
Gipc1
GIPC PDZ domain containing family, member 1
increases expression multiple interactions
ISO
Vitamin E results in increased expression of GIPC1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of GIPC1 mRNA
CTD
PMID:19244175
NCBI chr19:41,380,125...41,392,078
Ensembl chr19:24,453,123...24,486,997
G
Gja1
gap junction protein, alpha 1
multiple interactions
EXP
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of GJA1 protein]; [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of GJA1 protein]
CTD
PMID:29940330
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:35,755,991...35,768,582
G
Glg1
golgi glycoprotein 1
decreases expression increases expression
ISO
Vitamin E results in decreased expression of GLG1 mRNA Vitamin E results in increased expression of GLG1 mRNA
CTD
PMID:19244175
NCBI chr19:56,034,248...56,133,538
Ensembl chr19:39,124,641...39,224,178
G
Gli2
GLI family zinc finger 2
increases expression
ISO
Vitamin E results in increased expression of GLI2 mRNA
CTD
PMID:19244175
NCBI chr13:32,499,678...32,716,418
Ensembl chr13:29,946,809...30,163,574
G
Glmn
glomulin, FKBP associated protein
decreases expression
ISO
Vitamin E results in decreased expression of GLMN mRNA
CTD
PMID:19244175
NCBI chr14:2,332,052...2,375,366
Ensembl chr14:2,187,642...2,230,420
G
Gmppa
GDP-mannose pyrophosphorylase A
increases expression
ISO
Vitamin E results in increased expression of GMPPA mRNA
CTD
PMID:19244175
NCBI chr 9:76,926,724...76,934,274
Ensembl chr 9:76,926,739...76,934,269
G
Gnas
GNAS complex locus
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of GNAS mRNA
CTD
PMID:19244175
NCBI chr 3:183,489,648...183,554,570
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
G
Gnaz
G protein subunit alpha z
increases expression
ISO
Vitamin E results in increased expression of GNAZ mRNA
CTD
PMID:19244175
NCBI chr20:13,642,853...13,693,616
Ensembl chr20:13,644,640...13,669,907
G
Gng4
G protein subunit gamma 4
decreases expression
ISO
Vitamin E results in decreased expression of GNG4 mRNA
CTD
PMID:19244175
NCBI chr17:93,432,791...93,481,709
Ensembl chr17:86,449,022...86,495,254
G
Golga3
golgin A3
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of GOLGA3 mRNA Vitamin E results in increased expression of GOLGA3 mRNA
CTD
PMID:19244175
NCBI chr12:52,112,129...52,160,311
Ensembl chr12:46,454,870...46,500,509 Ensembl chr 4:46,454,870...46,500,509
G
Gosr1
golgi SNAP receptor complex member 1
decreases expression
ISO
Vitamin E results in decreased expression of GOSR1 mRNA
CTD
PMID:19244175
NCBI chr10:62,068,662...62,105,442
Ensembl chr10:61,450,494...61,607,177 Ensembl chr10:61,450,494...61,607,177
G
Got1
glutamic-oxaloacetic transaminase 1
multiple interactions
EXP
Vitamin E inhibits the reaction [Hexachlorobenzene results in increased activity of GOT1 protein]; Vitamin E inhibits the reaction [Tramadol results in increased expression of GOT1 protein]
CTD
PMID:30064338 PMID:31618080
NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:242,357,306...242,380,633
G
Gp6
glycoprotein VI
decreases expression
ISO
Vitamin E results in decreased expression of GP6 mRNA
CTD
PMID:19244175
NCBI chr 1:78,471,900...78,535,374
Ensembl chr 1:69,465,789...69,491,326
G
Gpatch8
G patch domain containing 8
decreases expression
ISO
Vitamin E results in decreased expression of GPATCH8 mRNA
CTD
PMID:19244175
NCBI chr10:87,432,020...87,512,594
Ensembl chr10:87,433,266...87,512,419
G
Gpi
glucose-6-phosphate isomerase
increases expression
ISO
Vitamin E results in increased expression of GPI mRNA
CTD
PMID:19244175
NCBI chr 1:95,965,389...95,996,932
Ensembl chr 1:86,828,216...86,856,086
G
Gpkow
G patch domain and KOW motifs
increases expression
ISO
Vitamin E results in increased expression of GPKOW mRNA
CTD
PMID:19244175
NCBI chr X:17,463,521...17,478,298
Ensembl chr X:14,791,610...14,806,384
G
Gpn3
GPN-loop GTPase 3
decreases expression
ISO
Vitamin E results in decreased expression of GPN3 mRNA
CTD
PMID:19244175
NCBI chr12:34,189,285...34,198,251
Ensembl chr12:34,189,577...34,198,206
G
Gpr107
G protein-coupled receptor 107
increases expression
ISO
Vitamin E results in increased expression of GPR107 mRNA
CTD
PMID:19244175
NCBI chr 3:14,431,704...14,497,623
Ensembl chr 3:14,434,723...14,495,958
G
Gprin2
G protein regulated inducer of neurite outgrowth 2
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of GPRIN2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of GPRIN2 mRNA
CTD
PMID:19244175
NCBI chr16:9,496,452...9,512,672
Ensembl chr16:9,505,643...9,507,010
G
Gpt
glutamic--pyruvic transaminase
multiple interactions
EXP
[Quercetin co-treated with Vitamin E] inhibits the reaction [Cyclosporine results in increased activity of GPT protein]; Vitamin E inhibits the reaction [Cyclophosphamide results in increased expression of GPT protein]; Vitamin E inhibits the reaction [Cyclosporine results in increased activity of GPT protein]; Vitamin E inhibits the reaction [Food Additives results in increased activity of GPT protein]; Vitamin E inhibits the reaction [Hexachlorobenzene results in increased activity of GPT protein]; Vitamin E inhibits the reaction [Tramadol results in increased expression of GPT protein]
CTD
PMID:16758767 PMID:17927767 PMID:25779342 PMID:30064338 PMID:31618080
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494
G
Gpx1
glutathione peroxidase 1
multiple interactions decreases expression
ISO EXP
[Ascorbic Acid co-treated with Vitamin E] results in increased expression of GPX1 mRNA; [Vitamin A co-treated with Ascorbic Acid co-treated with Vitamin E] results in increased expression of GPX1 protein; Vitamin E inhibits the reaction [Aluminum results in decreased activity of GPX1 protein] Vitamin E decreases expression of Gpx1 mRNA in distal colon [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of GPX1 protein]; [Curcumin co-treated with Vitamin E] inhibits the reaction [Thyroxine results in increased expression of GPX1 protein]; [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of GPX1 mRNA; [Vitamin E co-treated with Folic Acid] inhibits the reaction [Hydrogen Peroxide results in decreased activity of GPX1 protein]; Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of GPX1 protein]; Vitamin E inhibits the reaction [Endosulfan results in increased activity of GPX1 protein]; Vitamin E inhibits the reaction [Hexachlorobenzene results in increased activity of GPX1 protein]; Vitamin E inhibits the reaction [Thyroxine results in decreased expression of GPX1 mRNA]
CTD RGD
PMID:11444866 PMID:15337585 PMID:16298753 PMID:17179735 PMID:17709913 PMID:19914224 PMID:22207723 PMID:28849685 PMID:29663635 PMID:30064338 PMID:16038882 More...
RGD:152998891
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:109,026,905...109,028,024
G
Gpx2
glutathione peroxidase 2
multiple interactions
EXP
Vitamin E inhibits the reaction [phoxim results in increased expression of GPX2 mRNA]
CTD
PMID:30003487
NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:95,493,589...95,496,877
G
Gpx3
glutathione peroxidase 3
increases expression
ISO
Vitamin E results in increased expression of GPX3 mRNA
CTD
PMID:19244175
NCBI chr10:39,529,335...39,537,406
Ensembl chr10:39,028,570...39,037,035
G
Grhpr
glyoxylate and hydroxypyruvate reductase
increases expression
ISO
Vitamin E results in increased expression of GRHPR mRNA
CTD
PMID:19244175
NCBI chr 5:64,029,856...64,039,287
Ensembl chr 5:59,234,192...59,243,603
G
Gria2
glutamate ionotropic receptor AMPA type subunit 2
decreases expression
ISO
Vitamin E results in decreased expression of GRIA2 mRNA
CTD
PMID:19244175
NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:165,947,521...166,069,510
G
Grina
glutamate ionotropic receptor NMDA type subunit associated protein 1
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of GRINA mRNA
CTD
PMID:19244175
NCBI chr 7:109,842,870...109,846,048
Ensembl chr 7:107,962,207...107,965,366
G
Grk3
G protein-coupled receptor kinase 3
decreases expression
ISO
Vitamin E results in decreased expression of GRK3 mRNA
CTD
PMID:19244175
NCBI chr12:49,285,228...49,395,803
Ensembl chr12:43,624,897...43,731,262
G
Grn
granulin precursor
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of GRN mRNA Vitamin E results in increased expression of GRN mRNA
CTD
PMID:19244175
NCBI chr10:87,887,834...87,893,938
Ensembl chr10:87,387,638...87,393,775
G
Gsk3a
glycogen synthase kinase 3 alpha
increases expression
ISO
Vitamin E results in increased expression of GSK3A mRNA
CTD
PMID:19244175
NCBI chr 1:89,943,669...89,953,514
Ensembl chr 1:80,815,850...80,825,802
G
Gsk3b
glycogen synthase kinase 3 beta
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of GSK3B mRNA Vitamin E results in decreased expression of GSK3B mRNA Vitamin E inhibits the reaction [wortmannin results in decreased expression of GSK3B protein modified form]
CTD
PMID:15842767 PMID:19244175
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:62,504,316...62,648,646
G
Gsn
gelsolin
increases expression
ISO
Vitamin E results in increased expression of GSN mRNA
CTD
PMID:19244175
NCBI chr 3:38,982,605...39,035,849
Ensembl chr 3:18,585,172...18,638,402
G
Gsr
glutathione-disulfide reductase
multiple interactions
ISO EXP
Vitamin E inhibits the reaction [Cadmium results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Ethanol results in decreased activity of GSR protein] [Curcumin co-treated with Vitamin E] inhibits the reaction [Thyroxine results in decreased expression of GSR mRNA]; [Vitamin E co-treated with coenzyme Q10] inhibits the reaction [Cadmium Chloride results in decreased activity of GSR protein]; [Vitamin E co-treated with coenzyme Q10] results in increased activity of GSR protein; [Vitamin E co-treated with Folic Acid] inhibits the reaction [Hydrogen Peroxide results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Cadmium Chloride results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Cadmium results in increased activity of GSR protein]; Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Diethylnitrosamine results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Hydrogen Peroxide results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Methoxychlor results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Tetrachlorodibenzodioxin results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Thyroxine results in decreased expression of GSR mRNA]
CTD
PMID:11955947 PMID:12355564 PMID:14535831 PMID:16144695 PMID:16298753 PMID:17262218 PMID:19914224 PMID:19958828 PMID:21086752 PMID:28849685 More...
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
G
Gstk1
glutathione S-transferase kappa 1
increases expression
ISO
Vitamin E results in increased expression of GSTK1 mRNA
CTD
PMID:19244175
NCBI chr 4:72,085,532...72,089,934
Ensembl chr 4:71,118,896...71,123,292
G
Gstm5l
glutathione S-transferase, mu 5-like
increases expression
ISO
Vitamin E results in increased expression of GSTM5 mRNA
CTD
PMID:19244175
NCBI chr 2:195,544,424...195,549,895
Ensembl chr 2:195,544,426...195,628,961
G
Gstp1
glutathione S-transferase pi 1
increases expression multiple interactions
ISO
Vitamin E results in increased expression of GSTP1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of GSTP1 mRNA
CTD
PMID:19244175
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
G
Gtf2f1
general transcription factor IIF subunit 1
decreases expression
ISO
Vitamin E results in decreased expression of GTF2F1 mRNA
CTD
PMID:19244175
NCBI chr 9:1,931,033...1,940,197
Ensembl chr 9:1,843,901...1,853,423
G
Gtf2ird1
GTF2I repeat domain containing 1
decreases expression
ISO
Vitamin E results in decreased expression of GTF2IRD1 mRNA
CTD
PMID:19244175
NCBI chr12:22,254,113...22,361,052
Ensembl chr12:22,254,221...22,361,040
G
Gtpbp8
GTP binding protein 8
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of GTPBP8 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of GTPBP8 mRNA
CTD
PMID:19244175
NCBI chr11:55,945,778...55,955,743
Ensembl chr11:55,945,795...55,955,635
G
H3f3a
H3.3 histone A
decreases expression
ISO
Vitamin E results in decreased expression of H3-3A mRNA
CTD
PMID:19244175
NCBI chr13:92,533,289...92,544,902
Ensembl chr13:92,533,298...92,544,908
G
H6pd
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
increases expression multiple interactions
ISO
Vitamin E results in increased expression of H6PD mRNA [Selenium co-treated with Vitamin E] results in decreased expression of H6PD mRNA
CTD
PMID:19244175
NCBI chr 5:165,717,456...165,753,158
Ensembl chr 5:160,438,697...160,470,171
G
Hadha
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
decreases expression
ISO
Vitamin E results in decreased expression of HADHA mRNA
CTD
PMID:19244175
NCBI chr 6:31,907,801...31,947,434
Ensembl chr 6:26,187,956...26,227,869
G
Hagh
hydroxyacyl glutathione hydrolase
increases expression
ISO
Vitamin E results in increased expression of HAGH mRNA
CTD
PMID:19244175
NCBI chr10:14,379,400...14,394,046
Ensembl chr10:13,875,241...13,889,504
G
Hamp
hepcidin antimicrobial peptide
multiple interactions
ISO
Vitamin E inhibits the reaction [Ethanol results in decreased expression of HAMP mRNA]
CTD
PMID:16737972
NCBI chr 1:95,298,332...95,300,271
Ensembl chr 1:86,170,901...86,172,891
G
Hars1
histidyl-tRNA synthetase 1
increases expression
ISO
Vitamin E results in increased expression of HARS1 mRNA
CTD
PMID:19244175
NCBI chr18:28,655,669...28,672,712
Ensembl chr18:28,381,655...28,398,740
G
Haus3
HAUS augmin-like complex, subunit 3
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of HAUS3 mRNA Vitamin E results in decreased expression of HAUS3 mRNA
CTD
PMID:19244175
NCBI chr14:76,580,549...76,599,542
Ensembl chr14:76,580,546...76,752,463
G
Haus4
HAUS augmin-like complex, subunit 4
increases expression
ISO
Vitamin E results in increased expression of HAUS4 mRNA
CTD
PMID:19244175
NCBI chr15:31,964,555...31,976,853
Ensembl chr15:27,994,532...28,005,938
G
Hba-a2
hemoglobin alpha, adult chain 2
decreases expression
ISO
Vitamin E results in decreased expression of HBA1 protein
CTD
PMID:1991440
NCBI chr10:15,828,291...15,829,138
Ensembl chr10:15,307,815...15,338,392 Ensembl chr10:15,307,815...15,338,392
G
Hba-a3
hemoglobin alpha, adult chain 3
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of HBA2 mRNA
CTD
PMID:19244175
NCBI chr10:15,816,099...15,816,943
Ensembl chr10:15,311,634...15,312,481
G
Hcfc1
host cell factor C1
increases expression
ISO
Vitamin E results in increased expression of HCFC1 mRNA
CTD
PMID:19244175
NCBI chr X:156,839,100...156,864,132
Ensembl chr X:151,687,779...151,712,638
G
Hdac1
histone deacetylase 1
increases expression
ISO
Vitamin E results in increased expression of HDAC1 mRNA
CTD
PMID:19244175
NCBI chr 5:147,138,328...147,165,387
Ensembl chr 5:141,853,989...141,881,111
G
Hdac5
histone deacetylase 5
increases expression
ISO
Vitamin E results in increased expression of HDAC5 mRNA
CTD
PMID:19244175
NCBI chr10:87,653,139...87,688,078
Ensembl chr10:87,152,978...87,188,235
G
Hemk1
HemK methyltransferase family member 1
increases expression
ISO
Vitamin E results in increased expression of HEMK1 mRNA
CTD
PMID:19244175
NCBI chr 8:107,999,658...108,010,732
Ensembl chr 8:107,999,644...108,010,256
G
Hes1
hes family bHLH transcription factor 1
decreases expression multiple interactions
ISO EXP
Vitamin E results in decreased expression of HES1 mRNA [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of HES1 protein] [Selenium co-treated with Vitamin E] results in increased expression of HES1 mRNA
CTD
PMID:19244175 PMID:29663635
NCBI chr11:84,210,632...84,213,045
Ensembl chr11:70,705,764...70,708,192
G
Hif1a
hypoxia inducible factor 1 subunit alpha
decreases expression
ISO
Vitamin E results in decreased expression of HIF1A protein
CTD
PMID:16507596
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Hif1an
hypoxia inducible factor 1 subunit alpha inhibitor
increases expression
ISO
Vitamin E results in increased expression of HIF1AN mRNA
CTD
PMID:19244175
NCBI chr 1:253,368,400...253,385,495
Ensembl chr 1:243,419,194...243,434,327
G
Higd2a
HIG1 hypoxia inducible domain family, member 2A
increases expression
ISO
Vitamin E results in increased expression of HIGD2A mRNA
CTD
PMID:19244175
NCBI chr17:10,021,853...10,022,777
Ensembl chr17:10,021,859...10,022,796
G
Hipk2
homeodomain interacting protein kinase 2
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of HIPK2 mRNA Vitamin E results in decreased expression of HIPK2 mRNA
CTD
PMID:19244175
NCBI chr 4:68,399,358...68,586,404
Ensembl chr 4:67,440,501...67,619,223
G
Hmces
5-hydroxymethylcytosine binding, ES cell specific
increases expression
ISO
Vitamin E results in increased expression of HMCES mRNA
CTD
PMID:19244175
NCBI chr 4:121,950,129...121,972,937
Ensembl chr 4:120,366,542...120,415,616
G
Hmgb1
high mobility group box 1
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of HMGB1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of HMGB1 mRNA
CTD
PMID:19244175
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmgxb4
HMG-box containing 4
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of HMGXB4 mRNA Vitamin E results in decreased expression of HMGXB4 mRNA
CTD
PMID:19244175
NCBI chr19:13,364,741...13,403,563
Ensembl chr19:13,364,807...13,403,563
G
Hmox1
heme oxygenase 1
multiple interactions increases expression
EXP ISO
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of HMOX1 protein]; Vitamin E inhibits the reaction [Doxorubicin results in decreased expression of HMOX1 mRNA] [Vitamin E co-treated with bioallethrin] results in increased expression of HMOX1 protein; Vitamin E inhibits the reaction [Polychlorinated Biphenyls analog results in increased expression of HMOX1 protein] Vitamin E results in increased expression of HMOX1 mRNA
CTD
PMID:15571180 PMID:24361488 PMID:29663635 PMID:29940330 PMID:30513525 PMID:35511042 PMID:38997059 More...
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hnmt
histamine N-methyltransferase
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of HNMT mRNA Vitamin E results in decreased expression of HNMT mRNA
CTD
PMID:19244175
NCBI chr 3:26,978,274...27,010,291
Ensembl chr 3:6,591,463...6,624,012
G
Hnrnpm
heterogeneous nuclear ribonucleoprotein M
increases expression
ISO
Vitamin E results in increased expression of HNRNPM mRNA
CTD
PMID:19244175
NCBI chr 7:15,140,877...15,178,871
Ensembl chr 7:14,438,688...14,476,762
G
Hnrnpr
heterogeneous nuclear ribonucleoprotein R
decreases expression
ISO
Vitamin E results in decreased expression of HNRNPR mRNA
CTD
PMID:19244175
NCBI chr 5:153,826,482...153,872,272
Ensembl chr 5:148,543,044...148,574,867
G
Homer1
homer scaffold protein 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of HOMER1 mRNA Vitamin E results in decreased expression of HOMER1 mRNA
CTD
PMID:19244175
NCBI chr 2:26,279,012...26,388,279
Ensembl chr 2:24,543,093...24,644,785
G
Hook1
hook microtubule-tethering protein 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of HOOK1 mRNA Vitamin E results in decreased expression of HOOK1 mRNA
CTD
PMID:19244175
NCBI chr 5:110,824,501...110,887,791
Ensembl chr 5:110,824,501...110,887,787
G
Hoxa11
homeobox A11
increases expression
ISO
Vitamin E results in increased expression of HOXA11 mRNA
CTD
PMID:19244175
NCBI chr 4:81,342,527...81,346,189
Ensembl chr 4:81,342,528...81,346,232
G
Hoxa7
homeobox A7
decreases expression
ISO
Vitamin E results in decreased expression of HOXA7 mRNA
CTD
PMID:19244175
NCBI chr 4:82,646,342...82,652,449
Ensembl chr 4:81,314,625...81,317,659
G
Hpcal1
hippocalcin-like 1
increases expression multiple interactions
ISO
Vitamin E results in increased expression of HPCAL1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of HPCAL1 mRNA
CTD
PMID:19244175
NCBI chr 6:40,478,206...40,584,721
Ensembl chr 6:40,478,208...40,584,687
G
Hprt1
hypoxanthine phosphoribosyltransferase 1
multiple interactions
EXP
Vitamin E inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased mutagenesis of HPRT1 gene]
CTD
PMID:12467141
NCBI chr X:137,655,744...137,687,718
Ensembl chr X:132,736,096...132,768,154
G
Hras
HRas proto-oncogene, GTPase
multiple interactions increases expression
ISO
Vitamin E inhibits the reaction [Urethane promotes the reaction [RAF1 protein binds to HRAS protein]] Vitamin E results in increased expression of HRAS mRNA [Selenium co-treated with Vitamin E] results in increased expression of HRAS mRNA
CTD
PMID:11062179 PMID:19244175
NCBI chr 1:205,712,625...205,729,406
Ensembl chr 1:196,296,263...196,300,615
G
Hsd11b1
hydroxysteroid 11-beta dehydrogenase 1
increases expression
ISO
Vitamin E results in increased expression of HSD11B1 mRNA
CTD
PMID:19244175
NCBI chr13:107,277,526...107,327,462
Ensembl chr13:104,728,539...104,788,687
G
Hsd11b2
hydroxysteroid 11-beta dehydrogenase 2
multiple interactions
EXP
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of HSD11B2 mRNA
CTD
PMID:11444866
NCBI chr19:50,307,569...50,312,812
Ensembl chr19:33,397,656...33,402,899
G
Hsd17b3
hydroxysteroid (17-beta) dehydrogenase 3
multiple interactions
EXP
Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of HSD17B3 mRNA]
CTD
PMID:17280759
NCBI chr17:1,032,958...1,064,283
Ensembl chr17:1,027,229...1,058,554
G
Hsd17b8
hydroxysteroid (17-beta) dehydrogenase 8
increases expression
ISO
Vitamin E results in increased expression of HSD17B8 mRNA
CTD
PMID:19244175
NCBI chr20:4,826,725...4,828,742
Ensembl chr20:4,822,026...4,828,742
G
Hsd3b1
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
multiple interactions
EXP
Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of HSD3B1 mRNA]
CTD
PMID:17280759
NCBI chr 2:188,858,574...188,864,694
Ensembl chr 2:186,169,863...186,175,999
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of HSP90AA1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of HSP90AA1 mRNA
CTD
PMID:19244175
NCBI chr 6:135,523,604...135,529,687
Ensembl chr 6:129,702,383...129,707,268
G
Hsp90ab1
heat shock protein 90 alpha family class B member 1
increases expression
ISO
Vitamin E results in increased expression of HSP90AB1 mRNA
CTD
PMID:19244175
NCBI chr 9:22,930,249...22,935,929
Ensembl chr 9:15,433,691...15,438,488
G
Hsp90b1
heat shock protein 90 beta family member 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of HSP90B1 mRNA Vitamin E results in decreased expression of HSP90B1 mRNA
CTD
PMID:19244175
NCBI chr 7:22,997,962...23,012,293
Ensembl chr 7:21,110,457...21,124,788
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
increases expression
ISO
Vitamin E results in increased expression of HSPA1A mRNA
CTD
PMID:19244175
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,856,006...3,873,227
G
Hspa4
heat shock protein family A (Hsp70) member 4
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of HSPA4 mRNA Vitamin E results in increased expression of HSPA4 mRNA
CTD
PMID:19244175
NCBI chr10:37,908,866...37,951,994
Ensembl chr10:37,408,025...37,449,001
G
Hspa5
heat shock protein family A (Hsp70) member 5
multiple interactions
ISO
Vitamin E inhibits the reaction [pyrazole results in increased expression of HSPA5 protein]
CTD
PMID:18068688
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:18,055,405...18,059,891
G
Hspa9
heat shock protein family A (Hsp70) member 9
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of HSPA9 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of HSPA9 mRNA
CTD
PMID:19244175
NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,535,798...26,554,292
G
Hspb1
heat shock protein family B (small) member 1
increases expression
ISO
Vitamin E results in increased expression of HSPB1 mRNA
CTD
PMID:19244175
NCBI chr12:26,430,640...26,432,301
Ensembl chr12:20,794,028...20,795,743
G
Htra1
HtrA serine peptidase 1
increases expression
ISO
Vitamin E results in increased expression of HTRA1 mRNA
CTD
PMID:19244175
NCBI chr 1:194,928,069...194,977,619
Ensembl chr 1:185,497,735...185,547,379
G
Htra2
HtrA serine peptidase 2
multiple interactions
ISO
Vitamin E inhibits the reaction [cinnamaldehyde affects the localization of HTRA2 protein]
CTD
PMID:15566391
NCBI chr 4:117,114,631...117,117,793
Ensembl chr 4:115,556,916...115,560,095
G
Iars1
isoleucyl-tRNA synthetase 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of IARS1 mRNA Vitamin E results in decreased expression of IARS1 mRNA
CTD
PMID:19244175
NCBI chr17:15,147,357...15,193,716
Ensembl chr17:14,940,924...14,987,237
G
Ica1
islet cell autoantigen 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of ICA1 mRNA Vitamin E results in increased expression of ICA1 mRNA
CTD
PMID:19244175
NCBI chr 4:37,622,759...37,771,055
Ensembl chr 4:36,656,475...36,804,298
G
Icam1
intercellular adhesion molecule 1
multiple interactions
ISO
[Vitamin E co-treated with Bezafibrate] results in decreased expression of ICAM1 protein modified form; Vitamin E inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of ICAM1 protein]; Vitamin E inhibits the reaction [Norepinephrine results in increased expression of ICAM1 mRNA]; Vitamin E inhibits the reaction [Simvastatin results in decreased expression of ICAM1 protein modified form]
CTD
PMID:14602771 PMID:23114885 PMID:35349355
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Id2
inhibitor of DNA binding 2
decreases expression
ISO
Vitamin E results in decreased expression of ID2 mRNA
CTD
PMID:19244175
NCBI chr 6:47,469,162...47,470,995
Ensembl chr 6:41,728,946...41,744,400
G
Idh3b
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta
increases expression
ISO
Vitamin E results in increased expression of IDH3B mRNA
CTD
PMID:19244175
NCBI chr 3:137,934,971...137,940,275
Ensembl chr 3:117,481,845...117,486,982
G
Idh3g
isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of IDH3G mRNA Vitamin E results in increased expression of IDH3G mRNA
CTD
PMID:19244175
NCBI chr X:156,666,573...156,675,482
Ensembl chr X:151,515,247...151,524,171
G
Ids
iduronate 2-sulfatase
increases expression
ISO
Vitamin E results in increased expression of IDS mRNA
CTD
PMID:19244175
NCBI chr X:149,025,976...149,046,641
Ensembl chr X:149,025,976...149,046,663
G
Idua
alpha-L-iduronidase
increases expression multiple interactions
ISO
Vitamin E results in increased expression of IDUA mRNA [Selenium co-treated with Vitamin E] results in increased expression of IDUA mRNA
CTD
PMID:19244175
NCBI chr14:1,175,994...1,203,913
Ensembl chr14:1,032,171...1,046,522
G
Iffo1
intermediate filament family orphan 1
increases expression
ISO
Vitamin E results in increased expression of IFFO1 mRNA
CTD
PMID:19244175
NCBI chr 4:159,631,309...159,648,531
Ensembl chr 4:157,945,107...157,962,302
G
Ifi35
interferon-induced protein 35
increases expression
ISO
Vitamin E results in increased expression of IFI35 mRNA
CTD
PMID:19244175
NCBI chr10:86,881,270...86,889,523
Ensembl chr10:86,381,010...86,389,952
G
Ifitm1
interferon induced transmembrane protein 1
increases expression
ISO
Vitamin E results in increased expression of IFITM1 mRNA
CTD
PMID:19244175
NCBI chr 1:205,496,757...205,498,796
Ensembl chr 1:196,067,963...196,069,169
G
Ifitm2
interferon induced transmembrane protein 2
increases expression
ISO
Vitamin E results in increased expression of IFITM2 mRNA
CTD
PMID:19244175
NCBI chr 1:205,481,168...205,482,348
Ensembl chr 1:196,051,537...196,052,741
G
Ifitm3
interferon induced transmembrane protein 3
increases expression
ISO
Vitamin E results in increased expression of IFITM3 mRNA
CTD
PMID:19244175
NCBI chr 1:205,540,649...205,541,758
Ensembl chr 1:196,111,043...196,112,203
G
Ifng
interferon gamma
multiple interactions decreases expression
ISO EXP
Vitamin E inhibits the reaction [Ethanol results in increased activity of IFNG protein] Vitamin E inhibits the reaction [APP protein modified form promotes the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of NOS2 protein]] Vitamin E results in decreased expression of IFNG protein
CTD
PMID:14624943 PMID:15223066 PMID:21086752
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
G
Ift74
intraflagellar transport 74
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of IFT74 mRNA Vitamin E results in decreased expression of IFT74 mRNA
CTD
PMID:19244175
NCBI chr 5:109,460,372...109,563,839
Ensembl chr 5:109,474,255...109,563,833
G
Ift81
intraflagellar transport 81
decreases expression
ISO
Vitamin E results in decreased expression of IFT81 mRNA
CTD
PMID:19244175
NCBI chr12:39,618,559...39,697,971
Ensembl chr12:33,957,806...34,037,057
G
Igf1r
insulin-like growth factor 1 receptor
multiple interactions decreases expression
ISO EXP
Rutin results in increased susceptibility to [Vitamin E results in decreased expression of IGF1R protein] Vitamin E inhibits the reaction [Thyroxine results in increased expression of IGF1R protein] Vitamin E results in decreased expression of IGF1R mRNA; Vitamin E results in decreased expression of IGF1R protein
CTD
PMID:17447016 PMID:19244175 PMID:20015448
NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:121,550,743...121,831,777
G
Igf2bp2
insulin-like growth factor 2 mRNA binding protein 2
decreases expression
ISO
Vitamin E results in decreased expression of IGF2BP2 mRNA
CTD
PMID:19244175
NCBI chr11:92,378,908...92,478,893
Ensembl chr11:78,874,414...78,974,377
G
Igf2r
insulin-like growth factor 2 receptor
decreases expression
ISO
Vitamin E results in decreased expression of IGF2R mRNA
CTD
PMID:19244175
NCBI chr 1:50,526,878...50,615,265
Ensembl chr 1:47,979,109...48,067,501
G
Igfbp2
insulin-like growth factor binding protein 2
increases expression
ISO
Vitamin E results in increased expression of IGFBP2 mRNA
CTD
PMID:19244175
NCBI chr 9:81,864,811...81,892,179
Ensembl chr 9:74,415,546...74,442,937
G
Igfbp4
insulin-like growth factor binding protein 4
increases expression
ISO
Vitamin E results in increased expression of IGFBP4 mRNA
CTD
PMID:19244175
NCBI chr10:84,491,471...84,503,487
Ensembl chr10:83,989,591...84,007,225
G
Igfbp6
insulin-like growth factor binding protein 6
increases expression
ISO
Vitamin E results in increased expression of IGFBP6 mRNA
CTD
PMID:19244175
NCBI chr 7:135,154,919...135,159,550
Ensembl chr 7:133,276,234...133,280,966
G
Ik
IK cytokine
increases expression
ISO
Vitamin E results in increased expression of IK mRNA
CTD
PMID:19244175
NCBI chr18:28,632,025...28,646,829
Ensembl chr18:28,357,977...28,378,832
G
Il10
interleukin 10
multiple interactions
ISO EXP
Vitamin E inhibits the reaction [Ethanol results in increased activity of IL10 protein] [Vanadium co-treated with Selenium co-treated with Vitamin E co-treated with Chromium] inhibits the reaction [Streptozocin results in decreased expression of IL10 protein]
CTD
PMID:15862027 PMID:21086752
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
G
Il13
interleukin 13
multiple interactions
ISO
Vitamin E inhibits the reaction [Ozone results in increased expression of IL13 protein]
CTD
PMID:30090343
NCBI chr10:38,290,926...38,293,483
Ensembl chr10:37,790,130...37,792,737
G
Il13ra1
interleukin 13 receptor subunit alpha 1
increases expression
ISO
Vitamin E results in increased expression of IL13RA1 mRNA
CTD
PMID:19244175
NCBI chr X:120,213,670...120,294,777
Ensembl chr X:115,348,860...115,408,681 Ensembl chr11:115,348,860...115,408,681
G
Il1b
interleukin 1 beta
multiple interactions increases expression
ISO EXP
alpha-Tocopherol inhibits the reaction [Vitamin E deficiency results in increased expression of IL1B mRNA]; Quercetin inhibits the reaction [Vitamin E deficiency results in increased expression of IL1B mRNA] Vitamin E inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of IL1B protein] Vitamin E inhibits the reaction [[IL1B protein co-treated with TNF protein] results in increased chemical synthesis of Nitric Oxide]; Vitamin E inhibits the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of NOS2 protein]; Vitamin E inhibits the reaction [Aluminum results in increased expression of IL1B protein]; Vitamin E inhibits the reaction [Vehicle Emissions results in increased expression of IL1B mRNA]
CTD
PMID:15223066 PMID:16545059 PMID:18234736 PMID:19735175 PMID:35349355
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il2
interleukin 2
multiple interactions
EXP
Vitamin E inhibits the reaction [Formaldehyde results in increased expression of IL2 protein]
CTD
PMID:16937016
NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:120,004,862...120,009,566
G
Il4
interleukin 4
decreases expression multiple interactions
ISO EXP
Vitamin E results in decreased expression of IL4 protein Vitamin E inhibits the reaction [Ozone results in increased expression of IL4 protein] [Vanadium co-treated with Selenium co-treated with Vitamin E co-treated with Chromium] results in increased expression of IL4 protein
CTD
PMID:14624943 PMID:15862027 PMID:30090343
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:37,771,203...37,776,750
G
Il4r
interleukin 4 receptor
increases expression multiple interactions
ISO
Vitamin E results in increased expression of IL4R mRNA [Selenium co-treated with Vitamin E] results in decreased expression of IL4R mRNA
CTD
PMID:19244175
NCBI chr 1:189,545,739...189,570,639
Ensembl chr 1:180,115,120...180,139,980
G
Il5
interleukin 5
multiple interactions
ISO
[Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3,4-dihydroxyphenylethanol] results in decreased expression of IL5 mRNA Vitamin E inhibits the reaction [Ozone results in increased expression of IL5 protein]
CTD
PMID:16797527 PMID:30090343
NCBI chr10:38,375,132...38,378,003
Ensembl chr10:37,874,342...37,877,213
G
Il6
interleukin 6
multiple interactions decreases expression
ISO EXP
[Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3,4-dihydroxyphenylethanol] results in decreased expression of IL6 mRNA; Vitamin E inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of IL6 protein] Vitamin E inhibits the reaction [Doxorubicin results in increased expression of IL6 protein]; Vitamin E inhibits the reaction [phoxim results in decreased expression of IL6 mRNA]; Vitamin E inhibits the reaction [Vehicle Emissions results in increased expression of IL6 mRNA]; Vitamin E inhibits the reaction [Vehicle Emissions results in increased expression of IL6 protein] Vitamin E results in decreased expression of IL6 protein
CTD
PMID:16797527 PMID:18234736 PMID:20370442 PMID:30003487 PMID:35349355 PMID:38997059 More...
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Ilf3
interleukin enhancer binding factor 3
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ILF3 mRNA Vitamin E results in decreased expression of ILF3 mRNA
CTD
PMID:19244175
NCBI chr 8:28,198,454...28,236,634
Ensembl chr 8:19,922,460...19,960,350
G
Ilk
integrin-linked kinase
increases expression
ISO
Vitamin E results in increased expression of ILK mRNA
CTD
PMID:19244175
NCBI chr 1:169,500,716...169,506,972
Ensembl chr 1:160,088,897...160,095,140
G
Inpp5k
inositol polyphosphate-5-phosphatase K
increases expression
ISO
Vitamin E results in increased expression of INPP5K mRNA
CTD
PMID:19244175
NCBI chr10:60,974,183...60,995,047
Ensembl chr10:60,475,897...60,496,773
G
Ins1
insulin 1
multiple interactions
ISO EXP
[Selenium co-treated with Vitamin E co-treated with Vanadium co-treated with Chromium] results in increased expression of INS1 mRNA; [Selenium co-treated with Vitamin E co-treated with Vanadium co-treated with Chromium] results in increased expression of INS1 protein [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of INS1 protein]; Vitamin E inhibits the reaction [Triiodothyronine, Reverse inhibits the reaction [INS1 protein results in increased uptake of Glucose]]
CTD
PMID:17198541 PMID:20108212 PMID:21911000
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:251,244,973...251,245,536
G
Insr
insulin receptor
multiple interactions
EXP
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of INSR mRNA]
CTD
PMID:21911000
NCBI chr12:5,991,135...6,129,275
Ensembl chr12:1,197,100...1,330,883
G
Ints15
integrator complex subunit 15
increases expression
ISO
Vitamin E results in increased expression of INTS15 mRNA
CTD
PMID:19244175
NCBI chr12:11,245,045...11,260,170
Ensembl chr12:11,245,842...11,260,166
G
Ints6
integrator complex subunit 6
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of INTS6 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of INTS6 mRNA
CTD
PMID:19244175
NCBI chr15:41,080,584...41,224,350
Ensembl chr15:36,933,724...37,021,527
G
Ipp
intracisternal A particle-promoted polypeptide
decreases expression
ISO
Vitamin E results in decreased expression of IPP mRNA
CTD
PMID:19244175
NCBI chr 5:135,199,198...135,237,912
Ensembl chr 5:129,962,643...130,001,242
G
Iqcb1
IQ motif containing B1
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of IQCB1 mRNA
CTD
PMID:19244175
NCBI chr11:77,410,986...77,465,540
Ensembl chr11:63,905,590...63,960,093
G
Iqck
IQ motif containing K
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of IQCK mRNA [Selenium co-treated with Vitamin E] results in decreased expression of IQCK mRNA
CTD
PMID:19244175
NCBI chr 1:173,199,308...173,316,982
Ensembl chr 1:173,199,316...173,316,984
G
Iqgap1
IQ motif containing GTPase activating protein 1
decreases expression
ISO
Vitamin E results in decreased expression of IQGAP1 mRNA
CTD
PMID:19244175
NCBI chr 1:144,088,788...144,178,989
Ensembl chr 1:134,679,586...134,769,755
G
Iqsec1
IQ motif and Sec7 domain ArfGEF 1
increases expression
ISO
Vitamin E results in increased expression of IQSEC1 mRNA
CTD
PMID:19244175
NCBI chr 4:123,168,719...123,488,300
Ensembl chr 4:123,168,719...123,488,172
G
Irf9
interferon regulatory factor 9
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of IRF9 mRNA Vitamin E results in increased expression of IRF9 mRNA
CTD
PMID:19244175
NCBI chr15:33,065,422...33,071,881
Ensembl chr15:29,095,789...29,101,236
G
Irs1
insulin receptor substrate 1
multiple interactions decreases expression
ISO EXP
Rutin results in increased susceptibility to [Vitamin E results in decreased expression of IRS1 protein]; Vitamin E results in increased susceptibility to [Rutin results in decreased expression of IRS1 protein] [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of IRS1 protein]; [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in decreased phosphorylation of IRS1 protein]
CTD
PMID:20015448 PMID:21911000
NCBI chr 9:91,001,137...91,053,959
Ensembl chr 9:83,548,944...83,606,122
G
Isca1
iron-sulfur cluster assembly 1
decreases expression
ISO
Vitamin E results in decreased expression of ISCA1 mRNA
CTD
PMID:19244175
NCBI chr17:4,910,816...4,923,478
Ensembl chr17:4,905,287...4,917,955
G
Islr
immunoglobulin superfamily containing leucine-rich repeat
increases expression
ISO
Vitamin E results in increased expression of ISLR mRNA
CTD
PMID:19244175
NCBI chr 8:58,571,155...58,574,128
Ensembl chr 8:58,570,777...58,574,130
G
Isyna1
inositol-3-phosphate synthase 1
increases expression
ISO
Vitamin E results in increased expression of ISYNA1 mRNA
CTD
PMID:19244175
NCBI chr16:18,873,119...18,876,116
Ensembl chr16:18,839,145...18,841,979
G
Itga3
integrin subunit alpha 3
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ITGA3 mRNA Vitamin E results in increased expression of ITGA3 mRNA
CTD
PMID:19244175
NCBI chr10:80,486,998...80,522,548
Ensembl chr10:79,990,161...80,022,118
G
Itgb3bp
integrin subunit beta 3 binding protein
decreases expression
ISO
Vitamin E results in decreased expression of ITGB3BP mRNA
CTD
PMID:19244175
NCBI chr 5:114,460,217...114,525,538
Ensembl chr 5:114,460,221...114,525,704
G
Itm2c
integral membrane protein 2C
increases expression
ISO
Vitamin E results in increased expression of ITM2C mRNA
CTD
PMID:19244175
NCBI chr 9:86,545,927...86,559,745
Ensembl chr 9:86,545,921...86,559,742
G
Itpkb
inositol-trisphosphate 3-kinase B
increases expression
ISO
Vitamin E results in increased expression of ITPKB mRNA
CTD
PMID:19244175
NCBI chr13:94,601,072...94,696,180
Ensembl chr13:92,069,216...92,162,004
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases phosphorylation decreases expression
ISO
Rutin results in increased susceptibility to [Vitamin E results in decreased expression of JUN protein]; Vitamin E results in increased susceptibility to [Rutin results in decreased expression of JUN protein] Vitamin E promotes the reaction [Alcohols results in increased expression of JUN mRNA] Vitamin E results in increased phosphorylation of JUN protein Vitamin E results in decreased expression of JUN mRNA; Vitamin E results in decreased expression of JUN protein
CTD
PMID:11522656 PMID:18814483 PMID:19244175 PMID:20015448
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
G
Kat5
lysine acetyltransferase 5
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of KAT5 mRNA
CTD
PMID:19244175
NCBI chr 1:212,325,089...212,332,640
Ensembl chr 1:202,895,751...202,903,458
G
Kbtbd2
kelch repeat and BTB domain containing 2
increases expression
ISO
Vitamin E results in increased expression of KBTBD2 mRNA
CTD
PMID:19244175
NCBI chr 4:87,358,133...87,380,399
Ensembl chr 4:86,027,947...86,050,211
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
multiple interactions increases expression
ISO
Vitamin E inhibits the reaction [TNF protein results in decreased activity of KCNH2 protein] Vitamin E results in increased expression of KCNH2 mRNA
CTD
PMID:14973143 PMID:19244175
NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:10,826,928...10,859,008
G
Kcnj5
potassium inwardly-rectifying channel, subfamily J, member 5
decreases expression
ISO
Vitamin E results in decreased expression of KCNJ5 mRNA
CTD
PMID:19244175
NCBI chr 8:38,981,598...39,011,197
Ensembl chr 8:30,724,925...30,753,518
G
Kcnj8
potassium inwardly-rectifying channel, subfamily J, member 8
increases expression
ISO
Vitamin E results in increased expression of KCNJ8 mRNA
CTD
PMID:19244175
NCBI chr 4:177,240,692...177,246,548
Ensembl chr 4:175,508,912...175,515,603
G
Kctd17
potassium channel tetramerization domain containing 17
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of KCTD17 mRNA
CTD
PMID:19244175
NCBI chr 7:111,859,556...111,891,869
Ensembl chr 7:109,979,060...110,008,927
G
Kctd2
potassium channel tetramerization domain containing 2
increases expression
ISO
Vitamin E results in increased expression of KCTD2 mRNA
CTD
PMID:19244175
NCBI chr10:101,162,091...101,173,721
Ensembl chr10:100,662,884...100,674,336
G
Kdm6b
lysine demethylase 6B
increases expression
ISO
Vitamin E results in increased expression of KDM6B mRNA
CTD
PMID:19244175
NCBI chr10:54,120,716...54,142,212
Ensembl chr10:54,121,848...54,130,794
G
Keap1
Kelch-like ECH-associated protein 1
multiple interactions
EXP
Vitamin E inhibits the reaction [Doxorubicin results in increased expression of KEAP1 mRNA]
CTD
PMID:38997059
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:19,768,375...19,777,862
G
Khdrbs1
KH RNA binding domain containing, signal transduction associated 1
decreases expression
ISO
Vitamin E results in decreased expression of KHDRBS1 mRNA
CTD
PMID:19244175
NCBI chr 5:147,337,048...147,374,604
Ensembl chr 5:142,063,570...142,089,180
G
Kiaa0930
KIAA0930 homolog
increases expression
ISO
Vitamin E results in increased expression of KIAA0930 mRNA
CTD
PMID:19244175
NCBI chr 7:116,067,974...116,107,678
Ensembl chr 7:116,071,447...116,107,727
G
Kif16b
kinesin family member 16B
decreases expression
ISO
Vitamin E results in decreased expression of KIF16B mRNA
CTD
PMID:19244175
NCBI chr 3:129,974,692...130,254,194
Ensembl chr 3:129,974,800...130,254,019
G
Kif1b
kinesin family member 1B
decreases expression
ISO
Vitamin E results in decreased expression of KIF1B mRNA
CTD
PMID:19244175
NCBI chr 5:164,890,778...165,025,848
Ensembl chr 5:159,561,271...159,742,778
G
Kif5b
kinesin family member 5B
decreases expression
ISO
Vitamin E results in decreased expression of KIF5B mRNA
CTD
PMID:19244175
NCBI chr17:56,185,386...56,222,990
Ensembl chr17:51,489,944...51,527,508
G
Kif5c
kinesin family member 5C
decreases expression
ISO
Vitamin E results in decreased expression of KIF5C mRNA
CTD
PMID:19244175
NCBI chr 3:54,441,266...54,591,630
Ensembl chr 3:34,032,105...34,182,413
G
Kl
Klotho
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of KL mRNA
CTD
PMID:19244175
NCBI chr12:5,326,003...5,367,016
Ensembl chr12:490,399...530,080
G
Klc1
kinesin light chain 1
increases expression
ISO
Vitamin E results in increased expression of KLC1 mRNA
CTD
PMID:19244175
NCBI chr 6:136,644,592...136,690,399
Ensembl chr 6:130,823,419...130,867,031
G
Klf6
KLF transcription factor 6
multiple interactions
ISO
Vitamin E inhibits the reaction [[CYP2E1 protein co-treated with Paraquat] results in increased expression of KLF6 protein]; Vitamin E inhibits the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; Vitamin E inhibits the reaction [Arachidonic Acid promotes the reaction [CYP2E1 protein results in increased expression of KLF6 mRNA]]; Vitamin E inhibits the reaction [CYP2E1 protein promotes the reaction [Arachidonic Acid results in increased expression of KLF6 mRNA alternative form]]
CTD
PMID:22486562
NCBI chr17:69,449,483...69,458,478
Ensembl chr17:64,531,463...64,588,570
G
Klf9
KLF transcription factor 9
decreases expression
ISO
Vitamin E results in decreased expression of KLF9 mRNA
CTD
PMID:19244175
NCBI chr 1:230,126,646...230,151,641
Ensembl chr 1:220,700,108...220,725,037
G
Klhdc10
kelch domain containing 10
decreases expression
ISO
Vitamin E results in decreased expression of KLHDC10 mRNA
CTD
PMID:19244175
NCBI chr 4:59,988,710...60,046,518
Ensembl chr 4:59,021,310...59,074,941
G
Klhl20
kelch-like family member 20
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of KLHL20 mRNA Vitamin E results in decreased expression of KLHL20 mRNA
CTD
PMID:19244175
NCBI chr13:75,896,802...75,941,724
Ensembl chr13:73,363,455...73,408,337
G
Klhl24
kelch-like family member 24
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of KLHL24 mRNA
CTD
PMID:19244175
NCBI chr11:94,348,024...94,382,085
Ensembl chr11:80,846,755...80,877,636
G
Klhl4
kelch-like family member 4
decreases expression
ISO
Vitamin E results in decreased expression of KLHL4 mRNA
CTD
PMID:19244175
NCBI chr X:83,626,047...83,916,328
Ensembl chr X:79,622,113...79,719,480
G
Klhl9
kelch-like family member 9
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of KLHL9 mRNA
CTD
PMID:19244175
NCBI chr 5:103,333,747...103,337,931
G
Kmt2b
lysine methyltransferase 2B
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of KMT2B mRNA Vitamin E results in increased expression of KMT2B mRNA
CTD
PMID:19244175
NCBI chr 1:94,949,144...94,969,239
Ensembl chr 1:85,821,753...85,841,326
G
Kpna1
karyopherin subunit alpha 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of KPNA1 mRNA Vitamin E results in decreased expression of KPNA1 mRNA
CTD
PMID:19244175
NCBI chr11:78,221,165...78,279,778
Ensembl chr11:64,717,563...64,774,623
G
Kpna3
karyopherin subunit alpha 3
decreases expression
ISO
Vitamin E results in decreased expression of KPNA3 mRNA
CTD
PMID:19244175
NCBI chr15:39,712,375...39,786,127
Ensembl chr15:35,536,316...35,610,419
G
Kpnb1
karyopherin subunit beta 1
decreases expression increases expression multiple interactions
ISO
Vitamin E results in decreased expression of KPNB1 mRNA Vitamin E results in increased expression of KPNB1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of KPNB1 mRNA
CTD
PMID:19244175
NCBI chr10:82,642,082...82,670,856
Ensembl chr10:82,145,420...82,174,605
G
Ktn1
kinectin 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of KTN1 mRNA Vitamin E results in decreased expression of KTN1 mRNA
CTD
PMID:19244175
NCBI chr15:23,392,570...23,485,061
Ensembl chr15:20,914,642...21,002,578
G
Lad1
ladinin 1
decreases expression
ISO
Vitamin E results in decreased expression of LAD1 mRNA
CTD
PMID:19244175
NCBI chr13:47,249,605...47,263,967
Ensembl chr13:47,249,605...47,263,967
G
Lamb2
laminin subunit beta 2
increases expression
ISO
Vitamin E results in increased expression of LAMB2 mRNA
CTD
PMID:19244175
NCBI chr 8:118,056,899...118,069,090
Ensembl chr 8:109,178,409...109,190,549
G
Lamp1
lysosomal-associated membrane protein 1
increases expression
ISO
Vitamin E results in increased expression of LAMP1 mRNA
CTD
PMID:19244175
NCBI chr16:83,058,131...83,082,843
Ensembl chr16:76,355,984...76,381,883
G
Lamp2
lysosomal-associated membrane protein 2
multiple interactions
EXP
Vitamin E inhibits the reaction [Pilocarpine results in increased expression of LAMP2 protein]
CTD
PMID:19272430
NCBI chr X:122,038,734...122,087,745
Ensembl chr X:117,057,606...117,260,522
G
Larp4b
La ribonucleoprotein 4B
decreases expression
ISO
Vitamin E results in decreased expression of LARP4B mRNA
CTD
PMID:19244175
NCBI chr17:61,138,663...61,217,423
Ensembl chr17:61,138,709...61,187,960
G
Lcmt2
leucine carboxyl methyltransferase 2
increases expression
ISO
Vitamin E results in increased expression of LCMT2 mRNA; Vitamin E results in increased expression of LCMT2 protein
CTD
PMID:9359698
NCBI chr 3:108,099,960...108,102,084
Ensembl chr 3:108,099,961...108,102,084
G
Ldb2
LIM domain binding 2
increases expression
ISO
Vitamin E results in increased expression of LDB2 mRNA
CTD
PMID:19244175
NCBI chr14:70,489,243...70,810,573
Ensembl chr14:66,277,085...66,597,778
G
Ldha
lactate dehydrogenase A
multiple interactions
EXP
Vitamin E inhibits the reaction [Hexachlorobenzene affects the expression of LDHA protein]
CTD
PMID:30064338
NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:97,366,021...97,433,472
G
Lep
leptin
multiple interactions
EXP
Vitamin E inhibits the reaction [Dietary Fats results in decreased expression of LEP mRNA]; Vitamin E inhibits the reaction [Dietary Fats results in decreased expression of LEP protein]
CTD
PMID:20404018
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:57,661,131...57,675,262
G
Lhb
luteinizing hormone subunit beta
multiple interactions
EXP
[Vitamin E co-treated with LHB protein] results in increased chemical synthesis of Testosterone; Vitamin E inhibits the reaction [acetamiprid results in increased expression of LHB protein]; Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of LHB protein]; Vitamin E inhibits the reaction [chromium hexavalent ion results in decreased expression of LHB protein]; Vitamin E inhibits the reaction [cypermethrin results in decreased expression of LHB protein]; Vitamin E inhibits the reaction [Petroleum results in decreased expression of LHB protein]; Vitamin E inhibits the reaction [Potassium Dichromate results in decreased expression of LHB protein]
CTD
PMID:16054318 PMID:16298753 PMID:17280759 PMID:20079796 PMID:24759048 PMID:25046308 PMID:28395332 More...
NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Limch1
LIM and calponin homology domains 1
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of LIMCH1 mRNA
CTD
PMID:19244175
NCBI chr14:41,466,433...41,779,477
Ensembl chr14:41,114,803...41,425,191
G
Lipt1
lipoyltransferase 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of LIPT1 mRNA Vitamin E results in decreased expression of LIPT1 mRNA
CTD
PMID:19244175
NCBI chr 9:40,107,938...40,118,268
Ensembl chr 9:40,098,615...40,113,565
G
Lman2
lectin, mannose-binding 2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of LMAN2 mRNA Vitamin E results in increased expression of LMAN2 mRNA
CTD
PMID:19244175
NCBI chr17:9,274,362...9,294,950
Ensembl chr17:9,269,022...9,287,265
G
Lmna
lamin A/C
increases expression
ISO
Vitamin E results in increased expression of LMNA mRNA
CTD
PMID:19244175
NCBI chr 2:176,237,564...176,265,301
Ensembl chr 2:173,939,751...173,960,423
G
Lmo3
LIM domain only 3
increases expression
ISO
Vitamin E results in increased expression of LMO3 mRNA
CTD
PMID:19244175
NCBI chr 4:172,965,944...173,028,980
Ensembl chr 4:171,234,696...171,292,222
G
Lmod1
leiomodin 1
increases expression
ISO
Vitamin E results in increased expression of LMOD1 mRNA
CTD
PMID:19244175
NCBI chr13:46,754,048...46,796,186
Ensembl chr13:46,754,033...46,794,900
G
Lpar1
lysophosphatidic acid receptor 1
increases expression
ISO
Vitamin E results in increased expression of LPAR1 mRNA
CTD
PMID:19244175
NCBI chr 5:78,024,139...78,147,071
Ensembl chr 5:73,229,625...73,369,895
G
Lpar2
lysophosphatidic acid receptor 2
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of LPAR2 mRNA
CTD
PMID:19244175
NCBI chr16:19,625,974...19,633,905
Ensembl chr16:19,595,655...19,599,998
G
Lpin1
lipin 1
decreases expression
ISO
Vitamin E results in decreased expression of LPIN1 mRNA
CTD
PMID:19244175
NCBI chr 6:45,039,110...45,145,845
Ensembl chr 6:39,312,748...39,417,097
G
Lrrc41
leucine rich repeat containing 41
increases expression
ISO
Vitamin E results in increased expression of LRRC41 mRNA
CTD
PMID:19244175
NCBI chr 5:129,554,547...129,575,450
Ensembl chr 5:129,554,547...129,575,449
G
Lrrc47
leucine rich repeat containing 47
increases expression multiple interactions
ISO
Vitamin E results in increased expression of LRRC47 mRNA [Selenium co-treated with Vitamin E] results in increased expression of LRRC47 mRNA
CTD
PMID:19244175
NCBI chr 5:169,852,926...169,862,598
Ensembl chr 5:164,570,435...164,580,174
G
Lrrfip1
LRR binding FLII interacting protein 1
decreases expression
ISO
Vitamin E results in decreased expression of LRRFIP1 mRNA
CTD
PMID:19244175
NCBI chr 9:91,592,032...91,720,250
Ensembl chr 9:91,643,197...91,720,250
G
Lsm7
LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated
decreases expression
ISO
Vitamin E results in decreased expression of LSM7 mRNA
CTD
PMID:19244175
NCBI chr 7:9,507,373...9,509,787
Ensembl chr 7:8,856,489...8,859,119
G
Lsr
lipolysis stimulated lipoprotein receptor
increases expression
ISO
Vitamin E results in increased expression of LSR mRNA
CTD
PMID:19244175
NCBI chr 1:86,185,769...86,201,952
Ensembl chr 1:86,186,431...86,201,952
G
Ltb
lymphotoxin beta
increases expression
ISO
Vitamin E results in increased expression of LTB mRNA
CTD
PMID:19244175
NCBI chr20:3,632,209...3,634,054
Ensembl chr20:3,627,537...3,629,381
G
Ltbp4
latent transforming growth factor beta binding protein 4
increases expression
ISO
Vitamin E results in increased expression of LTBP4 mRNA
CTD
PMID:19244175
NCBI chr 1:91,727,769...91,759,822
Ensembl chr 1:82,600,136...82,632,178
G
Luc7l2
LUC7-like 2 pre-mRNA splicing factor
decreases expression
ISO
Vitamin E results in decreased expression of LUC7L2 mRNA
CTD
PMID:19244175
NCBI chr 4:68,251,435...68,314,861
Ensembl chr 4:67,287,640...67,347,964
G
Luc7l3
LUC7-like 3 pre-mRNA splicing factor
decreases expression
ISO
Vitamin E results in decreased expression of LUC7L3 mRNA
CTD
PMID:19244175
NCBI chr10:79,737,457...79,773,478
Ensembl chr10:79,240,563...79,276,538
G
Ly6e
lymphocyte antigen 6 family member E
increases expression
ISO
Vitamin E results in increased expression of LY6E mRNA
CTD
PMID:19244175
NCBI chr 7:108,815,970...108,820,444
Ensembl chr 7:106,935,761...106,939,689
G
Lyn
LYN proto-oncogene, Src family tyrosine kinase
decreases expression
ISO
Vitamin E results in decreased expression of LYN mRNA
CTD
PMID:19244175
NCBI chr 5:21,437,127...21,553,097
Ensembl chr 5:16,639,466...16,756,868
G
Lypla2
lysophospholipase 2
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of LYPLA2 mRNA
CTD
PMID:19244175
NCBI chr 5:148,198,466...148,203,062
Ensembl chr 5:148,198,439...148,203,092
G
Lyrm4
LYR motif containing 4
increases expression
ISO
Vitamin E results in increased expression of LYRM4 mRNA
CTD
PMID:19244175
NCBI chr17:28,746,457...28,861,849
Ensembl chr17:28,746,469...28,861,750
G
Macf1
microtubule-actin crosslinking factor 1
decreases expression
ISO
Vitamin E results in decreased expression of MACF1 mRNA
CTD
PMID:19244175
NCBI chr 5:140,908,829...141,234,127
Ensembl chr 5:135,623,742...135,945,905
G
Macroh2a2
macroH2A.2 histone
increases expression
ISO
Vitamin E results in increased expression of MACROH2A2 mRNA
CTD
PMID:19244175
NCBI chr20:30,220,975...30,270,652
Ensembl chr20:29,678,222...29,727,891
G
Maged2
MAGE family member D2
increases expression
ISO
Vitamin E results in increased expression of MAGED2 mRNA
CTD
PMID:19244175
NCBI chr X:19,733,593...19,741,769
Ensembl chr X:19,733,597...19,740,477
G
Man1b1
mannosidase, alpha, class 1B, member 1
increases expression
ISO
Vitamin E results in increased expression of MAN1B1 mRNA
CTD
PMID:19244175
NCBI chr 3:28,539,778...28,563,155
Ensembl chr 3:8,143,381...8,165,006
G
Map2k7
mitogen activated protein kinase kinase 7
decreases expression
ISO
Vitamin E results in decreased expression of MAP2K7 mRNA
CTD
PMID:19244175
NCBI chr12:7,389,032...7,398,377
Ensembl chr12:2,591,219...2,604,222
G
Map3k1
mitogen-activated protein kinase kinase kinase 1
multiple interactions
ISO
Vitamin E inhibits the reaction [Urethane results in increased phosphorylation of and results in increased activity of MAP3K1 protein]
CTD
PMID:11062179
NCBI chr 2:45,081,889...45,150,555
Ensembl chr 2:43,350,098...43,414,463
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
decreases expression
ISO
Vitamin E results in decreased expression of MAP3K5 mRNA
CTD
PMID:19244175
NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:14,685,492...14,904,800
G
Map3k8
mitogen-activated protein kinase kinase kinase 8
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of MAP3K8 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of MAP3K8 mRNA
CTD
PMID:19244175
NCBI chr17:58,078,175...58,098,455
Ensembl chr17:53,383,131...53,403,216
G
Map4
microtubule-associated protein 4
increases expression
ISO
Vitamin E results in increased expression of MAP4 mRNA
CTD
PMID:19244175
NCBI chr 8:109,925,233...110,064,370
Ensembl chr 8:109,925,575...110,064,362
G
Map4k5
mitogen-activated protein kinase kinase kinase kinase 5
multiple interactions
EXP
[Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of MAP4K5 mRNA
CTD
PMID:11444866
NCBI chr 6:94,020,079...94,112,943
Ensembl chr 6:88,284,094...88,376,799
G
Map6d1
MAP6 domain containing 1
decreases expression
ISO
Vitamin E results in decreased expression of MAP6D1 mRNA
CTD
PMID:19244175
NCBI chr11:94,238,552...94,244,781
Ensembl chr11:80,734,148...80,740,377
G
Mapk1
mitogen activated protein kinase 1
increases activity multiple interactions
ISO
Vitamin E results in increased activity of MAPK1 protein Vitamin E inhibits the reaction [Urethane results in increased phosphorylation of and results in increased activity of MAPK1 protein]
CTD
PMID:11062179 PMID:11522656
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk11
mitogen-activated protein kinase 11
increases expression
ISO
Vitamin E results in increased expression of MAPK11 mRNA
CTD
PMID:19244175
NCBI chr 7:122,098,120...122,105,023
Ensembl chr 7:120,218,478...120,225,395
G
Mapk3
mitogen activated protein kinase 3
multiple interactions increases activity
ISO
Vitamin E inhibits the reaction [Urethane results in increased phosphorylation of and results in increased activity of MAPK3 protein] Vitamin E results in increased activity of MAPK3 protein
CTD
PMID:11062179 PMID:11522656
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
increases activity decreases expression
ISO
Vitamin E results in increased activity of MAPK8 protein Vitamin E results in decreased expression of MAPK8 mRNA
CTD
PMID:11522656 PMID:19244175
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
G
Mapt
microtubule-associated protein tau
multiple interactions
ISO
Vitamin E inhibits the reaction [wortmannin results in increased phosphorylation of MAPT protein]
CTD
PMID:15842767
NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,138,627...89,236,129
G
Marchf6
membrane associated ring-CH-type finger 6
decreases expression
ISO
Vitamin E results in decreased expression of MARCHF6 mRNA
CTD
PMID:19244175
NCBI chr 2:82,455,686...82,532,917
Ensembl chr 2:82,455,689...82,532,910
G
Mast4
microtubule associated serine/threonine kinase family member 4
decreases expression
ISO
Vitamin E results in decreased expression of MAST4 mRNA
CTD
PMID:19244175
NCBI chr 2:33,893,241...34,483,682
Ensembl chr 2:33,894,436...34,483,723
G
Mau2
MAU2 sister chromatid cohesion factor
decreases expression
ISO
Vitamin E results in decreased expression of MAU2 mRNA
CTD
PMID:19244175
NCBI chr16:19,383,847...19,414,996
Ensembl chr16:19,383,492...19,408,727
G
Mb
myoglobin
increases expression
ISO
Vitamin E results in increased expression of MB mRNA
CTD
PMID:19244175
NCBI chr 7:110,640,511...110,647,742
Ensembl chr 7:108,759,904...108,767,383
G
Mbd1
methyl-CpG binding domain protein 1
decreases expression
ISO
Vitamin E results in decreased expression of MBD1 mRNA
CTD
PMID:19244175
NCBI chr18:67,869,870...67,884,501
Ensembl chr18:67,869,992...67,886,554
G
Mbd4
methyl-CpG binding domain 4 DNA glycosylase
decreases expression
ISO
Vitamin E results in decreased expression of MBD4 mRNA
CTD
PMID:19244175
NCBI chr 4:150,565,646...150,577,433
Ensembl chr 4:148,894,280...148,904,982
G
Mbnl1
muscleblind-like splicing regulator 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of MBNL1 mRNA Vitamin E results in decreased expression of MBNL1 mRNA
CTD
PMID:19244175
NCBI chr 2:146,789,570...146,964,136
Ensembl chr 2:144,670,285...144,814,368
G
Mboat7
membrane bound O-acyltransferase domain containing 7
decreases expression
ISO
Vitamin E results in decreased expression of MBOAT7 mRNA
CTD
PMID:19244175
NCBI chr 1:65,525,206...65,539,538
Ensembl chr 1:65,525,213...65,539,538
G
Mcam
melanoma cell adhesion molecule
increases expression
ISO
Vitamin E results in increased expression of MCAM mRNA
CTD
PMID:19244175
NCBI chr 8:44,479,391...44,487,575
Ensembl chr 8:44,479,376...44,487,571
G
Mcm3ap
minichromosome maintenance complex component 3 associated protein
decreases expression
ISO
Vitamin E results in decreased expression of MCM3AP mRNA
CTD
PMID:19244175
NCBI chr20:12,127,060...12,164,651
Ensembl chr20:12,127,570...12,165,165
G
Mcrs1
microspherule protein 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of MCRS1 mRNA Vitamin E results in increased expression of MCRS1 mRNA
CTD
PMID:19244175
NCBI chr 7:132,262,719...132,271,533
Ensembl chr 7:130,383,853...130,392,685
G
Mdh2
malate dehydrogenase 2
increases expression
ISO
Vitamin E results in increased expression of MDH2 mRNA
CTD
PMID:19244175
NCBI chr12:26,530,886...26,543,841
Ensembl chr12:20,894,262...20,907,271
G
Mdk
midkine
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of MDK mRNA Vitamin E results in increased expression of MDK mRNA
CTD
PMID:19244175
NCBI chr 3:98,356,789...98,358,960
Ensembl chr 3:77,901,158...77,903,130
G
Mdm1
Mdm1 nuclear protein
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of MDM1 mRNA Vitamin E results in decreased expression of MDM1 mRNA
CTD
PMID:19244175
NCBI chr 7:55,615,459...55,651,889
Ensembl chr 7:53,729,610...53,766,034
G
Mea1
male-enhanced antigen 1
increases expression
ISO
Vitamin E results in increased expression of MEA mRNA
CTD
PMID:19244175
NCBI chr 9:14,300,283...14,304,130
Ensembl chr 9:14,293,446...14,302,060
G
Med1
mediator complex subunit 1
decreases expression
ISO
Vitamin E results in decreased expression of MED1 mRNA
CTD
PMID:19244175
NCBI chr10:83,641,851...83,685,560
Ensembl chr10:83,145,568...83,189,299
G
Med15
mediator complex subunit 15
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of MED15 mRNA Vitamin E results in increased expression of MED15 mRNA
CTD
PMID:19244175
NCBI chr11:96,784,974...96,859,635
Ensembl chr11:83,280,762...83,355,362
G
Med27
mediator complex subunit 27
increases expression
ISO
Vitamin E results in increased expression of MED27 mRNA
CTD
PMID:19244175
NCBI chr 3:33,027,240...33,201,240
Ensembl chr 3:12,629,603...12,803,339
G
Metap2
methionyl aminopeptidase 2
decreases expression
ISO
Vitamin E results in decreased expression of METAP2 mRNA
CTD
PMID:19244175
NCBI chr 7:30,299,433...30,327,477
Ensembl chr 7:28,411,608...28,440,434
G
Mfap2
microfibril associated protein 2
increases expression
ISO
Vitamin E results in increased expression of MFAP2 mRNA
CTD
PMID:19244175
NCBI chr 5:153,312,068...153,320,266
Ensembl chr 5:153,314,711...153,320,259
G
Mfge8
milk fat globule EGF and factor V/VIII domain containing
increases expression multiple interactions
ISO
Vitamin E results in increased expression of MFGE8 mRNA [Selenium co-treated with Vitamin E] results in increased expression of MFGE8 mRNA
CTD
PMID:19244175
NCBI chr 1:142,474,027...142,489,431
Ensembl chr 1:133,064,665...133,080,073
G
Mfsd14b
major facilitator superfamily domain containing 14B
decreases expression
ISO
Vitamin E results in decreased expression of MFSD14B mRNA
CTD
PMID:19244175
NCBI chr17:77,895...130,837
Ensembl chr17:77,840...130,839
G
Mgp
matrix Gla protein
increases expression
ISO
Vitamin E results in increased expression of MGP mRNA
CTD
PMID:19244175
NCBI chr 4:171,497,472...171,500,888
Ensembl chr 4:169,766,279...169,769,667
G
Mia
MIA SH3 domain containing
increases expression
ISO
Vitamin E results in increased expression of MIA mRNA
CTD
PMID:19244175
NCBI chr 1:91,601,326...91,603,019
Ensembl chr 1:82,473,678...82,475,370
G
Mis12
MIS12 kinetochore complex component
decreases expression
ISO
Vitamin E results in decreased expression of MIS12 mRNA
CTD
PMID:19244175
NCBI chr10:56,238,317...56,246,491
Ensembl chr10:55,739,564...55,751,068
G
Mlec
malectin
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of MLEC mRNA Vitamin E results in decreased expression of MLEC mRNA
CTD
PMID:19244175
NCBI chr12:47,118,918...47,133,598
Ensembl chr12:41,458,231...41,468,708
G
Mlf2
myeloid leukemia factor 2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of MLF2 mRNA Vitamin E results in increased expression of MLF2 mRNA
CTD
PMID:19244175
NCBI chr 4:159,425,542...159,430,584
Ensembl chr 4:157,728,756...157,744,317
G
Mlh1
mutL homolog 1
multiple interactions increases expression
ISO
[Vitamin E co-treated with Hydrogen Peroxide] results in increased methylation of MLH1 promoter Vitamin E results in increased expression of MLH1 mRNA
CTD
PMID:29854080
NCBI chr 8:120,074,871...120,112,109
Ensembl chr 8:111,196,468...111,233,617
G
Mmp2
matrix metallopeptidase 2
increases expression multiple interactions
ISO EXP
Vitamin E results in increased expression of MMP2 mRNA [silybin co-treated with Phosphatidylcholines co-treated with Vitamin E] inhibits the reaction [Dimethylnitrosamine results in increased expression of MMP2 mRNA]
CTD
PMID:16169303 PMID:19244175
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
G
Mmp24
matrix metallopeptidase 24
increases expression
ISO
Vitamin E results in increased expression of MMP24 mRNA
CTD
PMID:19244175
NCBI chr 3:144,279,096...144,323,572
Ensembl chr 3:144,279,096...144,323,572
G
Mms19
MMS19 homolog, cytosolic iron-sulfur assembly component
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of MMS19 mRNA Vitamin E results in increased expression of MMS19 mRNA
CTD
PMID:19244175
NCBI chr 1:250,706,595...250,743,604
Ensembl chr 1:240,757,282...240,794,288
G
Mnt
MAX network transcriptional repressor
decreases expression
ISO
Vitamin E results in decreased expression of MNT mRNA
CTD
PMID:19244175
NCBI chr10:59,699,208...59,714,848
Ensembl chr10:59,699,585...59,714,835
G
Mog
myelin oligodendrocyte glycoprotein
decreases expression
ISO
Vitamin E results in decreased expression of MOG mRNA
CTD
PMID:19244175
NCBI chr20:1,514,110...1,528,716
Ensembl chr20:1,513,239...1,523,474
G
Mon2
MON2 homolog, regulator of endosome-to-Golgi trafficking
decreases expression
ISO
Vitamin E results in decreased expression of MON2 mRNA
CTD
PMID:19244175
NCBI chr 7:58,649,378...58,728,102
Ensembl chr 7:58,651,075...58,728,064
G
Moxd1
monooxygenase, DBH-like 1
increases expression
ISO
Vitamin E results in increased expression of MOXD1 mRNA
CTD
PMID:19244175
NCBI chr 1:22,894,543...22,984,599
Ensembl chr 1:21,075,122...21,161,779
G
Mphosph10
M-phase phosphoprotein 10
decreases expression
ISO
Vitamin E results in decreased expression of MPHOSPH10 mRNA
CTD
PMID:19244175
NCBI chr 1:117,948,134...117,964,149
Ensembl chr 1:117,948,134...117,964,149
G
Mpo
myeloperoxidase
multiple interactions
EXP
Vitamin E inhibits the reaction [Nicotine results in increased activity of MPO protein]
CTD
PMID:17216608
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819
G
Mprip
myosin phosphatase Rho interacting protein
increases expression
ISO
Vitamin E results in increased expression of MPRIP mRNA
CTD
PMID:19244175
NCBI chr10:44,453,949...44,573,843
Ensembl chr10:44,453,929...44,569,118
G
Mpst
mercaptopyruvate sulfurtransferase
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of MPST mRNA Vitamin E results in increased expression of MPST mRNA
CTD
PMID:19244175
NCBI chr 7:111,836,079...111,843,651
Ensembl chr 7:109,955,675...109,963,141
G
Mpzl1
myelin protein zero-like 1
increases expression
ISO
Vitamin E results in increased expression of MPZL1 mRNA
CTD
PMID:19244175
NCBI chr13:80,385,454...80,422,315
Ensembl chr13:77,852,467...77,896,616
G
Mr1
major histocompatibility complex, class I-related
decreases expression
ISO
Vitamin E results in decreased expression of MR1 mRNA
CTD
PMID:19244175
NCBI chr13:69,850,420...69,868,302
Ensembl chr13:67,299,585...67,317,970
G
Mrm3
mitochondrial rRNA methyltransferase 3
increases expression
ISO
Vitamin E results in increased expression of MRM3 mRNA
CTD
PMID:19244175
NCBI chr10:61,095,920...61,125,421
Ensembl chr10:61,095,952...61,102,630
G
Mrpl11
mitochondrial ribosomal protein L11
increases expression
ISO
Vitamin E results in increased expression of MRPL11 mRNA
CTD
PMID:19244175
NCBI chr 1:211,693,807...211,696,667
Ensembl chr 1:202,264,471...202,267,756
G
Mrpl12
mitochondrial ribosomal protein L12
increases expression
ISO
Vitamin E results in increased expression of MRPL12 mRNA
CTD
PMID:19244175
NCBI chr10:105,758,410...105,762,913
Ensembl chr10:105,758,410...105,762,913
G
Mrpl2
mitochondrial ribosomal protein L2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of MRPL2 mRNA Vitamin E results in increased expression of MRPL2 mRNA
CTD
PMID:19244175
NCBI chr 9:14,333,233...14,337,006
Ensembl chr 9:14,333,234...14,337,040
G
Mrpl24
mitochondrial ribosomal protein L24
increases expression
ISO
Vitamin E results in increased expression of MRPL24 mRNA
CTD
PMID:19244175
NCBI chr 2:173,383,062...173,389,249
Ensembl chr 2:173,383,224...173,389,248
G
Mrpl34
mitochondrial ribosomal protein L34
increases expression
ISO
Vitamin E results in increased expression of MRPL34 mRNA
CTD
PMID:19244175
NCBI chr16:18,152,470...18,153,205
Ensembl chr16:18,151,342...18,153,208
G
Mrpl35
mitochondrial ribosomal protein L35
decreases expression
ISO
Vitamin E results in decreased expression of MRPL35 mRNA
CTD
PMID:19244175
NCBI chr 4:105,424,076...105,431,844
Ensembl chr 4:103,865,812...103,880,887
G
Mrpl4
mitochondrial ribosomal protein L4
increases expression multiple interactions
ISO
Vitamin E results in increased expression of MRPL4 mRNA [Selenium co-treated with Vitamin E] results in increased expression of MRPL4 mRNA
CTD
PMID:19244175
NCBI chr 8:19,539,593...19,545,608
Ensembl chr 8:19,539,593...19,545,608
G
Mrpl44
mitochondrial ribosomal protein L44
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of MRPL44 mRNA Vitamin E results in decreased expression of MRPL44 mRNA
CTD
PMID:19244175
NCBI chr 9:81,106,658...81,111,709
Ensembl chr 9:81,106,655...81,112,812
G
Mrpl49
mitochondrial ribosomal protein L49
increases expression
ISO
Vitamin E results in increased expression of MRPL49 mRNA
CTD
PMID:19244175
NCBI chr 1:203,346,068...203,350,040
Ensembl chr 1:203,332,481...203,350,049
G
Mrpl9
mitochondrial ribosomal protein L9
increases expression
ISO
Vitamin E results in increased expression of MRPL9 mRNA
CTD
PMID:19244175
NCBI chr 2:182,082,012...182,086,758
Ensembl chr 2:182,076,369...182,087,095
G
Mrps6
mitochondrial ribosomal protein S6
decreases expression
ISO
Vitamin E results in decreased expression of MRPS6 mRNA
CTD
PMID:19244175
NCBI chr11:44,778,667...44,834,420
Ensembl chr11:31,295,614...31,348,484
G
Msh5
mutS homolog 5
decreases expression
ISO
Vitamin E results in decreased expression of MSH5 mRNA
CTD
PMID:19244175
NCBI chr20:3,779,180...3,797,996
Ensembl chr20:3,776,942...3,793,336
G
Msn
moesin
increases expression
ISO
Vitamin E results in increased expression of MSN mRNA
CTD
PMID:19244175
NCBI chr X:65,005,546...65,073,512
Ensembl chr X:60,995,951...61,065,628
G
Msra
methionine sulfoxide reductase A
increases expression
ISO
Vitamin E results in increased expression of MSRA mRNA
CTD
PMID:19244175
NCBI chr15:38,363,459...38,677,406
Ensembl chr15:38,351,445...38,676,585
G
Mt1
metallothionein 1
multiple interactions increases expression
EXP ISO
Vitamin E promotes the reaction [Mercuric Chloride results in increased expression of MT1A mRNA] Vitamin E inhibits the reaction [Copper results in increased activity of MT1 promoter] Vitamin E results in increased expression of MT1A mRNA
CTD
PMID:14576086 PMID:21787585
NCBI chr19:10,831,959...10,832,975
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
G
Mt3
metallothionein 3
multiple interactions
EXP
[Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of MT3 mRNA
CTD
PMID:11444866
NCBI chr19:10,854,676...10,856,080
Ensembl chr19:10,848,755...10,850,158
G
Mtch2
mitochondrial carrier 2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of MTCH2 mRNA Vitamin E results in increased expression of MTCH2 mRNA
CTD
PMID:19244175
NCBI chr 3:97,286,388...97,306,028
Ensembl chr 3:76,830,413...76,850,189
G
Mtcl2
microtubule crosslinking factor 2
decreases expression
ISO
Vitamin E results in decreased expression of MTCL2 mRNA
CTD
PMID:19244175
NCBI chr 3:145,669,102...145,741,578
Ensembl chr 3:145,675,443...145,740,871
G
Mterf3
mitochondrial transcription termination factor 3
decreases expression
ISO
Vitamin E results in decreased expression of MTERF3 mRNA
CTD
PMID:19244175
NCBI chr 7:63,826,418...63,844,747
Ensembl chr 7:63,826,427...63,844,658
G
Mtf1
metal-regulatory transcription factor 1
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of MTF1 mRNA
CTD
PMID:19244175
NCBI chr 5:142,347,024...142,391,810
Ensembl chr 5:137,062,376...137,107,136
G
Mtf2
metal response element binding transcription factor 2
decreases expression
ISO
Vitamin E results in decreased expression of MTF2 mRNA
CTD
PMID:19244175
NCBI chr14:1,639,256...1,683,513
Ensembl chr14:1,640,746...1,683,524
G
Mtfr1
mitochondrial fission regulator 1
decreases expression
ISO
Vitamin E results in decreased expression of MTFR1 mRNA
CTD
PMID:19244175
NCBI chr 2:103,594,458...103,629,697
Ensembl chr 2:101,679,265...101,713,544
G
Mtm1
myotubularin 1
decreases expression
ISO
Vitamin E results in decreased expression of MTM1 mRNA
CTD
PMID:19244175
NCBI chr 6:488,923...506,882
Ensembl chr 6:488,969...506,860
G
Mtmr9
myotubularin related protein 9
decreases expression
ISO
Vitamin E results in decreased expression of MTMR9 mRNA
CTD
PMID:19244175
NCBI chr15:37,769,161...37,791,195
Ensembl chr15:37,769,078...37,791,244
G
Mul1
mitochondrial E3 ubiquitin protein ligase 1
increases expression
ISO
Vitamin E results in increased expression of MUL1 mRNA
CTD
PMID:19244175
NCBI chr 5:155,936,112...155,945,163
Ensembl chr 5:150,652,812...150,661,863
G
Mx1
MX dynamin like GTPase 1
increases expression
ISO
Vitamin E results in increased expression of MX1 mRNA
CTD
PMID:19244175
NCBI chr11:50,269,056...50,294,699
Ensembl chr11:36,799,660...36,823,507
G
Myl6
myosin light chain 6
increases expression multiple interactions
ISO
Vitamin E results in increased expression of MYL6 mRNA [Selenium co-treated with Vitamin E] results in increased expression of MYL6 mRNA
CTD
PMID:19244175
NCBI chr 7:1,495,301...1,498,512
Ensembl chr 7:910,774...933,791
G
Myl9
myosin light chain 9
increases expression
ISO
Vitamin E results in increased expression of MYL9 mRNA
CTD
PMID:19244175
NCBI chr 3:165,742,020...165,748,409
Ensembl chr 3:145,281,937...145,288,333
G
Myo18a
myosin XVIIIa
increases expression multiple interactions
ISO
Vitamin E results in increased expression of MYO18A mRNA [Selenium co-treated with Vitamin E] results in increased expression of MYO18A mRNA
CTD
PMID:19244175
NCBI chr10:62,654,218...62,755,465
Ensembl chr10:62,654,281...62,755,468
G
Myo6
myosin VI
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of MYO6 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of MYO6 mRNA
CTD
PMID:19244175
NCBI chr 8:89,967,351...90,122,219
Ensembl chr 8:81,087,139...81,239,292
G
Myof
myoferlin
decreases expression
ISO
Vitamin E results in decreased expression of MYOF mRNA
CTD
PMID:19244175
NCBI chr 1:245,086,109...245,234,768
Ensembl chr 1:235,673,666...235,822,334
G
N4bp1
Nedd4 binding protein 1
decreases expression
ISO
Vitamin E results in decreased expression of N4BP1 mRNA
CTD
PMID:19244175
NCBI chr19:36,396,082...36,446,835
Ensembl chr19:20,222,776...20,273,570
G
N4bp2l2
NEDD4 binding protein 2-like 2
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of N4BP2L2 mRNA
CTD
PMID:19244175
NCBI chr12:4,972,967...5,038,027
Ensembl chr12:103,590...197,784
G
Naa10
N(alpha)-acetyltransferase 10, NatA catalytic subunit
increases expression
ISO
Vitamin E results in increased expression of NAA10 mRNA
CTD
PMID:19244175
NCBI chr X:156,807,378...156,812,632
Ensembl chr X:151,656,056...151,661,252
G
Naa15
N(alpha)-acetyltransferase 15, NatA auxiliary subunit
decreases expression
ISO
Vitamin E results in decreased expression of NAA15 mRNA
CTD
PMID:19244175
NCBI chr 2:137,608,883...137,671,618
Ensembl chr 2:135,457,948...135,520,756
G
Naa60
N(alpha)-acetyltransferase 60, NatF catalytic subunit
decreases expression
ISO
Vitamin E results in decreased expression of NAA60 mRNA
CTD
PMID:19244175
NCBI chr10:12,129,026...12,149,053
Ensembl chr10:11,587,916...11,642,755
G
Nacad
NAC alpha domain containing
increases expression
ISO
Vitamin E results in increased expression of NACAD mRNA
CTD
PMID:19244175
NCBI chr14:81,465,299...81,473,866
Ensembl chr14:81,465,299...81,473,781
G
Nacc2
NACC family member 2
increases expression
ISO
Vitamin E results in increased expression of NACC2 mRNA
CTD
PMID:19244175
NCBI chr 3:29,278,077...29,345,098
Ensembl chr 3:8,883,065...8,946,660
G
Nadk
NAD kinase
decreases expression
ISO
Vitamin E results in decreased expression of NADK mRNA
CTD
PMID:19244175
NCBI chr 5:171,427,973...171,458,586
Ensembl chr 5:166,145,481...166,176,322
G
Nagk
N-acetylglucosamine kinase
increases expression
ISO
Vitamin E results in increased expression of NAGK mRNA
CTD
PMID:19244175
NCBI chr 4:117,838,761...117,846,304
Ensembl chr 4:116,281,328...116,313,137
G
Nav3
neuron navigator 3
decreases expression
ISO
Vitamin E results in decreased expression of NAV3 mRNA
CTD
PMID:19244175
NCBI chr 7:46,938,577...47,726,839
Ensembl chr 7:45,054,296...45,840,698
G
Nbas
NBAS subunit of NRZ tethering complex
increases expression
ISO
Vitamin E results in increased expression of NBAS mRNA
CTD
PMID:19244175
NCBI chr 6:41,777,253...42,081,895
Ensembl chr 6:36,048,191...36,352,984
G
Ncapg2
non-SMC condensin II complex, subunit G2
decreases expression
ISO
Vitamin E results in decreased expression of NCAPG2 mRNA
CTD
PMID:19244175
NCBI chr 6:143,484,651...143,561,850
Ensembl chr 6:137,342,943...137,415,159
G
Ncdn
neurochondrin
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of NCDN mRNA Vitamin E results in increased expression of NCDN mRNA
CTD
PMID:19244175
NCBI chr 5:139,037,807...139,047,645
Ensembl chr 5:139,037,819...139,047,568
G
Ncoa2
nuclear receptor coactivator 2
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of NCOA2 mRNA Vitamin E results in decreased expression of NCOA2 mRNA
CTD
PMID:19244175
NCBI chr 5:10,618,712...10,852,776
Ensembl chr 5:5,835,706...6,067,451
G
Ncor1
nuclear receptor co-repressor 1
decreases expression
ISO
Vitamin E results in decreased expression of NCOR1 mRNA
CTD
PMID:19244175
NCBI chr10:47,498,852...47,641,612
Ensembl chr10:46,999,536...47,141,032
G
Ndrg2
NDRG family member 2
increases expression
ISO
Vitamin E results in increased expression of NDRG2 mRNA
CTD
PMID:19244175
NCBI chr15:27,074,481...27,087,376
Ensembl chr15:24,600,982...24,609,626
G
Ndufa3
NADH:ubiquinone oxidoreductase subunit A3
decreases expression
ISO
Vitamin E results in decreased expression of NDUFA3 mRNA
CTD
PMID:19244175
NCBI chr 1:74,512,928...74,515,558
Ensembl chr 1:65,597,578...65,600,235
G
Ndufa7
NADH:ubiquinone oxidoreductase subunit A7
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of NDUFA7 mRNA Vitamin E results in decreased expression of NDUFA7 mRNA
CTD
PMID:19244175
NCBI chr 7:15,311,446...15,324,226
Ensembl chr 7:14,609,146...14,631,976
G
Ndufb8
NADH:ubiquinone oxidoreductase subunit B8
increases expression
ISO
Vitamin E results in increased expression of NDUFB8 mRNA
CTD
PMID:19244175
NCBI chr 1:253,357,878...253,362,936
Ensembl chr 1:243,408,619...243,413,817
G
Ndufs3
NADH:ubiquinone oxidoreductase core subunit S3
increases expression
ISO
Vitamin E results in increased expression of NDUFS3 mRNA
CTD
PMID:19244175
NCBI chr 3:97,332,477...97,339,654
Ensembl chr 3:76,876,646...76,883,824
G
Ndufv1
NADH:ubiquinone oxidoreductase core subunit V1
increases expression
ISO
Vitamin E results in increased expression of NDUFV1 mRNA
CTD
PMID:19244175
NCBI chr 1:210,729,856...210,735,103
Ensembl chr 1:201,299,985...201,305,466
G
Nedd8
NEDD8 ubiquitin like modifier
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of NEDD8 mRNA Vitamin E results in increased expression of NEDD8 mRNA
CTD
PMID:19244175
NCBI chr15:33,123,505...33,135,522
Ensembl chr15:29,153,556...29,166,160
G
Nek1
NIMA-related kinase 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of NEK1 mRNA Vitamin E results in decreased expression of NEK1 mRNA
CTD
PMID:19244175
NCBI chr16:34,009,092...34,137,418
Ensembl chr16:28,998,231...29,117,723
G
Nek2
NIMA-related kinase 2
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of NEK2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of NEK2 mRNA
CTD
PMID:19244175
NCBI chr13:105,936,809...105,950,054
Ensembl chr13:103,405,819...103,419,051
G
Nelfa
negative elongation factor complex member A
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of NELFA mRNA
CTD
PMID:19244175
NCBI chr14:76,808,920...76,832,998
Ensembl chr14:76,808,870...76,832,994
G
Nenf
neudesin neurotrophic factor
increases expression
ISO
Vitamin E results in increased expression of NENF mRNA
CTD
PMID:19244175
NCBI chr13:105,419,113...105,425,911
Ensembl chr13:102,888,004...102,894,804
G
Nf2
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor
increases expression multiple interactions
ISO
Vitamin E results in increased expression of NF2 mRNA [Selenium co-treated with Vitamin E] results in increased expression of NF2 mRNA
CTD
PMID:19244175
NCBI chr14:83,850,894...83,934,263
Ensembl chr14:79,627,399...79,710,667
G
Nfat5
nuclear factor of activated T-cells 5
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of NFAT5 mRNA Vitamin E results in decreased expression of NFAT5 mRNA
CTD
PMID:19244175
NCBI chr19:52,108,982...52,196,418
Ensembl chr19:35,199,016...35,286,675
G
Nfatc3
nuclear factor of activated T-cells 3
decreases expression
ISO
Vitamin E results in decreased expression of NFATC3 mRNA
CTD
PMID:19244175
NCBI chr19:50,870,464...50,944,992
Ensembl chr19:33,960,852...34,035,150
G
Nfe2l1
NFE2 like bZIP transcription factor 1
increases expression
ISO
Vitamin E results in increased expression of NFE2L1 mRNA
CTD
PMID:19244175
NCBI chr10:82,296,824...82,309,472
Ensembl chr10:81,800,366...81,832,318
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions increases expression decreases expression
EXP ISO
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of NFE2L2 protein]; Vitamin E inhibits the reaction [Doxorubicin results in decreased expression of NFE2L2 protein] Vitamin E inhibits the reaction [Ozone results in decreased expression of NFE2L2 protein] Vitamin E results in increased expression of NFE2L2 mRNA Vitamin E results in decreased expression of NFE2L2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of NFE2L2 mRNA; Vitamin E inhibits the reaction [bioallethrin results in increased expression of NFE2L2 protein]; Vitamin E inhibits the reaction [Polychlorinated Biphenyls analog results in increased expression of NFE2L2 protein]
CTD
PMID:19244175 PMID:24361488 PMID:29663635 PMID:29940330 PMID:30090343 PMID:30513525 PMID:35511042 PMID:38997059 More...
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
ISO EXP
Vitamin E inhibits the reaction [Norepinephrine affects the localization of NFKB1 protein] Vitamin E inhibits the reaction [Doxorubicin results in increased expression of NFKB1 mRNA]
CTD
PMID:23114885 PMID:38997059
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
multiple interactions decreases expression
ISO
Vitamin E inhibits the reaction [Hydrogen Peroxide results in decreased expression of NFKBIA protein]; Vitamin E inhibits the reaction [Hydrogen Peroxide results in increased degradation of NFKBIA protein] Vitamin E inhibits the reaction [Alcohols results in increased expression of NFKBIA mRNA]; Vitamin E inhibits the reaction [Platelet Activating Factor results in increased degradation of NFKBIA protein] Vitamin E results in decreased expression of NFKBIA mRNA
CTD
PMID:10921504 PMID:15081873 PMID:18814483 PMID:19244175
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Nfkbib
NFKB inhibitor beta
increases expression
ISO
Vitamin E results in increased expression of NFKBIB mRNA
CTD
PMID:19244175
NCBI chr 1:93,173,817...93,181,387
Ensembl chr 1:84,046,295...84,053,862
G
Nfyc
nuclear transcription factor Y subunit gamma
increases expression
ISO
Vitamin E results in increased expression of NFYC mRNA
CTD
PMID:19244175
NCBI chr 5:134,336,802...134,405,372
Ensembl chr 5:134,336,808...134,405,377
G
Nhp2
NHP2 ribonucleoprotein
increases expression
ISO
Vitamin E results in increased expression of NOLA2 mRNA
CTD
PMID:19244175
NCBI chr10:36,378,020...36,381,362
Ensembl chr10:35,877,054...35,882,545
G
Nhsl3
NHS like 3
decreases expression
ISO
Vitamin E results in decreased expression of NHSL3 mRNA
CTD
PMID:19244175
NCBI chr 5:141,564,399...141,593,154
Ensembl chr 5:141,564,399...141,593,176
G
Niban1
niban apoptosis regulator 1
decreases expression
ISO
Vitamin E results in decreased expression of NIBAN1 mRNA
CTD
PMID:19244175
NCBI chr13:66,224,219...66,377,728
Ensembl chr13:63,674,171...63,827,729
G
Ninl
ninein-like
decreases expression
ISO
Vitamin E results in decreased expression of NINL mRNA
CTD
PMID:19244175
NCBI chr 3:139,748,353...139,814,683
Ensembl chr 3:139,748,355...139,814,622
G
Nipbl
NIPBL, cohesin loading factor
decreases expression
ISO
Vitamin E results in decreased expression of NIPBL mRNA
CTD
PMID:19244175
NCBI chr 2:59,126,676...59,314,841
Ensembl chr 2:57,399,445...57,565,899
G
Nktr
natural killer cell triggering receptor
decreases expression
ISO
Vitamin E results in decreased expression of NKTR mRNA
CTD
PMID:19244175
NCBI chr 8:121,380,010...121,420,495
Ensembl chr 8:121,382,436...121,418,314
G
Nkx2-1
NK2 homeobox 1
multiple interactions
EXP ISO
Vitamin E inhibits the reaction [nitrofen results in decreased expression of NKX2-1 protein] Vitamin E inhibits the reaction [nitrofen results in decreased expression of NKX2-1 mRNA]
CTD
PMID:16490937 PMID:16863852
NCBI chr 6:79,731,677...79,735,952
Ensembl chr 6:73,996,601...73,999,791
G
Noc3l
NOC3-like DNA replication regulator
decreases expression
ISO
Vitamin E results in decreased expression of NOC3L mRNA
CTD
PMID:19244175
NCBI chr 1:236,556,037...236,585,372
Ensembl chr 1:236,556,789...236,585,318
G
Nol3
nucleolar protein 3
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of NOL3 mRNA
CTD
PMID:19244175
NCBI chr19:50,066,493...50,068,175
Ensembl chr19:33,154,062...33,158,250
G
Nol8
nucleolar protein 8
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of NOL8 mRNA Vitamin E results in decreased expression of NOL8 mRNA
CTD
PMID:19244175
NCBI chr17:14,990,394...15,013,784
Ensembl chr17:14,990,417...15,013,848
G
Nolc1
nucleolar and coiled-body phosphoprotein 1
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of NOLC1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of NOLC1 mRNA
CTD
PMID:19244175
NCBI chr 1:254,870,195...254,881,070
Ensembl chr 1:244,921,377...244,932,088
G
Nop56
NOP56 ribonucleoprotein
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of NOP56 mRNA Vitamin E results in decreased expression of NOP56 mRNA
CTD
PMID:19244175
NCBI chr 3:117,476,963...117,481,847
Ensembl chr 3:117,477,053...117,481,841
G
Nos2
nitric oxide synthase 2
multiple interactions
EXP
[Ascorbic Acid co-treated with Vitamin E co-treated with beta Carotene co-treated with Copper] inhibits the reaction [Streptozocin results in increased expression of NOS2 mRNA]; Vitamin E inhibits the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of NOS2 protein]; Vitamin E inhibits the reaction [APP protein modified form promotes the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of NOS2 protein]]; Vitamin E inhibits the reaction [Lead results in increased expression of NOS2 protein]
CTD
PMID:10523326 PMID:15223066 PMID:18779489
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Nos3
nitric oxide synthase 3
multiple interactions decreases expression
EXP ISO
[Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Dexamethasone results in decreased expression of NOS3 protein]; Vitamin E inhibits the reaction [Lead results in increased expression of NOS3 protein] Vitamin E results in decreased expression of NOS3 protein
CTD
PMID:10523326 PMID:11597945 PMID:20068362
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
G
Nosip
nitric oxide synthase interacting protein
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of NOSIP mRNA Vitamin E results in increased expression of NOSIP mRNA
CTD
PMID:19244175
NCBI chr 1:95,543,329...95,559,101
Ensembl chr 1:95,543,360...95,558,650
G
Notch4
notch receptor 4
multiple interactions
EXP
Vitamin E inhibits the reaction [[Nicotine co-treated with Ritonavir co-treated with Saquinavir] results in decreased expression of NOTCH4 protein]; Vitamin E inhibits the reaction [[Nicotine co-treated with Saquinavir] results in decreased expression of NOTCH4 protein]
CTD
PMID:20722969
NCBI chr20:4,164,969...4,189,072
Ensembl chr20:4,160,445...4,184,465
G
Nova1
NOVA alternative splicing regulator 1
decreases expression
ISO
Vitamin E results in decreased expression of NOVA1 mRNA
CTD
PMID:19244175
NCBI chr 6:69,506,983...69,632,437
Ensembl chr 6:63,783,489...63,906,289
G
Npepl1
aminopeptidase-like 1
increases expression multiple interactions
ISO
Vitamin E results in increased expression of NPEPL1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of NPEPL1 mRNA
CTD
PMID:19244175
NCBI chr 3:162,893,932...162,906,491
Ensembl chr 3:162,893,943...162,906,492
G
Npepps
aminopeptidase puromycin sensitive
increases expression
ISO
Vitamin E results in increased expression of NPEPPS mRNA
CTD
PMID:19244175
NCBI chr10:82,191,454...82,273,967
Ensembl chr10:82,191,456...82,273,967
G
Npm1
nucleophosmin 1
multiple interactions
EXP
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of NPM1 mRNA
CTD
PMID:11444866
NCBI chr10:18,245,739...18,255,913
Ensembl chr10:17,739,941...17,751,645 Ensembl chr X:17,739,941...17,751,645
G
Nppb
natriuretic peptide B
multiple interactions
EXP
Vitamin E affects the reaction [Triiodothyronine, Reverse results in increased expression of NPPB mRNA]
CTD
PMID:17198541
NCBI chr 5:163,699,955...163,701,314
Ensembl chr 5:158,416,866...158,418,168
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions increases expression
EXP ISO
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of NQO1 protein]; [Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of NQO1 mRNA Vitamin E inhibits the reaction [Ozone results in decreased expression of NQO1 protein] [Vitamin E co-treated with bioallethrin] results in increased expression of NQO1 protein Vitamin E results in increased expression of NQO1 mRNA
CTD
PMID:11444866 PMID:29663635 PMID:30090343 PMID:30513525 PMID:35511042
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Nr2c1
nuclear receptor subfamily 2, group C, member 1
decreases expression
ISO
Vitamin E results in decreased expression of NR2C1 mRNA
CTD
PMID:19244175
NCBI chr 7:28,715,347...28,768,624
Ensembl chr 7:28,715,562...28,767,160
G
Nr2f1
nuclear receptor subfamily 2, group F, member 1
increases expression
ISO
Vitamin E results in increased expression of NR2F1 mRNA
CTD
PMID:19244175
NCBI chr 2:9,776,179...9,785,924
Ensembl chr 2:8,040,377...8,050,123
G
Nr2f2
nuclear receptor subfamily 2, group F, member 2
increases expression
ISO
Vitamin E results in increased expression of NR2F2 mRNA
CTD
PMID:19244175
NCBI chr 1:133,419,161...133,434,290
Ensembl chr 1:124,009,181...124,022,031
G
Nr4a2
nuclear receptor subfamily 4, group A, member 2
increases expression multiple interactions
EXP
Vitamin E results in increased expression of NR4A2 protein [Ascorbic Acid co-treated with Vitamin E] results in increased expression of NR4A2 protein
CTD
PMID:18772553
NCBI chr 3:62,098,739...62,115,926
Ensembl chr 3:41,689,851...41,697,877
G
Nras
NRAS proto-oncogene, GTPase
decreases expression
ISO
Vitamin E results in decreased expression of NRAS mRNA
CTD
PMID:19244175
NCBI chr 2:193,271,399...193,282,023
Ensembl chr 2:190,582,918...190,591,626
G
Nsfl1c
NSFL1 cofactor
increases expression
ISO
Vitamin E results in increased expression of NSFL1C mRNA
CTD
PMID:19244175
NCBI chr 3:160,438,708...160,463,261
Ensembl chr 3:139,978,301...140,002,870
G
Nsun5
NOP2/Sun RNA methyltransferase 5
decreases expression
ISO
Vitamin E results in decreased expression of NSUN5 mRNA
CTD
PMID:19244175
NCBI chr12:21,293,637...21,299,319
Ensembl chr12:21,293,645...21,299,272
G
Nt5dc2
5'-nucleotidase domain containing 2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of NT5DC2 mRNA Vitamin E results in increased expression of NT5DC2 mRNA
CTD
PMID:19244175
NCBI chr16:6,328,925...6,336,978
Ensembl chr16:6,322,236...6,330,537
G
Nudc
nuclear distribution C, dynein complex regulator
increases expression
ISO
Vitamin E results in increased expression of NUDC mRNA
CTD
PMID:19244175
NCBI chr 5:151,041,878...151,055,260
Ensembl chr 5:145,758,002...145,771,425
G
Nudt18
nudix hydrolase 18
increases expression
ISO
Vitamin E results in increased expression of NUDT18 mRNA
CTD
PMID:19244175
NCBI chr15:45,650,597...45,653,985
Ensembl chr15:45,650,664...45,653,963
G
Numa1
nuclear mitotic apparatus protein 1
decreases expression
ISO
Vitamin E results in decreased expression of NUMA1 mRNA
CTD
PMID:19244175
NCBI chr 1:165,709,893...165,784,848
Ensembl chr 1:156,326,259...156,372,855
G
Nup160
nucleoporin 160
decreases expression
ISO
Vitamin E results in decreased expression of NUP160 mRNA
CTD
PMID:19244175
NCBI chr 3:97,120,723...97,183,227
Ensembl chr 3:76,665,786...76,724,565
G
Nup93
nucleoporin 93
increases expression
ISO
Vitamin E results in increased expression of NUP93 mRNA
CTD
PMID:19244175
NCBI chr19:10,690,154...10,793,937
Ensembl chr19:10,682,075...10,788,026
G
Nutf2
nuclear transport factor 2
increases expression
ISO
Vitamin E results in increased expression of NUTF2 mRNA
CTD
PMID:19244175
NCBI chr19:50,662,168...50,683,457
Ensembl chr19:33,752,291...33,773,591
G
Oaz2
ornithine decarboxylase antizyme 2
increases expression
ISO
Vitamin E results in increased expression of OAZ2 mRNA
CTD
PMID:19244175
NCBI chr 8:75,094,817...75,108,634
Ensembl chr 8:66,199,706...66,231,453
G
Ocln
occludin
multiple interactions
EXP
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of OCLN protein]; Vitamin E inhibits the reaction [phoxim results in decreased expression of OCLN mRNA]
CTD
PMID:29940330 PMID:30003487
NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:31,657,220...31,764,150
G
Odc1
ornithine decarboxylase 1
multiple interactions
ISO EXP
Vitamin E inhibits the reaction [mezerein results in increased activity of ODC1 protein]; Vitamin E inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of ODC1 protein]; Vitamin E inhibits the reaction [Urethane results in increased activity of ODC1 protein] Vitamin E inhibits the reaction [ferric nitrilotriacetate results in increased activity of ODC1 protein]
CTD
PMID:3098411 PMID:11062179 PMID:15949125
NCBI chr 6:46,058,439...46,065,148
Ensembl chr 6:40,329,964...40,336,440
G
Ogfod1
2-oxoglutarate and iron-dependent oxygenase domain containing 1
decreases expression
ISO
Vitamin E results in decreased expression of OGFOD1 mRNA
CTD
PMID:19244175
NCBI chr19:10,945,031...10,974,602
Ensembl chr19:10,946,018...10,975,119
G
Ogfr
opioid growth factor receptor
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of OGFR mRNA Vitamin E results in increased expression of OGFR mRNA
CTD
PMID:19244175
NCBI chr 3:167,703,173...167,709,459
Ensembl chr 3:167,702,695...167,709,473
G
Olah
oleoyl-ACP hydrolase
decreases expression
ISO
Vitamin E results in decreased expression of OLAH mRNA
CTD
PMID:19244175
NCBI chr17:79,786,441...79,811,692
Ensembl chr17:74,877,655...74,902,518
G
Olfml3
olfactomedin-like 3
increases expression
ISO
Vitamin E results in increased expression of OLFML3 mRNA
CTD
PMID:19244175
NCBI chr 2:191,244,221...191,247,050
Ensembl chr 2:191,244,221...191,247,050
G
Or5v1b
olfactory receptor family 5 subfamily V member 1B
decreases expression
ISO
Vitamin E results in decreased expression of OR5V1 mRNA
CTD
PMID:19244175
NCBI chr20:1,163,321...1,164,274
Ensembl chr20:1,151,540...1,159,222
G
Orc6
origin recognition complex, subunit 6
decreases expression
ISO
Vitamin E results in decreased expression of ORC6 mRNA
CTD
PMID:19244175
NCBI chr19:37,931,085...37,938,856
Ensembl chr19:21,757,866...21,765,662
G
Orm1
orosomucoid 1
multiple interactions
EXP
[Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of ORM1 mRNA
CTD
PMID:11444866
NCBI chr 5:81,788,509...81,791,661
Ensembl chr 5:76,772,941...76,776,154
G
Os9
OS9, endoplasmic reticulum lectin
increases expression
ISO
Vitamin E results in increased expression of OS9 mRNA
CTD
PMID:19244175
NCBI chr 7:64,802,517...64,829,185
Ensembl chr 7:62,915,515...62,943,745
G
Osbpl1a
oxysterol binding protein-like 1A
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of OSBPL1A mRNA [Selenium co-treated with Vitamin E] results in decreased expression of OSBPL1A mRNA
CTD
PMID:19244175
NCBI chr18:3,904,006...4,094,635
Ensembl chr18:3,904,006...4,094,585
G
Osr2
odd-skipped related transcription factor 2
increases expression
ISO
Vitamin E results in increased expression of OSR2 mRNA
CTD
PMID:19244175
NCBI chr 7:66,487,841...66,495,003
Ensembl chr 7:66,487,839...66,495,224
G
P22k15
cystatin related protein 2
decreases expression
EXP
Vitamin E results in decreased expression of P22K15 mRNA
CTD
PMID:15084515
NCBI chr 3:136,960,300...136,967,358
Ensembl chr 3:136,960,303...136,967,358
G
Pa2g4
proliferation-associated 2G4
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PA2G4 mRNA
CTD
PMID:19244175
NCBI chr 7:1,569,326...1,576,794
Ensembl chr 7:983,971...992,331
G
Pabpc1
poly(A) binding protein, cytoplasmic 1
decreases expression
ISO
Vitamin E results in decreased expression of PABPC1 mRNA
CTD
PMID:19244175
NCBI chr 7:69,662,513...69,674,806
Ensembl chr 7:67,777,381...67,789,744
G
Pabpc6
poly(A) binding protein, cytoplasmic 6
decreases expression
ISO
Vitamin E results in decreased expression of PABPC3 mRNA
CTD
PMID:19244175
NCBI chr 1:51,045,264...51,048,340
Ensembl chr 1:51,045,233...51,048,340
G
Pafah1b1
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of PAFAH1B1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of PAFAH1B1 mRNA
CTD
PMID:19244175
NCBI chr10:60,031,441...60,090,259
Ensembl chr10:59,534,117...59,591,808
G
Pafah1b3
platelet-activating factor acetylhydrolase 1b, catalytic subunit 3
increases expression
ISO
Vitamin E results in increased expression of PAFAH1B3 mRNA
CTD
PMID:19244175
NCBI chr 1:80,881,263...80,883,789
Ensembl chr 1:80,881,309...80,883,893
G
Pak2
p21 (RAC1) activated kinase 2
increases expression
ISO
Vitamin E results in increased expression of PAK2 mRNA
CTD
PMID:19244175
NCBI chr11:82,212,896...82,273,803
Ensembl chr11:68,707,969...68,768,816
G
Pakap
paralemmin A kinase anchor protein
increases expression decreases expression
ISO
Vitamin E results in increased expression of PALM2AKAP2 mRNA Vitamin E results in decreased expression of PALM2AKAP2 mRNA
CTD
PMID:19244175
NCBI chr 5:76,976,906...77,443,656
Ensembl chr 5:72,181,718...72,648,524
G
Pam
peptidylglycine alpha-amidating monooxygenase
decreases expression
ISO
Vitamin E results in decreased expression of PAM mRNA
CTD
PMID:19244175
NCBI chr 9:105,445,812...105,719,287
Ensembl chr 9:98,122,916...98,271,965
G
Paox
polyamine oxidase
multiple interactions increases expression
ISO EXP
[Selenium co-treated with Vitamin E] results in decreased expression of PAOX mRNA Vitamin E results in increased expression of PAOX mRNA
CTD
PMID:19244175 PMID:28923436
NCBI chr 1:204,349,326...204,358,140
Ensembl chr 1:194,903,273...194,928,504
G
Pard3
par-3 family cell polarity regulator
decreases expression
ISO
Vitamin E results in decreased expression of PARD3 mRNA
CTD
PMID:19244175
NCBI chr19:71,977,420...72,527,273
Ensembl chr19:55,080,282...55,629,778
G
Parl
presenilin associated, rhomboid-like
increases expression
ISO
Vitamin E results in increased expression of PARL mRNA
CTD
PMID:19244175
NCBI chr11:94,097,559...94,124,915
Ensembl chr11:80,593,192...80,620,506
G
Parn
poly(A)-specific ribonuclease
increases expression
ISO
Vitamin E results in increased expression of PARN mRNA
CTD
PMID:19244175
NCBI chr10:1,410,636...1,548,573
Ensembl chr10:1,410,642...1,548,560
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions increases expression
ISO
Vitamin E inhibits the reaction [Benzo(a)pyrene results in increased expression of PARP1 protein]; Vitamin E inhibits the reaction [osimertinib results in increased expression of PARP1 protein modified form] Vitamin E results in increased expression of PARP1 mRNA
CTD
PMID:19244175 PMID:24664296 PMID:28237877
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Parva
parvin, alpha
decreases expression
ISO
Vitamin E results in decreased expression of PARVA mRNA
CTD
PMID:19244175
NCBI chr 1:175,981,725...176,139,523
Ensembl chr 1:166,547,132...166,704,950
G
Pawr
pro-apoptotic WT1 regulator
decreases expression
ISO
Vitamin E results in decreased expression of PAWR mRNA
CTD
PMID:19244175
NCBI chr 7:45,531,480...45,611,492
Ensembl chr 7:43,645,084...43,725,028
G
Pax4
paired box 4
decreases expression
ISO
Vitamin E results in decreased expression of PAX4 mRNA
CTD
PMID:19244175
NCBI chr 4:58,023,873...58,032,265
Ensembl chr 4:57,058,462...57,063,408
G
Paxbp1
PAX3 and PAX7 binding protein 1
decreases expression
ISO
Vitamin E results in decreased expression of PAXBP1 mRNA
CTD
PMID:19244175
NCBI chr11:43,758,116...43,787,624
Ensembl chr11:30,272,037...30,301,648
G
Pbxip1
PBX homeobox interacting protein 1
increases expression
ISO
Vitamin E results in increased expression of PBXIP1 mRNA
CTD
PMID:19244175
NCBI chr 2:177,154,056...177,167,810
Ensembl chr 2:174,856,397...174,868,919
G
Pcdhgc3
protocadherin gamma subfamily C, 3
increases expression
ISO
Vitamin E results in increased expression of PCDHGC3 mRNA
CTD
PMID:19244175
NCBI chr18:29,633,016...29,667,865
Ensembl chr18:29,493,954...29,667,868
G
Pcgf1
polycomb group ring finger 1
increases expression
ISO
Vitamin E results in increased expression of PCGF1 mRNA
CTD
PMID:19244175
NCBI chr 4:117,140,144...117,144,729
Ensembl chr 4:115,583,867...115,587,008
G
Pclaf
PCNA clamp associated factor
decreases expression
ISO
Vitamin E results in decreased expression of PCLAF mRNA
CTD
PMID:19244175
NCBI chr 8:75,311,028...75,328,108
Ensembl chr 8:66,420,587...66,432,994 Ensembl chr 8:66,420,587...66,432,994
G
Pcm1
pericentriolar material 1
decreases expression
ISO
Vitamin E results in decreased expression of PCM1 mRNA
CTD
PMID:19244175
NCBI chr16:57,711,833...57,808,842
Ensembl chr16:51,008,315...51,105,091
G
Pcna
proliferating cell nuclear antigen
multiple interactions
ISO
Vitamin E inhibits the reaction [Urethane results in increased expression of PCNA protein]
CTD
PMID:11062179
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:119,498,810...119,502,995
G
Pcolce
procollagen C-endopeptidase enhancer
increases expression
ISO
Vitamin E results in increased expression of PCOLCE mRNA
CTD
PMID:19244175
NCBI chr12:24,720,972...24,727,287
Ensembl chr12:19,084,210...19,090,508
G
Pcsk7
proprotein convertase subtilisin/kexin type 7
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PCSK7 mRNA Vitamin E results in increased expression of PCSK7 mRNA
CTD
PMID:19244175
NCBI chr 8:46,202,079...46,224,699
Ensembl chr 8:46,202,131...46,224,705
G
Pcyox1l
prenylcysteine oxidase 1 like
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PCYOX1L mRNA Vitamin E results in decreased expression of PCYOX1L mRNA
CTD
PMID:19244175
NCBI chr18:57,420,971...57,431,632
Ensembl chr18:55,150,650...55,161,327
G
Pde8a
phosphodiesterase 8A
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PDE8A mRNA Vitamin E results in decreased expression of PDE8A mRNA
CTD
PMID:19244175
NCBI chr 1:144,575,203...144,698,216
Ensembl chr 1:135,166,237...135,288,024
G
Pdgfa
platelet derived growth factor subunit A
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PDGFA mRNA
CTD
PMID:19244175
NCBI chr12:20,759,366...20,780,337
Ensembl chr12:15,645,541...15,666,497
G
Pdgfra
platelet derived growth factor receptor alpha
increases expression
ISO
Vitamin E results in increased expression of PDGFRA mRNA
CTD
PMID:19244175
NCBI chr14:33,360,027...33,408,604
Ensembl chr14:33,005,839...33,054,335
G
Pdgfrb
platelet derived growth factor receptor beta
increases expression
ISO
Vitamin E results in increased expression of PDGFRB mRNA
CTD
PMID:19244175
NCBI chr18:56,770,348...56,809,228
Ensembl chr18:54,499,964...54,538,843
G
Pdlim2
PDZ and LIM domain 2
increases expression
ISO
Vitamin E results in increased expression of PDLIM2 mRNA
CTD
PMID:19244175
NCBI chr15:45,235,421...45,250,187
Ensembl chr15:45,237,477...45,249,242
G
Pdlim3
PDZ and LIM domain 3
decreases expression
ISO
Vitamin E results in decreased expression of PDLIM3 mRNA
CTD
PMID:19244175
NCBI chr16:53,085,020...53,116,495
Ensembl chr16:46,352,467...46,383,657
G
Pdlim4
PDZ and LIM domain 4
increases expression
ISO
Vitamin E results in increased expression of PDLIM4 mRNA
CTD
PMID:19244175
NCBI chr10:38,699,444...38,713,696
Ensembl chr10:38,198,689...38,212,938
G
Pdlim7
PDZ and LIM domain 7
increases expression
ISO
Vitamin E results in increased expression of PDLIM7 mRNA
CTD
PMID:19244175
NCBI chr17:9,129,603...9,144,956
Ensembl chr17:9,124,649...9,139,811
G
Pdpk1
3-phosphoinositide dependent protein kinase-1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PDPK1 mRNA Vitamin E results in decreased expression of PDPK1 mRNA
CTD
PMID:19244175
NCBI chr10:13,610,000...13,687,226
Ensembl chr10:13,105,498...13,174,623
G
Pds5b
PDS5 cohesin associated factor B
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of APRIN mRNA
CTD
PMID:19244175
NCBI chr12:202,481...345,596
Ensembl chr12:255,313...345,596
G
Pea15
proliferation and apoptosis adaptor protein 15
increases expression
ISO
Vitamin E results in increased expression of PEA15 mRNA
CTD
PMID:19244175
NCBI chr13:87,190,189...87,199,811
Ensembl chr13:84,654,870...84,667,499
G
Pebp1
phosphatidylethanolamine binding protein 1
increases expression
ISO
Vitamin E results in increased expression of PEBP1 mRNA
CTD
PMID:19244175
NCBI chr12:44,946,307...44,967,890
Ensembl chr12:39,302,840...39,307,862
G
Pecam1
platelet and endothelial cell adhesion molecule 1
increases expression
ISO
Vitamin E results in increased expression of PECAM1 mRNA
CTD
PMID:19244175
NCBI chr10:92,090,263...92,152,002
Ensembl chr10:91,590,521...91,652,116
G
Pef1
penta-EF hand domain containing 1
increases expression
ISO
Vitamin E results in increased expression of PEF1 mRNA
CTD
PMID:19244175
NCBI chr 5:147,735,973...147,759,239
Ensembl chr 5:142,451,778...142,475,067
G
Peli1
pellino E3 ubiquitin protein ligase 1
decreases expression
ISO
Vitamin E results in decreased expression of PELI1 mRNA
CTD
PMID:19244175
NCBI chr14:99,455,970...99,510,474
Ensembl chr14:95,254,589...95,308,285 Ensembl chr 1:95,254,589...95,308,285
G
Pemt
phosphatidylethanolamine N-methyltransferase
increases expression
ISO
Vitamin E results in increased expression of PEMT mRNA
CTD
PMID:19244175
NCBI chr10:45,275,434...45,349,651
Ensembl chr10:44,775,911...44,850,013
G
Per3
period circadian regulator 3
decreases expression
ISO
Vitamin E results in decreased expression of PER3 mRNA
CTD
PMID:19244175
NCBI chr 5:166,740,914...166,778,243
Ensembl chr 5:161,459,533...161,495,607
G
Pes1
pescadillo ribosomal biogenesis factor 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PES1 mRNA Vitamin E results in increased expression of PES1 mRNA
CTD
PMID:19244175
NCBI chr14:78,850,754...78,867,134
Ensembl chr14:78,850,709...78,867,134
G
Pex1
peroxisomal biogenesis factor 1
decreases expression
ISO
Vitamin E results in decreased expression of PEX1 mRNA
CTD
PMID:19244175
NCBI chr 4:31,474,670...31,513,621
Ensembl chr 4:30,519,955...30,558,921
G
Pex16
peroxisomal biogenesis factor 16
decreases expression
ISO
Vitamin E results in decreased expression of PEX16 mRNA
CTD
PMID:19244175
NCBI chr 3:98,800,357...98,808,091
Ensembl chr 3:78,343,164...78,353,207
G
Pex3
peroxisomal biogenesis factor 3
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PEX3 mRNA Vitamin E results in decreased expression of PEX3 mRNA
CTD
PMID:19244175
NCBI chr 1:9,732,641...9,774,479
Ensembl chr 1:7,912,506...7,954,518
G
Pex5
peroxisomal biogenesis factor 5
increases expression
ISO
Vitamin E results in increased expression of PEX5 mRNA
CTD
PMID:19244175
NCBI chr 4:158,956,973...158,983,581
Ensembl chr 4:157,270,672...157,296,431
G
Pex7
peroxisomal biogenesis factor 7
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PEX7 mRNA
CTD
PMID:19244175
NCBI chr 1:16,402,319...16,466,304
Ensembl chr 1:14,582,699...14,646,748
G
Pfdn2
prefoldin subunit 2
increases expression
ISO
Vitamin E results in increased expression of PFDN2 mRNA
CTD
PMID:19244175
NCBI chr13:86,305,037...86,323,008
Ensembl chr13:83,753,877...83,790,504
G
Pfdn5
prefoldin subunit 5
increases expression
ISO
Vitamin E results in increased expression of PFDN5 mRNA
CTD
PMID:19244175
NCBI chr 7:133,451,778...133,456,516
Ensembl chr 7:133,451,453...133,456,516
G
Pfkl
phosphofructokinase, liver type
increases expression
ISO
Vitamin E results in increased expression of PFKL mRNA
CTD
PMID:19244175
NCBI chr20:10,663,907...10,685,967
Ensembl chr20:10,664,272...10,686,315
G
Pfkp
phosphofructokinase, platelet
increases expression
ISO
Vitamin E results in increased expression of PFKP mRNA
CTD
PMID:19244175
NCBI chr17:68,639,749...68,704,055
Ensembl chr17:63,729,780...63,794,018
G
Pfn1
profilin 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PFN1 mRNA Vitamin E results in increased expression of PFN1 mRNA
CTD
PMID:19244175
NCBI chr10:55,863,882...55,866,587
Ensembl chr10:55,365,262...55,527,631
G
Pgap2
post-GPI attachment to proteins 2
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PGAP2 mRNA
CTD
PMID:19244175
NCBI chr 1:166,003,593...166,030,088
Ensembl chr 1:156,591,615...156,618,114
G
Pgm3
phosphoglucomutase 3
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PGM3 mRNA
CTD
PMID:19244175
NCBI chr 8:96,398,331...96,416,045
Ensembl chr 8:87,517,701...87,536,022
G
Phactr2
phosphatase and actin regulator 2
decreases expression
ISO
Vitamin E results in decreased expression of PHACTR2 mRNA
CTD
PMID:19244175
NCBI chr 1:7,591,254...7,860,431
Ensembl chr 1:7,597,927...7,860,289
G
Phb1
prohibitin 1
increases expression
ISO
Vitamin E results in increased expression of PHB1 mRNA
CTD
PMID:19244175
NCBI chr10:81,102,043...81,114,815
Ensembl chr10:80,605,251...80,618,042
G
Phc2
polyhomeotic homolog 2
increases expression
ISO
Vitamin E results in increased expression of PHC2 mRNA
CTD
PMID:19244175
NCBI chr 5:141,000,604...141,099,268
Ensembl chr 5:141,050,842...141,099,268
G
Phf20
PHD finger protein 20
decreases expression
ISO
Vitamin E results in decreased expression of PHF20 mRNA
CTD
PMID:19244175
NCBI chr 3:144,710,253...144,816,696
Ensembl chr 3:144,710,353...144,814,439
G
Phf3
PHD finger protein 3
decreases expression
ISO
Vitamin E results in decreased expression of PHF3 mRNA
CTD
PMID:19244175
NCBI chr 9:33,063,855...33,136,013
Ensembl chr 9:33,063,857...33,135,994
G
Phlda1
pleckstrin homology-like domain, family A, member 1
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PHLDA1 mRNA
CTD
PMID:19244175
NCBI chr 7:46,967,433...46,969,637
Ensembl chr 7:46,967,409...46,969,861
G
Pi4kb
phosphatidylinositol 4-kinase beta
increases expression
ISO
Vitamin E results in increased expression of PI4KB mRNA
CTD
PMID:19244175
NCBI chr 2:185,229,392...185,261,697
Ensembl chr 2:182,540,567...182,588,488
G
Pias1
protein inhibitor of activated STAT, 1
decreases expression
ISO
Vitamin E results in decreased expression of PIAS1 mRNA
CTD
PMID:19244175
NCBI chr 8:72,233,566...72,347,085
Ensembl chr 8:63,338,150...63,438,905
G
Pias4
protein inhibitor of activated STAT, 4
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PIAS4 mRNA Vitamin E results in decreased expression of PIAS4 mRNA
CTD
PMID:19244175
NCBI chr 7:9,197,032...9,210,557
Ensembl chr 7:8,546,312...8,559,808
G
Pigg
phosphatidylinositol glycan anchor biosynthesis, class G
decreases expression
ISO
Vitamin E results in decreased expression of PIGG mRNA
CTD
PMID:19244175
NCBI chr14:1,549,891...1,578,174
Ensembl chr14:1,406,798...1,433,187
G
Pigh
phosphatidylinositol glycan anchor biosynthesis, class H
decreases expression
ISO
Vitamin E results in decreased expression of PIGH mRNA
CTD
PMID:19244175
NCBI chr 6:97,874,903...97,897,188
Ensembl chr 6:97,882,903...97,897,142
G
Pih1d1
PIH1 domain containing 1
increases expression multiple interactions
ISO
Vitamin E results in increased expression of PIH1D1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of PIH1D1 mRNA
CTD
PMID:19244175
NCBI chr 1:104,774,562...104,781,757
Ensembl chr 1:95,639,592...95,645,290
G
Pik3cd
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PIK3CD mRNA Vitamin E results in increased expression of PIK3CD mRNA
CTD
PMID:19244175
NCBI chr 5:165,377,994...165,426,620
Ensembl chr 5:160,094,952...160,120,930
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
decreases expression
ISO
Vitamin E results in decreased expression of PIK3R1 mRNA
CTD
PMID:19244175
NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:32,882,032...32,963,631
G
Pim1
Pim-1 proto-oncogene, serine/threonine kinase
increases expression
ISO
Vitamin E results in increased expression of PIM1 mRNA
CTD
PMID:19244175
NCBI chr20:7,556,496...7,560,747
Ensembl chr20:7,554,921...7,559,174
G
Pink1
PTEN induced kinase 1
increases expression
ISO
Vitamin E results in increased expression of PINK1 mRNA
CTD
PMID:19244175
NCBI chr 5:155,813,838...155,825,950
Ensembl chr 5:150,530,523...150,542,635
G
Pip4k2c
phosphatidylinositol-5-phosphate 4-kinase type 2 gamma
increases expression
ISO
Vitamin E results in increased expression of PIP4K2C mRNA
CTD
PMID:19244175
NCBI chr 7:63,020,004...63,035,086
Ensembl chr 7:63,020,000...63,035,078
G
Pitpna
phosphatidylinositol transfer protein, alpha
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of PITPNA mRNA [Selenium co-treated with Vitamin E] results in decreased expression of PITPNA mRNA
CTD
PMID:19244175
NCBI chr10:60,929,050...60,969,614
Ensembl chr10:60,430,748...60,471,342
G
Pitx1
paired-like homeodomain 1
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PITX1 mRNA
CTD
PMID:19244175
NCBI chr17:8,794,134...8,800,292
Ensembl chr17:8,794,134...8,800,291
G
Pja1
praja ring finger ubiquitin ligase 1
increases expression
ISO
Vitamin E results in increased expression of PJA1 mRNA
CTD
PMID:19244175
NCBI chr X:64,580,938...64,585,846
Ensembl chr X:64,580,849...64,585,833
G
Pkd1
polycystin 1, transient receptor potential channel interacting
increases expression
ISO
Vitamin E results in increased expression of PKD1 mRNA
CTD
PMID:19244175
NCBI chr10:14,077,733...14,125,682
Ensembl chr10:13,573,021...13,621,128
G
Pkm
pyruvate kinase M1/2
increases expression
ISO
Vitamin E results in increased expression of PKM mRNA
CTD
PMID:19244175
NCBI chr 8:68,949,731...68,975,394
Ensembl chr 8:60,057,402...60,079,599
G
Pkn2
protein kinase N2
decreases expression
ISO
Vitamin E results in decreased expression of PKN2 mRNA
CTD
PMID:19244175
NCBI chr 2:231,793,584...231,898,953
Ensembl chr 2:231,793,584...231,898,953
G
Pla2g12a
phospholipase A2, group XIIA
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of PLA2G12A mRNA [Selenium co-treated with Vitamin E] results in decreased expression of PLA2G12A mRNA
CTD
PMID:19244175
NCBI chr 2:221,110,722...221,126,966
Ensembl chr 2:218,436,513...218,452,740
G
Plaat3
phospholipase A and acyltransferase 3
increases expression
ISO
Vitamin E results in increased expression of PLAAT3 mRNA
CTD
PMID:19244175
NCBI chr 1:214,211,755...214,245,551
Ensembl chr 1:204,782,729...204,817,667
G
Plagl1
PLAG1 like zinc finger 1
decreases expression
ISO
Vitamin E results in decreased expression of PLAGL1 mRNA
CTD
PMID:19244175
NCBI chr 1:7,477,295...7,517,229
Ensembl chr 1:7,477,177...7,517,228
G
Plat
plasminogen activator, tissue type
multiple interactions increases activity
EXP
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Endosulfan results in increased activity of PLAT protein]; Ascorbic Acid promotes the reaction [Vitamin E results in increased activity of PLAT protein]
CTD
PMID:21804306
NCBI chr16:75,943,061...76,022,037
Ensembl chr16:69,240,585...69,268,223
G
Plcb4
phospholipase C, beta 4
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PLCB4 mRNA Vitamin E results in decreased expression of PLCB4 mRNA
CTD
PMID:19244175
NCBI chr 3:143,405,721...143,775,129
Ensembl chr 3:122,953,196...123,322,392
G
Plekha1
pleckstrin homology domain containing A1
decreases expression
ISO
Vitamin E results in decreased expression of PLEKHA1 mRNA
CTD
PMID:19244175
NCBI chr 1:185,427,982...185,479,157
Ensembl chr 1:185,428,048...185,479,156
G
Plekhf2
pleckstrin homology and FYVE domain containing 2
decreases expression
ISO
Vitamin E results in decreased expression of PLEKHF2 mRNA
CTD
PMID:19244175
NCBI chr 5:24,091,077...24,106,758
Ensembl chr 5:24,090,688...24,106,601
G
Plekhj1
pleckstrin homology domain containing J1
increases expression
ISO
Vitamin E results in increased expression of PLEKHJ1 mRNA
CTD
PMID:19244175
NCBI chr 7:8,915,492...8,920,491
G
Plekho1
pleckstrin homology domain containing O1
increases expression
ISO
Vitamin E results in increased expression of PLEKHO1 mRNA
CTD
PMID:19244175
NCBI chr 2:183,544,487...183,552,928
Ensembl chr 2:183,544,499...183,552,785
G
Plekho2
pleckstrin homology domain containing O2
increases expression
ISO
Vitamin E results in increased expression of PLEKHO2 mRNA
CTD
PMID:19244175
NCBI chr 8:74,973,578...75,000,532
Ensembl chr 8:66,078,448...66,105,266
G
Pllp
plasmolipin
increases expression
ISO
Vitamin E results in increased expression of PLLP mRNA
CTD
PMID:19244175
NCBI chr19:10,315,104...10,335,892
Ensembl chr19:10,315,104...10,335,892
G
Plod2
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2
decreases expression
ISO
Vitamin E results in decreased expression of PLOD2 mRNA
CTD
PMID:19244175
NCBI chr 8:101,964,318...102,047,022
Ensembl chr 8:93,084,513...93,167,255
G
Plpp3
phospholipid phosphatase 3
increases expression
ISO
Vitamin E results in increased expression of PLPP3 mRNA
CTD
PMID:19244175
NCBI chr 5:125,156,000...125,231,119
Ensembl chr 5:119,927,085...120,002,205
G
Pml
PML nuclear body scaffold
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PML mRNA Vitamin E results in increased expression of PML mRNA
CTD
PMID:19244175
NCBI chr 8:67,523,164...67,557,801
Ensembl chr 8:58,628,837...58,658,971
G
Pmpcb
peptidase, mitochondrial processing subunit beta
decreases expression
ISO
Vitamin E results in decreased expression of PMPCB mRNA
CTD
PMID:19244175
NCBI chr 4:14,189,807...14,202,584
Ensembl chr 4:13,297,559...13,310,367
G
Pms1
PMS1 homolog 1, mismatch repair system component
decreases expression
ISO
Vitamin E results in decreased expression of PMS1 mRNA
CTD
PMID:19244175
NCBI chr 9:55,721,393...55,832,225
Ensembl chr 9:48,253,410...48,340,237
G
Pmvk
phosphomevalonate kinase
increases expression decreases expression
ISO EXP
Vitamin E results in increased expression of PMVK mRNA Vitamin E results in decreased expression of PMVK mRNA
CTD
PMID:19244175 PMID:28923436
NCBI chr 2:177,174,344...177,184,076
Ensembl chr 2:174,876,657...174,886,364
G
Pnisr
PNN interacting serine and arginine rich protein
decreases expression
ISO
Vitamin E results in decreased expression of PNISR mRNA
CTD
PMID:19244175
NCBI chr 5:35,395,965...35,422,852
Ensembl chr 5:35,395,965...35,422,844
G
Pnkp
polynucleotide kinase 3'-phosphatase
decreases expression
ISO
Vitamin E results in decreased expression of PNKP mRNA
CTD
PMID:19244175
NCBI chr 1:104,476,801...104,483,409
Ensembl chr 1:95,341,620...95,346,920
G
Pnliprp1
pancreatic lipase-related protein 1
decreases expression
ISO
Vitamin E results in decreased expression of PNLIPRP1 mRNA
CTD
PMID:19244175
NCBI chr 1:267,854,027...267,869,654
Ensembl chr 1:257,867,885...257,883,514
G
Pnp
purine nucleoside phosphorylase
decreases expression
ISO
Vitamin E results in decreased expression of PNP mRNA
CTD
PMID:19244175
NCBI chr15:26,644,147...26,651,808
Ensembl chr15:24,170,602...24,203,986
G
Pnpla4
patatin like phospholipase domain containing 4
decreases expression
ISO
Vitamin E results in decreased expression of PNPLA4 mRNA
CTD
PMID:19244175
NCBI chr X:46,200,351...46,205,517
Ensembl chr X:42,305,373...42,318,552
G
Poli
DNA polymerase iota
decreases expression
ISO
Vitamin E results in decreased expression of POLI mRNA
CTD
PMID:19244175
NCBI chr18:64,116,774...64,134,373
Ensembl chr18:64,116,774...64,163,418
G
Poll
DNA polymerase lambda
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of POLL mRNA
CTD
PMID:19244175
NCBI chr 1:254,349,229...254,357,689
Ensembl chr 1:244,400,204...244,408,662
G
Polr2c
RNA polymerase II subunit C
increases expression
ISO
Vitamin E results in increased expression of POLR2C mRNA
CTD
PMID:19244175
NCBI chr19:10,158,153...10,164,935
Ensembl chr19:10,157,823...10,164,945
G
Pon1
paraoxonase 1
multiple interactions increases activity
EXP
Vitamin E inhibits the reaction [Propylthiouracil results in decreased activity of PON1 protein] Vitamin E results in increased activity of PON1 protein
CTD
PMID:15386442
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:33,294,722...33,321,360
G
Pon2
paraoxonase 2
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of PON2 mRNA Vitamin E results in decreased expression of and results in decreased activity of PON2 protein
CTD
PMID:15544923 PMID:19244175
NCBI chr 4:33,389,702...33,425,186
Ensembl chr 4:33,389,714...33,425,248
G
Pon3
paraoxonase 3
increases activity
ISO
Vitamin E results in increased activity of PON3 protein
CTD
PMID:12615656
NCBI chr 4:34,323,546...34,350,244
Ensembl chr 4:33,349,168...33,383,855
G
Por
cytochrome p450 oxidoreductase
increases expression
ISO
Vitamin E results in increased expression of POR mRNA
CTD
PMID:19244175
NCBI chr12:26,587,674...26,655,612
Ensembl chr12:20,951,058...20,999,245
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions
EXP
Vitamin E inhibits the reaction [Diethylhexyl Phthalate results in increased expression of PPARG mRNA]; Vitamin E inhibits the reaction [Doxorubicin results in decreased expression of PPARG protein]
CTD
PMID:28532275 PMID:38997059
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Ppat
phosphoribosyl pyrophosphate amidotransferase
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of PPAT mRNA [Selenium co-treated with Vitamin E] results in decreased expression of PPAT mRNA
CTD
PMID:19244175
NCBI chr14:31,570,010...31,604,410
Ensembl chr14:31,216,165...31,250,144
G
Ppdpf
pancreatic progenitor cell differentiation and proliferation factor
decreases expression
ISO
Vitamin E results in decreased expression of PPDPF mRNA
CTD
PMID:19244175
NCBI chr 3:168,299,309...168,301,040
Ensembl chr 3:168,299,791...168,301,036
G
Ppib
peptidylprolyl isomerase B
increases expression
ISO
Vitamin E results in increased expression of PPIB mRNA
CTD
PMID:19244175
NCBI chr 8:75,498,966...75,504,823
Ensembl chr 8:66,603,861...66,630,428
G
Ppic
peptidylprolyl isomerase C
increases expression
ISO
Vitamin E results in increased expression of PPIC mRNA
CTD
PMID:19244175
NCBI chr18:49,040,690...49,053,296
Ensembl chr18:46,842,409...46,855,017
G
Ppig
peptidylprolyl isomerase G
decreases expression
ISO
Vitamin E results in decreased expression of PPIG mRNA
CTD
PMID:19244175
NCBI chr 3:74,891,846...74,923,010
Ensembl chr 3:54,484,023...54,512,926
G
Ppl
periplakin
decreases expression
ISO
Vitamin E results in decreased expression of PPL mRNA
CTD
PMID:19244175
NCBI chr10:10,957,388...11,003,035
Ensembl chr10:10,450,919...10,496,575
G
Ppm1j
protein phosphatase, Mg2+/Mn2+ dependent, 1J
increases expression
ISO
Vitamin E results in increased expression of PPM1J mRNA
CTD
PMID:19244175
NCBI chr 2:192,278,597...192,283,883
Ensembl chr 2:192,278,517...192,283,882
G
Ppme1
protein phosphatase methylesterase 1
increases expression multiple interactions
ISO
Vitamin E results in increased expression of PPME1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of PPME1 mRNA
CTD
PMID:19244175
NCBI chr 1:154,668,099...154,715,079
Ensembl chr 1:154,668,109...154,715,110
G
Ppp1ca
protein phosphatase 1 catalytic subunit alpha
increases expression
ISO
Vitamin E results in increased expression of PPP1CA mRNA
CTD
PMID:19244175
NCBI chr 1:210,914,576...210,918,193
Ensembl chr 1:201,485,085...201,497,327
G
Ppp1r10
protein phosphatase 1, regulatory subunit 10
increases expression decreases expression multiple interactions
ISO
Vitamin E results in increased expression of PPP1R10 mRNA Vitamin E results in decreased expression of PPP1R10 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of PPP1R10 mRNA
CTD
PMID:19244175
NCBI chr20:2,827,802...2,842,418
Ensembl chr20:2,822,995...2,837,611
G
Ppp1r12b
protein phosphatase 1, regulatory subunit 12B
increases expression
ISO
Vitamin E results in increased expression of PPP1R12B mRNA
CTD
PMID:19244175
NCBI chr13:46,199,418...46,397,108
Ensembl chr13:46,201,251...46,397,108
G
Ppp1r9a
protein phosphatase 1, regulatory subunit 9A
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PPP1R9A mRNA Vitamin E results in decreased expression of PPP1R9A mRNA
CTD
PMID:19244175
NCBI chr 4:33,936,949...34,258,927
Ensembl chr 4:33,024,450...33,286,907
G
Ppp2r1a
protein phosphatase 2 scaffold subunit A alpha
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PPP2R1A mRNA Vitamin E results in increased expression of PPP2R1A mRNA
CTD
PMID:19244175
NCBI chr 1:69,213,198...69,232,441
Ensembl chr 1:60,540,194...60,560,129
G
Ppp2r1b
protein phosphatase 2 scaffold subunit A beta
decreases expression
ISO
Vitamin E results in decreased expression of PPP2R1B mRNA
CTD
PMID:19244175
NCBI chr 8:51,195,860...51,228,442
Ensembl chr 8:51,186,717...51,228,485
G
Ppp2r3a
protein phosphatase 2, regulatory subunit B'', alpha
decreases expression
ISO
Vitamin E results in decreased expression of PPP2R3A mRNA
CTD
PMID:19244175
NCBI chr 8:110,582,479...110,720,516
Ensembl chr 8:101,704,778...101,841,502
G
Ppp4c
protein phosphatase 4, catalytic subunit
increases expression
ISO
Vitamin E results in increased expression of PPP4C mRNA
CTD
PMID:19244175
NCBI chr 1:190,823,447...190,830,247
Ensembl chr 1:181,392,923...181,399,659
G
Ppp6r2
protein phosphatase 6, regulatory subunit 2
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PPP6R2 mRNA
CTD
PMID:19244175
NCBI chr 7:120,285,378...120,356,995
Ensembl chr 7:120,285,406...120,356,395
G
Prdm2
PR/SET domain 2
decreases expression increases expression
ISO
Vitamin E results in decreased expression of PRDM2 mRNA Vitamin E results in increased expression of PRDM2 mRNA
CTD
PMID:19244175
NCBI chr 5:155,421,066...155,531,884
Ensembl chr 5:155,422,134...155,531,825
G
Prdx2
peroxiredoxin 2
increases expression
ISO
Vitamin E results in increased expression of PRDX2 mRNA
CTD
PMID:19244175
NCBI chr19:40,085,788...40,091,083
Ensembl chr19:23,180,930...23,186,194
G
Prdx4
peroxiredoxin 4
decreases expression
ISO
Vitamin E results in decreased expression of PRDX4 mRNA
CTD
PMID:19244175
NCBI chr X:40,026,762...40,044,066
Ensembl chr X:40,026,651...40,044,066
G
Prelp
proline and arginine rich end leucine rich repeat protein
increases expression
ISO
Vitamin E results in increased expression of PRELP mRNA
CTD
PMID:19244175
NCBI chr13:45,368,407...45,391,480
Ensembl chr13:45,370,533...45,380,270
G
Prkci
protein kinase C, iota
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PRKCI mRNA Vitamin E results in decreased expression of PRKCI mRNA
CTD
PMID:19244175
NCBI chr 2:114,250,398...114,310,784
Ensembl chr 2:112,321,929...112,382,352
G
Prl
prolactin
multiple interactions
EXP
Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of PRL protein]
CTD
PMID:16298753
NCBI chr17:38,287,355...38,298,234
Ensembl chr17:37,860,007...37,870,062
G
Prmt1
protein arginine methyltransferase 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PRMT1 mRNA Vitamin E results in increased expression of PRMT1 mRNA
CTD
PMID:19244175
NCBI chr 1:104,595,339...104,605,552
Ensembl chr 1:95,458,850...95,468,345
G
Prmt2
protein arginine methyltransferase 2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PRMT2 mRNA Vitamin E results in increased expression of PRMT2 mRNA
CTD
PMID:19244175
NCBI chr20:12,391,388...12,420,096
Ensembl chr20:12,394,798...12,420,643
G
Prmt3
protein arginine methyltransferase 3
decreases expression
ISO
Vitamin E results in decreased expression of PRMT3 mRNA
CTD
PMID:19244175
NCBI chr 1:99,492,712...99,581,774
Ensembl chr 1:99,492,724...99,579,435
G
Prpf18
pre-mRNA processing factor 18
decreases expression
ISO
Vitamin E results in decreased expression of PRPF18 mRNA
CTD
PMID:19244175
NCBI chr17:78,539,004...78,570,483
Ensembl chr17:73,630,571...73,690,979
G
Prpf3
pre-mRNA processing factor 3
increases expression
ISO
Vitamin E results in increased expression of PRPF3 mRNA
CTD
PMID:19244175
NCBI chr 2:186,067,980...186,092,427
Ensembl chr 2:183,378,718...183,403,489
G
Prpf40a
pre-mRNA processing factor 40 homolog A
decreases expression
ISO
Vitamin E results in decreased expression of PRPF40A mRNA
CTD
PMID:19244175
NCBI chr 3:58,036,779...58,098,996
Ensembl chr 3:37,627,690...37,690,886
G
Prpf6
pre-mRNA processing factor 6
decreases expression increases expression multiple interactions
ISO
Vitamin E results in decreased expression of PRPF6 mRNA Vitamin E results in increased expression of PRPF6 mRNA [Selenium co-treated with Vitamin E] results in increased expression of PRPF6 mRNA
CTD
PMID:19244175
NCBI chr 3:189,084,465...189,148,705
Ensembl chr 3:168,704,299...168,774,991
G
Prr13
proline rich 13
decreases expression
ISO
Vitamin E results in decreased expression of PRR13 mRNA
CTD
PMID:19244175
NCBI chr 7:133,592,511...133,595,817
Ensembl chr 7:133,592,490...133,601,005
G
Prr14
proline rich 14
increases expression
ISO
Vitamin E results in increased expression of PRR14 mRNA
CTD
PMID:19244175
NCBI chr 1:182,083,838...182,089,330
Ensembl chr 1:182,084,126...182,089,317
G
Prrc2c
proline-rich coiled-coil 2C
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PRRC2C mRNA Vitamin E results in decreased expression of PRRC2C mRNA
CTD
PMID:19244175
NCBI chr13:77,537,226...77,606,926
Ensembl chr13:75,004,010...75,073,643
G
Prrg4
proline rich and Gla domain 4
decreases expression
ISO
Vitamin E results in decreased expression of PRRG4 mRNA
CTD
PMID:19244175
NCBI chr 3:91,214,646...91,243,347
Ensembl chr 3:91,214,653...91,243,273
G
Prune1
prune exopolyphosphatase 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PRUNE1 mRNA Vitamin E results in increased expression of PRUNE1 mRNA
CTD
PMID:19244175
NCBI chr 2:182,830,575...182,859,972
Ensembl chr 2:182,830,578...182,859,336
G
Psap
prosaposin
increases expression
ISO
Vitamin E results in increased expression of PSAP mRNA
CTD
PMID:19244175
NCBI chr20:28,756,951...28,783,422
Ensembl chr20:28,214,271...28,240,498
G
Psmb2
proteasome 20S subunit beta 2
increases expression
ISO
Vitamin E results in increased expression of PSMB2 mRNA
CTD
PMID:19244175
NCBI chr 5:144,255,058...144,287,200
Ensembl chr 5:138,970,533...139,021,137
G
Psmb3
proteasome 20S subunit beta 3
increases expression
ISO
Vitamin E results in increased expression of PSMB3 mRNA
CTD
PMID:19244175
NCBI chr10:82,697,425...82,704,521
Ensembl chr10:82,697,425...82,704,521
G
Psmb4
proteasome 20S subunit beta 4
increases expression
ISO
Vitamin E results in increased expression of PSMB4 mRNA
CTD
PMID:19244175
NCBI chr 2:185,131,787...185,134,561
Ensembl chr 2:182,442,756...182,445,746
G
Psmb5
proteasome 20S subunit beta 5
increases expression
ISO
Vitamin E results in increased expression of PSMB5 mRNA
CTD
PMID:19244175
NCBI chr15:32,042,784...32,047,379
Ensembl chr15:28,072,781...28,077,440
G
Psmb6
proteasome 20S subunit beta 6
increases expression
ISO
Vitamin E results in increased expression of PSMB6 mRNA
CTD
PMID:19244175
NCBI chr10:55,737,852...55,740,218
Ensembl chr10:55,239,241...55,241,586
G
Psmb9
proteasome 20S subunit beta 9
increases expression
ISO
Vitamin E results in increased expression of PSMB9 mRNA
CTD
PMID:19244175
NCBI chr20:4,668,952...4,674,421
Ensembl chr20:4,666,046...4,672,512
G
Psmc1
proteasome 26S subunit, ATPase 1
increases expression
ISO
Vitamin E results in increased expression of PSMC1 mRNA
CTD
PMID:19244175
NCBI chr 6:125,122,497...125,134,859
Ensembl chr 6:119,392,855...119,410,123
G
Psmc4
proteasome 26S subunit, ATPase 4
increases expression
ISO
Vitamin E results in increased expression of PSMC4 mRNA
CTD
PMID:19244175
NCBI chr 1:92,476,690...92,485,268
Ensembl chr 1:83,348,592...83,357,494
G
Psmd2
proteasome 26S subunit ubiquitin receptor, non-ATPase 2
increases expression
ISO
Vitamin E results in increased expression of PSMD2 mRNA
CTD
PMID:19244175
NCBI chr11:93,752,761...93,763,388
Ensembl chr11:80,248,364...80,259,043
G
Psmd4
proteasome 26S subunit ubiquitin receptor, non-ATPase 4
increases expression
ISO
Vitamin E results in increased expression of PSMD4 mRNA
CTD
PMID:19244175
NCBI chr 2:185,287,941...185,297,238
Ensembl chr 2:182,598,934...182,608,194
G
Ptgds
prostaglandin D2 synthase
increases expression
ISO
Vitamin E results in increased expression of PTGDS mRNA
CTD
PMID:19244175
NCBI chr 3:28,680,044...28,682,978
Ensembl chr 3:8,281,899...8,284,833
G
Ptges
prostaglandin E synthase
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PTGES mRNA Vitamin E results in increased expression of PTGES mRNA
CTD
PMID:19244175
NCBI chr 3:34,575,643...34,586,987
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO EXP
Vitamin E inhibits the reaction [Excitatory Amino Acid Agents results in increased expression of PTGS2 mRNA]; Vitamin E inhibits the reaction [Excitatory Amino Acid Agents results in increased expression of PTGS2 protein]; Vitamin E inhibits the reaction [JP8 aviation fuel results in increased expression of PTGS2 mRNA] Vitamin E inhibits the reaction [erastin analog results in increased expression of PTGS2 mRNA] [Vitamin E co-treated with Selenium] results in decreased expression of PTGS2 mRNA; [Vitamin E co-treated with Selenium] results in decreased expression of PTGS2 protein; Vitamin E inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein]; Vitamin E inhibits the reaction [decamethrin results in increased expression of PTGS2 mRNA]; Vitamin E inhibits the reaction [Vehicle Emissions results in increased expression of PTGS2 mRNA]
CTD
PMID:16012341 PMID:18234736 PMID:19095747 PMID:21873648 PMID:22223226 PMID:24439385 PMID:25439240 More...
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Ptms
parathymosin
increases expression
ISO
Vitamin E results in increased expression of PTMS mRNA
CTD
PMID:19244175
NCBI chr 4:159,408,647...159,412,837
Ensembl chr 4:157,722,386...157,727,009
G
Ptp4a1
protein tyrosine phosphatase 4A1
decreases expression
ISO
Vitamin E results in decreased expression of PTP4A1 mRNA
CTD
PMID:19244175
NCBI chr 9:40,710,250...40,718,176
Ensembl chr 9:33,214,208...33,221,964
G
Ptpa
protein phosphatase 2 phosphatase activator
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PTPA mRNA Vitamin E results in increased expression of PTPA mRNA
CTD
PMID:19244175
NCBI chr 3:34,087,637...34,118,100
Ensembl chr 3:13,689,741...13,722,549
G
Ptpn6
protein tyrosine phosphatase, non-receptor type 6
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PTPN6 mRNA Vitamin E results in increased expression of PTPN6 mRNA
CTD
PMID:19244175
NCBI chr 4:159,212,320...159,237,069
Ensembl chr 4:157,526,035...157,550,984
G
Ptprd
protein tyrosine phosphatase, receptor type, D
decreases expression
ISO
Vitamin E results in decreased expression of PTPRD mRNA
CTD
PMID:19244175
NCBI chr 5:95,093,221...97,415,498
Ensembl chr 5:90,048,966...92,369,396
G
Ptpro
protein tyrosine phosphatase, receptor type, O
decreases expression
ISO
Vitamin E results in decreased expression of PTPRO mRNA
CTD
PMID:19244175
NCBI chr 4:171,895,104...172,105,911
Ensembl chr 4:170,164,431...170,374,771
G
Puf60
poly-U binding splicing factor 60
increases expression
ISO
Vitamin E results in increased expression of PUF60 mRNA
CTD
PMID:19244175
NCBI chr 7:109,663,490...109,674,443
Ensembl chr 7:107,782,770...107,794,531
G
Pwp1
PWP1 homolog, endonuclein
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PWP1 mRNA Vitamin E results in decreased expression of PWP1 mRNA
CTD
PMID:19244175
NCBI chr 7:17,982,730...17,998,728
Ensembl chr 7:17,982,235...17,998,731
G
Pxdn
peroxidasin
decreases expression
ISO
Vitamin E results in decreased expression of PXDN mRNA
CTD
PMID:19244175
NCBI chr 6:52,308,347...52,385,943
Ensembl chr 6:46,580,761...46,658,345
G
Pxmp4
peroxisomal membrane protein 4
increases expression
EXP
Vitamin E results in increased expression of PXMP4 mRNA
CTD
PMID:28923436
NCBI chr 3:163,553,582...163,570,829
Ensembl chr 3:143,093,018...143,110,651
G
Pycr3
pyrroline-5-carboxylate reductase 3
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PYCR3 mRNA Vitamin E results in decreased expression of PYCR3 mRNA
CTD
PMID:19244175
NCBI chr 7:109,484,263...109,489,554
Ensembl chr 7:107,581,930...107,608,799
G
Pygb
glycogen phosphorylase B
increases expression
ISO
Vitamin E results in increased expression of PYGB mRNA
CTD
PMID:19244175
NCBI chr 3:160,072,141...160,118,930
Ensembl chr 3:139,611,749...139,663,553
G
Pygo2
pygopus family PHD finger 2
increases expression
ISO
Vitamin E results in increased expression of PYGO2 mRNA
CTD
PMID:19244175
NCBI chr 2:174,849,670...174,854,758
Ensembl chr 2:174,849,936...174,854,758
G
Qsox1
quiescin sulfhydryl oxidase 1
increases expression
ISO
Vitamin E results in increased expression of QSOX1 mRNA
CTD
PMID:19244175
NCBI chr13:67,949,780...67,987,434
Ensembl chr13:67,949,780...67,987,459
G
Qtrt1
queuine tRNA-ribosyltransferase catalytic subunit 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of QTRT1 mRNA Vitamin E results in increased expression of QTRT1 mRNA
CTD
PMID:19244175
NCBI chr 8:28,239,993...28,249,983
Ensembl chr 8:19,966,336...19,973,837
G
R3hdm1
R3H domain containing 1
decreases expression
ISO
Vitamin E results in decreased expression of R3HDM1 mRNA
CTD
PMID:19244175
NCBI chr13:39,595,848...39,733,876
Ensembl chr13:39,595,848...39,733,876
G
Rab14
RAB14, member RAS oncogene family
decreases expression
ISO
Vitamin E results in decreased expression of RAB14 mRNA
CTD
PMID:19244175
NCBI chr 3:38,899,430...38,920,572
Ensembl chr 3:18,501,963...18,523,172
G
Rab26
RAB26, member RAS oncogene family
decreases expression
ISO
Vitamin E results in decreased expression of RAB26 mRNA
CTD
PMID:19244175
NCBI chr10:13,553,395...13,558,063
Ensembl chr10:13,553,395...13,558,030
G
Rab2a
RAB2A, member RAS oncogene family
multiple interactions decreases expression increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of RAB2 mRNA Vitamin E results in decreased expression of RAB2 mRNA Vitamin E results in increased expression of RAB2 mRNA
CTD
PMID:19244175
NCBI chr 5:26,473,424...26,537,441
Ensembl chr 5:21,676,129...21,739,899
G
Rab31
RAB31, member RAS oncogene family
increases expression
ISO
Vitamin E results in increased expression of RAB31 mRNA
CTD
PMID:19244175
NCBI chr 9:112,693,596...112,828,104
Ensembl chr 9:105,246,709...105,381,253
G
Rab33b
RAB33B, member RAS oncogene family
decreases expression
ISO
Vitamin E results in decreased expression of RAB33B mRNA
CTD
PMID:19244175
NCBI chr 2:137,678,953...137,689,581
Ensembl chr 2:135,528,116...135,538,719
G
Rab3gap2
RAB3 GTPase activating non-catalytic protein subunit 2
decreases expression
ISO
Vitamin E results in decreased expression of RAB3GAP2 mRNA
CTD
PMID:19244175
NCBI chr13:96,757,430...96,828,930
Ensembl chr13:96,757,460...96,829,478
G
Rabac1
Rab acceptor 1
increases expression
ISO
Vitamin E results in increased expression of RABAC1 mRNA
CTD
PMID:19244175
NCBI chr 1:80,564,029...80,567,164
Ensembl chr 1:80,564,033...80,567,163
G
Rabgap1
RAB GTPase activating protein 1
decreases expression
ISO
Vitamin E results in decreased expression of RABGAP1 mRNA
CTD
PMID:19244175
NCBI chr 3:41,617,784...41,735,795
Ensembl chr 3:21,208,055...21,326,013
G
Rad23b
RAD23 homolog B, nucleotide excision repair protein
decreases expression
ISO
Vitamin E results in decreased expression of RAD23B mRNA
CTD
PMID:19244175
NCBI chr 5:74,885,518...74,923,621
Ensembl chr 5:70,090,232...70,128,319
G
Raf1
Raf-1 proto-oncogene, serine/threonine kinase
multiple interactions
ISO
Vitamin E inhibits the reaction [Urethane promotes the reaction [RAF1 protein binds to HRAS protein]]
CTD
PMID:11062179
NCBI chr 4:150,352,158...150,412,813
Ensembl chr 4:148,679,530...148,740,317
G
Rai14
retinoic acid induced 14
increases expression
ISO
Vitamin E results in increased expression of RAI14 mRNA
CTD
PMID:19244175
NCBI chr 2:59,546,284...59,682,687
Ensembl chr 2:59,546,284...59,681,971
G
Ralbp1
ralA binding protein 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of RALBP1 mRNA Vitamin E results in decreased expression of RALBP1 mRNA
CTD
PMID:19244175
NCBI chr 9:112,903,289...112,940,093
Ensembl chr 9:105,456,425...105,492,707
G
Ralgps1
Ral GEF with PH domain and SH3 binding motif 1
decreases expression
ISO
Vitamin E results in decreased expression of RALGPS1 mRNA
CTD
PMID:19244175
NCBI chr 3:16,433,323...16,670,276
Ensembl chr 3:16,433,742...16,669,972
G
Raly
RALY heterogeneous nuclear ribonucleoprotein
increases expression
ISO
Vitamin E results in increased expression of RALY mRNA
CTD
PMID:19244175
NCBI chr 3:163,766,183...163,830,726
Ensembl chr 3:143,306,300...143,370,539
G
Ranbp2
RAN binding protein 2
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of RANBP2 mRNA Vitamin E results in decreased expression of RANBP2 mRNA
CTD
PMID:19244175
NCBI chr20:26,984,520...27,036,573
Ensembl chr20:26,442,217...26,493,481
G
Ranbp3
RAN binding protein 3
increases expression
ISO
Vitamin E results in increased expression of RANBP3 mRNA
CTD
PMID:19244175
NCBI chr 9:1,594,344...1,631,587
Ensembl chr 9:1,507,361...1,544,460
G
Ranbp9
RAN binding protein 9
decreases expression
ISO
Vitamin E results in decreased expression of RANBP9 mRNA
CTD
PMID:19244175
NCBI chr17:21,220,807...21,303,009
Ensembl chr17:21,220,618...21,303,004
G
Rangap1
RAN GTPase activating protein 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of RANGAP1 mRNA Vitamin E results in increased expression of RANGAP1 mRNA
CTD
PMID:19244175
NCBI chr 7:115,104,820...115,130,564
Ensembl chr 7:113,224,703...113,250,438
G
Rapgef2
Rap guanine nucleotide exchange factor 2
decreases expression
ISO
Vitamin E results in decreased expression of RAPGEF2 mRNA
CTD
PMID:19244175
NCBI chr 2:166,505,868...166,728,139
Ensembl chr 2:164,207,513...164,244,247
G
Rapgef6
Rap guanine nucleotide exchange factor 6
decreases expression
ISO
Vitamin E results in decreased expression of RAPGEF6 mRNA
CTD
PMID:19244175
NCBI chr10:38,655,854...38,824,227
Ensembl chr10:38,655,867...38,823,211
G
Rarres2
retinoic acid receptor responder 2
increases expression
ISO
Vitamin E results in increased expression of RARRES2 mRNA
CTD
PMID:19244175
NCBI chr 4:78,853,450...78,856,652
Ensembl chr 4:77,522,535...77,525,556
G
Rasgrp2
RAS guanyl releasing protein 2
increases expression
ISO
Vitamin E results in increased expression of RASGRP2 mRNA
CTD
PMID:19244175
NCBI chr 1:203,705,777...203,722,993
Ensembl chr 1:203,707,481...203,722,993
G
Rassf1
Ras association domain family member 1
increases expression
ISO
Vitamin E results in increased expression of RASSF1 mRNA
CTD
PMID:19244175
NCBI chr 8:117,103,665...117,114,805
Ensembl chr 8:108,225,023...108,236,164
G
Rassf7
Ras association domain family member 7
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of RASSF7 mRNA
CTD
PMID:19244175
NCBI chr 1:196,319,600...196,323,787
Ensembl chr 1:196,320,902...196,323,770
G
Rbbp4
RB binding protein 4, chromatin remodeling factor
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of RBBP4 mRNA
CTD
PMID:19244175
NCBI chr 5:141,655,863...141,675,157
Ensembl chr 5:141,638,421...141,675,284 Ensembl chr 2:141,638,421...141,675,284
G
Rbbp6
RB binding protein 6, ubiquitin ligase
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of RBBP6 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of RBBP6 mRNA
CTD
PMID:19244175
NCBI chr 1:186,934,563...186,966,852
Ensembl chr 1:177,503,313...177,535,678
G
Rbfox2
RNA binding fox-1 homolog 2
decreases expression increases expression
ISO
Vitamin E results in decreased expression of RBFOX2 mRNA Vitamin E results in increased expression of RBFOX2 mRNA
CTD
PMID:19244175
NCBI chr 7:110,691,230...110,934,901
Ensembl chr 7:108,810,628...109,054,691
G
Rbm14
RNA binding motif protein 14
increases expression
ISO
Vitamin E results in increased expression of RBM14 mRNA
CTD
PMID:19244175
NCBI chr 1:211,476,298...211,535,077
Ensembl chr 1:202,078,287...202,105,665 Ensembl chr 1:202,078,287...202,105,665
G
Rbm25
RNA binding motif protein 25
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of RBM25 mRNA Vitamin E results in decreased expression of RBM25 mRNA
CTD
PMID:19244175
NCBI chr 6:108,993,119...109,050,159
Ensembl chr 6:103,271,801...103,317,854
G
Rbm4
RNA binding motif protein 4
decreases expression
ISO
Vitamin E results in decreased expression of RBM4 mRNA
CTD
PMID:19244175
NCBI chr 1:211,507,845...211,516,907
Ensembl chr 1:202,085,279...202,105,380
G
Rbm42
RNA binding motif protein 42
increases expression
ISO
Vitamin E results in increased expression of RBM42 mRNA
CTD
PMID:19244175
NCBI chr 1:95,026,050...95,036,020
Ensembl chr 1:85,898,625...85,908,573
G
Rbm5
RNA binding motif protein 5
decreases expression
ISO
Vitamin E results in decreased expression of RBM5 mRNA
CTD
PMID:19244175
NCBI chr 8:117,298,866...117,328,107
Ensembl chr 8:108,420,222...108,449,430
G
Rbms1
RNA binding motif, single stranded interacting protein 1
decreases expression
ISO
Vitamin E results in decreased expression of RBMS1 mRNA
CTD
PMID:19244175
NCBI chr 3:45,195,828...45,420,406
Ensembl chr 3:45,197,972...45,420,376
G
Rbp1
retinol binding protein 1
increases expression
ISO
Vitamin E results in increased expression of RBP1 mRNA
CTD
PMID:19244175
NCBI chr 8:107,904,589...107,926,109
Ensembl chr 8:99,025,206...99,046,743
G
Rbpms
RNA binding protein, mRNA processing factor
increases expression
ISO
Vitamin E results in increased expression of RBPMS mRNA
CTD
PMID:19244175
NCBI chr16:64,942,159...65,098,504
Ensembl chr16:58,239,474...58,395,426
G
Rchy1
ring finger and CHY zinc finger domain containing 1
decreases expression
ISO
Vitamin E results in decreased expression of RCHY1 mRNA
CTD
PMID:19244175
NCBI chr14:16,397,533...16,413,286
Ensembl chr14:16,113,224...16,129,167
G
Rcn2
reticulocalbin 2
decreases expression
ISO
Vitamin E results in decreased expression of RCN2 mRNA
CTD
PMID:19244175
NCBI chr 8:56,449,206...56,466,253
Ensembl chr 8:56,449,206...56,466,251
G
Rcor3
REST corepressor 3
decreases expression
ISO
Vitamin E results in decreased expression of RCOR3 mRNA
CTD
PMID:19244175
NCBI chr13:106,156,166...106,196,542
Ensembl chr13:103,624,971...103,665,565
G
Recql
RecQ like helicase
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of RECQL mRNA Vitamin E results in decreased expression of RECQL mRNA
CTD
PMID:19244175
NCBI chr 4:175,308,337...175,332,965
Ensembl chr 4:175,304,117...175,332,945
G
Reep1
receptor accessory protein 1
decreases expression
ISO
Vitamin E results in decreased expression of REEP1 mRNA
CTD
PMID:19244175
NCBI chr 4:105,303,974...105,420,611
Ensembl chr 4:103,745,633...103,862,338
G
Rel
REL proto-oncogene, NF-kB subunit
multiple interactions
EXP ISO
Vitamin E affects the reaction [[REL binds to GCLC promoter] which affects the expression of GCLC mRNA]; Vitamin E affects the reaction [[REL binds to GCLM promoter] which affects the expression of GCLM mRNA] Vitamin E inhibits the reaction [Norepinephrine affects the localization of REL protein]
CTD
PMID:16298738 PMID:23114885
NCBI chr14:101,891,238...101,922,324
Ensembl chr14:97,695,161...97,720,892
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO EXP
Vitamin E inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased phosphorylation of RELA protein]; Vitamin E inhibits the reaction [Norepinephrine affects the localization of RELA protein] [Vitamin E co-treated with Selenium] results in decreased activity of RELA protein Vitamin E inhibits the reaction [Alcohols results in increased expression of RELA mRNA]; Vitamin E inhibits the reaction [Ethanol results in increased expression of RELA mRNA]
CTD
PMID:18814483 PMID:20067348 PMID:22223226 PMID:23114885 PMID:35349355
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Retreg1
reticulophagy regulator 1
decreases expression
ISO
Vitamin E results in decreased expression of RETREG1 mRNA
CTD
PMID:19244175
NCBI chr 2:78,045,435...78,205,316
Ensembl chr 2:76,335,609...76,493,898
G
Rfng
RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
increases expression
ISO
Vitamin E results in increased expression of RFNG mRNA
CTD
PMID:19244175
NCBI chr10:106,047,221...106,050,331
Ensembl chr10:106,047,221...106,050,345
G
Rftn1
raftlin lipid raft linker 1
increases expression
ISO
Vitamin E results in increased expression of RFTN1 mRNA
CTD
PMID:19244175
NCBI chr 9:18,302,143...18,499,819
Ensembl chr 9:10,804,611...11,002,084
G
Rgs2
regulator of G-protein signaling 2
increases expression
ISO
Vitamin E results in increased expression of RGS2 mRNA
CTD
PMID:19244175
NCBI chr13:58,350,063...58,352,666
Ensembl chr13:55,798,829...55,802,385
G
Rhobtb1
Rho-related BTB domain containing 1
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of RHOBTB1 mRNA
CTD
PMID:19244175
NCBI chr20:19,326,197...19,455,182
Ensembl chr20:19,327,155...19,403,012
G
Rhobtb3
Rho-related BTB domain containing 3
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of RHOBTB3 mRNA Vitamin E results in decreased expression of RHOBTB3 mRNA
CTD
PMID:19244175
NCBI chr 2:7,094,972...7,201,507
Ensembl chr 2:5,363,388...5,419,041
G
Rhog
ras homolog family member G
increases expression
ISO
Vitamin E results in increased expression of RHOG mRNA
CTD
PMID:19244175
NCBI chr 1:156,618,713...156,630,710
Ensembl chr 1:156,615,349...156,631,257
G
Rhoq
ras homolog family member Q
decreases expression
ISO
Vitamin E results in decreased expression of RHOQ mRNA
CTD
PMID:19244175
NCBI chr 6:13,368,499...13,403,929
Ensembl chr 1:106,622,141...106,623,699
G
Riok3
RIO kinase 3
decreases expression
ISO
Vitamin E results in decreased expression of RIOK3 mRNA
CTD
PMID:19244175
NCBI chr18:3,602,535...3,628,108
Ensembl chr18:3,327,776...3,353,343
G
Rlim
ring finger protein, LIM domain interacting
decreases expression
ISO
Vitamin E results in decreased expression of RLIM mRNA
CTD
PMID:19244175
NCBI chr X:68,983,259...69,004,368
Ensembl chr X:68,988,375...69,004,271
G
Rnaseh1
ribonuclease H1
decreases expression
ISO
Vitamin E results in decreased expression of RNASEH1 mRNA
CTD
PMID:19244175
NCBI chr 6:45,282,849...45,292,258
Ensembl chr 6:45,282,854...45,292,236
G
Rnaset2
ribonuclease T2
increases expression
ISO
Vitamin E results in increased expression of RNASET2 mRNA
CTD
PMID:19244175
NCBI chr 1:55,133,532...55,150,701
Ensembl chr 1:52,585,929...52,603,147
G
Rnd3
Rho family GTPase 3
decreases expression
ISO
Vitamin E results in decreased expression of RND3 mRNA
CTD
PMID:19244175
NCBI chr 3:55,981,142...55,998,494
Ensembl chr 3:35,571,143...35,589,327
G
Rnf111
ring finger protein 111
decreases expression
ISO
Vitamin E results in decreased expression of RNF111 mRNA
CTD
PMID:19244175
NCBI chr 8:71,103,967...71,180,172
Ensembl chr 8:71,103,973...71,145,070
G
Rnf113a1
ring finger protein 113A1
increases expression
ISO
Vitamin E results in increased expression of RNF113A mRNA
CTD
PMID:19244175
NCBI chr X:121,293,621...121,294,844
Ensembl chr X:116,427,684...116,433,762
G
Rnf5
ring finger protein 5
increases expression
ISO
Vitamin E results in increased expression of RNF5 mRNA
CTD
PMID:19244175
NCBI chr20:4,145,539...4,147,985
Ensembl chr20:4,145,507...4,147,985
G
Rnps1
RNA binding protein with serine rich domain 1
increases expression
ISO
Vitamin E results in increased expression of RNPS1 mRNA
CTD
PMID:19244175
NCBI chr10:13,950,151...13,960,396
Ensembl chr10:13,445,653...13,455,858
G
Ro60
Ro60, Y RNA binding protein
decreases expression
ISO
Vitamin E results in decreased expression of RO60 mRNA
CTD
PMID:19244175
NCBI chr13:58,049,838...58,070,828
Ensembl chr13:55,499,534...55,520,504
G
Rora
RAR-related orphan receptor A
decreases expression
ISO
Vitamin E results in decreased expression of RORA mRNA
CTD
PMID:19244175
NCBI chr 8:78,182,710...78,915,730
Ensembl chr 8:69,301,733...70,025,931
G
Rpa3
replication protein A3
multiple interactions
ISO
[Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3,4-dihydroxyphenylethanol] results in increased expression of RPA3 mRNA
CTD
PMID:16797527
NCBI chr 4:37,270,966...37,273,997
Ensembl chr 4:36,304,651...36,307,709
G
Rpl10
ribosomal protein L10
increases expression
ISO
Vitamin E results in increased expression of RPL10 mRNA
CTD
PMID:19244175
NCBI chr X:157,205,850...157,208,057
Ensembl chr X:152,054,452...152,056,761
G
Rpl10a
ribosomal protein L10A
decreases expression
ISO
Vitamin E results in decreased expression of RPL10A mRNA
CTD
PMID:19244175
NCBI chr20:6,388,800...6,391,358
Ensembl chr20:6,385,823...6,391,357 Ensembl chr 9:6,385,823...6,391,357
G
Rpl14
ribosomal protein L14
decreases expression
ISO
Vitamin E results in decreased expression of RPL14 mRNA
CTD
PMID:19244175
NCBI chr 8:129,163,620...129,166,745
Ensembl chr 8:120,284,645...120,289,064
G
Rpl23
ribosomal protein L23
decreases expression
ISO
Vitamin E results in decreased expression of RPL23 mRNA
CTD
PMID:19244175
NCBI chr10:83,268,223...83,272,184
Ensembl chr10:82,771,538...82,775,870
G
Rpl27
ribosomal protein L27
decreases expression
ISO
Vitamin E results in decreased expression of RPL27 mRNA
CTD
PMID:19244175
NCBI chr10:86,375,511...86,379,210
Ensembl chr10:86,375,454...86,379,193
G
Rpl28
ribosomal protein L28
decreases expression
ISO
Vitamin E results in decreased expression of RPL28 mRNA
CTD
PMID:19244175
NCBI chr 1:69,052,148...69,054,735
Ensembl chr 1:69,053,203...69,055,032
G
Rpl38
ribosomal protein L38
decreases expression
ISO
Vitamin E results in decreased expression of RPL38 mRNA
CTD
PMID:19244175
NCBI chr10:99,701,330...99,705,004
Ensembl chr10:99,701,362...99,705,004 Ensembl chr14:99,701,362...99,705,004 Ensembl chr 3:99,701,362...99,705,004 Ensembl chr 2:99,701,362...99,705,004 Ensembl chr16:99,701,362...99,705,004
G
Rpl7
ribosomal protein L7
decreases expression
ISO
Vitamin E results in decreased expression of RPL7 mRNA
CTD
PMID:19244175
NCBI chr 5:3,217,184...3,220,192
G
Rprd2
regulation of nuclear pre-mRNA domain containing 2
increases expression
ISO
Vitamin E results in increased expression of RPRD2 mRNA
CTD
PMID:19244175
NCBI chr 2:183,311,132...183,367,959
Ensembl chr 2:183,293,114...183,367,407
G
Rprm
reprimo, TP53 dependent G2 arrest mediator homolog
increases expression
ISO
Vitamin E results in increased expression of RPRM mRNA
CTD
PMID:19244175
NCBI chr 3:58,948,618...58,950,035
Ensembl chr 3:38,539,581...38,540,998
G
Rps19
ribosomal protein S19
decreases expression
ISO
Vitamin E results in decreased expression of RPS19 mRNA
CTD
PMID:19244175
NCBI chr 1:89,608,408...89,614,390
Ensembl chr 1:80,480,951...80,486,508 Ensembl chr 7:80,480,951...80,486,508
G
Rps27
ribosomal protein S27
decreases expression
ISO
Vitamin E results in decreased expression of RPS27 mRNA
CTD
PMID:19244175
NCBI chr 2:177,963,499...177,964,708
Ensembl chr 2:175,665,853...175,666,964 Ensembl chr12:175,665,853...175,666,964
G
Rps6ka1
ribosomal protein S6 kinase A1
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of RPS6KA1 mRNA
CTD
PMID:19244175
NCBI chr 5:146,079,018...146,118,272
Ensembl chr 5:146,079,021...146,118,272
G
Rps6ka2
ribosomal protein S6 kinase A2
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of RPS6KA2 mRNA
CTD
PMID:19244175
NCBI chr 1:55,178,988...55,454,271
Ensembl chr 1:52,631,736...52,906,739
G
Rps7
ribosomal protein S7
decreases expression
ISO
Vitamin E results in decreased expression of RPS7 mRNA
CTD
PMID:19244175
NCBI chr 6:50,994,581...50,999,447
Ensembl chr 6:45,223,980...45,271,145 Ensembl chr 5:45,223,980...45,271,145
G
Rraga
Ras-related GTP binding A
increases expression
ISO
Vitamin E results in increased expression of RRAGA mRNA
CTD
PMID:19244175
NCBI chr 5:101,113,341...101,114,936
Ensembl chr 5:101,112,859...101,114,510
G
Rrbp1
ribosome binding protein 1
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of RRBP1 mRNA
CTD
PMID:19244175
NCBI chr 3:151,768,386...151,830,255
Ensembl chr 3:131,314,998...131,376,981
G
Rrp1
ribosomal RNA processing 1
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of RRP1 mRNA
CTD
PMID:19244175
NCBI chr20:10,260,580...10,271,829
Ensembl chr20:10,260,870...10,272,144
G
Rrp7a
ribosomal RNA processing 7 homolog A
increases expression
ISO
Vitamin E results in increased expression of RRP7A mRNA
CTD
PMID:19244175
NCBI chr 7:114,262,929...114,272,817
Ensembl chr 7:114,256,472...114,272,817
G
Rrs1
ribosome biogenesis regulator 1 homolog
increases expression
ISO
Vitamin E results in increased expression of RRS1 mRNA
CTD
PMID:19244175
NCBI chr 5:14,516,303...14,517,936
Ensembl chr 5:9,733,091...9,735,140
G
Rsad1
radical S-adenosyl methionine domain containing 1
increases expression
ISO
Vitamin E results in increased expression of RSAD1 mRNA
CTD
PMID:19244175
NCBI chr10:79,485,253...79,499,616
Ensembl chr10:79,489,909...79,499,573
G
Rsrc2
arginine and serine rich coiled-coil 2
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of RSRC2 mRNA Vitamin E results in decreased expression of RSRC2 mRNA
CTD
PMID:19244175
NCBI chr12:32,839,840...32,859,820
Ensembl chr12:32,839,809...32,859,799
G
Rsrp1
arginine and serine rich protein 1
decreases expression
ISO
Vitamin E results in decreased expression of RSRP1 mRNA
CTD
PMID:19244175
NCBI chr 5:147,147,774...147,151,523
Ensembl chr 5:147,147,784...147,151,523
G
RT1-A2
RT1 class Ia, locus A2
increases expression
ISO
Vitamin E results in increased expression of HLA-E mRNA
CTD
PMID:19244175
NCBI chr20:4,872,720...4,876,425
G
RT1-Bb
RT1 class II, locus Bb
increases expression
ISO
Vitamin E results in increased expression of HLA-DQB1 mRNA
CTD
PMID:19244175
NCBI chr20:4,598,475...4,604,118
Ensembl chr20:4,596,559...4,607,597
G
RT1-Da
RT1 class II, locus Da
increases expression
ISO
Vitamin E results in increased expression of HLA-DRA mRNA
CTD
PMID:19244175
NCBI chr20:4,515,393...4,520,387
Ensembl chr20:4,512,911...4,518,455
G
RT1-Ha
RT1 class II, locus Ha
increases expression
ISO
Vitamin E results in increased expression of HLA-DPA1 mRNA
CTD
PMID:19244175
NCBI chr20:4,762,425...4,772,439
Ensembl chr20:4,760,118...4,770,244
G
RT1-M3-1
RT1 class Ib, locus M3, gene 1
increases expression
ISO
Vitamin E results in increased expression of HLA-G mRNA
CTD
PMID:19244175
NCBI chr20:1,329,227...1,333,394
Ensembl chr20:1,287,521...1,328,117
G
Rtl8a
retrotransposon Gag like 8A
increases expression multiple interactions
ISO
Vitamin E results in increased expression of RTL8A mRNA [Selenium co-treated with Vitamin E] results in decreased expression of RTL8A mRNA
CTD
PMID:19244175
NCBI chr X:133,414,027...133,415,240
Ensembl chr X:133,414,030...133,415,240
G
Rufy1
RUN and FYVE domain containing 1
decreases expression
ISO
Vitamin E results in decreased expression of RUFY1 mRNA
CTD
PMID:19244175
NCBI chr10:35,206,801...35,251,696
Ensembl chr10:34,705,741...34,750,644
G
Rufy2
RUN and FYVE domain containing 2
decreases expression
ISO
Vitamin E results in decreased expression of RUFY2 mRNA
CTD
PMID:19244175
NCBI chr20:25,626,958...25,658,157
Ensembl chr20:25,621,999...25,658,186
G
Rufy3
RUN and FYVE domain containing 3
decreases expression
ISO
Vitamin E results in decreased expression of RUFY3 mRNA
CTD
PMID:19244175
NCBI chr14:19,715,593...19,790,530
Ensembl chr14:19,432,524...19,507,004
G
Rundc3b
RUN domain containing 3B
decreases expression
ISO
Vitamin E results in decreased expression of RUNDC3B mRNA
CTD
PMID:19244175
NCBI chr 4:26,417,501...26,554,404
Ensembl chr 4:25,462,752...25,599,471
G
Runx1t1
RUNX1 partner transcriptional co-repressor 1
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of RUNX1T1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of RUNX1T1 mRNA
CTD
PMID:19244175
NCBI chr 5:31,984,946...32,136,878
Ensembl chr 5:27,187,551...27,335,592
G
Rybp
RING1 and YY1 binding protein
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of RYBP mRNA [Selenium co-treated with Vitamin E] results in decreased expression of RYBP mRNA
CTD
PMID:19244175
NCBI chr 4:134,432,663...134,484,732
Ensembl chr 4:132,876,361...132,928,316
G
S100a11
S100 calcium binding protein A11
increases expression
ISO
Vitamin E results in increased expression of S100A11 mRNA
CTD
PMID:19244175
NCBI chr 2:181,875,132...181,880,542
Ensembl chr 2:179,191,715...179,197,044
G
S100a6
S100 calcium binding protein A6
increases expression
ISO
Vitamin E results in increased expression of S100A6 mRNA
CTD
PMID:19244175
NCBI chr 2:178,398,189...178,399,763
Ensembl chr 2:176,100,899...176,102,180
G
S100b
S100 calcium binding protein B
multiple interactions
EXP
Vitamin E inhibits the reaction [Aluminum results in increased expression of S100B protein]
CTD
PMID:16545059
NCBI chr20:12,372,345...12,381,159
Ensembl chr20:12,372,881...12,394,743
G
Sacs
sacsin molecular chaperone
decreases expression
ISO
Vitamin E results in decreased expression of SACS mRNA
CTD
PMID:19244175
NCBI chr15:39,461,853...39,546,419
Ensembl chr15:35,285,782...35,370,335
G
Samm50
SAMM50 sorting and assembly machinery component
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SAMM50 mRNA
CTD
PMID:19244175
NCBI chr 7:117,197,460...117,221,668
Ensembl chr 7:115,317,404...115,341,682
G
Sart3
spliceosome associated factor 3, U4/U6 recycling protein
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SART3 mRNA Vitamin E results in decreased expression of SART3 mRNA
CTD
PMID:19244175
NCBI chr12:48,519,579...48,547,584
Ensembl chr12:42,859,305...42,887,038
G
Sash1
SAM and SH3 domain containing 1
decreases expression
ISO
Vitamin E results in decreased expression of SASH1 mRNA
CTD
PMID:19244175
NCBI chr 1:4,940,207...5,238,777
Ensembl chr 1:3,121,332...3,439,870
G
Sat1
spermidine/spermine N1-acetyl transferase 1
decreases expression
ISO
Vitamin E results in decreased expression of SAT1 mRNA
CTD
PMID:19244175
NCBI chr X:44,008,089...44,011,376
Ensembl chr X:40,157,046...40,196,813
G
Satb1
SATB homeobox 1
decreases expression
ISO
Vitamin E results in decreased expression of SATB1 mRNA
CTD
PMID:19244175
NCBI chr 9:4,916,958...5,010,359
Ensembl chr 9:4,680,920...4,753,251
G
Sbp
spermine binding protein
decreases expression
EXP
Vitamin E results in decreased expression of SBP mRNA
CTD
PMID:15084515
NCBI chr10:12,946,036...12,968,439
Ensembl chr10:12,946,036...12,968,439
G
Scaf11
SR-related CTD-associated factor 11
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SCAF11 mRNA Vitamin E results in decreased expression of SCAF11 mRNA
CTD
PMID:19244175
NCBI chr 7:129,450,872...129,503,280
Ensembl chr 7:127,574,463...127,624,101
G
Scaf4
SR-related CTD-associated factor 4
decreases expression
ISO
Vitamin E results in decreased expression of SCAF4 mRNA
CTD
PMID:19244175
NCBI chr11:42,951,254...43,007,293
Ensembl chr11:29,465,106...29,521,153
G
Scamp3
secretory carrier membrane protein 3
increases expression multiple interactions
ISO
Vitamin E results in increased expression of SCAMP3 mRNA [Selenium co-treated with Vitamin E] results in increased expression of SCAMP3 mRNA
CTD
PMID:19244175
NCBI chr 2:174,583,124...174,588,984
Ensembl chr 2:174,570,653...174,588,985
G
Scaper
S-phase cyclin A-associated protein in the ER
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of SCAPER mRNA [Selenium co-treated with Vitamin E] results in decreased expression of SCAPER mRNA
CTD
PMID:19244175
NCBI chr 8:55,932,717...56,332,222
Ensembl chr 8:55,933,306...56,332,122
G
Scd
stearoyl-CoA desaturase
decreases expression
ISO
Vitamin E results in decreased expression of SCD4 mRNA
CTD
PMID:19244175
NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:243,269,747...243,282,562
G
Scgb1d2
secretoglobin, family 1D, member 2
decreases expression
EXP
Vitamin E results in decreased expression of SCGB1D2 mRNA
CTD
PMID:15084515
NCBI chr 1:206,228,546...206,233,587
Ensembl chr 1:206,228,778...206,231,785
G
Scgb1d4
secretoglobin family 1D member 4
decreases expression
EXP
Vitamin E results in decreased expression of SCGB1D4 mRNA
CTD
PMID:15084515
NCBI chr 1:206,330,454...206,333,329
Ensembl chr 1:206,330,454...206,333,329
G
Scmh1
Scm polycomb group protein homolog 1
decreases expression
ISO
Vitamin E results in decreased expression of SCMH1 mRNA
CTD
PMID:19244175
NCBI chr 5:133,991,167...134,115,893
Ensembl chr 5:133,990,520...134,122,105
G
Scml1
Scm polycomb group protein like 1
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of SCML1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of SCML1 mRNA
CTD
PMID:19244175
NCBI chr X:32,893,100...32,912,686
Ensembl chr X:32,894,327...32,911,366
G
Scp2
sterol carrier protein 2
increases expression
EXP
Vitamin E results in increased expression of SCP2 mRNA
CTD
PMID:28923436
NCBI chr 5:128,035,714...128,110,015
Ensembl chr 5:122,776,549...122,881,287
G
Sdc2
syndecan 2
increases expression
ISO
Vitamin E results in increased expression of SDC2 mRNA
CTD
PMID:19244175
NCBI chr 7:66,012,405...66,125,101
Ensembl chr 7:64,127,110...64,241,081
G
Sdc3
syndecan 3
increases expression
ISO
Vitamin E results in increased expression of SDC3 mRNA
CTD
PMID:19244175
NCBI chr 5:148,249,792...148,282,524
Ensembl chr 5:142,965,591...142,996,480
G
Sdccag8
SHH signaling and ciliogenesis regulator SDCCAG8
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SDCCAG8 mRNA Vitamin E results in decreased expression of SDCCAG8 mRNA
CTD
PMID:19244175
NCBI chr13:91,286,787...91,518,255
Ensembl chr13:88,754,626...89,097,111
G
Sdf2l1
stromal cell-derived factor 2-like 1
increases expression
ISO
Vitamin E results in increased expression of SDF2L1 mRNA
CTD
PMID:19244175
NCBI chr11:97,376,878...97,379,120
Ensembl chr11:83,872,659...83,874,902
G
Sdhc
succinate dehydrogenase complex subunit C
increases expression
ISO
Vitamin E results in increased expression of SDHC mRNA
CTD
PMID:19244175
NCBI chr13:86,077,133...86,098,025
Ensembl chr13:83,544,652...83,566,253
G
Sdr39u1
short chain dehydrogenase/reductase family 39U, member 1
decreases expression
ISO
Vitamin E results in decreased expression of SDR39U1 mRNA
CTD
PMID:19244175
NCBI chr15:33,348,057...33,350,892
Ensembl chr15:29,378,026...29,381,560
G
Sec13
SEC13 homolog, nuclear pore and COPII coat complex component
increases expression
ISO
Vitamin E results in increased expression of SEC13 mRNA
CTD
PMID:19244175
NCBI chr 4:148,433,344...148,446,735
Ensembl chr 4:146,875,524...146,891,173
G
Sec16a
SEC16 homolog A, endoplasmic reticulum export factor
decreases expression
ISO
Vitamin E results in decreased expression of SEC16A mRNA
CTD
PMID:19244175
NCBI chr 3:29,627,779...29,662,925
Ensembl chr 3:9,229,687...9,264,273
G
Sec31a
SEC31 homolog A, COPII coat complex component
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SEC31A mRNA Vitamin E results in decreased expression of SEC31A mRNA
CTD
PMID:19244175
NCBI chr14:9,214,324...9,269,281
Ensembl chr14:9,214,349...9,269,273
G
Sec62
SEC62 homolog, preprotein translocation factor
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of SEC62 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of SEC62 mRNA
CTD
PMID:19244175
NCBI chr 2:114,499,317...114,526,705
Ensembl chr 2:112,570,819...112,601,814
G
Sec63
SEC63 homolog, protein translocation regulator
decreases expression
ISO
Vitamin E results in decreased expression of SEC63 mRNA
CTD
PMID:19244175
NCBI chr20:47,827,291...47,896,248
Ensembl chr20:46,245,101...46,314,055
G
Secisbp2
SECIS binding protein 2
decreases expression
ISO
Vitamin E results in decreased expression of SBP2 mRNA
CTD
PMID:19244175
NCBI chr17:13,538,513...13,569,573
Ensembl chr17:13,538,513...13,569,523
G
Secisbp2l
SECIS binding protein 2-like
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SECISBP2L mRNA
CTD
PMID:19244175
NCBI chr 3:133,443,023...133,489,467
Ensembl chr 3:112,991,908...113,035,884
G
Sele
selectin E
multiple interactions
ISO
[Vitamin E co-treated with Bezafibrate] results in decreased expression of SELE protein modified form; Vitamin E inhibits the reaction [Simvastatin results in decreased expression of SELE protein modified form]
CTD
PMID:14602771
NCBI chr13:78,935,997...78,945,905
Ensembl chr13:76,403,304...76,412,741
G
Selenow
selenoprotein W
increases expression
ISO
Vitamin E results in increased expression of SELENOW mRNA
CTD
PMID:19244175
NCBI chr 1:76,599,441...76,604,514
Ensembl chr 1:76,598,779...76,604,724 Ensembl chr 1:76,598,779...76,604,724
G
Sephs1
selenophosphate synthetase 1
increases expression
ISO
Vitamin E results in increased expression of SEPHS1 mRNA
CTD
PMID:19244175
NCBI chr17:73,354,435...73,382,803
Ensembl chr17:73,356,530...73,382,593
G
Septin6
septin 6
increases expression
ISO
Vitamin E results in increased expression of SEPTIN6 mRNA
CTD
PMID:19244175
NCBI chr X:121,018,951...121,157,677
Ensembl chr X:116,153,255...116,230,115
G
Septin8
septin 8
increases expression
ISO
Vitamin E results in increased expression of SEPTIN8 mRNA
CTD
PMID:19244175
NCBI chr10:38,185,454...38,214,502
Ensembl chr10:37,684,639...37,713,174
G
Serbp1
Serpine1 mRNA binding protein 1
decreases expression
ISO
Vitamin E results in decreased expression of SERBP1 mRNA
CTD
PMID:19244175
NCBI chr 4:96,401,587...96,421,816
Ensembl chr 4:96,401,477...96,421,813
G
Serinc3
serine incorporator 3
increases expression
ISO
Vitamin E results in increased expression of SERINC3 mRNA
CTD
PMID:19244175
NCBI chr 3:172,721,208...172,749,853
Ensembl chr 3:152,301,772...152,321,808
G
Serpina3n
serpin family A member 3N
multiple interactions
EXP
[Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of SERPINA3N mRNA
CTD
PMID:11444866
NCBI chr 6:129,088,392...129,095,950
Ensembl chr 6:123,323,629...123,332,433
G
Serpine1
serpin family E member 1
multiple interactions
EXP
Ascorbic Acid promotes the reaction [Vitamin E inhibits the reaction [Endosulfan results in increased activity of SERPINE1 protein]]; Vitamin E inhibits the reaction [Endosulfan results in increased activity of SERPINE1 protein]
CTD
PMID:21804306
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
G
Serpinf1
serpin family F member 1
increases expression
ISO
Vitamin E results in increased expression of SERPINF1 mRNA
CTD
PMID:19244175
NCBI chr10:60,748,504...60,760,898
Ensembl chr10:60,249,708...60,262,646
G
Serping1
serpin family G member 1
increases expression
ISO
Vitamin E results in increased expression of SERPING1 mRNA
CTD
PMID:19244175
NCBI chr 3:90,249,410...90,259,299
Ensembl chr 3:69,842,739...69,852,034
G
Sertad2
SERTA domain containing 2
decreases expression
ISO
Vitamin E results in decreased expression of SERTAD2 mRNA
CTD
PMID:19244175
NCBI chr14:98,935,428...99,039,536
Ensembl chr14:94,733,579...94,838,313
G
Set
Set nuclear proto-oncogene
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of SET mRNA [Selenium co-treated with Vitamin E] results in decreased expression of SET mRNA
CTD
PMID:19244175
NCBI chr 3:33,732,319...33,743,433
Ensembl chr 3:13,335,041...13,363,567
G
Setbp1
SET binding protein 1
decreases expression
ISO
Vitamin E results in decreased expression of SETBP1 mRNA
CTD
PMID:19244175
NCBI chr18:74,465,616...74,827,455
Ensembl chr18:72,191,035...72,552,556
G
Setd2
SET domain containing 2, histone lysine methyltransferase
decreases expression
ISO
Vitamin E results in decreased expression of SETD2 mRNA
CTD
PMID:19244175
NCBI chr 8:119,390,207...119,475,863
Ensembl chr 8:110,511,772...110,597,489
G
Setd6
SET domain containing 6, protein lysine methyltransferase
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of SETD6 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of SETD6 mRNA
CTD
PMID:19244175
NCBI chr19:9,349,011...9,356,515
Ensembl chr19:9,347,458...9,350,453
G
Sf1
splicing factor 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SF1 mRNA Vitamin E results in decreased expression of SF1 mRNA
CTD
PMID:19244175
NCBI chr 1:213,090,256...213,112,688
Ensembl chr 1:203,670,018...203,684,330
G
Sf3a2
splicing factor 3A subunit 2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of SF3A2 mRNA Vitamin E results in increased expression of SF3A2 mRNA
CTD
PMID:19244175
NCBI chr 7:9,560,182...9,566,205
Ensembl chr 7:8,909,507...8,915,530
G
Sf3b1
splicing factor 3b, subunit 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SF3B1 mRNA Vitamin E results in decreased expression of SF3B1 mRNA
CTD
PMID:19244175
NCBI chr 9:63,986,829...64,026,723
Ensembl chr 9:56,492,403...56,532,300
G
Sf3b5
splicing factor 3b, subunit 5
increases expression
ISO
Vitamin E results in increased expression of SF3B5 mRNA
CTD
PMID:19244175
NCBI chr 1:9,177,189...9,177,901
Ensembl chr 1:7,350,731...7,357,839
G
Sfswap
splicing factor SWAP
decreases expression
ISO
Vitamin E results in decreased expression of SFSWAP mRNA
CTD
PMID:19244175
NCBI chr12:27,109,607...27,179,941
Ensembl chr12:27,109,611...27,179,884
G
Sftpb
surfactant protein B
multiple interactions
ISO EXP
Vitamin E inhibits the reaction [nitrofen results in decreased expression of SFTPB mRNA] Vitamin E inhibits the reaction [nitrofen results in decreased expression of SFTPB protein]
CTD
PMID:16490937 PMID:16863852
NCBI chr 4:105,917,495...105,926,631
Ensembl chr 4:104,359,396...104,368,436
G
Sgsm2
small G protein signaling modulator 2
decreases expression
ISO
Vitamin E results in decreased expression of SGSM2 mRNA
CTD
PMID:19244175
NCBI chr10:59,718,180...59,759,822
Ensembl chr10:59,718,183...59,759,447
G
Sgsm3
small G protein signaling modulator 3
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of SGSM3 mRNA
CTD
PMID:19244175
NCBI chr 7:114,394,724...114,424,285
Ensembl chr 7:112,514,630...112,544,108
G
Shank2
SH3 and multiple ankyrin repeat domains 2
decreases expression
ISO
Vitamin E results in decreased expression of SHANK2 mRNA
CTD
PMID:19244175
NCBI chr 1:208,575,144...209,020,300
Ensembl chr 1:199,169,429...199,589,394
G
Siah1
siah E3 ubiquitin protein ligase 1
decreases expression
ISO
Vitamin E results in decreased expression of SIAH1 mRNA
CTD
PMID:19244175
NCBI chr19:36,552,165...36,575,773
Ensembl chr19:20,378,439...20,403,808
G
Sipa1l3
signal-induced proliferation-associated 1 like 3
increases expression
ISO
Vitamin E results in increased expression of SIPA1L3 mRNA
CTD
PMID:19244175
NCBI chr 1:93,746,187...93,953,606
Ensembl chr 1:84,618,719...84,703,802
G
Sirt1
sirtuin 1
decreases expression
ISO
Vitamin E results in decreased expression of SIRT1 mRNA
CTD
PMID:19244175
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,306,917...25,329,260
G
Skap2
src kinase associated phosphoprotein 2
decreases expression
ISO
Vitamin E results in decreased expression of SKAP2 mRNA
CTD
PMID:19244175
NCBI chr 4:80,948,832...81,100,900
Ensembl chr 4:80,950,580...81,100,891
G
Ski
Ski proto-oncogene
increases expression
ISO
Vitamin E results in increased expression of SKI mRNA
CTD
PMID:19244175
NCBI chr 5:170,995,851...171,064,957
Ensembl chr 5:165,714,093...165,782,733
G
Skic3
SKI3 subunit of superkiller complex
decreases expression
ISO
Vitamin E results in decreased expression of SKIC3 mRNA
CTD
PMID:19244175
NCBI chr 2:7,363,417...7,526,351
Ensembl chr 2:5,631,635...5,751,626
G
Skp1
S-phase kinase-associated protein 1
increases expression
ISO
Vitamin E results in increased expression of SKP1 mRNA
CTD
PMID:19244175
NCBI chr10:36,898,670...36,917,828
Ensembl chr10:36,402,153...36,417,388
G
Slc11a2
solute carrier family 11 member 2
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of SLC11A2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of SLC11A2 mRNA Vitamin E inhibits the reaction [Ethanol results in increased expression of SLC11A2 protein]
CTD
PMID:16737972 PMID:19244175
NCBI chr 7:133,381,878...133,429,921
Ensembl chr 7:131,503,081...131,540,145
G
Slc12a2
solute carrier family 12 member 2
decreases expression multiple interactions
ISO EXP
Vitamin E results in decreased expression of SLC12A2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of SLC12A2 mRNA Vitamin E inhibits the reaction [Manganese results in increased expression of SLC12A2 protein]; Vitamin E inhibits the reaction [Manganese results in increased phosphorylation of and results in increased activity of SLC12A2 protein]
CTD
PMID:19244175 PMID:25817889
NCBI chr18:53,546,263...53,614,478
Ensembl chr18:51,348,302...51,416,440
G
Slc19a1
solute carrier family 19 member 1
decreases expression
ISO
Vitamin E results in decreased expression of SLC19A1 mRNA
CTD
PMID:19244175
NCBI chr20:11,583,928...11,601,959
Ensembl chr20:11,584,411...11,601,972
G
Slc25a1
solute carrier family 25 member 1
increases expression
ISO
Vitamin E results in increased expression of SLC25A1 mRNA
CTD
PMID:19244175
NCBI chr11:83,055,764...83,058,781
Ensembl chr11:83,055,748...83,058,781
G
Slc25a12
solute carrier family 25 member 12
decreases expression
ISO
Vitamin E results in decreased expression of SLC25A12 mRNA
CTD
PMID:19244175
NCBI chr 3:76,504,868...76,599,536
Ensembl chr 3:56,097,269...56,192,100
G
Slc25a16
solute carrier family 25 member 16
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SLC25A16 mRNA Vitamin E results in decreased expression of SLC25A16 mRNA
CTD
PMID:19244175
NCBI chr20:25,659,847...25,717,080
Ensembl chr20:25,662,055...25,716,319
G
Slc25a36
solute carrier family 25 member 36
decreases expression
ISO
Vitamin E results in decreased expression of SLC25A36 mRNA
CTD
PMID:19244175
NCBI chr 8:106,539,355...106,573,240
Ensembl chr 8:97,662,127...97,693,703
G
Slc25a4
solute carrier family 25 member 4
increases expression
ISO
Vitamin E results in increased expression of SLC25A4 mRNA
CTD
PMID:19244175
NCBI chr16:52,805,521...52,809,316
Ensembl chr16:46,072,939...46,076,733
G
Slc25a5-ps11
solute carrier family 25 member 5, pseudogene 11
increases expression
ISO
Vitamin E results in increased expression of SLC25A6 mRNA
CTD
PMID:19244175
NCBI chr18:70,846,358...70,847,597
Ensembl chr18:68,571,300...68,572,199
G
Slc29a1
solute carrier family 29 member 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of SLC29A1 mRNA Vitamin E results in increased expression of SLC29A1 mRNA
CTD
PMID:19244175
NCBI chr 9:22,897,099...22,911,640
Ensembl chr 9:15,399,612...15,414,203
G
Slc2a4
solute carrier family 2 member 4
multiple interactions
EXP
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate affects the localization of SLC2A4 protein]; Vitamin E affects the reaction [Triiodothyronine, Reverse results in decreased expression of SLC2A4 mRNA]
CTD
PMID:17198541 PMID:21911000
NCBI chr10:55,164,721...55,170,289
Ensembl chr10:54,666,015...54,671,565
G
Slc30a5
solute carrier family 30 member 5
decreases expression
ISO
Vitamin E results in decreased expression of SLC30A5 mRNA
CTD
PMID:19244175
NCBI chr 2:31,945,745...31,975,969
Ensembl chr 2:31,945,729...31,975,934
G
Slc35d1
solute carrier family 35 member D1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SLC35D1 mRNA Vitamin E results in decreased expression of SLC35D1 mRNA
CTD
PMID:19244175
NCBI chr 5:123,157,739...123,210,350
Ensembl chr 5:117,934,352...117,981,311
G
Slc39a1
solute carrier family 39 member 1
increases expression multiple interactions
ISO
Vitamin E results in increased expression of SLC39A1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of SLC39A1 mRNA
CTD
PMID:19244175
NCBI chr 2:178,001,052...178,006,689
Ensembl chr 2:175,703,441...175,709,058
G
Slc39a2
solute carrier family 39 member 2
increases expression
ISO
Vitamin E results in increased expression of SLC39A2 mRNA
CTD
PMID:19244175
NCBI chr15:27,063,699...27,066,349
Ensembl chr15:24,590,738...24,592,850
G
Slc47a1
solute carrier family 47 member 1
increases expression
ISO
Vitamin E results in increased expression of SLC47A1 mRNA
CTD
PMID:19244175
NCBI chr10:46,533,580...46,590,128
Ensembl chr10:46,034,122...46,087,637
G
Slc4a4
solute carrier family 4 member 4
decreases expression
ISO
Vitamin E results in decreased expression of SLC4A4 mRNA
CTD
PMID:19244175
NCBI chr14:18,841,289...19,293,297
Ensembl chr14:18,845,159...19,272,883
G
Slc4a7
solute carrier family 4 member 7
decreases expression
ISO
Vitamin E results in decreased expression of SLC4A7 mRNA
CTD
PMID:19244175
NCBI chr15:13,015,854...13,095,485
Ensembl chr15:10,588,979...10,664,781
G
Slc6a2
solute carrier family 6 member 2
decreases expression
ISO
Vitamin E results in decreased expression of SLC6A2 mRNA
CTD
PMID:19244175
NCBI chr19:30,183,289...30,228,292
Ensembl chr19:14,010,386...14,050,357
G
Slc6a8
solute carrier family 6 member 8
increases expression
ISO
Vitamin E results in increased expression of SLC6A8 mRNA
CTD
PMID:19244175
NCBI chr X:156,536,017...156,545,321
Ensembl chr X:151,384,675...151,393,979
G
Slf2
SMC5-SMC6 complex localization factor 2
increases expression
ISO
Vitamin E results in increased expression of SLF2 mRNA
CTD
PMID:19244175
NCBI chr 1:253,731,979...253,794,577
Ensembl chr 1:243,782,246...243,845,250
G
Smad3
SMAD family member 3
increases expression
ISO
Vitamin E results in increased expression of SMAD3 mRNA
CTD
PMID:19244175
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:64,110,039...64,236,960
G
Smad5
SMAD family member 5
decreases expression
ISO
Vitamin E results in decreased expression of SMAD5 mRNA
CTD
PMID:19244175
NCBI chr17:7,867,640...7,896,983
Ensembl chr17:7,864,720...7,891,634
G
Smap1
small ArfGAP 1
increases expression
ISO
Vitamin E results in increased expression of SMAP1 mRNA
CTD
PMID:19244175
NCBI chr 9:26,250,178...26,342,151
Ensembl chr 9:26,249,978...26,342,170
G
Smarca5
SNF2 related chromatin remodeling ATPase 5
decreases expression
ISO
Vitamin E results in decreased expression of SMARCA5 mRNA
CTD
PMID:19244175
NCBI chr19:44,172,465...44,208,967
Ensembl chr19:27,271,148...27,304,594
G
Smarcc1
SWI/SNF related BAF chromatin remodeling complex subunit C1
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of SMARCC1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of SMARCC1 mRNA
CTD
PMID:19244175
NCBI chr 8:118,986,917...119,093,161
Ensembl chr 8:110,111,122...110,214,720
G
Smarcd2
SWI/SNF related BAF chromatin remodeling complex subunit D2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of SMARCD2 mRNA Vitamin E results in increased expression of SMARCD2 mRNA
CTD
PMID:19244175
NCBI chr10:91,693,542...91,702,408
Ensembl chr10:91,193,752...91,204,341
G
Smc5
structural maintenance of chromosomes 5
decreases expression
ISO
Vitamin E results in decreased expression of SMC5 mRNA
CTD
PMID:19244175
NCBI chr 1:230,195,894...230,265,677
Ensembl chr 1:220,769,366...220,839,096
G
Smc6
structural maintenance of chromosomes 6
decreases expression
ISO
Vitamin E results in decreased expression of SMC6 mRNA
CTD
PMID:19244175
NCBI chr 6:39,697,810...39,752,275
Ensembl chr 6:33,978,716...34,031,746
G
Smchd1
structural maintenance of chromosomes flexible hinge domain containing 1
decreases expression
ISO
Vitamin E results in decreased expression of SMCHD1 mRNA
CTD
PMID:19244175
NCBI chr 9:118,690,050...118,837,281
Ensembl chr 9:111,247,702...111,349,665
G
Smg5
SMG5 nonsense mediated mRNA decay factor
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SMG5 mRNA Vitamin E results in increased expression of SMG5 mRNA
CTD
PMID:19244175
NCBI chr 2:176,102,812...176,129,925
Ensembl chr 2:173,805,019...173,832,102
G
Smg6
SMG6 nonsense mediated mRNA decay factor
increases expression
ISO
Vitamin E results in increased expression of SMG6 mRNA
CTD
PMID:19244175
NCBI chr10:60,284,628...60,512,738
Ensembl chr10:59,786,258...60,014,395
G
Smox
spermine oxidase
increases expression
ISO
Vitamin E results in increased expression of SMOX mRNA
CTD
PMID:19244175
NCBI chr 3:139,184,793...139,220,174
Ensembl chr 3:118,731,900...118,765,710 Ensembl chr X:118,731,900...118,765,710
G
Smpd4
sphingomyelin phosphodiesterase 4
increases expression
ISO
Vitamin E results in increased expression of SMPD4 mRNA
CTD
PMID:19244175
NCBI chr11:96,866,805...96,890,520
Ensembl chr11:83,362,534...83,386,250
G
Smtn
smoothelin
increases expression
ISO
Vitamin E results in increased expression of SMTN mRNA
CTD
PMID:19244175
NCBI chr14:78,398,595...78,420,908
Ensembl chr14:78,397,778...78,420,886
G
Smurf2
SMAD specific E3 ubiquitin protein ligase 2
decreases expression
ISO
Vitamin E results in decreased expression of SMURF2 mRNA
CTD
PMID:19244175
NCBI chr10:92,261,516...92,362,185
Ensembl chr10:91,761,807...91,862,488
G
Smyd2
SET and MYND domain containing 2
decreases expression
ISO
Vitamin E results in decreased expression of SMYD2 mRNA
CTD
PMID:19244175
NCBI chr13:103,956,470...103,997,774
Ensembl chr13:101,425,273...101,466,576
G
Snap25
synaptosome associated protein 25
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SNAP25 mRNA
CTD
PMID:19244175
NCBI chr 3:144,494,579...144,576,449
Ensembl chr 3:124,041,898...124,123,760
G
Snf8
SNF8 subunit of ESCRT-II
increases expression
ISO
Vitamin E results in increased expression of SNF8 mRNA
CTD
PMID:19244175
NCBI chr10:81,481,054...81,493,430
Ensembl chr10:80,984,363...80,996,734
G
Snrnp27
small nuclear ribonucleoprotein U4/U6.U5 subunit 27
decreases expression
ISO
Vitamin E results in decreased expression of SNRNP27 mRNA
CTD
PMID:19244175
NCBI chr 4:120,681,054...120,691,343
Ensembl chr 4:119,121,877...119,133,234
G
Snrnp35
small nuclear ribonucleoprotein U11/U12 subunit 35
increases expression
ISO
Vitamin E results in increased expression of SNRNP35 mRNA
CTD
PMID:19244175
NCBI chr12:32,112,032...32,119,829
Ensembl chr12:32,110,993...32,122,660
G
Snrpb
small nuclear ribonucleoprotein polypeptides B and B1
increases expression
ISO
Vitamin E results in increased expression of SNRPB mRNA
CTD
PMID:19244175
NCBI chr 3:137,824,870...137,832,479
Ensembl chr 3:117,370,100...117,379,339
G
Snrpd3
small nuclear ribonucleoprotein D3 polypeptide
increases expression
ISO
Vitamin E results in increased expression of SNRPD3 mRNA
CTD
PMID:19244175
NCBI chr20:13,129,555...13,145,100
Ensembl chr20:13,130,119...13,145,978
G
Sntb2
syntrophin, beta 2
decreases expression
ISO
Vitamin E results in decreased expression of SNTB2 mRNA
CTD
PMID:19244175
NCBI chr19:51,739,492...51,832,083
Ensembl chr19:34,831,584...34,914,113
G
Snu13
small nuclear ribonucleoprotein 13
increases expression
ISO
Vitamin E results in increased expression of SNU13 mRNA
CTD
PMID:19244175
NCBI chr 7:115,445,415...115,451,008
Ensembl chr 7:113,565,295...113,570,872 Ensembl chr 1:113,565,295...113,570,872
G
Snx13
sorting nexin 13
decreases expression
ISO
Vitamin E results in decreased expression of SNX13 mRNA
CTD
PMID:19244175
NCBI chr 6:57,478,139...57,589,624
Ensembl chr 6:51,753,036...51,860,224
G
Snx17
sorting nexin 17
increases expression
ISO
Vitamin E results in increased expression of SNX17 mRNA
CTD
PMID:19244175
NCBI chr 6:30,897,500...30,902,972
Ensembl chr 6:25,177,391...25,183,030
G
Snx6
sorting nexin 6
increases expression
ISO
Vitamin E results in increased expression of SNX6 mRNA
CTD
PMID:19244175
NCBI chr 6:77,966,141...78,009,343
Ensembl chr 6:72,229,870...72,315,911
G
Sobp
sine oculis binding protein homolog
decreases expression
ISO
Vitamin E results in decreased expression of SOBP mRNA
CTD
PMID:19244175
NCBI chr20:48,064,445...48,243,607
Ensembl chr20:46,482,765...46,663,541
G
Sod1
superoxide dismutase 1
multiple interactions
ISO EXP
[Ascorbic Acid co-treated with Vitamin E] results in increased expression of SOD1 mRNA; Vitamin E inhibits the reaction [Epinephrine results in increased activity of SOD1 protein] [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of SOD1 protein]; [Curcumin co-treated with Vitamin E] inhibits the reaction [Thyroxine results in decreased expression of SOD1 mRNA]; [Curcumin co-treated with Vitamin E] inhibits the reaction [Thyroxine results in increased activity of SOD1 protein]; [Curcumin co-treated with Vitamin E] promotes the reaction [Thyroxine results in decreased activity of SOD1 protein]; Vitamin E inhibits the reaction [Cadmium results in increased activity of SOD1 protein]; Vitamin E inhibits the reaction [Hexachlorobenzene results in decreased activity of SOD1 protein]; Vitamin E inhibits the reaction [Thyroxine results in decreased expression of SOD1 mRNA]; Vitamin E inhibits the reaction [Thyroxine results in decreased expression of SOD1 protein]; Vitamin E inhibits the reaction [Thyroxine results in increased activity of SOD1 protein]; Vitamin E inhibits the reaction [Thyroxine results in increased expression of SOD1 protein]; Vitamin E inhibits the reaction [Triiodothyronine, Reverse results in decreased activity of and results in decreased expression of SOD1 protein]; Vitamin E inhibits the reaction [Triiodothyronine, Reverse results in decreased expression of SOD1 mRNA]; Vitamin E promotes the reaction [Thyroxine results in decreased activity of SOD1 protein]
CTD
PMID:11163531 PMID:14535831 PMID:17198541 PMID:17447016 PMID:19914224 PMID:22207723 PMID:29663635 PMID:30064338 More...
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
multiple interactions
EXP ISO
[Ascorbic Acid co-treated with Vitamin E co-treated with beta Carotene co-treated with Copper] inhibits the reaction [Streptozocin results in decreased expression of SOD2 mRNA]; [Ascorbic Acid co-treated with Vitamin E co-treated with beta Carotene co-treated with Copper] inhibits the reaction [Streptozocin results in decreased expression of SOD2 protein]; [Vitamin E co-treated with Curcumin] inhibits the reaction [Thyroxine results in decreased expression of SOD2 mRNA]; Vitamin E affects the reaction [Ethanol affects the activity of SOD2 protein]; Vitamin E inhibits the reaction [Thyroxine results in decreased expression of SOD2 mRNA]; Vitamin E promotes the reaction [Thyroxine results in increased expression of SOD2 protein] Vitamin E inhibits the reaction [Epinephrine results in increased activity of SOD2 protein]; Vitamin E inhibits the reaction [Norepinephrine results in increased expression of SOD2 mRNA]
CTD
PMID:10787391 PMID:11163531 PMID:18779489 PMID:19914224 PMID:23114885
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Son
SON DNA and RNA binding protein
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SON mRNA Vitamin E results in decreased expression of SON mRNA
CTD
PMID:19244175
NCBI chr11:44,336,818...44,409,127
Ensembl chr11:30,892,005...30,923,167
G
Sort1
sortilin 1
decreases expression
ISO
Vitamin E results in decreased expression of SORT1 mRNA
CTD
PMID:19244175
NCBI chr 2:198,609,466...198,690,481
Ensembl chr 2:195,924,099...196,002,354
G
Sos1
SOS Ras/Rac guanine nucleotide exchange factor 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SOS1 mRNA Vitamin E results in decreased expression of SOS1 mRNA
CTD
PMID:19244175
NCBI chr 6:20,286,117...20,363,350
Ensembl chr 6:14,533,360...14,611,107
G
Sox4
SRY-box transcription factor 4
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SOX4 mRNA Vitamin E results in decreased expression of SOX4 mRNA
CTD
PMID:19244175
NCBI chr17:35,876,298...35,881,004
Ensembl chr17:35,667,537...35,673,665
G
Sox9
SRY-box transcription factor 9
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SOX9 mRNA Vitamin E results in decreased expression of SOX9 mRNA
CTD
PMID:19244175
NCBI chr10:98,305,744...98,311,250
Ensembl chr10:97,806,485...97,811,994
G
Sp100
SP100 nuclear antigen
decreases expression
ISO
Vitamin E results in decreased expression of SP100 mRNA
CTD
PMID:19244175
NCBI chr 9:93,758,975...93,825,068
Ensembl chr 9:86,311,032...86,377,034
G
Spag7
sperm associated antigen 7
increases expression
ISO
Vitamin E results in increased expression of SPAG7 mRNA
CTD
PMID:19244175
NCBI chr10:55,377,249...55,383,404
Ensembl chr10:55,377,249...55,383,404
G
Spata20
spermatogenesis associated 20
increases expression
ISO
Vitamin E results in increased expression of SPATA20 mRNA
CTD
PMID:19244175
NCBI chr10:79,427,525...79,435,472
Ensembl chr10:79,427,528...79,434,368
G
Spcs2
signal peptidase complex subunit 2
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SPCS2 mRNA Vitamin E results in decreased expression of SPCS2 mRNA
CTD
PMID:19244175
NCBI chr 1:154,163,724...154,183,152
Ensembl chr 1:154,163,724...154,183,186
G
Speg
striated muscle enriched protein kinase
increases expression
ISO
Vitamin E results in increased expression of SPEG mRNA
CTD
PMID:19244175
NCBI chr 9:76,865,714...76,923,170
Ensembl chr 9:76,865,754...76,923,144
G
Spen
spen family transcriptional repressor
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SPEN mRNA Vitamin E results in decreased expression of SPEN mRNA
CTD
PMID:19244175
NCBI chr 5:159,058,258...159,131,789
Ensembl chr 5:153,776,234...153,848,811
G
Spidr
scaffold protein involved in DNA repair
decreases expression
ISO
Vitamin E results in decreased expression of SPIDR mRNA
CTD
PMID:19244175
NCBI chr11:98,270,779...98,511,760
Ensembl chr11:84,766,593...85,007,600
G
Sppl2b
signal peptide peptidase-like 2B
increases expression
ISO
Vitamin E results in increased expression of SPPL2B mRNA
CTD
PMID:19244175
NCBI chr 7:8,843,918...8,856,642
Ensembl chr 7:8,843,918...8,856,608
G
Spsb3
splA/ryanodine receptor domain and SOCS box containing 3
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of SPSB3 mRNA
CTD
PMID:19244175
NCBI chr10:14,411,692...14,417,357
Ensembl chr10:13,907,253...13,912,841
G
Sptan1
spectrin, alpha, non-erythrocytic 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of SPTAN1 mRNA Vitamin E results in increased expression of SPTAN1 mRNA
CTD
PMID:19244175
NCBI chr 3:13,241,164...13,306,047
Ensembl chr 3:13,241,217...13,306,046
G
Sptb
spectrin, beta, erythrocytic
decreases expression
ISO
Vitamin E results in decreased expression of SPTB mRNA
CTD
PMID:19244175
NCBI chr 6:95,310,342...95,437,221
Ensembl chr 6:95,310,326...95,437,118
G
Sptbn5
spectrin, beta, non-erythrocytic 5
decreases expression
ISO
Vitamin E results in decreased expression of SPTBN5 mRNA
CTD
PMID:19244175
NCBI chr 3:127,467,137...127,511,814
Ensembl chr 3:107,013,265...107,054,324
G
Sptlc3
serine palmitoyltransferase, long chain base subunit 3
decreases expression
ISO
Vitamin E results in decreased expression of SPTLC3 mRNA
CTD
PMID:19244175
NCBI chr 3:147,301,570...147,431,696
Ensembl chr 3:126,847,878...126,978,010
G
Srd5a1
steroid 5 alpha-reductase 1
affects expression
EXP
Vitamin E affects the expression of SRD5A1 mRNA
CTD
PMID:20447326
NCBI chr 1:35,514,914...35,548,898
Ensembl chr 1:33,686,391...33,720,461
G
Srpk1
SRSF protein kinase 1
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of SRPK1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of SRPK1 mRNA
CTD
PMID:19244175
NCBI chr20:6,645,809...6,682,448
Ensembl chr20:6,645,809...6,682,134
G
Srpk2
SRSF protein kinase 2
decreases expression
ISO
Vitamin E results in decreased expression of SRPK2 mRNA
CTD
PMID:19244175
NCBI chr 4:11,464,684...11,655,993
Ensembl chr 4:11,464,674...11,655,990
G
Srrm2
serine/arginine repetitive matrix 2
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of SRRM2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of SRRM2 mRNA
CTD
PMID:19244175
NCBI chr10:13,320,059...13,353,337
Ensembl chr10:12,815,471...12,848,751
G
Srsf11
serine and arginine rich splicing factor 11
decreases expression
ISO
Vitamin E results in decreased expression of SRSF11 mRNA
CTD
PMID:19244175
NCBI chr 2:249,733,464...249,760,296
Ensembl chr 2:247,074,631...247,101,425
G
Srsf7
serine and arginine rich splicing factor 7
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SRSF7 mRNA Vitamin E results in decreased expression of SRSF7 mRNA
CTD
PMID:19244175
NCBI chr 6:20,564,035...20,571,205
Ensembl chr 6:14,811,808...14,818,965
G
Srsf9
serine and arginine rich splicing factor 9
increases expression
ISO
Vitamin E results in increased expression of SRSF9 mRNA
CTD
PMID:19244175
NCBI chr12:46,938,948...46,945,213
Ensembl chr12:41,275,687...41,284,499
G
Ssr4
signal sequence receptor subunit 4
decreases expression
ISO
Vitamin E results in decreased expression of SSR4 mRNA
CTD
PMID:19244175
NCBI chr X:156,675,658...156,679,545
Ensembl chr X:151,524,009...151,528,202
G
Ssx2ip
SSX family member 2 interacting protein
decreases expression
ISO
Vitamin E results in decreased expression of SSX2IP mRNA
CTD
PMID:19244175
NCBI chr 2:235,298,012...235,330,750
Ensembl chr 2:235,298,088...235,330,745
G
St13
ST13, Hsp70 interacting protein
multiple interactions
EXP
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of ST13 mRNA
CTD
PMID:11444866
NCBI chr 7:114,769,758...114,805,877
Ensembl chr 7:112,844,375...112,925,945
G
Stab1
stabilin 1
increases expression multiple interactions
ISO
Vitamin E results in increased expression of STAB1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of STAB1 mRNA
CTD
PMID:19244175
NCBI chr16:6,336,871...6,367,374
Ensembl chr16:6,330,444...6,360,923
G
Stag2
STAG2 cohesin complex component
decreases expression
ISO
Vitamin E results in decreased expression of STAG2 mRNA
CTD
PMID:19244175
NCBI chr X:125,839,660...125,971,209
Ensembl chr X:120,974,857...121,105,677
G
Star
steroidogenic acute regulatory protein
multiple interactions
EXP
Vitamin E inhibits the reaction [acetamiprid results in decreased expression of STAR mRNA]; Vitamin E inhibits the reaction [acetamiprid results in decreased expression of STAR protein]; Vitamin E inhibits the reaction [Cadmium results in decreased expression of STAR mRNA]
CTD
PMID:15055539 PMID:28395332
NCBI chr16:72,969,824...72,974,447
Ensembl chr16:66,264,807...66,271,672
G
Stard5
StAR-related lipid transfer domain containing 5
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of STARD5 mRNA
CTD
PMID:19244175
NCBI chr 1:147,015,304...147,025,170
Ensembl chr 1:137,606,177...137,616,469
G
Stat1
signal transducer and activator of transcription 1
decreases expression
ISO
Vitamin E results in decreased expression of STAT1 mRNA
CTD
PMID:19244175
NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:49,419,340...49,588,540
G
Stat2
signal transducer and activator of transcription 2
multiple interactions
ISO
[Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3,4-dihydroxyphenylethanol] results in decreased expression of STAT2 mRNA
CTD
PMID:16797527
NCBI chr 7:1,287,025...1,302,858
Ensembl chr 7:702,495...718,967
G
Stat5a
signal transducer and activator of transcription 5A
increases expression
ISO
Vitamin E results in increased expression of STAT5A mRNA
CTD
PMID:19244175
NCBI chr10:86,285,859...86,310,187
Ensembl chr10:85,785,537...85,809,866
G
Stat5b
signal transducer and activator of transcription 5B
increases expression
ISO
Vitamin E results in increased expression of STAT5B mRNA
CTD
PMID:19244175
NCBI chr10:86,205,148...86,276,178
Ensembl chr10:85,705,670...85,775,668
G
Stc1
stanniocalcin 1
decreases expression
ISO
Vitamin E results in decreased expression of STC1 mRNA
CTD
PMID:19244175
NCBI chr15:50,709,439...50,720,093
Ensembl chr15:44,299,621...44,310,264
G
Stk38
serine/threonine kinase 38
increases expression
ISO
Vitamin E results in increased expression of STK38 mRNA
CTD
PMID:19244175
NCBI chr20:7,035,923...7,070,657
Ensembl chr20:7,034,242...7,068,198
G
Stk38l
serine/threonine kinase 38 like
decreases expression
ISO
Vitamin E results in decreased expression of STK38L mRNA
CTD
PMID:19244175
NCBI chr 4:179,616,288...179,693,177
Ensembl chr 4:179,634,275...179,690,983
G
Stk4
serine/threonine kinase 4
decreases expression
ISO
Vitamin E results in decreased expression of STK4 mRNA
CTD
PMID:19244175
NCBI chr 3:173,165,238...173,247,135
Ensembl chr 3:152,745,681...152,827,744
G
Stom
stomatin
increases expression
ISO
Vitamin E results in increased expression of STOM mRNA
CTD
PMID:19244175
NCBI chr 3:18,645,058...18,667,343
Ensembl chr 3:18,644,378...18,667,354
G
Stoml1
stomatin like 1
increases expression
ISO
Vitamin E results in increased expression of STOML1 mRNA
CTD
PMID:19244175
NCBI chr 8:58,661,980...58,669,860
Ensembl chr 8:58,661,992...58,669,860
G
Stoml2
stomatin like 2
increases expression
ISO
Vitamin E results in increased expression of STOML2 mRNA
CTD
PMID:19244175
NCBI chr 5:62,052,042...62,055,639
Ensembl chr 5:57,256,220...57,259,920
G
Strn
striatin
decreases expression
ISO
Vitamin E results in decreased expression of STRN mRNA
CTD
PMID:19244175
NCBI chr 6:16,335,265...16,422,159
Ensembl chr 6:16,335,358...16,417,083
G
Stt3a
STT3 oligosaccharyltransferase complex catalytic subunit A
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of STT3A mRNA Vitamin E results in increased expression of STT3A mRNA
CTD
PMID:19244175
NCBI chr 8:36,443,623...36,483,111
Ensembl chr 8:36,446,788...36,483,293
G
Stub1
STIP1 homology and U-box containing protein 1
increases expression
ISO
Vitamin E results in increased expression of STUB1 mRNA
CTD
PMID:19244175
NCBI chr10:15,355,278...15,357,559
Ensembl chr10:14,850,765...14,853,046
G
Stx17
syntaxin 17
decreases expression
ISO
Vitamin E results in decreased expression of STX17 mRNA
CTD
PMID:19244175
NCBI chr 5:67,241,673...67,302,228
Ensembl chr 5:62,446,187...62,504,451
G
Styxl1
serine/threonine/tyrosine interacting-like 1
increases expression
ISO
Vitamin E results in increased expression of STYXL1 mRNA
CTD
PMID:19244175
NCBI chr12:20,907,410...20,940,232
Ensembl chr12:20,907,435...20,939,752
G
Sult1e1
sulfotransferase family 1E member 1
increases expression
EXP
Vitamin E results in increased expression of SULT1E1 mRNA
CTD
PMID:28923436
NCBI chr14:20,700,444...20,718,719
Ensembl chr14:20,422,324...20,439,275
G
Sult2a1
sulfotransferase family 2A member 1
decreases expression
EXP
Vitamin E results in decreased expression of SULT2A1 mRNA
CTD
PMID:28923436
NCBI chr 1:84,582,011...84,639,001
Ensembl chr 1:74,911,100...75,508,134
G
Sumo2
small ubiquitin-like modifier 2
increases expression
ISO
Vitamin E results in increased expression of SUMO2 mRNA
CTD
PMID:19244175
NCBI chr10:100,771,941...100,784,503
Ensembl chr10:100,686,797...100,784,513 Ensembl chr 5:100,686,797...100,784,513
G
Sun2
Sad1 and UNC84 domain containing 2
increases expression
ISO
Vitamin E results in increased expression of SUN2 mRNA
CTD
PMID:19244175
NCBI chr 7:111,275,374...111,292,565
Ensembl chr 7:111,275,380...111,292,553
G
Supt4h1
SPT4 homolog, DSIF elongation factor subunit
increases expression
ISO
Vitamin E results in increased expression of SUPT4H1 mRNA
CTD
PMID:19244175
NCBI chr10:73,036,560...73,042,821
Ensembl chr10:72,539,382...72,545,831
G
Supt5h
SPT5 homolog, DSIF elongation factor subunit
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of SUPT5H mRNA Vitamin E results in increased expression of SUPT5H mRNA
CTD
PMID:19244175
NCBI chr 1:92,714,276...92,745,489
Ensembl chr 1:83,586,718...83,616,892
G
Surf2
surfeit 2
increases expression
ISO
Vitamin E results in increased expression of SURF2 mRNA
CTD
PMID:19244175
NCBI chr 3:30,642,735...30,648,525
Ensembl chr 3:10,244,654...10,250,077
G
Suz12
SUZ12 polycomb repressive complex 2 subunit
decreases expression
ISO
Vitamin E results in decreased expression of SUZ12 mRNA
CTD
PMID:19244175
NCBI chr10:64,967,035...65,012,916
Ensembl chr10:64,966,967...65,012,738
G
Swap70
switching B-cell complex subunit SWAP70
increases expression
ISO
Vitamin E results in increased expression of SWAP70 mRNA
CTD
PMID:19244175
NCBI chr 1:164,267,588...164,328,796
Ensembl chr 1:164,267,609...164,328,794
G
Syde1
synapse defective Rho GTPase homolog 1
increases expression
ISO
Vitamin E results in increased expression of SYDE1 mRNA
CTD
PMID:19244175
NCBI chr 7:11,683,505...11,689,491
Ensembl chr 7:11,032,898...11,039,869
G
Syncrip
synaptotagmin binding, cytoplasmic RNA interacting protein
decreases expression
ISO
Vitamin E results in decreased expression of SYNCRIP mRNA
CTD
PMID:19244175
NCBI chr 8:98,282,358...98,315,412
Ensembl chr 8:89,402,866...89,435,515
G
Syndig1
synapse differentiation inducing 1
increases expression
ISO
Vitamin E results in increased expression of SYNDIG1 mRNA
CTD
PMID:19244175
NCBI chr 3:158,491,474...158,695,174
Ensembl chr 3:138,031,769...138,198,122
G
Syngr1
synaptogyrin 1
increases expression
ISO
Vitamin E results in increased expression of SYNGR1 mRNA
CTD
PMID:19244175
NCBI chr 7:113,516,246...113,542,918
Ensembl chr 7:111,635,918...111,659,341
G
Synj2
synaptojanin 2
increases expression
ISO
Vitamin E results in increased expression of SYNJ2 mRNA
CTD
PMID:19244175
NCBI chr 1:48,923,742...49,027,153
Ensembl chr 1:46,518,709...46,633,687
G
Synpo
synaptopodin
increases expression
ISO
Vitamin E results in increased expression of SYNPO mRNA
CTD
PMID:19244175
NCBI chr18:54,048,299...54,106,388
Ensembl chr18:54,026,152...54,102,126
G
Tada3
transcriptional adaptor 3
increases expression
ISO
Vitamin E results in increased expression of TADA3 mRNA
CTD
PMID:19244175
NCBI chr 4:148,065,859...148,077,347
Ensembl chr 4:146,510,246...146,521,590
G
Taf1d
TATA-box binding protein associated factor, RNA polymerase I subunit D
decreases expression
ISO
Vitamin E results in decreased expression of TAF1D mRNA
CTD
PMID:19244175
NCBI chr 8:20,427,894...20,438,046
Ensembl chr 8:12,146,605...12,156,618
G
Taf5l1
TATA-box binding protein associated factor 5 like 1
decreases expression
ISO
Vitamin E results in decreased expression of TAF5L mRNA
CTD
PMID:19244175
NCBI chr19:68,889,153...68,908,480
Ensembl chr19:51,991,708...52,011,295
G
Taf6
TATA-box binding protein associated factor 6
increases expression
ISO
Vitamin E results in increased expression of TAF6 mRNA
CTD
PMID:19244175
NCBI chr12:22,169,570...22,178,031
Ensembl chr12:17,055,873...17,064,247
G
Taf9b
TATA-box binding protein associated factor 9b
decreases expression
ISO
Vitamin E results in decreased expression of TAF9B mRNA
CTD
PMID:19244175
NCBI chr X:71,289,290...71,300,142
Ensembl chr X:71,289,290...71,300,604
G
Tagln
transgelin
increases expression
ISO
Vitamin E results in increased expression of TAGLN mRNA
CTD
PMID:19244175
NCBI chr 8:55,121,647...55,127,121
Ensembl chr 8:46,222,472...46,230,668
G
Tarbp2
Tarbp2 subunit of RISC loading complex
increases expression multiple interactions
ISO
Vitamin E results in increased expression of TARBP2 mRNA [Selenium co-treated with Vitamin E] results in increased expression of TARBP2 mRNA
CTD
PMID:19244175
NCBI chr 7:135,527,710...135,532,826
Ensembl chr 7:133,649,090...133,654,314
G
Tas2r116
taste receptor, type 2, member 116
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of TAS2R14 mRNA
CTD
PMID:19244175
NCBI chr 4:167,998,392...167,999,366
Ensembl chr 4:166,266,984...166,267,958
G
Tasor
transcription activation suppressor
decreases expression
ISO
Vitamin E results in decreased expression of TASOR mRNA
CTD
PMID:19244175
NCBI chr16:2,606,807...2,669,902
Ensembl chr16:2,603,936...2,667,292
G
Tax1bp3
Tax1 binding protein 3
increases expression
ISO
Vitamin E results in increased expression of TAX1BP3 mRNA
CTD
PMID:19244175
NCBI chr10:57,795,845...57,800,363
Ensembl chr10:57,795,382...57,800,363
G
Tbc1d4
TBC1 domain family, member 4
multiple interactions
EXP
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of TBC1D4 protein]
CTD
PMID:21911000
NCBI chr15:84,670,756...84,848,876
Ensembl chr15:78,257,121...78,434,265
G
Tbc1d8b
TBC1 domain family member 8B
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of TBC1D8B mRNA
CTD
PMID:19244175
NCBI chr X:103,319,181...103,407,137
Ensembl chr X:103,319,340...103,407,133
G
Tbc1d9b
TBC1 domain family member 9B
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of TBC1D9B mRNA
CTD
PMID:19244175
NCBI chr10:34,459,930...34,497,146
Ensembl chr10:34,459,953...34,497,145
G
Tbcb
tubulin folding cofactor B
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of TBCB mRNA Vitamin E results in increased expression of TBCB mRNA
CTD
PMID:19244175
NCBI chr 1:85,477,639...85,483,488
Ensembl chr 1:85,477,640...85,483,488
G
Tbl1x
transducin (beta)-like 1 X-linked
decreases expression
ISO
Vitamin E results in decreased expression of TBL1X mRNA
CTD
PMID:19244175
NCBI chr X:45,452,983...45,609,532
Ensembl chr X:41,576,047...41,731,101
G
Tcaf1
TRPM8 channel-associated factor 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of TCAF1 mRNA Vitamin E results in decreased expression of TCAF1 mRNA
CTD
PMID:19244175
NCBI chr 4:72,589,710...72,639,304
Ensembl chr 4:71,591,200...71,613,309
G
Tcea2
transcription elongation factor A2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of TCEA2 mRNA Vitamin E results in increased expression of TCEA2 mRNA
CTD
PMID:19244175
NCBI chr 3:189,173,756...189,181,633
Ensembl chr 3:168,796,331...168,804,116
G
Tcerg1
transcription elongation regulator 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of TCERG1 mRNA Vitamin E results in decreased expression of TCERG1 mRNA
CTD
PMID:19244175
NCBI chr18:34,756,558...34,817,441
Ensembl chr18:34,505,751...34,566,470
G
Tcf21
transcription factor 21
increases expression
ISO
Vitamin E results in increased expression of TCF21 mRNA
CTD
PMID:19244175
NCBI chr 1:24,520,499...24,523,358
Ensembl chr 1:22,701,353...22,704,202
G
Tcf7l1
transcription factor 7 like 1
increases expression
ISO
Vitamin E results in increased expression of TCF7L1 mRNA
CTD
PMID:19244175
NCBI chr 4:106,238,892...106,404,012
Ensembl chr 4:104,680,739...104,845,287
G
Tcf7l2
transcription factor 7 like 2
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of TCF7L2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of TCF7L2 mRNA
CTD
PMID:19244175
NCBI chr 1:264,791,335...264,984,225
Ensembl chr 1:254,786,091...254,978,967
G
Tcp1
t-complex 1
multiple interactions
EXP
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of TCP1 mRNA
CTD
PMID:11444866
NCBI chr 1:50,376,848...50,384,527
Ensembl chr 1:47,828,652...47,836,839
G
Tctn1
tectonic family member 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of TCTN1 mRNA Vitamin E results in decreased expression of TCTN1 mRNA
CTD
PMID:19244175
NCBI chr12:34,309,795...34,347,190
Ensembl chr12:34,309,897...34,342,267
G
Tdg
thymine-DNA glycosylase
decreases expression
ISO
Vitamin E results in decreased expression of TDG mRNA
CTD
PMID:19244175
NCBI chr 7:22,965,388...22,990,311
Ensembl chr 7:21,077,853...21,097,567
G
Tent4a
terminal nucleotidyltransferase 4A
decreases expression
ISO
Vitamin E results in decreased expression of TENT4A mRNA
CTD
PMID:19244175
NCBI chr 1:33,765,949...33,799,405
Ensembl chr 1:33,765,672...33,799,433
G
Terf1
telomeric repeat binding factor 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of TERF1 mRNA Vitamin E results in decreased expression of TERF1 mRNA
CTD
PMID:19244175
NCBI chr 5:8,226,345...8,255,614
Ensembl chr 5:3,443,106...3,472,340
G
Tfb2m
transcription factor B2, mitochondrial
decreases expression
ISO
Vitamin E results in decreased expression of TFB2M mRNA
CTD
PMID:19244175
NCBI chr13:91,278,889...91,296,709
Ensembl chr13:91,278,898...91,296,657
G
Tfeb
transcription factor EB
increases expression
ISO
Vitamin E results in increased expression of TFEB mRNA
CTD
PMID:19244175
NCBI chr 9:20,696,440...20,752,265
Ensembl chr 9:13,198,891...13,254,714
G
Tgfb1
transforming growth factor, beta 1
multiple interactions affects expression
ISO EXP
Vitamin E inhibits the reaction [Ethanol results in increased activity of TGFB1 protein] [Silybin co-treated with Phosphatidylcholines co-treated with Vitamin E] inhibits the reaction [Dimethylnitrosamine results in increased expression of TGFB1 mRNA]; Vitamin E inhibits the reaction [Cyclosporine results in increased secretion of TGFB1 protein]; Vitamin E inhibits the reaction [Streptozocin results in increased expression of TGFB1 mRNA] Vitamin E affects the expression of TGFB1 protein
CTD
PMID:10353404 PMID:15001429 PMID:15309289 PMID:16169303 PMID:21086752
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
G
Tgfbi
transforming growth factor, beta induced
increases expression
ISO
Vitamin E results in increased expression of TGFBI mRNA
CTD
PMID:19244175
NCBI chr17:7,960,885...7,990,234
Ensembl chr17:7,955,603...7,985,240
G
Tgoln2
trans-golgi network protein 2
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of TGOLN2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of TGOLN2 mRNA
CTD
PMID:19244175
NCBI chr 4:104,663,356...104,671,208
Ensembl chr 4:104,663,353...104,671,164
G
Th
tyrosine hydroxylase
multiple interactions
EXP
[Ascorbic Acid co-treated with Vitamin E] results in increased expression of TH protein
CTD
PMID:18772553
NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:198,071,503...198,109,767
G
Thada
THADA, armadillo repeat containing
increases expression
ISO
Vitamin E results in increased expression of THADA mRNA
CTD
PMID:19244175
NCBI chr 6:10,183,942...10,488,007
Ensembl chr 6:10,183,982...10,487,159
G
Thap4
THAP domain containing 4
increases expression
ISO
Vitamin E results in increased expression of THAP4 mRNA
CTD
PMID:19244175
NCBI chr 9:94,242,581...94,282,312
Ensembl chr 9:94,242,581...94,282,306
G
Thbd
thrombomodulin
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of THBD mRNA Vitamin E results in decreased expression of THBD mRNA
CTD
PMID:19244175
NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:135,862,835...135,867,193
G
Thoc2
THO complex subunit 2
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of THOC2 mRNA Vitamin E results in decreased expression of THOC2 mRNA
CTD
PMID:19244175
NCBI chr X:125,500,549...125,615,139
Ensembl chr X:120,634,968...120,749,513
G
Thsd7a
thrombospondin type 1 domain containing 7A
decreases expression
ISO
Vitamin E results in decreased expression of THSD7A mRNA
CTD
PMID:19244175
NCBI chr 4:41,427,276...41,865,524
Ensembl chr 4:40,460,814...40,899,583
G
Thy1
Thy-1 cell surface antigen
increases expression
ISO
Vitamin E results in increased expression of THY1 mRNA
CTD
PMID:19244175
NCBI chr 8:53,286,396...53,291,541
Ensembl chr 8:44,389,513...44,394,659
G
Thyn1
thymocyte nuclear protein 1
increases expression
ISO
Vitamin E results in increased expression of THYN1 mRNA
CTD
PMID:19244175
NCBI chr 8:25,406,563...25,415,445
Ensembl chr 8:25,406,500...25,415,445
G
Tia1
TIA1 cytotoxic granule-associated RNA binding protein
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of TIA1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of TIA1 mRNA
CTD
PMID:19244175
NCBI chr 4:118,852,765...118,883,252
Ensembl chr 4:118,852,837...118,880,586
G
Tial1
Tia1 cytotoxic granule-associated RNA binding protein-like 1
decreases expression
ISO
Vitamin E results in decreased expression of TIAL1 mRNA
CTD
PMID:19244175
NCBI chr 1:192,438,794...192,475,520
Ensembl chr 1:183,009,253...183,031,637
G
Timm13
translocase of inner mitochondrial membrane 13
decreases expression
ISO
Vitamin E results in decreased expression of TIMM13 mRNA
CTD
PMID:19244175
NCBI chr 7:9,459,490...9,460,849
Ensembl chr 7:8,809,058...8,809,910
G
Timm8a1
translocase of inner mitochondrial membrane 8A1
decreases expression
ISO
Vitamin E results in decreased expression of TIMM8A mRNA
CTD
PMID:19244175
NCBI chr X:102,011,206...102,015,444
Ensembl chr X:97,717,920...97,721,960
G
Timp1
TIMP metallopeptidase inhibitor 1
increases expression multiple interactions
ISO EXP
Vitamin E results in increased expression of TIMP1 mRNA [silybin co-treated with Phosphatidylcholines co-treated with Vitamin E] inhibits the reaction [Dimethylnitrosamine results in increased expression of TIMP1 mRNA]
CTD
PMID:16169303 PMID:19244175
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:1,212,972...1,217,664
G
Timp3
TIMP metallopeptidase inhibitor 3
increases expression
ISO
Vitamin E results in increased expression of TIMP3 mRNA
CTD
PMID:19244175
NCBI chr 7:19,408,539...19,459,558
Ensembl chr 7:17,521,919...17,571,839
G
Tjp1
tight junction protein 1
multiple interactions
EXP
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of TJP1 protein]; Vitamin E inhibits the reaction [[Nicotine co-treated with Ritonavir co-treated with Saquinavir] results in decreased expression of TJP1 protein]; Vitamin E inhibits the reaction [[Nicotine co-treated with Saquinavir] results in decreased expression of TJP1 protein]
CTD
PMID:20722969 PMID:29940330
NCBI chr 1:128,260,330...128,505,018
Ensembl chr 1:118,849,838...119,094,432
G
Tkt
transketolase
increases expression
ISO
Vitamin E results in increased expression of TKT mRNA
CTD
PMID:19244175
NCBI chr16:5,729,381...5,755,170
Ensembl chr16:5,723,762...5,748,698
G
Tln1
talin 1
increases expression
ISO
Vitamin E results in increased expression of TLN1 mRNA
CTD
PMID:19244175
NCBI chr 5:62,583,730...62,613,687
Ensembl chr 5:57,787,943...57,817,900
G
Tm6sf1
transmembrane 6 superfamily member 1
decreases expression
ISO
Vitamin E results in decreased expression of TM6SF1 mRNA
CTD
PMID:19244175
NCBI chr 1:135,799,844...135,828,515
Ensembl chr 1:135,786,381...135,828,443
G
Tm9sf1
transmembrane 9 superfamily member 1
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of TM9SF1 mRNA
CTD
PMID:19244175
NCBI chr15:33,097,541...33,108,106
Ensembl chr15:29,127,584...29,135,349
G
Tma16
translation machinery associated 16 homolog
decreases expression
ISO
Vitamin E results in decreased expression of TMA16 mRNA
CTD
PMID:19244175
NCBI chr16:23,236,686...23,252,706
Ensembl chr16:23,236,710...23,252,701
G
Tmbim1
transmembrane BAX inhibitor motif containing 1
increases expression
ISO
Vitamin E results in increased expression of TMBIM1 mRNA
CTD
PMID:19244175
NCBI chr 9:83,320,972...83,338,469
Ensembl chr 9:75,871,835...75,889,069
G
Tmc5
transmembrane channel-like 5
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of TMC5 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of TMC5 mRNA
CTD
PMID:19244175
NCBI chr 1:182,349,102...182,433,679
Ensembl chr 1:172,914,457...172,999,474
G
Tmem11
transmembrane protein 11
increases expression
ISO
Vitamin E results in increased expression of TMEM11 mRNA
CTD
PMID:19244175
NCBI chr10:45,542,753...45,557,570
Ensembl chr10:45,542,755...45,557,570 Ensembl chr 6:45,542,755...45,557,570
G
Tmem161b
transmembrane protein 161B
decreases expression
ISO
Vitamin E results in decreased expression of TMEM161B mRNA
CTD
PMID:19244175
NCBI chr 2:14,714,451...14,793,809
Ensembl chr 2:14,715,701...14,793,803
G
Tmem176a
transmembrane protein 176A
increases expression
ISO
Vitamin E results in increased expression of TMEM176A mRNA
CTD
PMID:19244175
NCBI chr 4:79,101,946...79,109,499
Ensembl chr 4:77,774,843...77,778,620
G
Tmem186
transmembrane protein 186
increases expression
ISO
Vitamin E results in increased expression of TMEM186 mRNA
CTD
PMID:19244175
NCBI chr10:7,489,599...7,492,917
Ensembl chr10:6,982,916...6,986,256
G
Tmem208
transmembrane protein 208
increases expression
ISO
Vitamin E results in increased expression of TMEM208 mRNA
CTD
PMID:19244175
NCBI chr19:50,113,494...50,116,210
Ensembl chr19:33,203,587...33,212,183
G
Tmem222
transmembrane protein 222
increases expression
ISO
Vitamin E results in increased expression of TMEM222 mRNA
CTD
PMID:19244175
NCBI chr 5:145,465,847...145,477,932
Ensembl chr 5:145,465,847...145,484,491
G
Tmem260
transmembrane protein 260
decreases expression
ISO
Vitamin E results in decreased expression of TMEM260 mRNA
CTD
PMID:19244175
NCBI chr15:21,734,119...21,804,049
Ensembl chr15:21,734,151...21,806,801
G
Tmem63a
transmembrane protein 63a
increases expression
ISO
Vitamin E results in increased expression of TMEM63A mRNA
CTD
PMID:19244175
NCBI chr13:92,662,872...92,696,186
Ensembl chr13:92,663,968...92,696,183
G
Tmf1
TATA element modulatory factor 1
decreases expression
ISO
Vitamin E results in decreased expression of TMF1 mRNA
CTD
PMID:19244175
NCBI chr 4:131,316,630...131,345,666
Ensembl chr 4:129,763,114...129,785,629
G
Tmprss6
transmembrane serine protease 6
increases expression
ISO
Vitamin E results in increased expression of TMPRSS6 mRNA
CTD
PMID:19244175
NCBI chr 7:111,871,504...111,902,127
Ensembl chr 7:109,985,931...110,021,624
G
Tnf
tumor necrosis factor
multiple interactions increases expression
ISO EXP
Vitamin E inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of TNF protein]; Vitamin E inhibits the reaction [Ethanol results in increased secretion of TNF protein]; Vitamin E inhibits the reaction [Oleic Acid results in increased expression of TNF mRNA]; Vitamin E inhibits the reaction [Oleic Acid results in increased expression of TNF protein]; Vitamin E inhibits the reaction [TNF protein results in decreased activity of KCNH2 protein]; Vitamin E inhibits the reaction [TNF protein results in increased abundance of Reactive Oxygen Species] [Vanadium co-treated with Selenium co-treated with Vitamin E co-treated with Chromium] inhibits the reaction [Streptozocin results in increased expression of TNF protein]; Vitamin E inhibits the reaction [[IL1B protein co-treated with TNF protein] results in increased chemical synthesis of Nitric Oxide]; Vitamin E inhibits the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of NOS2 protein]; Vitamin E inhibits the reaction [Aluminum results in increased expression of TNF protein]; Vitamin E inhibits the reaction [Doxorubicin results in increased expression of TNF protein]; Vitamin E inhibits the reaction [Nicotine results in increased expression of TNF protein]; Vitamin E inhibits the reaction [phoxim results in increased expression of TNF protein]; Vitamin E inhibits the reaction [Tramadol results in increased expression of TNF protein] Vitamin E deficiency results in increased expression of TNF mRNA alpha-Tocopherol inhibits the reaction [Vitamin E deficiency results in increased expression of TNF mRNA]; Quercetin inhibits the reaction [Vitamin E deficiency results in increased expression of TNF mRNA]; Vitamin E inhibits the reaction [Ethanol results in increased activity of TNF protein]; Vitamin E inhibits the reaction [Platelet Activating Factor results in increased expression of TNF mRNA]
CTD
PMID:10921504 PMID:14973143 PMID:15223066 PMID:15862027 PMID:16545059 PMID:17216608 PMID:19735175 PMID:21086752 PMID:22841563 PMID:23348005 PMID:30003487 PMID:31618080 PMID:35349355 PMID:38997059 More...
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfsf10
TNF superfamily member 10
decreases expression
ISO
Vitamin E results in decreased expression of TNFSF10 mRNA
CTD
PMID:19244175
NCBI chr 2:112,136,550...112,155,903
Ensembl chr 2:110,207,916...110,225,135
G
Tnik
TRAF2 and NCK interacting kinase
decreases expression
ISO
Vitamin E results in decreased expression of TNIK mRNA
CTD
PMID:19244175
NCBI chr 2:113,112,937...113,511,341
Ensembl chr 2:111,184,387...111,580,750
G
Tnpo1
transportin 1
decreases expression
ISO
Vitamin E results in decreased expression of TNPO1 mRNA
CTD
PMID:19244175
NCBI chr 2:31,941,731...32,034,366
Ensembl chr 2:30,211,510...30,300,375
G
Tnpo2
transportin 2
decreases expression
ISO
Vitamin E results in decreased expression of TNPO2 mRNA
CTD
PMID:19244175
NCBI chr19:40,004,271...40,024,565
Ensembl chr19:23,099,401...23,119,596
G
Tns1
tensin 1
increases expression
ISO
Vitamin E results in increased expression of TNS1 mRNA
CTD
PMID:19244175
NCBI chr 9:82,941,068...83,152,007
Ensembl chr 9:75,495,814...75,703,225
G
Tns2
tensin 2
increases expression
ISO
Vitamin E results in increased expression of TNS2 mRNA
CTD
PMID:19244175
NCBI chr 7:135,108,401...135,126,505
Ensembl chr 7:133,206,364...133,247,888
G
Tob2
transducer of ERBB2, 2
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of TOB2 mRNA Vitamin E results in decreased expression of TOB2 mRNA
CTD
PMID:19244175
NCBI chr 7:115,242,843...115,251,563
Ensembl chr 7:113,361,148...113,372,688
G
Top1
DNA topoisomerase I
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of TOP1 mRNA Vitamin E results in decreased expression of TOP1 mRNA
CTD
PMID:19244175
NCBI chr 3:169,713,195...169,796,330
Ensembl chr 3:149,293,403...149,376,623
G
Tor1a
torsin family 1, member A
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of TOR1A mRNA
CTD
PMID:19244175
NCBI chr 3:14,250,667...14,257,704
Ensembl chr 3:14,250,676...14,257,691
G
Tor3a
torsin family 3, member A
increases expression multiple interactions
ISO
Vitamin E results in increased expression of TOR3A mRNA [Selenium co-treated with Vitamin E] results in increased expression of TOR3A mRNA
CTD
PMID:19244175
NCBI chr13:68,769,893...68,798,738
Ensembl chr13:68,769,605...68,798,475
G
Tox4
TOX high mobility group box family member 4
increases expression
ISO
Vitamin E results in increased expression of TOX4 mRNA
CTD
PMID:19244175
NCBI chr15:27,462,735...27,476,320
Ensembl chr15:24,988,853...25,002,833
G
Tp53
tumor protein p53
multiple interactions increases expression
ISO EXP
[Selenium co-treated with Vitamin E] results in increased expression of TP53 mRNA; [Vitamin E co-treated with Curcumin] results in decreased expression of TP53 protein; Vitamin E inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of and results in increased activity of TP53 protein]; Vitamin E inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of TP53 protein] [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of TP53 mRNA]; Vitamin E inhibits the reaction [cypermethrin results in increased expression of TP53 mRNA]; Vitamin E inhibits the reaction [decamethrin results in increased expression of TP53 mRNA] Vitamin E results in increased expression of TP53 mRNA
CTD
PMID:15837074 PMID:19244175 PMID:21628957 PMID:24664296 PMID:24759048 PMID:25439240 PMID:30935902 More...
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Tpi1
triosephosphate isomerase 1
increases expression
ISO
Vitamin E results in increased expression of TPI1 mRNA
CTD
PMID:19244175
NCBI chr 4:159,301,558...159,305,088
Ensembl chr 4:157,615,386...157,619,541
G
Tpm2
tropomyosin 2
increases expression
ISO
Vitamin E results in increased expression of TPM2 mRNA
CTD
PMID:19244175
NCBI chr 5:62,566,712...62,576,066
Ensembl chr 5:57,770,864...57,779,992
G
Tpp1
tripeptidyl peptidase 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of TPP1 mRNA Vitamin E results in increased expression of TPP1 mRNA
CTD
PMID:19244175
NCBI chr 1:160,097,984...160,104,108
Ensembl chr 1:160,096,833...160,104,129
G
Tpr
translocated promoter region, nuclear basket protein
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of TPR mRNA Vitamin E results in decreased expression of TPR mRNA
CTD
PMID:19244175
NCBI chr13:64,974,419...65,037,604
Ensembl chr13:62,424,312...62,487,496
G
Tra2a
transformer 2 alpha
decreases expression increases expression
ISO
Vitamin E results in decreased expression of TRA2A mRNA Vitamin E results in increased expression of TRA2A mRNA
CTD
PMID:19244175
NCBI chr 4:79,551,699...79,570,621
Ensembl chr 4:78,220,883...78,239,712
G
Traf3ip1
TRAF3 interacting protein 1
decreases expression
ISO
Vitamin E results in decreased expression of TRAF3IP1 mRNA
CTD
PMID:19244175
NCBI chr 9:99,521,176...99,557,966
Ensembl chr 9:92,073,640...92,108,977
G
Traf4
Tnf receptor associated factor 4
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of TRAF4 mRNA
CTD
PMID:19244175
NCBI chr10:63,552,251...63,558,356
Ensembl chr10:63,054,181...63,060,284
G
Trafd1
TRAF type zinc finger domain containing 1
increases expression
ISO
Vitamin E results in increased expression of TRAFD1 mRNA
CTD
PMID:19244175
NCBI chr12:40,826,251...40,840,169
Ensembl chr12:35,165,606...35,179,525
G
Tram2
translocation associated membrane protein 2
increases expression
ISO
Vitamin E results in increased expression of TRAM2 mRNA
CTD
PMID:19244175
NCBI chr 9:30,915,624...30,995,162
Ensembl chr 9:23,424,232...23,498,689
G
Trappc10
trafficking protein particle complex subunit 10
decreases expression
ISO
Vitamin E results in decreased expression of TRAPPC10 mRNA
CTD
PMID:19244175
NCBI chr20:10,438,737...10,499,074
Ensembl chr20:10,438,737...10,499,074
G
Trappc3
trafficking protein particle complex subunit 3
increases expression
ISO
Vitamin E results in increased expression of TRAPPC3 mRNA
CTD
PMID:19244175
NCBI chr 5:143,843,612...143,857,347
Ensembl chr 5:138,557,754...138,572,819
G
Trappc8
trafficking protein particle complex subunit 8
decreases expression
ISO
Vitamin E results in decreased expression of TRAPPC8 mRNA
CTD
PMID:19244175
NCBI chr18:12,103,874...12,180,422
Ensembl chr18:12,103,877...12,180,107
G
Trex1
three prime repair exonuclease 1
decreases expression
ISO
Vitamin E results in decreased expression of TREX1 mRNA
CTD
PMID:19244175
NCBI chr 8:118,585,082...118,586,382
Ensembl chr 8:109,706,613...109,708,796
G
Trib3
tribbles pseudokinase 3
decreases expression
ISO
Vitamin E results in decreased expression of TRIB3 mRNA
CTD
PMID:19244175
NCBI chr 3:161,269,939...161,275,533
Ensembl chr 3:140,809,043...140,814,497
G
Trim14
tripartite motif-containing 14
decreases expression
ISO
Vitamin E results in decreased expression of TRIM14 mRNA
CTD
PMID:19244175
NCBI chr 5:65,596,149...65,620,434
Ensembl chr 5:60,800,032...60,824,858
G
Trim24
tripartite motif-containing 24
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of TRIM24 mRNA Vitamin E results in decreased expression of TRIM24 mRNA
CTD
PMID:19244175
NCBI chr 4:67,534,240...67,659,014
Ensembl chr 4:66,566,686...66,717,241
G
Trim27
tripartite motif-containing 27
decreases expression
ISO
Vitamin E results in decreased expression of TRIM27 mRNA
CTD
PMID:19244175
NCBI chr17:48,233,999...48,246,348
Ensembl chr17:43,538,285...43,550,643
G
Trim29
tripartite motif-containing 29
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of TRIM29 mRNA
CTD
PMID:19244175
NCBI chr 8:43,682,221...43,706,992
Ensembl chr 8:43,682,221...43,706,992
G
Trim38
tripartite motif containing 38
decreases expression
ISO
Vitamin E results in decreased expression of TRIM38 mRNA
CTD
PMID:19244175
NCBI chr17:41,774,419...41,787,709
G
Trim44
tripartite motif-containing 44
increases expression
ISO
Vitamin E results in increased expression of TRIM44 mRNA
CTD
PMID:19244175
NCBI chr 3:109,048,643...109,183,821
Ensembl chr 3:88,592,719...88,729,188
G
Trip6
thyroid hormone receptor interactor 6
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of TRIP6 mRNA Vitamin E results in increased expression of TRIP6 mRNA
CTD
PMID:19244175
NCBI chr12:25,022,959...25,027,366
Ensembl chr12:19,386,014...19,390,618
G
Trit1
tRNA isopentenyltransferase 1
decreases expression
ISO
Vitamin E results in decreased expression of TRIT1 mRNA
CTD
PMID:19244175
NCBI chr 5:135,293,472...135,341,522
Ensembl chr 5:135,295,330...135,338,764
G
Trmt11
tRNA methyltransferase 11 homolog
decreases expression
ISO
Vitamin E results in decreased expression of TRMT11 mRNA
CTD
PMID:19244175
NCBI chr 1:27,054,437...27,109,765
Ensembl chr 1:27,054,420...27,201,610
G
Trmt112
tRNA methyltransferase activator subunit 11-2
increases expression
ISO
Vitamin E results in increased expression of TRMT112 mRNA
CTD
PMID:19244175
NCBI chr 1:204,103,298...204,104,151
G
Trmt12
tRNA methyltransferase 12
increases expression
ISO
Vitamin E results in increased expression of TRMT12 mRNA
CTD
PMID:19244175
NCBI chr 7:90,417,846...90,419,472
Ensembl chr 7:90,417,862...90,419,867
G
Tro
trophinin
increases expression
ISO
Vitamin E results in increased expression of TRO mRNA
CTD
PMID:19244175
NCBI chr X:19,563,395...19,574,507
Ensembl chr X:19,563,517...19,572,953
G
Trpm6
transient receptor potential cation channel, subfamily M, member 6
decreases expression
ISO
Vitamin E results in decreased expression of TRPM6 mRNA
CTD
PMID:19244175
NCBI chr 1:225,559,528...225,747,106
Ensembl chr 1:216,170,038...216,320,520
G
Tsc2
TSC complex subunit 2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of TSC2 mRNA Vitamin E results in increased expression of TSC2 mRNA
CTD
PMID:19244175
NCBI chr10:14,125,679...14,160,317
Ensembl chr10:13,621,136...13,655,951
G
Tsc22d2
TSC22 domain family, member 2
decreases expression
ISO
Vitamin E results in decreased expression of TSC22D2 mRNA
CTD
PMID:19244175
NCBI chr 2:142,646,778...142,697,977
Ensembl chr 2:142,644,744...142,693,606
G
Tshb
thyroid stimulating hormone subunit beta
multiple interactions
EXP
Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of TSHB protein]
CTD
PMID:16298753
NCBI chr 2:192,913,171...192,918,054
Ensembl chr 2:190,224,676...190,229,559
G
Tslp
thymic stromal lymphopoietin
multiple interactions
ISO
Vitamin E inhibits the reaction [Ozone results in increased expression of TSLP protein]
CTD
PMID:30090343
NCBI chr18:24,723,990...24,728,419
Ensembl chr18:24,449,844...24,453,548
G
Tspan14
tetraspanin 14
increases expression multiple interactions
ISO
Vitamin E results in increased expression of TSPAN14 mRNA [Selenium co-treated with Vitamin E] results in increased expression of TSPAN14 mRNA
CTD
PMID:19244175
NCBI chr16:16,784,242...16,841,368
Ensembl chr16:16,783,234...16,841,400
G
Tsr3
TSR3 ribosome maturation factor
increases expression
ISO
Vitamin E results in increased expression of TSR3 mRNA
CTD
PMID:19244175
NCBI chr10:14,257,161...14,259,562
Ensembl chr10:14,257,171...14,259,561
G
Ttc17
tetratricopeptide repeat domain 17
decreases expression
ISO
Vitamin E results in decreased expression of TTC17 mRNA
CTD
PMID:19244175
NCBI chr 3:80,263,488...80,374,137
Ensembl chr 3:80,263,495...80,373,812
G
Ttc24
tetratricopeptide repeat domain 24
decreases expression
ISO
Vitamin E results in decreased expression of TTC24 mRNA
CTD
PMID:19244175
NCBI chr 2:173,525,204...173,533,182
Ensembl chr 2:173,524,600...173,533,107
G
Ttc3
tetratricopeptide repeat domain 3
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of TTC3 mRNA Vitamin E results in decreased expression of TTC3 mRNA
CTD
PMID:19244175
NCBI chr11:47,158,766...47,258,612
Ensembl chr11:33,688,952...33,788,975
G
Ttf1
transcription termination factor 1
decreases expression
ISO
Vitamin E results in decreased expression of TTF1 mRNA
CTD
PMID:19244175
NCBI chr 3:32,782,544...32,807,202
Ensembl chr 3:12,384,655...12,409,257
G
Ttpa
alpha tocopherol transfer protein
decreases abundance affects abundance increases response to substance
ISO
TTPA gene mutant form results in decreased abundance of Vitamin E; TTPA protein mutant form results in decreased abundance of Vitamin E TTPA affects the abundance of Vitamin E TTPA results in increased susceptibility to Vitamin E
CTD
PMID:10896705 PMID:11095717 PMID:15300460 PMID:19566498 PMID:20826775
NCBI chr 5:38,294,415...38,315,471
Ensembl chr 5:33,497,137...33,518,073
G
Tuba1b
tubulin, alpha 1B
increases expression
ISO
Vitamin E results in increased expression of TUBA1B mRNA
CTD
PMID:19244175
NCBI chr 7:130,090,663...130,093,644
Ensembl chr 7:130,081,032...130,196,186
G
Tuba1c
tubulin, alpha 1C
increases expression
ISO
Vitamin E results in increased expression of TUBA1C mRNA
CTD
PMID:19244175
NCBI chr 7:131,636,974...132,078,589
Ensembl chr 7:130,192,016...130,199,647 Ensembl chr X:130,192,016...130,199,647
G
Tuba4a
tubulin, alpha 4A
increases expression
ISO
Vitamin E results in increased expression of TUBA4A mRNA
CTD
PMID:19244175
NCBI chr 9:84,158,871...84,174,041
Ensembl chr 9:76,709,614...76,713,918
G
Tubb2b
tubulin, beta 2B class IIb
increases expression
ISO
Vitamin E results in increased expression of TUBB2B mRNA
CTD
PMID:19244175
NCBI chr17:30,747,734...30,750,781
Ensembl chr17:30,747,734...30,750,638
G
Tubb3
tubulin, beta 3 class III
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of TUBB3 mRNA Vitamin E results in increased expression of TUBB3 mRNA
CTD
PMID:19244175
NCBI chr19:68,365,687...68,374,741
Ensembl chr19:51,457,184...51,466,243
G
Tubb4b
tubulin, beta 4B class IVb
increases expression
ISO
Vitamin E results in increased expression of TUBB4B mRNA
CTD
PMID:19244175
NCBI chr 3:28,435,999...28,438,455
Ensembl chr 3:8,037,799...8,040,296
G
Tubb5
tubulin, beta 5 class I
increases expression
ISO
Vitamin E results in increased expression of TUBB mRNA
CTD
PMID:19244175
NCBI chr20:2,917,577...2,921,726
Ensembl chr20:2,912,778...2,916,940
G
Tug1
taurine up-regulated 1
decreases expression
ISO
Vitamin E results in decreased expression of TUG1 mRNA
CTD
PMID:19244175
NCBI chr14:82,743,501...82,750,534
Ensembl chr14:78,522,506...78,526,927
G
Tulp3
TUB like protein 3
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of TULP3 mRNA Vitamin E results in decreased expression of TULP3 mRNA
CTD
PMID:19244175
NCBI chr 4:163,276,583...163,318,297
Ensembl chr 4:161,590,479...161,632,149
G
Txlna
taxilin alpha
increases expression
ISO
Vitamin E results in increased expression of TXLNA mRNA
CTD
PMID:19244175
NCBI chr 5:141,969,337...141,985,054
Ensembl chr 5:141,969,346...141,984,583
G
Tymp
thymidine phosphorylase
increases expression
ISO
Vitamin E results in increased expression of TYMP mRNA
CTD
PMID:19244175
NCBI chr 7:122,318,396...122,323,716
Ensembl chr 7:120,438,770...120,443,874 Ensembl chr 7:120,438,770...120,443,874
G
U2af1
U2 small nuclear RNA auxiliary factor 1
increases expression
ISO
Vitamin E results in increased expression of U2AF1 mRNA
CTD
PMID:19244175
NCBI chr20:9,744,206...9,755,146
Ensembl chr20:9,742,905...9,753,832
G
Uba1
ubiquitin-like modifier activating enzyme 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of UBA1 mRNA Vitamin E results in increased expression of UBA1 mRNA
CTD
PMID:19244175
NCBI chr X:4,062,216...4,084,192
Ensembl chr X:1,508,666...1,530,636
G
Uba52
ubiquitin A-52 residue ribosomal protein fusion product 1
decreases expression
ISO
Vitamin E results in decreased expression of UBA52 mRNA
CTD
PMID:19244175
NCBI chr16:18,952,583...18,954,780
Ensembl chr16:18,900,616...18,920,807
G
Ubap2
ubiquitin-associated protein 2
decreases expression
ISO
Vitamin E results in decreased expression of UBAP2 mRNA
CTD
PMID:19244175
NCBI chr 5:56,348,243...56,437,403
Ensembl chr 5:56,348,246...56,437,049
G
Ubap2l
ubiquitin associated protein 2-like
increases expression
ISO
Vitamin E results in increased expression of UBAP2L mRNA
CTD
PMID:19244175
NCBI chr 2:177,736,378...177,791,746
Ensembl chr 2:175,438,703...175,493,998
G
Ube2d1
ubiquitin-conjugating enzyme E2D 1
decreases expression
ISO
Vitamin E results in decreased expression of UBE2D1 mRNA
CTD
PMID:19244175
NCBI chr20:17,309,315...17,343,770
Ensembl chr20:17,309,315...17,342,295
G
Ube2l3
ubiquitin-conjugating enzyme E2L 3
increases expression
ISO
Vitamin E results in increased expression of UBE2L3 mRNA
CTD
PMID:19244175
NCBI chr11:97,300,584...97,343,084
Ensembl chr11:83,797,722...83,838,862
G
Ube2v1
ubiquitin conjugating enzyme E2 V1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of UBE2V1 mRNA Vitamin E results in decreased expression of UBE2V1 mRNA
CTD
PMID:19244175
NCBI chr 3:176,736,325...176,759,174
Ensembl chr 3:156,316,781...156,340,273
G
Ube2z
ubiquitin-conjugating enzyme E2Z
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of UBE2Z mRNA Vitamin E results in increased expression of UBE2Z mRNA
CTD
PMID:19244175
NCBI chr10:80,997,816...81,016,936
Ensembl chr10:80,997,817...81,016,936
G
Ube3a
ubiquitin protein ligase E3A
decreases expression
ISO
Vitamin E results in decreased expression of UBE3A mRNA
CTD
PMID:19244175
NCBI chr 1:119,204,244...119,297,097
Ensembl chr 1:110,070,480...110,157,250
G
Ube4b
ubiquitination factor E4B
increases expression
ISO
Vitamin E results in increased expression of UBE4B mRNA
CTD
PMID:19244175
NCBI chr 5:159,766,829...159,870,509
Ensembl chr 5:159,766,829...159,870,509
G
Ubl3
ubiquitin-like 3
decreases expression
ISO
Vitamin E results in decreased expression of UBL3 mRNA
CTD
PMID:19244175
NCBI chr12:11,509,912...11,554,548
Ensembl chr12:6,473,460...6,518,862
G
Ubl4a
ubiquitin-like 4A
increases expression
ISO
Vitamin E results in increased expression of UBL4A mRNA
CTD
PMID:19244175
NCBI chr X:157,302,528...157,305,380
Ensembl chr X:152,151,460...152,154,069
G
Ubn1
ubinuclein 1
multiple interactions increases expression decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of UBN1 mRNA; [Selenium co-treated with Vitamin E] results in increased expression of UBN1 mRNA Vitamin E results in increased expression of UBN1 mRNA Vitamin E results in decreased expression of UBN1 mRNA
CTD
PMID:19244175
NCBI chr10:10,496,576...10,532,010
Ensembl chr10:10,496,576...10,532,010
G
Ubxn4
UBX domain protein 4
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of UBXD2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of UBXD2 mRNA
CTD
PMID:19244175
NCBI chr13:39,740,064...39,772,493
Ensembl chr13:39,740,107...39,772,491
G
Uchl1
ubiquitin C-terminal hydrolase L1
increases expression
ISO
Vitamin E results in increased expression of UCHL1 mRNA
CTD
PMID:19244175
NCBI chr14:41,838,859...41,849,743
Ensembl chr14:41,485,031...41,495,590
G
Ucp2
uncoupling protein 2
multiple interactions
EXP
Vitamin E inhibits the reaction [Carbon Tetrachloride results in increased expression of UCP2 mRNA]
CTD
PMID:18314881
NCBI chr 1:164,251,373...164,257,742
Ensembl chr 1:154,839,209...154,845,611
G
Ugcg
UDP-glucose ceramide glucosyltransferase
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of UGCG mRNA [Selenium co-treated with Vitamin E] results in decreased expression of UGCG mRNA
CTD
PMID:19244175
NCBI chr 5:78,828,006...78,860,725
Ensembl chr 5:74,032,978...74,065,393
G
Uggt2
UDP-glucose glycoprotein glucosyltransferase 2
decreases expression
ISO
Vitamin E results in decreased expression of UGGT2 mRNA
CTD
PMID:19244175
NCBI chr15:96,074,557...96,239,365
Ensembl chr15:96,074,564...96,237,806
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
decreases expression
EXP
Vitamin E results in decreased expression of UGT1A2 mRNA
CTD
PMID:28923436
NCBI chr 9:96,239,019...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a9
UDP glucuronosyltransferase family 1 member A9
decreases expression
EXP
Vitamin E results in decreased expression of UGT1A9 mRNA
CTD
PMID:28923436
NCBI chr 9:96,144,786...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
decreases expression
EXP
Vitamin E results in decreased expression of UGT2B4 mRNA
CTD
PMID:28923436
NCBI chr14:21,378,882...21,390,631
Ensembl chr14:21,024,006...21,035,986
G
Ugt8
UDP glycosyltransferase 8
decreases expression
ISO
Vitamin E results in decreased expression of UGT8 mRNA
CTD
PMID:19244175
NCBI chr 2:214,264,483...214,332,769
Ensembl chr 2:214,264,483...214,332,660
G
Upf3a
UPF3A, regulator of nonsense mediated mRNA decay
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of UPF3A mRNA [Selenium co-treated with Vitamin E] results in decreased expression of UPF3A mRNA
CTD
PMID:19244175
NCBI chr16:82,459,651...82,470,686
Ensembl chr16:75,757,441...75,769,345
G
Upf3b
UPF3B, regulator of nonsense mediated mRNA decay
decreases expression
ISO
Vitamin E results in decreased expression of UPF3B mRNA
CTD
PMID:19244175
NCBI chr X:121,200,993...121,219,059
Ensembl chr X:116,335,308...116,353,236
G
Uqcrc1
ubiquinol-cytochrome c reductase core protein 1
increases expression
ISO
Vitamin E results in increased expression of UQCRC1 mRNA
CTD
PMID:19244175
NCBI chr 8:118,468,223...118,479,968
Ensembl chr 8:109,589,706...109,601,480
G
Urod
uroporphyrinogen decarboxylase
increases activity
ISO
Vitamin E results in increased activity of UROD protein
CTD
PMID:12030801
NCBI chr 5:135,701,294...135,705,380
Ensembl chr 5:130,455,217...130,468,808
G
Usf2
upstream transcription factor 2, c-fos interacting
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of USF2 mRNA Vitamin E results in increased expression of USF2 mRNA
CTD
PMID:19244175
NCBI chr 1:86,174,703...86,185,942
Ensembl chr 1:86,174,703...86,185,617
G
Usp3
ubiquitin specific peptidase 3
decreases expression
ISO
Vitamin E results in decreased expression of USP3 mRNA
CTD
PMID:19244175
NCBI chr 8:75,973,278...76,049,151
Ensembl chr 8:67,079,927...67,154,111
G
Usp33
ubiquitin specific peptidase 33
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of USP33 mRNA Vitamin E results in decreased expression of USP33 mRNA
CTD
PMID:19244175
NCBI chr 2:243,938,958...243,988,424
Ensembl chr 2:241,292,985...241,328,479
G
Usp4
ubiquitin specific peptidase 4
decreases expression
ISO
Vitamin E results in decreased expression of USP4 mRNA
CTD
PMID:19244175
NCBI chr 8:117,912,576...117,957,934
Ensembl chr 8:109,036,099...109,080,427
G
Usp47
ubiquitin specific peptidase 47
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of USP47 mRNA Vitamin E results in decreased expression of USP47 mRNA
CTD
PMID:19244175
NCBI chr 1:175,586,758...175,669,904
Ensembl chr 1:166,152,199...166,235,312
G
Usp9x
ubiquitin specific peptidase 9, X-linked
decreases expression
ISO
Vitamin E results in decreased expression of USP9X mRNA
CTD
PMID:19244175
NCBI chr X:12,261,633...12,399,780
Ensembl chr X:9,588,825...9,696,711
G
Uspl1
ubiquitin specific peptidase like 1
decreases expression
ISO
Vitamin E results in decreased expression of USPL1 mRNA
CTD
PMID:19244175
NCBI chr12:5,823,460...5,850,470
Ensembl chr12:5,823,359...5,850,366
G
Utp11
UTP11, small subunit processome component
decreases expression
ISO
Vitamin E results in decreased expression of UTP11 mRNA
CTD
PMID:19244175
NCBI chr 5:142,215,974...142,230,859
Ensembl chr 5:136,931,008...136,946,191
G
Utp20
UTP20 small subunit processome component
decreases expression
ISO
Vitamin E results in decreased expression of UTP20 mRNA
CTD
PMID:19244175
NCBI chr 7:25,022,029...25,103,024
Ensembl chr 7:23,134,637...23,215,632
G
Utp25
UTP25 small subunit processome component
decreases expression
ISO
Vitamin E results in decreased expression of UTP25 mRNA
CTD
PMID:19244175
NCBI chr13:104,630,390...104,651,681
Ensembl chr13:104,630,391...104,651,662
G
Vars2
valyl-tRNA synthetase 2, mitochondrial
increases expression
ISO
Vitamin E results in increased expression of VARS2 mRNA
CTD
PMID:19244175
NCBI chr20:3,081,869...3,092,907
Ensembl chr20:3,077,132...3,087,994
G
Vat1
vesicle amine transport 1
increases expression
ISO
Vitamin E results in increased expression of VAT1 mRNA
CTD
PMID:19244175
NCBI chr10:86,889,793...86,897,411
Ensembl chr10:86,389,545...86,397,224
G
Vcam1
vascular cell adhesion molecule 1
multiple interactions
ISO
[Vitamin E co-treated with Bezafibrate] results in decreased expression of VCAM1 protein modified form; Vitamin E inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of VCAM1 protein]; Vitamin E inhibits the reaction [Simvastatin results in decreased expression of VCAM1 protein modified form]
CTD
PMID:14602771 PMID:35349355
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:204,038,114...204,057,958
G
Vegfa
vascular endothelial growth factor A
multiple interactions decreases expression
ISO
Rutin results in increased susceptibility to [Vitamin E results in decreased expression of VEGFA mRNA]; Rutin results in increased susceptibility to [Vitamin E results in decreased secretion of and results in decreased expression of VEGFA protein]; Vitamin E results in decreased secretion of and results in decreased expression of VEGFA protein; Vitamin E results in increased susceptibility to [Rutin results in decreased expression of VEGFA mRNA]; Vitamin E results in increased susceptibility to [Rutin results in decreased secretion of and results in decreased expression of VEGFA protein] Vitamin E inhibits the reaction [Ethanol results in increased activity of VEGFA protein]
CTD
PMID:20015448 PMID:21086752
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Vezf1
vascular endothelial zinc finger 1
decreases expression
ISO
Vitamin E results in decreased expression of VEZF1 mRNA
CTD
PMID:19244175
NCBI chr10:72,859,669...72,876,111
Ensembl chr10:72,859,877...72,876,111
G
Vezt
vezatin, adherens junctions transmembrane protein
decreases expression
ISO
Vitamin E results in decreased expression of VEZT mRNA
CTD
PMID:19244175
NCBI chr 7:28,512,214...28,597,429
Ensembl chr 7:28,534,249...28,597,356
G
Vgf
VGF nerve growth factor inducible
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of VGF mRNA
CTD
PMID:19244175
NCBI chr12:25,274,004...25,281,803
Ensembl chr12:19,637,320...19,640,341
G
Vgll4
vestigial-like family member 4
decreases expression
ISO
Vitamin E results in decreased expression of VGLL4 mRNA
CTD
PMID:19244175
NCBI chr 4:149,598,151...149,711,186
Ensembl chr 4:147,927,034...148,038,471
G
Vipas39
VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog
increases expression
ISO
Vitamin E results in increased expression of VIPAS39 mRNA
CTD
PMID:19244175
NCBI chr 6:112,619,228...112,644,089
Ensembl chr 6:106,888,284...106,913,117
G
Vkorc1
vitamin K epoxide reductase complex, subunit 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of VKORC1 mRNA Vitamin E results in increased expression of VKORC1 mRNA
CTD
PMID:19244175
NCBI chr 1:191,932,969...191,935,490
Ensembl chr 1:182,500,844...182,505,008
G
Vps13d
vacuolar protein sorting 13 homolog D
increases expression
ISO
Vitamin E results in increased expression of VPS13D mRNA
CTD
PMID:19244175
NCBI chr 5:162,113,732...162,339,121
Ensembl chr 5:156,830,512...157,055,891
G
Vps39
VPS39 subunit of HOPS complex
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of VPS39 mRNA Vitamin E results in increased expression of VPS39 mRNA
CTD
PMID:19244175
NCBI chr 3:127,721,076...127,758,658
Ensembl chr 3:107,267,310...107,304,975
G
Vps4a
vacuolar protein sorting 4 homolog A
increases expression
ISO
Vitamin E results in increased expression of VPS4A mRNA
CTD
PMID:19244175
NCBI chr19:51,838,411...51,858,639
Ensembl chr19:34,934,961...34,948,887
G
Vps72
vacuolar protein sorting 72 homolog
increases expression
ISO
Vitamin E results in increased expression of TCFL1 mRNA
CTD
PMID:19244175
NCBI chr 2:185,367,329...185,379,199
Ensembl chr 2:182,678,609...182,690,182
G
Vstm4
V-set and transmembrane domain containing 4
increases expression
ISO
Vitamin E results in increased expression of VSTM4 mRNA
CTD
PMID:19244175
NCBI chr16:8,126,630...8,206,556
Ensembl chr16:8,120,336...8,200,269
G
Vti1b
vesicle transport through interaction with t-SNAREs 1B
increases expression
ISO
Vitamin E results in increased expression of VTI1B mRNA
CTD
PMID:19244175
NCBI chr 6:103,694,342...103,709,544
Ensembl chr 6:97,961,346...97,976,465
G
Vwf
von Willebrand factor
increases expression
ISO
Vitamin E results in increased expression of VWF mRNA
CTD
PMID:19244175
NCBI chr 4:160,042,900...160,177,757
Ensembl chr 4:158,360,152...158,491,539
G
Wasf2
WASP family member 2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of WASF2 mRNA Vitamin E results in increased expression of WASF2 mRNA
CTD
PMID:19244175
NCBI chr 5:145,336,817...145,402,041
Ensembl chr 5:145,336,842...145,399,242
G
Washc2c
WASH complex subunit 2C
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of WASHC2C mRNA Vitamin E results in decreased expression of WASHC2C mRNA
CTD
PMID:19244175
NCBI chr 4:149,267,851...149,325,850
Ensembl chr 4:149,267,924...149,325,851
G
Wbp2
WW domain binding protein 2
increases expression
ISO
Vitamin E results in increased expression of WBP2 mRNA
CTD
PMID:19244175
NCBI chr10:101,811,308...101,819,766
Ensembl chr10:101,312,446...101,320,736
G
Wdr1
WD repeat domain 1
increases expression
ISO
Vitamin E results in increased expression of WDR1 mRNA
CTD
PMID:19244175
NCBI chr14:76,470,238...76,504,086
Ensembl chr14:72,257,956...72,291,766
G
Wdr19
WD repeat domain 19
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of WDR19 mRNA Vitamin E results in decreased expression of WDR19 mRNA
CTD
PMID:19244175
NCBI chr14:43,396,130...43,460,012
Ensembl chr14:43,042,478...43,106,288
G
Wdr4
WD repeat domain 4
increases expression
ISO
Vitamin E results in increased expression of WDR4 mRNA
CTD
PMID:19244175
NCBI chr20:9,588,532...9,604,718
Ensembl chr20:9,587,207...9,603,581
G
Wdr83os
WD repeat domain 83 opposite strand
increases expression
ISO
Vitamin E results in increased expression of WDR83OS mRNA
CTD
PMID:19244175
NCBI chr19:39,980,247...39,981,619
Ensembl chr19:23,075,376...23,076,894
G
Wfdc2
WAP four-disulfide core domain 2
increases expression
ISO
Vitamin E results in increased expression of WFDC2 mRNA
CTD
PMID:19244175
NCBI chr 3:153,286,946...153,314,832
Ensembl chr 3:153,286,131...153,292,807
G
Wipi2
WD repeat domain, phosphoinositide interacting 2
decreases expression
ISO
Vitamin E results in decreased expression of WIPI2 mRNA
CTD
PMID:19244175
NCBI chr12:17,024,876...17,053,306
Ensembl chr12:11,911,337...11,939,794
G
Wls
Wnt ligand secretion mediator
increases expression
ISO
Vitamin E results in increased expression of WLS mRNA
CTD
PMID:19244175
NCBI chr 2:251,590,653...251,705,991
Ensembl chr 2:248,931,903...249,048,298
G
Wrap53
WD repeat containing, antisense to TP53
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of WRAP53 mRNA Vitamin E results in increased expression of WRAP53 mRNA
CTD
PMID:19244175
NCBI chr10:54,780,873...54,797,919
Ensembl chr10:54,282,105...54,298,929
G
Wscd1
WSC domain containing 1
decreases expression
ISO
Vitamin E results in decreased expression of WSCD1 mRNA
CTD
PMID:19244175
NCBI chr10:56,884,404...56,924,013
Ensembl chr10:56,395,874...56,424,677
G
Wt1
WT1 transcription factor
affects expression
EXP
Vitamin E affects the expression of WT1 mRNA
CTD
PMID:15370891
NCBI chr 3:112,019,721...112,068,454
Ensembl chr 3:91,567,001...91,613,643
G
Wwp1
WW domain containing E3 ubiquitin protein ligase 1
decreases expression
ISO
Vitamin E results in decreased expression of WWP1 mRNA
CTD
PMID:19244175
NCBI chr 5:37,889,280...37,982,743
Ensembl chr 5:33,098,494...33,186,046
G
Xdh
xanthine dehydrogenase
multiple interactions
EXP
Vitamin E inhibits the reaction [Petroleum results in increased activity of XDH protein]
CTD
PMID:25046308
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:21,530,113...21,592,268
G
Xiap
X-linked inhibitor of apoptosis
multiple interactions
ISO
Vitamin E inhibits the reaction [cinnamaldehyde results in decreased expression of XIAP protein]; Vitamin E inhibits the reaction [phenethyl isothiocyanate results in decreased expression of XIAP protein]
CTD
PMID:15566391 PMID:16054126
NCBI chr X:125,756,107...125,803,979
Ensembl chr X:120,897,907...120,934,700
G
Xkr8
XK related 8
increases expression
ISO
Vitamin E results in increased expression of XKR8 mRNA
CTD
PMID:19244175
NCBI chr 5:144,938,061...144,945,195
Ensembl chr 5:144,938,064...144,945,195
G
Xpo6
exportin 6
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of XPO6 mRNA Vitamin E results in decreased expression of XPO6 mRNA
CTD
PMID:19244175
NCBI chr 1:190,102,719...190,192,138
Ensembl chr 1:180,672,119...180,761,543
G
Xrcc2
X-ray repair cross complementing 2
decreases expression
ISO
Vitamin E results in decreased expression of XRCC2 mRNA
CTD
PMID:19244175
NCBI chr 4:10,157,130...10,237,089
Ensembl chr 4:9,423,898...9,442,482
G
Xrcc6
X-ray repair cross complementing 6
increases expression
ISO
Vitamin E results in increased expression of XRCC6 mRNA
CTD
PMID:19244175
NCBI chr 7:115,423,026...115,443,884
Ensembl chr 7:113,543,057...113,563,762
G
Ybx3
Y box binding protein 3
decreases expression
ISO
Vitamin E results in decreased expression of YBX3 mRNA
CTD
PMID:19244175
NCBI chr 4:166,861,180...166,884,532
Ensembl chr 4:165,129,758...165,153,161
G
Yipf3
Yip1 domain family, member 3
increases expression
ISO
Vitamin E results in increased expression of YIPF3 mRNA
CTD
PMID:19244175
NCBI chr 9:14,730,289...14,735,644
Ensembl chr 9:14,730,284...14,735,641
G
Ylpm1
YLP motif containing 1
decreases expression
ISO
Vitamin E results in decreased expression of YLPM1 mRNA
CTD
PMID:19244175
NCBI chr 6:104,642,615...104,718,508
Ensembl chr 6:104,642,615...104,718,508
G
Ywhae
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon
decreases expression
ISO
Vitamin E results in decreased expression of YWHAE mRNA
CTD
PMID:19244175
NCBI chr10:61,082,934...61,120,618
Ensembl chr10:60,584,652...60,671,589
G
Ywhaz
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of YWHAZ mRNA
CTD
PMID:19244175
NCBI chr 7:69,826,404...69,848,702
Ensembl chr 7:67,940,017...67,963,668
G
Yy1
YY1 transcription factor
decreases expression
ISO
Vitamin E results in decreased expression of YY1 mRNA
CTD
PMID:19244175
NCBI chr 6:133,471,615...133,500,875
Ensembl chr 6:127,707,596...127,732,747
G
Zbtb11
zinc finger and BTB domain containing 11
decreases expression
ISO
Vitamin E results in decreased expression of ZBTB11 mRNA
CTD
PMID:19244175
NCBI chr11:44,598,694...44,652,559
Ensembl chr11:44,616,289...44,651,050
G
Zbtb18
zinc finger and BTB domain containing 18
increases expression
ISO
Vitamin E results in increased expression of ZBTB18 mRNA
CTD
PMID:19244175
NCBI chr13:91,971,602...91,980,058
Ensembl chr13:89,439,420...89,448,862
G
Zbtb20
zinc finger and BTB domain containing 20
decreases expression
ISO
Vitamin E results in decreased expression of ZBTB20 mRNA
CTD
PMID:19244175
NCBI chr11:70,558,010...71,297,039
Ensembl chr11:57,072,880...57,510,210
G
Zc2hc1a
zinc finger, C2HC-type containing 1A
decreases expression
ISO
Vitamin E results in decreased expression of ZC2HC1A mRNA
CTD
PMID:19244175
NCBI chr 2:94,287,352...94,324,655
Ensembl chr 2:94,287,354...94,324,882
G
Zc3h15
zinc finger CCCH-type containing 15
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of ZC3H15 mRNA Vitamin E results in decreased expression of ZC3H15 mRNA
CTD
PMID:19244175
NCBI chr 3:68,744,591...68,764,335
Ensembl chr 3:68,744,604...68,764,333
G
Zcchc2
zinc finger CCHC-type containing 2
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of ZCCHC2 mRNA Vitamin E results in decreased expression of ZCCHC2 mRNA
CTD
PMID:19244175
NCBI chr13:22,621,275...22,708,232
Ensembl chr13:22,119,568...22,166,373
G
Zcchc24
zinc finger CCHC-type containing 24
decreases expression
ISO
Vitamin E results in decreased expression of ZCCHC24 mRNA
CTD
PMID:19244175
NCBI chr16:1,274,544...1,326,664
Ensembl chr16:1,274,548...1,326,696
G
Zcchc8
zinc finger CCHC-type containing 8
decreases expression
ISO
Vitamin E results in decreased expression of ZCCHC8 mRNA
CTD
PMID:19244175
NCBI chr12:38,530,037...38,553,595
Ensembl chr12:32,869,310...32,891,325
G
Zcwpw1
zinc finger CW-type and PWWP domain containing 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ZCWPW1 mRNA Vitamin E results in increased expression of ZCWPW1 mRNA
CTD
PMID:19244175
NCBI chr12:24,517,428...24,547,942
Ensembl chr12:18,880,633...18,910,711
G
Zeb1
zinc finger E-box binding homeobox 1
decreases expression
ISO
Vitamin E results in decreased expression of ZEB1 mRNA
CTD
PMID:19244175
NCBI chr17:56,644,397...56,811,155
Ensembl chr17:51,948,948...52,115,214
G
Zer1
zyg-11 related, cell cycle regulator
increases expression
ISO
Vitamin E results in increased expression of ZER1 mRNA
CTD
PMID:19244175
NCBI chr 3:13,369,688...13,397,524
Ensembl chr 3:13,369,688...13,397,420
G
Zfand5
zinc finger AN1-type containing 5
decreases expression
ISO
Vitamin E results in decreased expression of ZFAND5 mRNA
CTD
PMID:19244175
NCBI chr 1:218,765,735...218,780,391
Ensembl chr 1:218,766,614...218,775,843
G
Zfp110
zinc finger protein 110
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of ZNF274 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of ZNF274 mRNA
CTD
PMID:19244175
NCBI chr 1:82,509,563...82,533,294
Ensembl chr 1:73,445,336...73,461,086
G
Zfp12
zinc finger protein 12
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of ZNF12 mRNA Vitamin E results in decreased expression of ZNF12 mRNA
CTD
PMID:19244175
NCBI chr12:11,316,971...11,330,498
Ensembl chr12:11,316,872...11,330,558
G
Zfp131
zinc finger protein 131
decreases expression
ISO
Vitamin E results in decreased expression of ZNF131 mRNA
CTD
PMID:19244175
NCBI chr 2:51,722,774...51,753,662
Ensembl chr 2:51,725,541...51,753,639
G
Zfp148
zinc finger protein 148
decreases expression
ISO
Vitamin E results in decreased expression of ZNF148 mRNA
CTD
PMID:19244175
NCBI chr11:80,780,865...80,890,877
Ensembl chr11:67,281,707...67,385,772
G
Zfp160
zinc finger protein 160
decreases expression
ISO
Vitamin E results in decreased expression of ZNF665 mRNA
CTD
PMID:19244175
NCBI chr 1:60,683,775...60,706,242
Ensembl chr 1:60,683,592...60,706,643
G
Zfp180
zinc finger protein 180
decreases expression
ISO
Vitamin E results in decreased expression of ZNF180 mRNA
CTD
PMID:19244175
NCBI chr 1:79,652,441...79,672,737
Ensembl chr 1:79,652,441...79,672,733
G
Zfp212
Zinc finger protein 212
increases expression multiple interactions
ISO
Vitamin E results in increased expression of ZNF212 mRNA [Selenium co-treated with Vitamin E] results in increased expression of ZNF212 mRNA
CTD
PMID:19244175
NCBI chr 4:76,923,638...76,936,076
Ensembl chr 4:76,923,668...76,936,066
G
Zfp219
zinc finger protein 219
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ZNF219 mRNA Vitamin E results in increased expression of ZNF219 mRNA
CTD
PMID:19244175
NCBI chr15:27,169,335...27,183,555
Ensembl chr15:24,695,837...24,710,030
G
Zfp239
zinc finger protein 239
decreases expression
ISO
Vitamin E results in decreased expression of ZNF239 mRNA
CTD
PMID:19244175
NCBI chr 4:152,701,818...152,711,698
Ensembl chr 4:151,029,405...151,039,529
G
Zfp266
zinc finger protein 266
decreases expression
ISO
Vitamin E results in decreased expression of ZNF562 mRNA
CTD
PMID:19244175
NCBI chr 8:27,307,015...27,338,624
Ensembl chr 8:19,030,768...19,060,937
G
Zfp358
zinc finger protein 358
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ZNF358 mRNA
CTD
PMID:19244175
NCBI chr12:6,350,266...6,354,359
Ensembl chr12:1,552,366...1,556,460
G
Zfp36
zinc finger protein 36
decreases expression
ISO
Vitamin E results in decreased expression of ZFP36 mRNA
CTD
PMID:19244175
NCBI chr 1:92,796,628...92,799,108
Ensembl chr 1:83,669,084...83,671,564
G
Zfp580
zinc finger protein 580
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ZNF580 mRNA
CTD
PMID:19244175
NCBI chr 1:77,815,959...77,818,127
Ensembl chr 1:68,787,118...68,789,286
G
Zfp593
zinc finger protein 593
decreases expression
ISO
Vitamin E results in decreased expression of ZNF593 mRNA
CTD
PMID:19244175
NCBI chr 5:146,462,670...146,464,998
Ensembl chr 5:146,462,670...146,465,198
G
Zfp692
zinc finger protein 692
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of ZNF692 mRNA Vitamin E results in decreased expression of ZNF692 mRNA
CTD
PMID:19244175
NCBI chr10:42,484,576...42,496,573
Ensembl chr10:42,488,588...42,496,018
G
Zfp709
zinc finger protein 709
decreases expression
ISO
Vitamin E results in decreased expression of ZNF443 mRNA
CTD
PMID:19244175
NCBI chr16:17,907,599...17,920,047
Ensembl chr16:17,909,641...17,919,700
G
Zfp768
zinc finger protein 768
increases expression
ISO
Vitamin E results in increased expression of ZNF768 mRNA
CTD
PMID:19244175
NCBI chr 1:181,966,314...181,968,950
Ensembl chr 1:181,966,316...181,969,147
G
Zfp839
zinc finger protein 839
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of ZNF839 mRNA
CTD
PMID:19244175
NCBI chr 6:129,865,859...129,885,816
Ensembl chr 6:129,864,915...129,886,389
G
Zkscan1
zinc finger with KRAB and SCAN domains 1
decreases expression
ISO
Vitamin E results in decreased expression of ZKSCAN1 mRNA
CTD
PMID:19244175
NCBI chr12:16,966,287...16,987,680
Ensembl chr12:16,966,654...16,983,865
G
Zmym2
zinc finger MYM-type containing 2
decreases expression
ISO
Vitamin E results in decreased expression of ZMYM2 mRNA
CTD
PMID:19244175
NCBI chr15:31,035,835...31,108,945
Ensembl chr15:31,035,838...31,109,357
G
Zyx
zyxin
increases expression multiple interactions
ISO
Vitamin E results in increased expression of ZYX mRNA [Selenium co-treated with Vitamin E] results in increased expression of ZYX mRNA
CTD
PMID:19244175
NCBI chr 4:71,236,767...71,246,553
Ensembl chr 4:71,237,451...71,246,553
G
Zzef1
zinc finger ZZ-type and EF-hand domain containing 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ZZEF1 mRNA Vitamin E results in decreased expression of ZZEF1 mRNA
CTD
PMID:19244175
NCBI chr10:57,413,265...57,550,888
Ensembl chr10:57,411,149...57,549,568
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [nickel chloride results in increased expression of ABCB1 protein]
CTD
PMID:24448832
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
G
Abcd1
ATP binding cassette subfamily D member 1
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in decreased expression of ABCD1 mRNA]
CTD
PMID:29065513
NCBI chr X:156,579,669...156,601,448
Ensembl chr X:151,428,578...151,450,115
G
Abcd3
ATP binding cassette subfamily D member 3
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in decreased expression of ABCD3 mRNA]
CTD
PMID:29065513
NCBI chr 2:212,536,791...212,590,379
Ensembl chr 2:209,852,087...209,906,020
G
Acat1
acetyl-CoA acetyltransferase 1
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [iron(II)-ascorbic acid complex results in decreased activity of ACAT1 protein]
CTD
PMID:10656290
NCBI chr 8:62,876,003...62,905,080
Ensembl chr 8:53,979,813...54,008,855
G
Ache
acetylcholinesterase
multiple interactions
EXP ISO
alpha-Tocopherol inhibits the reaction [Streptozocin results in increased activity of ACHE protein] [alpha-Tocopherol co-treated with Paraoxon] results in decreased activity of ACHE protein; ALB protein inhibits the reaction [alpha-Tocopherol binds to and results in decreased activity of ACHE protein]; alpha-Tocopherol binds to and results in decreased activity of ACHE protein; alpha-Tocopherol promotes the reaction [2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide results in decreased activity of ACHE protein]
CTD
PMID:19464315 PMID:34506764
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651
G
Acvrl1
activin A receptor like type 1
increases expression
EXP
alpha-Tocopherol results in increased expression of ACVRL1 mRNA
CTD
PMID:16908007
NCBI chr 7:134,117,917...134,135,306
Ensembl chr 7:132,239,729...132,256,591
G
Agt
angiotensinogen
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [AGT protein results in increased expression of PSMC6 protein]; alpha-Tocopherol inhibits the reaction [AGT protein results in increased phosphorylation of NFKBIA protein]
CTD
PMID:17532611
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:52,529,185...52,540,977
G
Akr1b1
aldo-keto reductase family 1 member B1
increases expression
EXP
alpha-Tocopherol results in increased expression of AKR1B1 mRNA
CTD
PMID:16908007
NCBI chr 4:63,899,222...63,913,315
Ensembl chr 4:62,932,031...62,946,157
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
EXP ISO
alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in decreased phosphorylation of and results in decreased activity of AKT1 protein] alpha-Tocopherol inhibits the reaction [28-O-acetylbetulin-3-ylglucopyranoside results in decreased phosphorylation of AKT1 protein]
CTD
PMID:19351882 PMID:22343715
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Alad
aminolevulinate dehydratase
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [[Streptozocin results in increased abundance of Blood Glucose] which results in decreased expression of ALAD protein]
CTD
PMID:7728901
NCBI chr 5:80,977,562...80,987,901
Ensembl chr 5:75,961,993...75,972,474
G
Alas1
5'-aminolevulinate synthase 1
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [Paraquat results in increased activity of ALAS1 protein]
CTD
PMID:12180188
NCBI chr 8:115,755,238...115,768,642
Ensembl chr 8:106,876,514...106,889,917
G
Alb
albumin
multiple interactions
EXP ISO
alpha-Tocopherol inhibits the reaction [beryllium nitrate results in decreased expression of ALB protein]; sodium-4,5-dihydroxy-1,3-benzene disulfonate promotes the reaction [alpha-Tocopherol inhibits the reaction [beryllium nitrate results in decreased expression of ALB protein]] [alpha-Tocopherol co-treated with hempseed oil co-treated with Glycerol co-treated with Propylene Glycol] results in increased secretion of ALB protein; ALB protein inhibits the reaction [alpha-Tocopherol binds to and results in decreased activity of ACHE protein]
CTD
PMID:17429802 PMID:34506764 PMID:36372912
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
G
Ano6
anoctamin 6
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Ozone results in increased expression of ANO6 mRNA]
CTD
PMID:27886375
NCBI chr 7:128,812,842...128,992,805
Ensembl chr 7:126,933,936...127,113,589
G
Apex2
apurinic/apyrimidinic endodeoxyribonuclease 2
multiple interactions decreases expression
EXP
alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of APEX2 mRNA] alpha-Tocopherol results in decreased expression of APEX2 mRNA
CTD
PMID:26332274
NCBI chr X:22,914,943...22,937,713
Ensembl chr X:19,487,419...19,508,439
G
Apoa1
apolipoprotein A1
decreases expression decreases activity
ISO EXP
alpha-Tocopherol results in decreased expression of APOA1 mRNA; alpha-Tocopherol results in decreased expression of APOA1 protein alpha-Tocopherol results in decreased activity of APOA1 promoter
CTD
PMID:16423621
NCBI chr 8:55,423,945...55,425,729
Ensembl chr 8:46,527,144...46,529,035
G
Apob
apolipoprotein B
multiple interactions
ISO
alpha-Tocopherol promotes the reaction [APOB protein results in increased reduction of Copper]
CTD
PMID:11368321
NCBI chr 6:36,563,704...36,603,300
Ensembl chr 6:30,844,368...30,892,497
G
App
amyloid beta precursor protein
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [APP protein results in increased activity of MAPK14 protein]; alpha-Tocopherol inhibits the reaction [APP protein results in increased activity of MAPK8 protein]
CTD
PMID:12684028
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561
G
Atf2
activating transcription factor 2
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased phosphorylation of ATF2 protein]
CTD
PMID:14645110
NCBI chr 3:79,125,814...79,202,896
Ensembl chr 3:58,718,332...58,795,236
G
Bace1
beta-secretase 1
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Oxygen deficiency results in increased expression of BACE1 mRNA]
CTD
PMID:19196431
NCBI chr 8:55,038,842...55,061,138
Ensembl chr 8:46,142,116...46,165,876
G
Bad
BCL2-associated agonist of cell death
increases expression
EXP
alpha-Tocopherol results in increased expression of BAD mRNA
CTD
PMID:26332274
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:204,131,501...204,142,823
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions increases expression
ISO EXP
alpha-Tocopherol affects the reaction [Lipopolysaccharides results in increased expression of BAX protein]; alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in increased expression of BAX protein] alpha-Tocopherol inhibits the reaction [Acrylamide results in increased expression of BAX protein]; alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in increased expression of BAX protein] alpha-Tocopherol results in increased expression of BAX mRNA
CTD
PMID:11805214 PMID:26332274 PMID:32134168 PMID:36058301 PMID:38242491
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bche
butyrylcholinesterase
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Endosulfan results in decreased activity of BCHE protein]
CTD
PMID:24299906
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:158,307,584...158,401,148
G
Bcl2
BCL2, apoptosis regulator
multiple interactions decreases expression
ISO EXP
alpha-Tocopherol affects the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]; alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]; benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein]; DDIT3 mRNA affects the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein]; salubrinal inhibits the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein]; TNFRSF10B mRNA affects the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein] alpha-Tocopherol analog results in decreased expression of BCL2 mRNA; alpha-Tocopherol analog results in decreased expression of BCL2 protein [alpha-Tocopherol co-treated with Ascorbic Acid] inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 mRNA]; alpha-Tocopherol inhibits the reaction [mancozeb results in decreased expression of BCL2 protein]; alpha-Tocopherol inhibits the reaction [Triiodothyronine, Reverse results in increased activity of BCL2 protein]
CTD
PMID:11805214 PMID:16005924 PMID:16135673 PMID:20686688 PMID:29297235 PMID:36058301 More...
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
decreases expression multiple interactions
EXP
alpha-Tocopherol results in decreased expression of BCL2L1 protein alpha-Tocopherol inhibits the reaction [Acrylamide results in decreased expression of BCL2L1 protein]
CTD
PMID:18942769 PMID:38242491
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Bdnf
brain-derived neurotrophic factor
multiple interactions
ISO
[alpha-Tocopherol co-treated with Nimodipine] inhibits the reaction [Dibutyl Phthalate results in decreased expression of BDNF protein]
CTD
PMID:30776390
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Bpifb1
BPI fold containing family B, member 1
multiple interactions
ISO
[alpha-Tocopherol co-treated with hempseed oil co-treated with Glycerol co-treated with Propylene Glycol] results in decreased secretion of BPIFB1 protein
CTD
PMID:36372912
NCBI chr 3:163,133,151...163,166,420
Ensembl chr 3:142,672,995...142,706,256
G
Canx
calnexin
affects localization increases expression
EXP
alpha-Tocopherol affects the localization of CANX protein alpha-Tocopherol results in increased expression of CANX mRNA; alpha-Tocopherol results in increased expression of CANX protein
CTD
PMID:16908007
NCBI chr10:35,124,941...35,157,954
Ensembl chr10:34,625,191...34,656,821
G
Casp3
caspase 3
multiple interactions decreases activity
ISO EXP
[alpha-Tocopherol co-treated with beta-ionone] results in increased activity of CASP3 protein; [alpha-Tocopherol co-treated with Tretinoin] results in increased activity of CASP3 protein; alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Acetaldehyde results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [cholest-5-en-3 beta,7 alpha-diol results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Galactosamine results in increased cleavage of and results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP3 protein]; alpha-Tocopherol inhibits the reaction [S-(1,2-dichlorovinyl)cysteine results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Vitamin A results in increased activity of CASP3 protein]; alpha-Tocopherol promotes the reaction [Amiodarone results in increased activity of CASP3 protein]; alpha-Tocopherol promotes the reaction [beta Carotene metabolite results in decreased activity of CASP3 protein]; alpha-Tocopherol promotes the reaction [TNF protein promotes the reaction [Amiodarone results in increased activity of CASP3 protein]]; alpha-Tocopherol results in increased cleavage of and results in increased activity of CASP3 protein [alpha-Tocopherol co-treated with Nimodipine] inhibits the reaction [Dibutyl Phthalate results in increased expression of CASP3 protein]; alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in increased cleavage of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of CASP3 protein] [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Diclofenac results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in increased expression of CASP3 protein] alpha-Tocopherol results in decreased activity of CASP3 protein
CTD
PMID:12450566 PMID:14599462 PMID:14722101 PMID:15095415 PMID:17618090 PMID:17874176 PMID:17936189 PMID:21869839 PMID:22389237 PMID:23042730 PMID:29065513 PMID:29129777 PMID:30776390 PMID:31712109 PMID:32134168 PMID:36058301 More...
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [S-(1,2-dichlorovinyl)cysteine results in increased activity of CASP7 protein]; alpha-Tocopherol promotes the reaction [Amiodarone results in increased activity of CASP7 protein]; alpha-Tocopherol promotes the reaction [TNF protein promotes the reaction [Amiodarone results in increased activity of CASP7 protein]]
CTD
PMID:23042730 PMID:29129777
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:255,437,172...255,476,729
G
Casp8
caspase 8
increases cleavage
ISO
alpha-Tocopherol analog results in increased cleavage of CASP8 protein
CTD
PMID:20686688
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
increases cleavage multiple interactions
ISO EXP
alpha-Tocopherol analog results in increased cleavage of CASP9 protein alpha-Tocopherol inhibits the reaction [Acrylamide results in increased expression of CASP9 protein] alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of CASP9 protein] alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP9 protein]; alpha-Tocopherol results in increased cleavage of and results in increased activity of CASP9 protein
CTD
PMID:20686688 PMID:21869839 PMID:31712109 PMID:36058301 PMID:38242491
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
multiple interactions increases activity increases expression
EXP ISO
[Ascorbic Acid co-treated with beta Carotene co-treated with alpha-Tocopherol co-treated with Sodium Selenite] inhibits the reaction [Galactosamine results in increased activity of CAT protein]; [Curcumin co-treated with alpha-Tocopherol] inhibits the reaction [Chlorpyrifos results in decreased activity of CAT protein]; [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; [Sodium Selenite co-treated with alpha-Tocopherol] inhibits the reaction [bisphenol A results in decreased activity of CAT protein]; alpha-Tocopherol affects the reaction [Copper Sulfate results in decreased activity of CAT protein]; alpha-Tocopherol affects the reaction [flubendiamide results in decreased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [Camptothecin results in increased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [Chlorpyrifos results in decreased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [cholestane-3,5,6-triol results in decreased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [Malathion results in increased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [Streptozocin results in decreased expression of CAT protein] alpha-Tocopherol inhibits the reaction [Hexachlorobenzene results in increased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in decreased expression of and results in decreased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in decreased expression of CAT mRNA] alpha-Tocopherol results in increased activity of CAT protein alpha-Tocopherol results in increased expression of CAT protein alpha-Tocopherol results in increased expression of CAT mRNA; alpha-Tocopherol results in increased expression of CAT protein
CTD
PMID:9306888 PMID:16979807 PMID:18547560 PMID:19083475 PMID:19464315 PMID:19941068 PMID:20194575 PMID:21322096 PMID:22732938 PMID:25233897 PMID:25304969 PMID:26365763 PMID:27823922 PMID:30057697 PMID:31022331 PMID:36058301 More...
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Cav1
caveolin 1
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 mRNA]
CTD
PMID:27257344
NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:45,634,918...45,673,705
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
ISO EXP
alpha-Tocopherol inhibits the reaction [Vitamin E deficiency results in increased expression of CCL2 protein] alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of CCL2 mRNA]; alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]
CTD
PMID:19735175 PMID:24333275 PMID:26332274
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccnd1
cyclin D1
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of CCND1 mRNA]
CTD
PMID:26332274
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
G
Ccnd2
cyclin D2
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of CCND2 mRNA]
CTD
PMID:26332274
NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:159,962,363...159,989,495
G
Cd36
CD36 molecule
affects expression multiple interactions
EXP
alpha-Tocopherol affects the expression of CD36 mRNA alpha-Tocopherol inhibits the reaction [[troglitazone co-treated with Ethanol] results in increased expression of CD36 protein]
CTD
PMID:16407258
NCBI chr 4:18,209,088...18,302,142
Ensembl chr 4:17,354,466...17,513,903
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions decreases expression
EXP
alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of CDKN1A mRNA] alpha-Tocopherol results in decreased expression of CDKN1A mRNA
CTD
PMID:26332274
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
G
Cftr
CF transmembrane conductance regulator
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Cadmium results in decreased expression of CFTR protein]
CTD
PMID:20363832
NCBI chr 4:47,422,084...47,694,646
Ensembl chr 4:46,560,885...46,728,756
G
Chat
choline O-acetyltransferase
multiple interactions
EXP
[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in increased expression of CHAT protein; Tobacco Smoke Pollution inhibits the reaction [[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in increased expression of CHAT protein]
CTD
PMID:25891525
NCBI chr16:7,663,665...7,723,416
Ensembl chr16:7,657,362...7,717,093
G
Clcn3
chloride voltage-gated channel 3
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Ozone results in increased expression of CLCN3 mRNA]
CTD
PMID:27886375
NCBI chr16:34,138,004...34,210,984
Ensembl chr16:29,127,419...29,200,119
G
Cldn2
claudin 2
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [Potassium Dichromate affects the localization of CLDN2 protein]
CTD
PMID:19766176
NCBI chr X:108,248,383...108,258,847
Ensembl chr X:103,459,780...103,474,838
G
Cpt1a
carnitine palmitoyltransferase 1A
multiple interactions increases expression
ISO
alpha-Tocopherol inhibits the reaction [Galactosamine results in decreased expression of CPT1A mRNA]; alpha-Tocopherol promotes the reaction [NR1I2 results in increased expression of CPT1A mRNA] alpha-Tocopherol results in increased expression of CPT1A mRNA
CTD
PMID:17936189
NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:200,565,613...200,627,055
G
Crabp2
cellular retinoic acid binding protein 2
multiple interactions
ISO
[Tretinoin co-treated with alpha-Tocopherol] results in increased expression of CRABP2 mRNA; [Tretinoin co-treated with alpha-Tocopherol] results in increased expression of CRABP2 protein
CTD
PMID:15225641
NCBI chr 2:173,417,004...173,421,352
Ensembl chr 2:173,416,857...173,421,379
G
Creb1
cAMP responsive element binding protein 1
multiple interactions
ISO
[alpha-Tocopherol co-treated with Nimodipine] inhibits the reaction [Dibutyl Phthalate results in decreased phosphorylation of CREB1 protein]
CTD
PMID:30776390
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Crp
C-reactive protein
multiple interactions
ISO
[alpha-Tocopherol co-treated with gamma-Tocopherol] results in decreased expression of CRP protein
CTD
PMID:18191645
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:85,124,977...85,175,178
G
Cryaa
crystallin, alpha A
increases expression
EXP
alpha-Tocopherol results in increased expression of CRYAA mRNA
CTD
PMID:16908007
NCBI chr20:9,783,605...9,787,351
Ensembl chr20:9,783,605...9,787,349
G
Ctsd
cathepsin D
increases expression
EXP
alpha-Tocopherol results in increased expression of CTSD protein
CTD
PMID:18942769
NCBI chr 1:206,956,945...206,968,821
Ensembl chr 1:197,527,467...197,539,488
G
Cxcl1
C-X-C motif chemokine ligand 1
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL1 mRNA]
CTD
PMID:24333275
NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,193,365...17,195,215
G
Cxcl2
C-X-C motif chemokine ligand 2
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL2 mRNA]
CTD
PMID:24333275
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,181,062...17,183,075
G
Cxcl3
C-X-C motif chemokine ligand 3
multiple interactions
ISO
[alpha-Tocopherol co-treated with SB 239063] inhibits the reaction [Ozone promotes the reaction [Ovalbumin results in increased expression of CXCL1 mRNA]]
CTD
PMID:29284473
NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,270,146...17,289,511
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression multiple interactions
EXP
alpha-Tocopherol results in increased expression of CYP1A1 mRNA [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of CYP1A1 mRNA]; alpha-Tocopherol results in increased expression of and results in increased activity of CYP1A1 protein
CTD
PMID:15665910 PMID:22389237
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases activity multiple interactions
EXP ISO
alpha-Tocopherol results in increased activity of CYP1A2 protein alpha-Tocopherol inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of CYP1A2 mRNA]
CTD
PMID:15665910 PMID:26102010
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
decreases expression
ISO
alpha-Tocopherol results in decreased expression of CYP2B10 mRNA
CTD
PMID:26102010
NCBI chr 1:90,780,468...90,859,852
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of CYP2C29 protein]
CTD
PMID:26102010
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
increases expression multiple interactions
EXP ISO
alpha-Tocopherol results in increased expression of CYP2E1 mRNA [Methionine co-treated with Thiamine co-treated with Niacinamide co-treated with alpha-Tocopherol co-treated with Zinc] inhibits the reaction [[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased activity of CYP2E1 protein]; [Methionine co-treated with Thiamine co-treated with Niacinamide co-treated with alpha-Tocopherol co-treated with Zinc] inhibits the reaction [[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased expression of CYP2E1 mRNA]; alpha-Tocopherol promotes the reaction [Acrylonitrile results in increased expression of CYP2E1 mRNA]
CTD
PMID:26332274 PMID:27919644 PMID:28062356
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions increases expression
EXP ISO
[Methionine co-treated with Thiamine co-treated with Niacinamide co-treated with alpha-Tocopherol co-treated with Zinc] inhibits the reaction [[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased expression of CYP3A2 mRNA] alpha-Tocopherol results in increased expression of CYP3A4 mRNA alpha-Tocopherol inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Testosterone]; alpha-Tocopherol inhibits the reaction [Galactosamine results in decreased expression of CYP3A4 mRNA]; Galactosamine inhibits the reaction [alpha-Tocopherol results in increased expression of CYP3A4 mRNA]
CTD
PMID:17936189 PMID:27919644 PMID:31102695
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
increases expression multiple interactions
ISO
alpha-Tocopherol results in increased expression of CYP3A13 mRNA; alpha-Tocopherol results in increased expression of CYP3A13 protein alpha-Tocopherol inhibits the reaction [CYP3A5 protein results in increased hydroxylation of Testosterone]
CTD
PMID:26102010 PMID:31102695
NCBI chr12:21,919,955...21,960,160
Ensembl chr12:16,806,207...16,846,422
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions increases expression
EXP ISO
alpha-Tocopherol inhibits the reaction [Cadmium Chloride results in increased expression of DDIT3 mRNA] alpha-Tocopherol analog results in increased expression of DDIT3 protein benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [alpha-Tocopherol analog results in increased expression of DDIT3 protein]; DDIT3 mRNA affects the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein]; salubrinal inhibits the reaction [alpha-Tocopherol analog results in increased expression of DDIT3 protein]
CTD
PMID:20459685 PMID:20686688
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201
G
Diablo
diablo, IAP-binding mitochondrial protein
affects localization
ISO
alpha-Tocopherol affects the localization of DIABLO protein
CTD
PMID:15582575
NCBI chr12:38,716,668...38,731,285
Ensembl chr12:33,055,263...33,070,387
G
Eif2a
eukaryotic translation initiation factor 2A
increases phosphorylation multiple interactions
ISO
alpha-Tocopherol analog results in increased phosphorylation of EIF2A protein benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of EIF2A protein]; salubrinal inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of EIF2A protein]
CTD
PMID:20686688
NCBI chr 2:144,911,247...144,944,705
Ensembl chr 2:142,761,416...142,795,068
G
Esr1
estrogen receptor 1
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR1 protein]
CTD
PMID:22389237
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR2 mRNA]
CTD
PMID:22389237
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:94,809,547...94,908,919
G
Faslg
Fas ligand
increases expression
EXP
alpha-Tocopherol results in increased expression of FASLG mRNA
CTD
PMID:26332274
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:74,154,954...74,162,215
G
Fbl
fibrillarin
decreases expression
EXP
alpha-Tocopherol deficiency results in decreased expression of FBL protein
CTD
PMID:15247049
NCBI chr 1:83,469,832...83,478,932
Ensembl chr 1:83,469,832...83,478,932
G
Fmo1
flavin containing dimethylaniline monoxygenase 1
increases expression
EXP
alpha-Tocopherol results in increased expression of FMO1 mRNA
CTD
PMID:16908007
NCBI chr13:77,715,405...77,747,666
Ensembl chr13:75,182,176...75,214,647
G
Fn1
fibronectin 1
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Glucose results in increased expression of and results in increased secretion of FN1 protein]
CTD
PMID:9225831
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:73,196,044...73,264,678
G
Fyn
FYN proto-oncogene, Src family tyrosine kinase
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [bis(2-hydroxy-2-ethylbutanoato)oxochromate(V) results in increased phosphorylation of FYN protein]; alpha-Tocopherol inhibits the reaction [Potassium Dichromate results in increased phosphorylation of FYN protein]
CTD
PMID:14572611
NCBI chr20:44,322,635...44,514,498
Ensembl chr20:42,766,369...42,959,911
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression
EXP
alpha-Tocopherol results in increased expression of GADD45A mRNA
CTD
PMID:26332274
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:96,154,789...96,157,115
G
Gclc
glutamate-cysteine ligase, catalytic subunit
multiple interactions
ISO
[alpha-Tocopherol co-treated with Paraquat] results in increased expression of GCLC mRNA
CTD
PMID:24530478
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
multiple interactions
EXP ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GCLM mRNA] [alpha-Tocopherol co-treated with Paraquat] results in increased expression of GCLM mRNA
CTD
PMID:22389237 PMID:24530478
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:210,347,482...210,367,535
G
Gfap
glial fibrillary acidic protein
increases expression
EXP
alpha-Tocopherol results in increased expression of GFAP protein
CTD
PMID:18942769
NCBI chr10:88,352,987...88,361,661
Ensembl chr10:87,852,890...87,861,589
G
Gnai2
G protein subunit alpha i2
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [Glucose results in decreased expression of GNAI2 protein]
CTD
PMID:18441196
NCBI chr 8:117,167,045...117,187,652
Ensembl chr 8:108,288,401...108,308,979
G
Gnai3
G protein subunit alpha i3
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [Glucose results in decreased expression of GNAI3 protein]
CTD
PMID:18441196
NCBI chr 2:198,430,920...198,468,874
Ensembl chr 2:195,742,642...195,780,742
G
Gpt
glutamic--pyruvic transaminase
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [beryllium nitrate results in increased activity of GPT protein]
CTD
PMID:17429802
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494
G
Gpx1
glutathione peroxidase 1
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Hexachlorobenzene results in increased activity of GPX1 protein]; alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in decreased expression of GPX1 mRNA] [alpha-Tocopherol co-treated with SB 239063] inhibits the reaction [Ovalbumin promotes the reaction [Ozone results in increased activity of GPX1 protein]]
CTD
PMID:26365763 PMID:29284473 PMID:36058301
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:109,026,905...109,028,024
G
Gpx4
glutathione peroxidase 4
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Sodium Selenite results in increased expression of GPX4 mRNA]
CTD
PMID:14642406
NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:9,650,185...9,652,982
G
Gsr
glutathione-disulfide reductase
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [Camptothecin results in decreased activity of GSR protein]; alpha-Tocopherol inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of GSR protein]
CTD
PMID:16979807 PMID:25304969
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
G
Gstm1
glutathione S-transferase mu 1
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GSTM1 mRNA]
CTD
PMID:22389237
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:195,649,845...195,655,411
G
Gstt1
glutathione S-transferase theta 1
increases expression
EXP
alpha-Tocopherol results in increased expression of GSTT1 protein
CTD
PMID:9855024
NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,669...12,873,585
G
Gusb
glucuronidase, beta
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [cumene hydroperoxide results in decreased uptake of GUSB protein]; alpha-Tocopherol inhibits the reaction [cumene hydroperoxide results in increased secretion of GUSB protein]
CTD
PMID:19135433
NCBI chr12:32,337,281...32,350,838
Ensembl chr12:26,697,951...26,726,905
G
Hal
histidine ammonia lyase
increases expression
EXP
alpha-Tocopherol results in increased expression of HAL mRNA
CTD
PMID:16908007
NCBI chr 7:29,894,495...29,924,744
Ensembl chr 7:28,006,972...28,037,701
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
multiple interactions
EXP
[Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Cadmium results in increased activity of HMGCR protein]; [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in increased activity of HMGCR protein]
CTD
PMID:19595682 PMID:21535577
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:27,997,525...28,019,703
G
Hmox1
heme oxygenase 1
affects expression multiple interactions
ISO EXP
alpha-Tocopherol affects the expression of HMOX1 mRNA [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of HMOX1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of HMOX1 protein]; alpha-Tocopherol inhibits the reaction [Paraquat results in increased activity of HMOX1 protein] alpha-Tocopherol inhibits the reaction [benzo(a)pyrene-7,8-dione results in increased expression of HMOX1 protein]; alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in decreased expression of HMOX1 mRNA]; alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in decreased expression of HMOX1 protein]
CTD
PMID:8743975 PMID:12180188 PMID:22053912 PMID:22389237 PMID:36058301
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hp
haptoglobin
affects activity multiple interactions
ISO
alpha-Tocopherol affects the activity of HP protein polymorphism Ascorbic Acid inhibits the reaction [alpha-Tocopherol affects the activity of HP protein polymorphism]
CTD
PMID:19769483
NCBI chr19:54,449,151...54,453,701
Ensembl chr19:37,539,627...37,544,523
G
Hsd17b3
hydroxysteroid (17-beta) dehydrogenase 3
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in decreased expression of HSD17B3 mRNA]
CTD
PMID:32134168
NCBI chr17:1,032,958...1,064,283
Ensembl chr17:1,027,229...1,058,554
G
Hsd3b2
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in decreased expression of HSD3B2 mRNA]
CTD
PMID:32134168
NCBI chr 2:188,784,614...188,812,535
Ensembl chr 2:186,095,897...186,101,852
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
increases expression
EXP
alpha-Tocopherol results in increased expression of HSPA1B mRNA
CTD
PMID:16908007
NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Icam1
intercellular adhesion molecule 1
multiple interactions
ISO
[Ascorbic Acid co-treated with lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; alpha-Tocopherol inhibits the reaction [Vehicle Emissions results in increased expression of ICAM1 protein]
CTD
PMID:22313677 PMID:25551565
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Ifng
interferon gamma
multiple interactions
EXP ISO
[alpha-Tocopherol co-treated with Lipopolysaccharides] results in increased expression of IFNG mRNA; alpha-Tocopherol results in decreased susceptibility to [IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] alpha-Tocopherol inhibits the reaction [Ozone promotes the reaction [Ovalbumin results in increased expression of IFNG protein]]
CTD
PMID:16307444 PMID:24333275 PMID:29284473
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
G
Igfbp5
insulin-like growth factor binding protein 5
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of IGFBP5 mRNA
CTD
PMID:23859036
NCBI chr 9:81,901,605...81,914,187
Ensembl chr 9:74,448,382...74,465,156
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in increased phosphorylation of IKBKB protein]
CTD
PMID:34310962
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:69,319,554...69,373,250
G
Il10
interleukin 10
multiple interactions
ISO EXP
[Ascorbic Acid co-treated with lycopene co-treated with alpha-Tocopherol] promotes the reaction [TNF protein results in increased expression of and results in increased secretion of IL10 protein]; alpha-Tocopherol promotes the reaction [TNF protein results in increased expression of and results in increased secretion of IL10 protein] [alpha-Tocopherol co-treated with Lipopolysaccharides] results in increased expression of IL10 mRNA
CTD
PMID:24333275 PMID:25551565
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
G
Il13
interleukin 13
multiple interactions
ISO
[alpha-Tocopherol co-treated with SB 239063] inhibits the reaction [Ozone promotes the reaction [Ovalbumin results in increased expression of IL13 protein]]
CTD
PMID:29284473
NCBI chr10:38,290,926...38,293,483
Ensembl chr10:37,790,130...37,792,737
G
Il17a
interleukin 17A
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Ozone promotes the reaction [Ovalbumin results in increased expression of IL17A mRNA]]
CTD
PMID:29284473
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:23,144,402...23,147,889
G
Il1a
interleukin 1 alpha
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [Hexachlorocyclohexane results in increased expression of IL1A mRNA]; alpha-Tocopherol inhibits the reaction [Hexachlorocyclohexane results in increased expression of IL1A protein]
CTD
PMID:15025948
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
multiple interactions
ISO EXP
alpha-Tocopherol inhibits the reaction [cumene hydroperoxide results in increased secretion of IL1B protein]; alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of IL1B protein]; alpha-Tocopherol inhibits the reaction [Vitamin E deficiency results in increased expression of IL1B mRNA] alpha-Tocopherol inhibits the reaction [Acrylamide results in increased expression of IL1B protein]; alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of IL1B mRNA]
CTD
PMID:19135433 PMID:19735175 PMID:26332274 PMID:31712109 PMID:38242491
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il5
interleukin 5
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Ozone promotes the reaction [Ovalbumin results in increased expression of IL5 mRNA]]
CTD
PMID:29284473
NCBI chr10:38,375,132...38,378,003
Ensembl chr10:37,874,342...37,877,213
G
Il6
interleukin 6
multiple interactions
ISO EXP
alpha-Tocopherol inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of and results in increased secretion of IL6 protein] alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in increased expression of IL6 protein] alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]; alpha-Tocopherol inhibits the reaction [Ozone promotes the reaction [Ovalbumin results in increased expression of IL6 protein]]
CTD
PMID:15630180 PMID:24296301 PMID:29284473 PMID:32134168
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Ins1
insulin 1
multiple interactions
EXP
[Lutein co-treated with alpha-Tocopherol] results in decreased expression of INS1 protein
CTD
PMID:12949374
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:251,244,973...251,245,536
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression
ISO
alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased phosphorylation of JUN protein] alpha-Tocopherol results in increased expression of JUN mRNA; alpha-Tocopherol results in increased expression of JUN protein
CTD
PMID:14645110 PMID:19000923 PMID:20025956
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
G
Kcnh2
potassium voltage-gated channel subfamily H member 2
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Glucose results in decreased activity of KCNH2 protein]
CTD
PMID:12531891
NCBI chr 4:11,719,357...11,751,424
Ensembl chr 4:10,826,928...10,859,008
G
Keap1
Kelch-like ECH-associated protein 1
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in increased expression of KEAP1 mRNA]; alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in increased expression of KEAP1 protein]
CTD
PMID:36058301
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:19,768,375...19,777,862
G
Lcat
lecithin cholesterol acyltransferase
multiple interactions
EXP
[Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Cadmium results in decreased activity of LCAT protein]; [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein]
CTD
PMID:19595682 PMID:21535577
NCBI chr19:50,744,598...50,748,064
Ensembl chr19:33,834,403...33,838,231
G
Lck
LCK proto-oncogene, Src family tyrosine kinase
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [bis(2-hydroxy-2-ethylbutanoato)oxochromate(V) results in increased phosphorylation of LCK protein]; alpha-Tocopherol inhibits the reaction [Potassium Dichromate results in increased phosphorylation of LCK protein]
CTD
PMID:14572611
NCBI chr 5:147,172,642...147,201,267
Ensembl chr 5:141,888,326...141,903,794
G
Ldha
lactate dehydrogenase A
multiple interactions
EXP ISO
[Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in increased expression of LDHA protein] [Ascorbic Acid co-treated with alpha-Tocopherol co-treated with ferulic acid] inhibits the reaction [[Ozone co-treated with Oxygen] results in increased secretion of LDHA protein]
CTD
PMID:21322096 PMID:26270818
NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:97,366,021...97,433,472
G
Ldhb
lactate dehydrogenase B
multiple interactions
EXP
[Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in increased expression of LDHB protein]
CTD
PMID:21322096
NCBI chr 4:177,159,389...177,177,408
Ensembl chr 4:175,428,385...175,446,403
G
Lgals3bp
galectin 3 binding protein
multiple interactions
ISO
[alpha-Tocopherol co-treated with hempseed oil co-treated with Glycerol co-treated with Propylene Glycol] results in decreased secretion of LGALS3BP protein
CTD
PMID:36372912
NCBI chr10:103,619,912...103,629,251
Ensembl chr10:103,619,908...103,629,256
G
Lyn
LYN proto-oncogene, Src family tyrosine kinase
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [bis(2-hydroxy-2-ethylbutanoato)oxochromate(V) results in increased phosphorylation of LYN protein]; alpha-Tocopherol inhibits the reaction [Potassium Dichromate results in increased phosphorylation of LYN protein]
CTD
PMID:14572611
NCBI chr 5:21,437,127...21,553,097
Ensembl chr 5:16,639,466...16,756,868
G
Mapk1
mitogen activated protein kinase 1
multiple interactions affects activity
ISO EXP
alpha-Tocopherol inhibits the reaction [Tamoxifen results in decreased phosphorylation of MAPK1 protein] [Nimodipine co-treated with alpha-Tocopherol] inhibits the reaction [Dibutyl Phthalate results in increased expression of and results in increased phosphorylation of MAPK1 protein]; alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of MAPK1 protein] [alpha-Tocopherol affects the activity of MAPK1 protein] which results in decreased susceptibility to Potassium Dichromate
CTD
PMID:17011908 PMID:19766176 PMID:30776390
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk14
mitogen activated protein kinase 14
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [[4-hydroxy-2-nonenal co-treated with Hydrogen Peroxide] results in increased activity of MAPK14 protein]; alpha-Tocopherol inhibits the reaction [APP protein results in increased activity of MAPK14 protein]; alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased activity of MAPK14 protein] alpha-Tocopherol inhibits the reaction [[Ovalbumin co-treated with Ozone] results in increased phosphorylation of MAPK14 protein]
CTD
PMID:12684028 PMID:14645110 PMID:29284473
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,749,670...6,810,589
G
Mapk3
mitogen activated protein kinase 3
multiple interactions affects activity
ISO EXP
alpha-Tocopherol inhibits the reaction [Tamoxifen results in decreased phosphorylation of MAPK3 protein]; alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased activity of MAPK3 protein] [Nimodipine co-treated with alpha-Tocopherol] inhibits the reaction [Dibutyl Phthalate results in increased expression of and results in increased phosphorylation of MAPK3 protein]; alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of MAPK3 protein] [alpha-Tocopherol affects the activity of MAPK3 protein] which results in decreased susceptibility to Potassium Dichromate
CTD
PMID:14645110 PMID:17011908 PMID:19766176 PMID:30776390
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions increases phosphorylation
ISO
alpha-Tocopherol inhibits the reaction [APP protein results in increased activity of MAPK8 protein]; alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased activity of MAPK8 protein]; benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of MAPK8 protein]; salubrinal inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of MAPK8 protein]
CTD
PMID:12684028 PMID:14645110 PMID:20686688
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
G
Mapk9
mitogen-activated protein kinase 9
increases phosphorylation multiple interactions
ISO
alpha-Tocopherol analog results in increased phosphorylation of MAPK9 protein benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of MAPK9 protein]; salubrinal inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of MAPK9 protein]
CTD
PMID:20686688
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,169,675...34,210,178
G
Mb
myoglobin
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [MB modified form results in decreased secretion of very low density lipoprotein triglyceride]
CTD
PMID:17478120
NCBI chr 7:110,640,511...110,647,742
Ensembl chr 7:108,759,904...108,767,383
G
Mbp
myelin basic protein
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased expression of MBP protein]
CTD
PMID:14645110
NCBI chr18:78,130,652...78,241,174
Ensembl chr18:75,855,878...75,966,404
G
Mgat3
beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase
increases expression
EXP
alpha-Tocopherol results in increased expression of MGAT3 mRNA
CTD
PMID:16908007
NCBI chr 7:111,708,353...111,761,825
Ensembl chr 7:111,675,730...111,762,026
G
Mki67
marker of proliferation Ki-67
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of MKI67 mRNA
CTD
PMID:23859036
NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:190,496,319...190,522,762
G
Mpo
myeloperoxidase
multiple interactions
EXP
[Ascorbic Acid co-treated with beta Carotene co-treated with alpha-Tocopherol co-treated with Sodium Selenite] inhibits the reaction [Galactosamine results in increased activity of MPO protein]
CTD
PMID:31022331
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:72,594,661...72,604,819
G
Muc4
mucin 4, cell surface associated
multiple interactions
ISO
[alpha-Tocopherol co-treated with hempseed oil co-treated with Glycerol co-treated with Propylene Glycol] results in decreased secretion of MUC4 protein
CTD
PMID:36372912
NCBI chr11:81,513,321...81,575,200
G
Muc5ac
mucin 5AC, oligomeric mucus/gel-forming
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased expression of MUC5AC mRNA]
CTD
PMID:24333275
NCBI chr 1:206,293,717...206,326,006
Ensembl chr 1:196,864,336...196,896,475
G
Myc
MYC proto-oncogene, bHLH transcription factor
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [mancozeb results in decreased expression of MYC protein]
CTD
PMID:16005924
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:93,593,705...93,598,630
G
Nefh
neurofilament heavy chain
increases expression
EXP
alpha-Tocopherol results in increased expression of NEFH protein modified form
CTD
PMID:18942769
NCBI chr14:84,044,428...84,054,413
Ensembl chr14:79,830,362...79,840,351
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
EXP ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NFE2L2 protein]; [alpha-Tocopherol co-treated with Hydrogen Peroxide] affects the localization of NFE2L2 protein; alpha-Tocopherol inhibits the reaction [Arsenic Trioxide results in decreased expression of NFE2L2 mRNA]; alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in decreased expression of NFE2L2 protein] [Ascorbic Acid co-treated with alpha-Tocopherol co-treated with ferulic acid] promotes the reaction [[Ozone co-treated with Oxygen] results in increased localization of NFE2L2 protein]; alpha-Tocopherol promotes the reaction [Hydrogen Peroxide affects the localization of NFE2L2 protein]
CTD
PMID:22389237 PMID:26270818 PMID:29297235 PMID:31412289 PMID:32134168 PMID:36058301 More...
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions increases activity
EXP ISO
alpha-Tocopherol inhibits the reaction [Hexachlorocyclohexane results in increased activity of NFKB1 protein]; alpha-Tocopherol inhibits the reaction [Triiodothyronine, Reverse results in increased activity of [NFKB1 protein binds to RELA protein]] alpha-Tocopherol inhibits the reaction [Galactosamine results in increased activity of [NFKB1 protein binds to NFKB1 protein]]; alpha-Tocopherol inhibits the reaction [Galactosamine results in increased activity of [RELA protein binds to NFKB1 protein]] alpha-Tocopherol results in increased activity of NFKB1 protein
CTD
PMID:15025948 PMID:16135673 PMID:17936189 PMID:19083475
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO EXP
alpha-Tocopherol inhibits the reaction [AGT protein results in increased phosphorylation of NFKBIA protein]; alpha-Tocopherol inhibits the reaction [DCD protein results in increased phosphorylation of NFKBIA protein] [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of NFKBIA mRNA]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of NFKBIA mRNA] alpha-Tocopherol inhibits the reaction [Acrylamide results in increased phosphorylation of NFKBIA protein]; alpha-Tocopherol inhibits the reaction [Triiodothyronine, Reverse results in increased phosphorylation of NFKBIA protein]
CTD
PMID:16135673 PMID:17532611 PMID:25551565 PMID:38242491
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [cumene hydroperoxide results in increased expression of NOS2 protein] alpha-Tocopherol inhibits the reaction [Galactosamine results in increased expression of NOS2 mRNA]
CTD
PMID:17936189 PMID:19135433
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Nos3
nitric oxide synthase 3
increases expression
ISO
alpha-Tocopherol results in increased expression of NOS3 mRNA; alpha-Tocopherol results in increased expression of NOS3 protein
CTD
PMID:16949522
NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:10,793,834...10,814,166
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
EXP ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NQO1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NQO1 protein] alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in decreased expression of NQO1 mRNA]; alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in decreased expression of NQO1 protein]
CTD
PMID:22389237 PMID:36058301
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
alpha-Tocopherol promotes the reaction [NR1I2 results in increased expression of CPT1A mRNA]
CTD
PMID:17936189
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:62,460,213...62,496,658
G
Ogdh
oxoglutarate dehydrogenase
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [sodium arsenite results in decreased activity of OGDH protein]
CTD
PMID:12915223
NCBI chr14:85,363,949...85,431,405
Ensembl chr14:81,150,091...81,217,479
G
Orm1
orosomucoid 1
increases expression
ISO
alpha-Tocopherol results in increased expression of ORM1 mRNA; alpha-Tocopherol results in increased expression of ORM1 protein
CTD
PMID:19000923 PMID:20025956
NCBI chr 5:81,788,509...81,791,661
Ensembl chr 5:76,772,941...76,776,154
G
Park7
Parkinsonism associated deglycase
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Rotenone affects the localization of PARK7 protein]
CTD
PMID:16439141
NCBI chr 5:166,636,551...166,659,825
Ensembl chr 5:161,353,719...161,376,970
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
ISO EXP
alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased cleavage of PARP1 protein] alpha-Tocopherol inhibits the reaction [nickel chloride results in increased cleavage of PARP1 protein]
CTD
PMID:14645110 PMID:24448832
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Pawr
pro-apoptotic WT1 regulator
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [Nerve Growth Factors deficiency results in increased expression of PAWR mRNA]; alpha-Tocopherol inhibits the reaction [Nerve Growth Factors deficiency results in increased expression of PAWR protein]
CTD
PMID:10428045
NCBI chr 7:45,531,480...45,611,492
Ensembl chr 7:43,645,084...43,725,028
G
Pax3
paired box 3
multiple interactions increases expression
ISO
alpha-Tocopherol inhibits the reaction [Glucose results in decreased expression of PAX3 mRNA] alpha-Tocopherol results in increased expression of PAX3 mRNA
CTD
PMID:12739027
NCBI chr 9:87,015,960...87,112,531
Ensembl chr 9:79,568,634...79,664,042
G
Pck1
phosphoenolpyruvate carboxykinase 1
decreases expression
EXP
alpha-Tocopherol results in decreased expression of PCK1 mRNA
CTD
PMID:11597575
NCBI chr 3:182,348,572...182,354,521
Ensembl chr 3:161,930,256...161,936,191
G
Pcna
proliferating cell nuclear antigen
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PCNA protein]
CTD
PMID:22389237
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:119,498,810...119,502,995
G
Pdgfrb
platelet derived growth factor receptor beta
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of PDGFRB mRNA; [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of PDGFRB protein
CTD
PMID:23859036
NCBI chr18:56,770,348...56,809,228
Ensembl chr18:54,499,964...54,538,843
G
Pgk1
phosphoglycerate kinase 1
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in increased expression of PGK1 protein]
CTD
PMID:18603805
NCBI chr X:75,336,988...75,352,962
Ensembl chr X:71,271,440...71,287,418
G
Plg
plasminogen
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Arsenic promotes the reaction [Humic Substances results in decreased activity of PLG protein]]; alpha-Tocopherol inhibits the reaction [Humic Substances results in decreased activity of PLG protein]
CTD
PMID:11419606
NCBI chr 1:50,872,927...50,915,406
Ensembl chr 1:48,325,185...48,367,786
G
Pltp
phospholipid transfer protein
decreases abundance
ISO
PLTP mutant form results in decreased abundance of alpha-Tocopherol
CTD
PMID:16675720
NCBI chr 3:173,994,162...174,011,982
Ensembl chr 3:153,574,825...153,592,647
G
Ppara
peroxisome proliferator activated receptor alpha
multiple interactions increases expression
ISO
alpha-Tocopherol inhibits the reaction [Galactosamine results in decreased expression of PPARA mRNA] alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in decreased expression of PPARA mRNA] alpha-Tocopherol results in increased expression of PPARA mRNA
CTD
PMID:17936189 PMID:29065513
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346
G
Pparg
peroxisome proliferator-activated receptor gamma
increases expression multiple interactions increases activity
ISO EXP
alpha-Tocopherol results in increased expression of PPARG mRNA; alpha-Tocopherol results in increased expression of PPARG protein [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein] alpha-Tocopherol results in increased activity of PPARG protein
CTD
PMID:11752099 PMID:14521714 PMID:19083475 PMID:22389237 PMID:28062356
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Ppia
peptidylprolyl isomerase A
increases expression
EXP
alpha-Tocopherol results in increased expression of PPIA mRNA
CTD
PMID:16908007
NCBI chr14:85,491,223...85,496,884
Ensembl chr14:81,275,091...81,299,601
G
Psmc6
proteasome 26S subunit, ATPase 6
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [AGT protein results in increased expression of PSMC6 protein]
CTD
PMID:17532611
NCBI chr15:21,022,314...21,043,785
Ensembl chr15:18,542,563...18,564,055
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases activity multiple interactions
ISO EXP
alpha-Tocopherol metabolite results in decreased activity of PTGS2 protein; alpha-Tocopherol results in decreased activity of PTGS2 protein [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PTGS2 protein]
CTD
PMID:15225597 PMID:22389237
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Rela
RELA proto-oncogene, NF-kB subunit
affects localization multiple interactions
ISO EXP
alpha-Tocopherol affects the localization of RELA protein [Ascorbic Acid co-treated with alpha-Tocopherol co-treated with ferulic acid] inhibits the reaction [[Ozone co-treated with Oxygen] results in increased localization of RELA protein]; alpha-Tocopherol affects the reaction [[manganese chloride results in increased abundance of Manganese] which affects the localization of RELA protein]; alpha-Tocopherol inhibits the reaction [Galactosamine results in increased activity of [RELA protein binds to NFKB1 protein]] alpha-Tocopherol inhibits the reaction [Hexachlorocyclohexane results in increased activity of RELA protein]; alpha-Tocopherol inhibits the reaction [Triiodothyronine, Reverse results in increased activity of [NFKB1 protein binds to RELA protein]]
CTD
PMID:15025948 PMID:16135673 PMID:16882165 PMID:17936189 PMID:26270818 PMID:34310962 More...
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Rps6
ribosomal protein S6
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [28-O-acetylbetulin-3-ylglucopyranoside results in decreased phosphorylation of RPS6 protein]
CTD
PMID:22343715
NCBI chr 5:106,417,680...106,420,540
Ensembl chr 5:101,371,136...101,374,602 Ensembl chr 5:101,371,136...101,374,602
G
Rxra
retinoid X receptor alpha
multiple interactions
ISO
[Tretinoin co-treated with alpha-Tocopherol co-treated with Okadaic Acid] results in decreased phosphorylation of RXRA protein; [Tretinoin co-treated with alpha-Tocopherol] results in decreased phosphorylation of RXRA protein
CTD
PMID:15225641
NCBI chr 3:31,387,892...31,474,415
Ensembl chr 3:10,989,832...11,073,712
G
Sele
selectin E
multiple interactions
ISO
[Ascorbic Acid co-treated with lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of SELE mRNA]; alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in increased expression of SELE protein]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of SELE mRNA]
CTD
PMID:12566129 PMID:25551565
NCBI chr13:78,935,997...78,945,905
Ensembl chr13:76,403,304...76,412,741
G
Slc1a2
solute carrier family 1 member 2
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SLC1A2 mRNA]; alpha-Tocopherol inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SLC1A2 protein]
CTD
PMID:34310962
NCBI chr 3:109,460,109...109,590,445
Ensembl chr 3:89,005,129...89,126,498
G
Slc7a11
solute carrier family 7 member 11
multiple interactions
ISO
[alpha-Tocopherol co-treated with Paraquat] results in increased expression of SLC7A11 mRNA; [alpha-Tocopherol co-treated with Paraquat] results in increased expression of SLC7A11 protein
CTD
PMID:24530478
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:133,963,107...134,517,536
G
Slpi
secretory leukocyte peptidase inhibitor
multiple interactions
ISO
[alpha-Tocopherol co-treated with hempseed oil co-treated with Glycerol co-treated with Propylene Glycol] results in decreased secretion of SLPI protein
CTD
PMID:36372912
NCBI chr 3:173,501,573...173,503,822
Ensembl chr 3:153,082,369...153,084,453
G
Smad4
SMAD family member 4
multiple interactions
ISO
SMAD4 results in decreased susceptibility to [Fluorouracil co-treated with alpha-Tocopherol]
CTD
PMID:20562578
NCBI chr18:69,518,988...69,549,684
Ensembl chr18:67,243,742...67,274,438
G
Snca
synuclein alpha
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Rotenone results in increased expression of SNCA protein]
CTD
PMID:16439141
NCBI chr 4:91,026,474...91,127,444
Ensembl chr 4:89,696,420...89,796,262
G
Sod1
superoxide dismutase 1
multiple interactions increases expression
EXP ISO
[alpha-Tocopherol co-treated with Ascorbic Acid] inhibits the reaction [arsenite results in increased expression of SOD1 protein]; alpha-Tocopherol inhibits the reaction [Malathion results in increased activity of SOD1 protein] alpha-Tocopherol inhibits the reaction [Hexachlorobenzene results in increased activity of SOD1 protein] alpha-Tocopherol results in increased expression of SOD1 mRNA; alpha-Tocopherol results in increased expression of SOD1 protein
CTD
PMID:19083475 PMID:20194575 PMID:21344382 PMID:22732938 PMID:26365763
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
decreases expression increases expression multiple interactions
EXP
alpha-Tocopherol results in decreased expression of SOD2 protein alpha-Tocopherol results in increased expression of SOD2 mRNA; alpha-Tocopherol results in increased expression of SOD2 protein [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of SOD2 mRNA; alpha-Tocopherol inhibits the reaction [Malathion results in increased activity of SOD2 protein]; alpha-Tocopherol inhibits the reaction [Triiodothyronine, Reverse results in increased expression of and results in increased activity of SOD2 protein]
CTD
PMID:16135673 PMID:18942769 PMID:20194575 PMID:22732938 PMID:23859036
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Srsf2
serine and arginine rich splicing factor 2
decreases expression
EXP
alpha-Tocopherol deficiency results in decreased expression of SRSF2 protein
CTD
PMID:15247049
NCBI chr10:102,550,962...102,554,200
Ensembl chr10:102,052,314...102,055,338
G
Star
steroidogenic acute regulatory protein
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in decreased expression of STAR mRNA]
CTD
PMID:32134168
NCBI chr16:72,969,824...72,974,447
Ensembl chr16:66,264,807...66,271,672
G
Stat3
signal transducer and activator of transcription 3
increases expression
EXP
alpha-Tocopherol results in increased expression of STAT3 mRNA
CTD
PMID:16908007
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
G
Tert
telomerase reverse transcriptase
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in decreased activity of TERT protein]
CTD
PMID:20112180
NCBI chr 1:31,465,766...31,488,650
Ensembl chr 1:29,637,506...29,659,561
G
Tf
transferrin
multiple interactions
ISO
[alpha-Tocopherol co-treated with hempseed oil co-treated with Glycerol co-treated with Propylene Glycol] results in increased secretion of TF protein
CTD
PMID:36372912
NCBI chr 8:112,668,667...112,695,376
Ensembl chr 8:103,767,995...103,816,511
G
Tgfa
transforming growth factor alpha
decreases response to substance
EXP
alpha-Tocopherol results in decreased susceptibility to TGFA protein
CTD
PMID:7593635
NCBI chr 4:120,175,549...120,258,342
Ensembl chr 4:118,618,269...118,700,894
G
Tgfb1
transforming growth factor, beta 1
multiple interactions decreases expression
EXP
alpha-Tocopherol inhibits the reaction [Acrylamide results in increased expression of TGFB1 protein]; alpha-Tocopherol inhibits the reaction [TGFB1 protein results in increased abundance of Reactive Oxygen Species] alpha-Tocopherol results in decreased expression of TGFB1 mRNA
CTD
PMID:9608545 PMID:14732287 PMID:38242491
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
G
Th
tyrosine hydroxylase
multiple interactions
EXP
[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in decreased expression of TH protein; alpha-Tocopherol inhibits the reaction [Rotenone results in decreased expression of TH protein]
CTD
PMID:15790535 PMID:25891525
NCBI chr 1:207,500,959...207,508,276
Ensembl chr 1:198,071,503...198,109,767
G
Tnf
tumor necrosis factor
multiple interactions affects expression decreases response to substance decreases expression
ISO EXP
[alpha-Tocopherol co-treated with gamma-Tocopherol] results in decreased expression of TNF protein; [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of CXCL8 protein]; [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of TNF protein]; [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of NFKBIA mRNA]; [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of SELE mRNA]; [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of TNF mRNA]; [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] promotes the reaction [TNF protein results in increased expression of and results in increased secretion of IL10 protein]; alpha-Tocopherol inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in increased secretion of TNF protein]; alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; alpha-Tocopherol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of TNF protein]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased abundance of Reactive Oxygen Species]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of CXCL8 protein]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of TNF protein]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of NFKBIA mRNA]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of SELE mRNA]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of TNF mRNA]; alpha-Tocopherol promotes the reaction [TNF protein promotes the reaction [Amiodarone results in increased activity of CASP3 protein]]; alpha-Tocopherol promotes the reaction [TNF protein promotes the reaction [Amiodarone results in increased activity of CASP7 protein]]; alpha-Tocopherol promotes the reaction [TNF protein results in increased expression of and results in increased secretion of IL10 protein] alpha-Tocopherol inhibits the reaction [Acrylamide results in increased expression of TNF protein]; alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of TNF mRNA]; alpha-Tocopherol inhibits the reaction [Hexachlorocyclohexane results in increased expression of TNF mRNA]; alpha-Tocopherol inhibits the reaction [Hexachlorocyclohexane results in increased expression of TNF protein]; alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in increased expression of TNF protein]; alpha-Tocopherol inhibits the reaction [Triiodothyronine, Reverse results in increased secretion of TNF protein] alpha-Tocopherol affects the expression of TNF protein alpha-Tocopherol results in decreased susceptibility to TNF protein [alpha-Tocopherol co-treated with Nimodipine] inhibits the reaction [Dibutyl Phthalate results in increased expression of TNF protein]; alpha-Tocopherol inhibits the reaction [cumene hydroperoxide results in increased secretion of TNF protein]; alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of TNF protein]; alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; alpha-Tocopherol inhibits the reaction [Ozone promotes the reaction [Ovalbumin results in increased expression of TNF mRNA]]; alpha-Tocopherol inhibits the reaction [Vitamin E deficiency results in increased expression of TNF mRNA] alpha-Tocopherol results in decreased expression of TNF protein
CTD
PMID:10588948 PMID:11805214 PMID:12195823 PMID:15025948 PMID:15630180 PMID:16135673 PMID:16750838 PMID:18191645 PMID:19135038 PMID:19135433 PMID:19735175 PMID:23042730 PMID:25551565 PMID:26332274 PMID:29284473 PMID:30776390 PMID:31712109 PMID:32134168 PMID:34310962 PMID:38242491 More...
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [arsenite results in increased expression of TP53 mRNA]; alpha-Tocopherol inhibits the reaction [arsenite results in increased expression of TP53 protein]
CTD
PMID:12126965
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Txn1
thioredoxin 1
multiple interactions
EXP
[alpha-Tocopherol co-treated with Ascorbic Acid] inhibits the reaction [arsenite results in increased expression of TXN1 protein]
CTD
PMID:21344382
NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:72,711,933...72,724,629
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of UGT1A1 mRNA]
CTD
PMID:22389237
NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Vcam1
vascular cell adhesion molecule 1
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in increased expression of VCAM1 protein]; alpha-Tocopherol inhibits the reaction [Vehicle Emissions results in increased expression of VCAM1 protein]
CTD
PMID:12566129 PMID:22313677
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:204,038,114...204,057,958
G
Xbp1
X-box binding protein 1
increases expression
ISO
alpha-Tocopherol analog results in increased expression of XBP1 mRNA
CTD
PMID:20686688
NCBI chr14:84,604,623...84,609,707
Ensembl chr14:80,390,643...80,395,693
G
Xrcc6
X-ray repair cross complementing 6
multiple interactions
EXP
alpha-Tocopherol promotes the reaction [Acrylonitrile results in increased expression of XRCC6 mRNA]
CTD
PMID:26332274
NCBI chr 7:115,423,026...115,443,884
Ensembl chr 7:113,543,057...113,563,762
G
Yy1
YY1 transcription factor
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in increased expression of YY1 mRNA]; alpha-Tocopherol inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in increased expression of YY1 protein]
CTD
PMID:34310962
NCBI chr 6:133,471,615...133,500,875
Ensembl chr 6:127,707,596...127,732,747
G
Abcb1a
ATP binding cassette subfamily B member 1A
increases expression
ISO
tocotrienol, alpha results in increased expression of ABCB1
CTD
PMID:15269186
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions increases expression
ISO
tocotrienol, alpha inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Testosterone]; tocotrienol, alpha inhibits the reaction [CYP3A4 protein results in increased oxidation of Lithocholic Acid] tocotrienol, alpha results in increased expression of CYP3A4
CTD
PMID:15269186 PMID:31102695
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
affects response to substance multiple interactions
ISO
CYP3A5 gene polymorphism affects the susceptibility to tocotrienol, alpha tocotrienol, alpha inhibits the reaction [CYP3A5 protein results in increased hydroxylation of Testosterone]; tocotrienol, alpha inhibits the reaction [CYP3A5 protein results in increased oxidation of Lithocholic Acid]
CTD
PMID:31102695
NCBI chr12:21,919,955...21,960,160
Ensembl chr12:16,806,207...16,846,422
G
Gstm1
glutathione S-transferase mu 1
multiple interactions
ISO
GSTM1 gene polymorphism affects the susceptibility to [Ascorbic Acid co-treated with tocotrienol, alpha]
CTD
PMID:15668500
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:195,649,845...195,655,411
G
Ncor1
nuclear receptor co-repressor 1
multiple interactions
ISO
tocotrienol, alpha inhibits the reaction [NR1I2 protein binds to NCOR1 protein]
CTD
PMID:15269186
NCBI chr10:47,498,852...47,641,612
Ensembl chr10:46,999,536...47,141,032
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
tocotrienol, alpha binds to and results in increased activity of NR1I2 protein; tocotrienol, alpha inhibits the reaction [NR1I2 protein binds to NCOR1 protein]
CTD
PMID:15269186
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:62,460,213...62,496,658
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases expression
ISO
tocotrienol, alpha results in increased expression of UGT1A1
CTD
PMID:15269186
NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Casp3
caspase 3
multiple interactions
EXP ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of CASP3 protein] beta-Tocopherol affects the reaction [7-ketocholesterol results in increased activity of CASP3 protein]; beta-Tocopherol affects the reaction [cholest-5-en-3 beta,7 alpha-diol results in increased activity of CASP3 protein]
CTD
PMID:12450566 PMID:22389237
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of CYP1A1 mRNA]
CTD
PMID:22389237
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Esr1
estrogen receptor 1
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR1 protein]
CTD
PMID:22389237
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR2 mRNA]
CTD
PMID:22389237
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:94,809,547...94,908,919
G
Gclm
glutamate cysteine ligase, modifier subunit
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GCLM mRNA]
CTD
PMID:22389237
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:210,347,482...210,367,535
G
Gstm1
glutathione S-transferase mu 1
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GSTM1 mRNA]
CTD
PMID:22389237
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:195,649,845...195,655,411
G
Hmox1
heme oxygenase 1
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of HMOX1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of HMOX1 protein]
CTD
PMID:22389237
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NFE2L2 protein]
CTD
PMID:22389237
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NQO1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NQO1 protein]
CTD
PMID:22389237
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Pcna
proliferating cell nuclear antigen
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PCNA protein]
CTD
PMID:22389237
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:119,498,810...119,502,995
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein]
CTD
PMID:22389237
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PTGS2 protein]
CTD
PMID:22389237
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of UGT1A1 mRNA]
CTD
PMID:22389237
NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Abcb1a
ATP binding cassette subfamily B member 1A
increases expression
ISO
tocotrienol, beta results in increased expression of ABCB1
CTD
PMID:15269186
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases expression
ISO
tocotrienol, beta results in increased expression of CYP3A4
CTD
PMID:15269186
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008
G
Ncor1
nuclear receptor co-repressor 1
multiple interactions
ISO
tocotrienol, beta inhibits the reaction [NR1I2 protein binds to NCOR1 protein]
CTD
PMID:15269186
NCBI chr10:47,498,852...47,641,612
Ensembl chr10:46,999,536...47,141,032
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
tocotrienol, beta binds to and results in increased activity of NR1I2 protein; tocotrienol, beta inhibits the reaction [NR1I2 protein binds to NCOR1 protein]
CTD
PMID:15269186
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:62,460,213...62,496,658
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases expression
ISO
tocotrienol, beta results in increased expression of UGT1A1
CTD
PMID:15269186
NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Abcg8
ATP binding cassette subfamily G member 8
affects expression
EXP
Corn Oil affects the expression of ABCG8 mRNA
CTD
PMID:16360708
NCBI chr 6:15,698,448...15,717,730
Ensembl chr 6:9,945,629...9,964,912
G
Acaca
acetyl-CoA carboxylase alpha
increases expression
EXP
Corn Oil results in increased expression of ACACA mRNA
CTD
PMID:1973097
NCBI chr10:69,511,627...69,773,888
Ensembl chr10:69,014,170...69,276,457
G
Acly
ATP citrate lyase
affects expression
EXP
Corn Oil affects the expression of ACLY mRNA
CTD
PMID:16360708
NCBI chr10:85,912,402...85,964,605
Ensembl chr10:85,412,049...85,463,320
G
Acot2
acyl-CoA thioesterase 2
affects expression
EXP
Corn Oil affects the expression of ACOT2 mRNA
CTD
PMID:16360708
NCBI chr 6:109,341,426...109,352,818
Ensembl chr 6:103,611,544...103,619,245
G
Adipoq
adiponectin, C1Q and collagen domain containing
multiple interactions
EXP
Corn Oil promotes the reaction [Glucose results in increased expression of ADIPOQ protein]
CTD
PMID:29165388
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
G
Akr1b7
aldo-keto reductase family 1, member B7
affects expression
EXP
Corn Oil affects the expression of AKR1B7 mRNA
CTD
PMID:16360708
NCBI chr 4:64,043,901...64,083,751
Ensembl chr 4:63,076,800...63,089,502
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
affects expression
EXP
Corn Oil affects the expression of ALDH1A1 mRNA
CTD
PMID:16360708
NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:218,042,127...218,152,961
G
Angptl4
angiopoietin-like 4
affects expression
EXP
Corn Oil affects the expression of ANGPTL4 mRNA
CTD
PMID:16360708
NCBI chr 7:15,252,450...15,259,971
Ensembl chr 7:14,550,311...14,556,519
G
Areg
amphiregulin
multiple interactions
ISO
[Estradiol co-treated with Progesterone co-treated with Corn Oil] results in increased expression of AREG mRNA
CTD
PMID:32186404
NCBI chr14:17,256,384...17,265,641
Ensembl chr14:16,972,187...16,981,535
G
Bad
BCL2-associated agonist of cell death
increases expression
EXP
Corn Oil results in increased expression of BAD mRNA
CTD
PMID:22760963
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:204,131,501...204,142,823
G
Bdkrb1
bradykinin receptor B1
multiple interactions
EXP
Corn Oil inhibits the reaction [Glucose results in increased expression of BDKRB1 protein]
CTD
PMID:29165388
NCBI chr 6:130,275,631...130,284,968
Ensembl chr 6:124,510,870...124,513,747
G
Bhlhe40
basic helix-loop-helix family, member e40
affects expression
EXP
Corn Oil affects the expression of BHLHE40 mRNA
CTD
PMID:16360708
NCBI chr 4:143,174,450...143,180,150
Ensembl chr 4:141,618,476...141,624,774
G
Bhmt
betaine-homocysteine S-methyltransferase
affects expression
EXP
Corn Oil affects the expression of BHMT mRNA
CTD
PMID:16360708
NCBI chr 2:26,594,852...26,614,429
Ensembl chr 2:24,859,873...24,879,742
G
Birc3
baculoviral IAP repeat-containing 3
increases expression
ISO
Corn Oil results in increased expression of BIRC3 mRNA
CTD
PMID:33263755
NCBI chr 8:13,285,702...13,313,329
Ensembl chr 8:5,000,845...5,015,802
G
Bmp1
bone morphogenetic protein 1
affects expression
EXP
Corn Oil affects the expression of BMP1 mRNA
CTD
PMID:16360708
NCBI chr15:51,961,310...52,005,597
Ensembl chr15:45,551,603...45,595,776
G
Bmp2
bone morphogenetic protein 2
multiple interactions
ISO
[Estradiol co-treated with Progesterone co-treated with Corn Oil] results in increased expression of BMP2 mRNA
CTD
PMID:32186404
NCBI chr 3:141,264,648...141,275,416
Ensembl chr 3:120,812,882...120,821,397
G
Cadm1
cell adhesion molecule 1
affects expression
EXP
Corn Oil affects the expression of CADM1 mRNA
CTD
PMID:16360708
NCBI chr 8:56,744,374...57,075,264
Ensembl chr 8:47,847,325...48,182,833
G
Calca
calcitonin-related polypeptide alpha
multiple interactions
ISO
[Estradiol co-treated with Progesterone co-treated with Corn Oil] results in increased expression of CALCA mRNA
CTD
PMID:32186404
NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:168,878,214...168,883,105
G
Car6
carbonic anhydrase 6
increases expression
ISO
Corn Oil results in increased expression of CAR6 mRNA
CTD
PMID:33263755
NCBI chr 5:165,941,028...165,959,566
Ensembl chr 5:160,658,105...160,676,644
G
Card9
caspase recruitment domain family, member 9
increases expression
ISO
Corn Oil results in increased expression of CARD9 mRNA
CTD
PMID:33263755
NCBI chr 3:29,569,907...29,578,402
Ensembl chr 3:9,171,815...9,180,237
G
Cat
catalase
multiple interactions decreases expression
ISO
[bisphenol A co-treated with Resveratrol co-treated with Corn Oil] results in decreased expression of CAT protein Corn Oil results in decreased expression of CAT protein
CTD
PMID:36432690
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Cav3
caveolin 3
decreases expression
ISO
Corn Oil results in decreased expression of CAV3 mRNA
CTD
PMID:33263755
NCBI chr 4:147,137,993...147,153,967
Ensembl chr 4:145,582,060...145,598,137
G
Ccl3
C-C motif chemokine ligand 3
increases expression decreases expression
ISO EXP
Corn Oil results in increased expression of CCL3 mRNA Corn Oil results in decreased expression of CCL3 mRNA
CTD
PMID:22760963 PMID:23409006
NCBI chr10:68,948,889...68,950,439
Ensembl chr10:68,451,388...68,452,938
G
Ccnd1
cyclin D1
affects expression
EXP
Corn Oil affects the expression of CCND1 mRNA
CTD
PMID:16360708
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
G
Cd36
CD36 molecule
decreases expression
EXP
Corn Oil results in decreased expression of CD36 mRNA
CTD
PMID:22760963
NCBI chr 4:18,209,088...18,302,142
Ensembl chr 4:17,354,466...17,513,903
G
Cdhr1
cadherin-related family member 1
increases expression
EXP
Corn Oil results in increased expression of CDHR1 mRNA
CTD
PMID:22760963
NCBI chr16:12,863,696...12,883,579
Ensembl chr16:12,843,437...12,863,396
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
affects expression increases expression
EXP
Corn Oil affects the expression of CDKN1A mRNA Corn Oil results in increased expression of CDKN1A mRNA
CTD
PMID:16360708 PMID:22760963
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
G
Cenpt
centromere protein T
increases expression
EXP
Corn Oil results in increased expression of CENPT mRNA
CTD
PMID:22760963
NCBI chr19:50,644,548...50,651,048
Ensembl chr19:33,734,685...33,741,142
G
Cfb
complement factor B
increases expression
EXP
Corn Oil results in increased expression of CFB mRNA
CTD
PMID:22760963
NCBI chr20:3,975,271...3,981,138
Ensembl chr20:3,951,474...3,976,505
G
Cldn1
claudin 1
decreases expression
ISO
Corn Oil results in decreased expression of CLDN1 mRNA
CTD
PMID:33263755
NCBI chr11:87,926,376...87,941,533
Ensembl chr11:74,421,569...74,436,724
G
Cldn9
claudin 9
increases expression
ISO
Corn Oil results in increased expression of CLDN9 mRNA
CTD
PMID:33263755
NCBI chr10:13,218,728...13,220,159
G
Cox7a1
cytochrome c oxidase subunit 7A1
decreases expression
ISO
Corn Oil results in decreased expression of COX7A1 mRNA
CTD
PMID:23409006
NCBI chr 1:94,549,663...94,572,330
Ensembl chr 1:85,441,871...85,445,151
G
Cpt1a
carnitine palmitoyltransferase 1A
increases expression multiple interactions affects expression
EXP ISO
Corn Oil results in increased expression of CPT1A mRNA [bisphenol A co-treated with Resveratrol co-treated with Corn Oil] results in increased expression of CPT1A mRNA Corn Oil affects the expression of CPT1A mRNA
CTD
PMID:16360708 PMID:22760963 PMID:36432690
NCBI chr 1:209,993,881...210,056,329
Ensembl chr 1:200,565,613...200,627,055
G
Cpt2
carnitine palmitoyltransferase 2
multiple interactions
ISO
[bisphenol A co-treated with Resveratrol co-treated with Corn Oil] results in increased expression of CPT2 mRNA
CTD
PMID:36432690
NCBI chr 5:127,893,450...127,911,347
Ensembl chr 5:122,664,677...122,682,095
G
Crot
carnitine O-octanoyltransferase
affects expression multiple interactions
EXP ISO
Corn Oil affects the expression of CROT mRNA [bisphenol A co-treated with Resveratrol co-treated with Corn Oil] results in increased expression of CROT mRNA
CTD
PMID:16360708 PMID:36432690
NCBI chr 4:26,031,729...26,088,057
Ensembl chr 4:25,080,587...25,133,109
G
Ctsg
cathepsin G
increases expression
EXP
Corn Oil results in increased expression of CTSG mRNA
CTD
PMID:22760963
NCBI chr15:33,901,230...33,907,596
Ensembl chr15:29,931,003...29,937,353
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
affects expression
EXP
Corn Oil affects the expression of CYP17A1 mRNA
CTD
PMID:16360708
NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:245,535,462...245,541,573
G
Cyp7a1
cytochrome P450 family 7 subfamily A member 1
affects expression
EXP
Corn Oil affects the expression of CYP7A1 mRNA
CTD
PMID:16360708
NCBI chr 5:24,174,505...24,184,202
Ensembl chr 5:19,376,974...19,386,688
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
affects expression
EXP
Corn Oil affects the expression of CYP8B1 mRNA
CTD
PMID:16360708
NCBI chr 8:130,455,622...130,457,592
Ensembl chr 8:121,557,062...121,580,166
G
Ephx2
epoxide hydrolase 2
affects expression
EXP
Corn Oil affects the expression of EPHX2 mRNA
CTD
PMID:16360708
NCBI chr15:44,465,447...44,503,157
Ensembl chr15:40,289,902...40,327,615
G
Ets1
ETS proto-oncogene 1, transcription factor
decreases expression
EXP
Corn Oil results in decreased expression of ETS1 mRNA
CTD
PMID:22760963
NCBI chr 8:39,303,936...39,426,022
Ensembl chr 8:31,045,945...31,168,010
G
Fabp1
fatty acid binding protein 1
multiple interactions
EXP
[Ethanol co-treated with Corn Oil] results in decreased expression of FABP1 mRNA
CTD
PMID:15016835
NCBI chr 4:104,744,302...104,753,119
Ensembl chr 4:103,191,006...103,194,788
G
Fabp2
fatty acid binding protein 2
affects expression
EXP
Corn Oil affects the expression of FABP2 mRNA
CTD
PMID:16360708
NCBI chr 2:213,724,629...213,728,686
Ensembl chr 2:211,040,032...211,044,089
G
Fabp7
fatty acid binding protein 7
affects expression
EXP
Corn Oil affects the expression of FABP7 mRNA
CTD
PMID:16360708
NCBI chr20:37,667,125...37,673,299
Ensembl chr20:37,123,193...37,126,880
G
Fasn
fatty acid synthase
affects expression
EXP
Corn Oil affects the expression of FASN mRNA
CTD
PMID:16360708
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,072,091...106,090,261
G
Fcgrt
Fc gamma receptor and transporter
decreases expression
EXP
Corn Oil results in decreased expression of FCGRT mRNA
CTD
PMID:22760963
NCBI chr 1:95,574,436...95,584,171
Ensembl chr 1:95,567,175...95,584,084
G
Fgb
fibrinogen beta chain
affects expression
EXP
Corn Oil affects the expression of FGB mRNA
CTD
PMID:16360708
NCBI chr 2:170,693,966...170,700,875
Ensembl chr 2:168,394,916...168,405,979
G
Fgf21
fibroblast growth factor 21
affects expression
EXP
Corn Oil affects the expression of FGF21 mRNA
CTD
PMID:16360708
NCBI chr 1:105,219,825...105,221,376
Ensembl chr 1:96,083,441...96,090,454
G
Fst
follistatin
multiple interactions
ISO
[Estradiol co-treated with Progesterone co-treated with Corn Oil] results in increased expression of FST mRNA
CTD
PMID:32186404
NCBI chr 2:47,856,345...47,863,670
Ensembl chr 2:46,123,439...46,130,571
G
G0s2
G0/G1switch 2
affects expression
EXP
Corn Oil affects the expression of G0S2 mRNA
CTD
PMID:16360708
NCBI chr13:107,335,036...107,335,948
Ensembl chr13:104,806,156...104,807,451
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
affects expression
EXP
Corn Oil affects the expression of GADD45A mRNA
CTD
PMID:16360708
NCBI chr 4:97,484,497...97,486,799
Ensembl chr 4:96,154,789...96,157,115
G
Gal
galanin and GMAP prepropeptide
increases expression
EXP
Corn Oil results in increased expression of GAL mRNA
CTD
PMID:22760963
NCBI chr 1:210,079,709...210,084,572
Ensembl chr 1:200,650,439...200,654,959
G
Gck
glucokinase
affects expression
EXP
Corn Oil affects the expression of GCK mRNA
CTD
PMID:16360708
NCBI chr14:84,999,019...85,041,098
Ensembl chr14:80,785,060...80,826,995
G
Gjd2
gap junction protein, delta 2
increases expression
ISO
Corn Oil results in increased expression of GJD2 mRNA
CTD
PMID:33263755
NCBI chr 3:121,226,372...121,229,367
Ensembl chr 3:100,772,062...100,775,061
G
Got1
glutamic-oxaloacetic transaminase 1
affects expression
EXP
Corn Oil affects the expression of GOT1 mRNA
CTD
PMID:16360708
NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:242,357,306...242,380,633
G
Got2
glutamic-oxaloacetic transaminase 2
decreases expression
EXP
Corn Oil results in decreased expression of GOT2 mRNA
CTD
PMID:34987138
NCBI chr19:9,180,428...9,206,113
Ensembl chr19:9,174,311...9,199,994
G
Gpd2
glycerol-3-phosphate dehydrogenase 2
affects expression
EXP
Corn Oil affects the expression of GPD2 mRNA
CTD
PMID:16360708
NCBI chr 3:62,209,432...62,346,590
Ensembl chr 3:41,801,930...41,936,901
G
Gpt
glutamic--pyruvic transaminase
multiple interactions
EXP
[Corn Oil co-treated with (5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido(4,5-b)(1,4)oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl)acetic acid] results in increased activity of GPT protein; Dactinomycin inhibits the reaction [[Corn Oil co-treated with (5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido(4,5-b)(1,4)oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl)acetic acid] results in increased activity of GPT protein]; Orlistat inhibits the reaction [[Corn Oil co-treated with (5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido(4,5-b)(1,4)oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl)acetic acid] results in increased activity of GPT protein]
CTD
PMID:29479035
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494
G
H2ac25
H2A clustered histone 25
affects expression
EXP
Corn Oil affects the expression of H2A mRNA
CTD
PMID:16360708
NCBI chr10:44,233,283...44,234,835
Ensembl chr10:43,733,668...43,744,874
G
Hal
histidine ammonia lyase
affects expression
EXP
Corn Oil affects the expression of HAL mRNA
CTD
PMID:16360708
NCBI chr 7:29,894,495...29,924,744
Ensembl chr 7:28,006,972...28,037,701
G
Hamp
hepcidin antimicrobial peptide
affects expression
EXP
Corn Oil affects the expression of HAMP mRNA
CTD
PMID:16360708
NCBI chr 1:95,298,332...95,300,271
Ensembl chr 1:86,170,901...86,172,891
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
affects expression
EXP
Corn Oil affects the expression of HMGCR mRNA
CTD
PMID:16360708
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:27,997,525...28,019,703
G
Hoxa11
homeobox A11
multiple interactions
ISO
[Estradiol co-treated with Progesterone co-treated with Corn Oil] results in increased expression of HOXA11 mRNA
CTD
PMID:32186404
NCBI chr 4:81,342,527...81,346,189
Ensembl chr 4:81,342,528...81,346,232
G
Hp
haptoglobin
increases expression
EXP
Corn Oil results in increased expression of HP mRNA
CTD
PMID:22760963
NCBI chr19:54,449,151...54,453,701
Ensembl chr19:37,539,627...37,544,523
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
increases expression
ISO
Corn Oil results in increased expression of HSP90AA1 mRNA
CTD
PMID:33263755
NCBI chr 6:135,523,604...135,529,687
Ensembl chr 6:129,702,383...129,707,268
G
Idi1
isopentenyl-diphosphate delta isomerase 1
affects expression
EXP
Corn Oil affects the expression of IDI1 mRNA
CTD
PMID:16360708
NCBI chr17:66,539,761...66,547,524
Ensembl chr17:61,629,594...61,637,357
G
Igf2bp2
insulin-like growth factor 2 mRNA binding protein 2
affects expression increases expression
EXP
Corn Oil affects the expression of IGF2BP2 mRNA Corn Oil results in increased expression of IGF2BP2 mRNA
CTD
PMID:22760963
NCBI chr11:92,378,908...92,478,893
Ensembl chr11:78,874,414...78,974,377
G
Igfbp1
insulin-like growth factor binding protein 1
affects expression
EXP
Corn Oil affects the expression of IGFBP1 mRNA
CTD
PMID:16360708
NCBI chr14:86,261,277...86,266,344
Ensembl chr14:82,047,415...82,052,482
G
Ihh
Indian hedgehog signaling molecule
multiple interactions
ISO
[Estradiol co-treated with Progesterone co-treated with Corn Oil] results in increased expression of IHH mRNA
CTD
PMID:32186404
NCBI chr 9:83,952,986...83,959,203
Ensembl chr 9:76,504,315...76,510,532
G
Il12b
interleukin 12B
increases secretion
EXP
Corn Oil results in increased secretion of IL12B protein
CTD
PMID:33263755
NCBI chr10:29,390,300...29,405,194
Ensembl chr10:28,893,008...28,902,903
G
Il18
interleukin 18
increases expression
ISO
Corn Oil results in increased expression of IL18 mRNA
CTD
PMID:33263755
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:50,906,960...50,932,887
G
Il1a
interleukin 1 alpha
increases secretion
EXP
Corn Oil results in increased secretion of IL1A protein
CTD
PMID:33263755
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
increases secretion
EXP
Corn Oil results in increased secretion of IL1B protein
CTD
PMID:33263755
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
increases expression
EXP
Corn Oil results in increased expression of IL1RN mRNA
CTD
PMID:22760963
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:7,111,550...7,127,445
G
Il4
interleukin 4
increases expression increases secretion decreases expression
ISO EXP
Corn Oil results in increased expression of IL4 mRNA Corn Oil results in increased secretion of IL4 protein Corn Oil results in decreased expression of IL4 mRNA
CTD
PMID:23409006 PMID:33263755
NCBI chr10:38,272,003...38,277,549
Ensembl chr10:37,771,203...37,776,750
G
Il6r
interleukin 6 receptor
increases expression
EXP
Corn Oil results in increased expression of IL6R mRNA
CTD
PMID:22760963
NCBI chr 2:177,582,020...177,646,705
Ensembl chr 2:175,298,686...175,347,536
G
Il9
interleukin 9
increases secretion
EXP
Corn Oil results in increased secretion of IL9 protein
CTD
PMID:33263755
NCBI chr17:8,117,028...8,120,151
Ensembl chr17:8,111,772...8,114,895
G
Inhbe
inhibin subunit beta E
affects expression
EXP
Corn Oil affects the expression of INHBE mRNA
CTD
PMID:16360708
NCBI chr 7:65,061,531...65,064,519
Ensembl chr 7:63,176,219...63,179,172
G
Ins1
insulin 1
multiple interactions
EXP
Corn Oil inhibits the reaction [Glucose results in increased expression of INS1 protein]
CTD
PMID:29165388
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:251,244,973...251,245,536
G
Irak1
interleukin-1 receptor-associated kinase 1
increases expression
ISO
Corn Oil results in increased expression of IRAK1 mRNA
CTD
PMID:33263755
NCBI chr X:156,919,927...156,929,825
Ensembl chr X:151,768,777...151,778,521
G
Irf5
interferon regulatory factor 5
increases expression
ISO
Corn Oil results in increased expression of IRF5 mRNA
CTD
PMID:33263755
NCBI chr 4:59,092,914...59,104,596
Ensembl chr 4:58,127,640...58,139,267
G
Irf7
interferon regulatory factor 7
increases expression
ISO
Corn Oil results in increased expression of IRF7 mRNA
CTD
PMID:33263755
NCBI chr 1:205,796,956...205,800,543
Ensembl chr 1:196,367,361...196,370,832
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Corn Oil results in increased expression of JUN mRNA
CTD
PMID:33263755
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
G
Klf2
KLF transcription factor 2
affects expression
EXP
Corn Oil affects the expression of KLF2 mRNA
CTD
PMID:16360708
NCBI chr16:17,555,136...17,557,768
Ensembl chr16:17,514,552...17,523,944
G
Lcat
lecithin cholesterol acyltransferase
multiple interactions
ISO
[bisphenol A co-treated with Resveratrol co-treated with Corn Oil] results in increased expression of LCAT mRNA
CTD
PMID:36432690
NCBI chr19:50,744,598...50,748,064
Ensembl chr19:33,834,403...33,838,231
G
Lcn2
lipocalin 2
increases expression
EXP
Corn Oil results in increased expression of LCN2 mRNA
CTD
PMID:22760963
NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:15,680,687...15,684,095
G
Lep
leptin
multiple interactions
EXP
Corn Oil inhibits the reaction [Glucose results in increased expression of LEP protein]
CTD
PMID:29165388
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:57,661,131...57,675,262
G
Lgals1
galectin 1
increases expression
EXP
Corn Oil results in increased expression of LGALS1 mRNA
CTD
PMID:22760963
NCBI chr 7:112,365,695...112,368,801
Ensembl chr 7:110,481,392...110,488,345
G
Lox
lysyl oxidase
multiple interactions
ISO
Corn Oil results in increased activity of and results in increased cleavage of LOX protein
CTD
PMID:26240151
NCBI chr18:48,162,889...48,175,640
Ensembl chr18:45,967,343...46,041,477
G
Ly75
lymphocyte antigen 75
increases expression
EXP
Corn Oil results in increased expression of LY75 mRNA
CTD
PMID:22760963
NCBI chr 3:44,764,702...44,852,219
Ensembl chr 3:44,765,122...44,852,374
G
Map2k1
mitogen activated protein kinase kinase 1
increases expression
ISO
Corn Oil results in increased expression of MAP2K1 mRNA
CTD
PMID:33263755
NCBI chr 8:73,578,747...73,650,184
Ensembl chr 8:64,683,449...64,755,147
G
Map2k3
mitogen activated protein kinase kinase 3
increases expression
ISO
Corn Oil results in increased expression of MAP2K3 mRNA
CTD
PMID:33263755
NCBI chr10:46,107,639...46,128,986
Ensembl chr10:45,607,163...45,629,492
G
Map2k6
mitogen-activated protein kinase kinase 6
affects expression
EXP
Corn Oil affects the expression of MAP2K6 mRNA
CTD
PMID:16360708
NCBI chr10:95,872,747...95,987,747
Ensembl chr10:95,373,204...95,488,293
G
Map3k7
mitogen activated protein kinase kinase kinase 7
increases expression
ISO
Corn Oil results in increased expression of MAP3K7 mRNA
CTD
PMID:33263755
NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:46,357,931...46,415,597
G
Mapk1
mitogen activated protein kinase 1
increases expression
ISO
Corn Oil results in increased expression of MAPK1 mRNA
CTD
PMID:33263755
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk14
mitogen activated protein kinase 14
increases expression
ISO
Corn Oil results in increased expression of MAPK14 mRNA
CTD
PMID:33263755
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,749,670...6,810,589
G
Mapk3
mitogen activated protein kinase 3
increases expression
ISO
Corn Oil results in increased expression of MAPK3 mRNA
CTD
PMID:33263755
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mdm2
MDM2 proto-oncogene
decreases expression
EXP
Corn Oil results in decreased expression of MDM2 mRNA
CTD
PMID:22760963
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:53,290,664...53,314,915
G
Mgmt
O-6-methylguanine-DNA methyltransferase
increases expression
EXP
Corn Oil results in increased expression of MGMT mRNA
CTD
PMID:22760963
NCBI chr 1:201,140,832...201,367,481
Ensembl chr 1:191,710,930...191,937,756
G
Mgst2
microsomal glutathione S-transferase 2
increases expression
EXP
Corn Oil results in increased expression of MGST2 mRNA
CTD
PMID:22760963
NCBI chr 2:137,821,787...137,866,664
Ensembl chr 2:135,693,557...135,715,828
G
Mlycd
malonyl-CoA decarboxylase
decreases expression
EXP
Corn Oil results in decreased expression of MLYCD mRNA
CTD
PMID:22760963
NCBI chr19:64,356,582...64,372,447
Ensembl chr19:47,447,970...47,463,793
G
Msmo1
methylsterol monooxygenase 1
affects expression
EXP
Corn Oil affects the expression of MSMO1 mRNA
CTD
PMID:16360708
NCBI chr16:29,747,113...29,764,360
Ensembl chr16:24,980,697...24,998,016
G
Mtr
5-methyltetrahydrofolate-homocysteine methyltransferase
multiple interactions
ISO
[bisphenol A co-treated with Resveratrol co-treated with Corn Oil] results in increased expression of MTR mRNA
CTD
PMID:36432690
NCBI chr17:62,911,705...62,996,544
Ensembl chr17:58,220,071...58,304,822
G
Mx2
MX dynamin like GTPase 2
affects expression
EXP
Corn Oil affects the expression of MX2 mRNA
CTD
PMID:16360708
NCBI chr11:50,375,101...50,399,373
Ensembl chr11:36,906,111...36,930,342
G
Myd88
MYD88, innate immune signal transduction adaptor
increases expression
ISO
Corn Oil results in increased expression of MYD88 mRNA
CTD
PMID:33263755
NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:119,074,437...119,079,415
G
Nfe2l2
NFE2 like bZIP transcription factor 2
decreases activity
ISO
Corn Oil results in decreased activity of NFE2L2 protein
CTD
PMID:30203046
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nfkbia
NFKB inhibitor alpha
increases expression
ISO
Corn Oil results in increased expression of NFKBIA mRNA
CTD
PMID:33263755
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Nlrc4
NLR family, CARD domain containing 4
increases expression
ISO
Corn Oil results in increased expression of NLRC4 mRNA
CTD
PMID:33263755
NCBI chr 6:26,743,658...26,771,783
Ensembl chr 6:20,995,266...21,018,248
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
affects expression
EXP
Corn Oil affects the expression of NR1H4 mRNA
CTD
PMID:16360708
NCBI chr 7:25,733,471...25,829,440
Ensembl chr 7:23,846,122...23,942,047
G
Nr4a2
nuclear receptor subfamily 4, group A, member 2
increases expression
EXP
Corn Oil results in increased expression of NR4A2 mRNA
CTD
PMID:22760963
NCBI chr 3:62,098,739...62,115,926
Ensembl chr 3:41,689,851...41,697,877
G
Nsmce3
NSE3 homolog, SMC5-SMC6 complex component
affects expression
EXP
Corn Oil affects the expression of NSMCE3 mRNA
CTD
PMID:16360708
NCBI chr 1:118,401,302...118,402,629
G
Oat
ornithine aminotransferase
affects expression
EXP
Corn Oil affects the expression of OAT mRNA
CTD
PMID:16360708
NCBI chr 1:196,777,973...196,797,754
Ensembl chr 1:187,347,865...187,367,682
G
Osgin1
oxidative stress induced growth inhibitor 1
affects expression
EXP
Corn Oil affects the expression of OSGIN1 mRNA
CTD
PMID:16360708
NCBI chr19:64,380,336...64,409,165
Ensembl chr19:47,492,171...47,500,516
G
P2rx5
purinergic receptor P2X 5
affects expression
EXP
Corn Oil affects the expression of P2RX5 mRNA
CTD
PMID:16360708
NCBI chr10:58,276,329...58,291,108
Ensembl chr10:57,777,819...57,789,423
G
Pax8
paired box 8
affects expression
EXP
Corn Oil affects the expression of PAX8 mRNA
CTD
PMID:16360708
NCBI chr 3:27,584,000...27,641,094
Ensembl chr 3:7,185,723...7,242,363
G
Pdgfa
platelet derived growth factor subunit A
affects expression
EXP
Corn Oil affects the expression of PDGFA mRNA
CTD
PMID:16360708
NCBI chr12:20,759,366...20,780,337
Ensembl chr12:15,645,541...15,666,497
G
Pdgfrb
platelet derived growth factor receptor beta
increases expression
EXP
Corn Oil results in increased expression of PDGFRB mRNA
CTD
PMID:22760963
NCBI chr18:56,770,348...56,809,228
Ensembl chr18:54,499,964...54,538,843
G
Pdlim1
PDZ and LIM domain 1
affects expression
EXP
Corn Oil affects the expression of PDLIM1 mRNA
CTD
PMID:16360708
NCBI chr 1:248,991,818...249,040,409
Ensembl chr 1:239,042,385...239,091,076
G
Pdlim2
PDZ and LIM domain 2
affects expression
EXP
Corn Oil affects the expression of PDLIM2 mRNA
CTD
PMID:16360708
NCBI chr15:45,235,421...45,250,187
Ensembl chr15:45,237,477...45,249,242
G
Pgf
placental growth factor
increases expression
EXP
Corn Oil results in increased expression of PGF mRNA
CTD
PMID:22760963
NCBI chr 6:110,547,165...110,557,747
Ensembl chr 6:104,816,104...104,826,685
G
Pgrmc2
progesterone receptor membrane component 2
affects expression
EXP
Corn Oil affects the expression of PGRMC2 mRNA
CTD
PMID:16360708
NCBI chr 2:125,996,190...126,012,090
Ensembl chr 2:124,068,260...124,084,155
G
Pik3ca
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
increases expression
ISO
Corn Oil results in increased expression of PIK3CA mRNA
CTD
PMID:33263755
NCBI chr 2:117,103,643...117,177,411
Ensembl chr 2:115,174,984...115,249,032
G
Plin2
perilipin 2
affects expression
EXP
Corn Oil affects the expression of PLIN2 mRNA
CTD
PMID:16360708
NCBI chr 5:106,202,634...106,258,748
Ensembl chr 5:101,154,411...101,242,319
G
Prlr
prolactin receptor
affects expression
EXP
Corn Oil affects the expression of PRLR mRNA
CTD
PMID:16360708
NCBI chr 2:60,861,391...61,051,883
Ensembl chr 2:59,134,588...59,324,718
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
[Estradiol co-treated with Progesterone co-treated with Corn Oil] results in increased expression of PTGS2 mRNA
CTD
PMID:32186404
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Ptprf
protein tyrosine phosphatase, receptor type, F
affects expression
EXP
Corn Oil affects the expression of PTPRF mRNA
CTD
PMID:16360708
NCBI chr 5:137,027,376...137,109,405
Ensembl chr 5:131,742,754...131,810,023
G
Pycard
PYD and CARD domain containing
increases expression
ISO
Corn Oil results in increased expression of PYCARD mRNA
CTD
PMID:33263755
NCBI chr 1:192,032,124...192,033,419
Ensembl chr 1:182,601,174...182,602,955
G
Rac1
Rac family small GTPase 1
increases expression
ISO
Corn Oil results in increased expression of RAC1 mRNA
CTD
PMID:33263755
NCBI chr12:16,150,411...16,170,864
Ensembl chr12:11,036,698...11,057,251
G
Ripk1
receptor interacting serine/threonine kinase 1
increases expression
ISO
Corn Oil results in increased expression of RIPK1 mRNA
CTD
PMID:33263755
NCBI chr17:31,044,983...31,077,167
Ensembl chr17:30,839,650...30,871,824
G
Ripk2
receptor-interacting serine-threonine kinase 2
increases expression
ISO
Corn Oil results in increased expression of RIPK2 mRNA
CTD
PMID:33263755
NCBI chr 5:34,428,573...34,459,808
Ensembl chr 5:29,631,570...29,662,657
G
RT1-A
RT1 class I, locus A
increases expression
EXP
Corn Oil results in increased expression of RT1-A mRNA
CTD
PMID:22760963
G
RT1-Bb
RT1 class II, locus Bb
increases expression
EXP
Corn Oil results in increased expression of RT1-BB mRNA
CTD
PMID:22760963
NCBI chr20:4,598,475...4,604,118
Ensembl chr20:4,596,559...4,607,597
G
RT1-CE11
RT1 class I, locus CE11
decreases expression
EXP
Corn Oil results in decreased expression of RT1-CE11 mRNA
CTD
PMID:22760963
NCBI chr20:3,355,422...3,385,063
Ensembl chr20:3,350,937...3,380,362
G
RT1-CE14
RT1 class I, locus CE14
increases expression
EXP
Corn Oil results in increased expression of RT1-CE14 mRNA
CTD
PMID:22760963
NCBI chr20:3,301,813...3,305,472
Ensembl chr20:3,297,196...3,305,134
G
RT1-CE15
RT1 class I, locus CE15
decreases expression
EXP
Corn Oil results in decreased expression of RT1-CE15 mRNA
CTD
PMID:22760963
NCBI chr20:3,275,575...3,279,074
Ensembl chr20:3,264,172...3,279,563 Ensembl chr20:3,264,172...3,279,563
G
RT1-CE16
RT1 class I, locus CE16
increases expression
EXP
Corn Oil results in increased expression of RT1-CE16 mRNA
CTD
PMID:22760963
NCBI chr20:3,261,656...3,265,548
Ensembl chr20:3,257,123...3,279,563
G
RT1-CE2
RT1 class I, locus CE2
increases expression
EXP
Corn Oil results in increased expression of RT1-CE2 mRNA
CTD
PMID:22760963
NCBI chr20:3,538,452...3,541,841
Ensembl chr20:3,537,809...3,541,790
G
RT1-CE3
RT1 class I, locus CE3
increases expression
EXP
Corn Oil results in increased expression of RT1-CE3 mRNA
CTD
PMID:22760963
NCBI chr20:3,521,323...3,525,218
Ensembl chr20:2,623,953...2,692,081
G
RT1-CE4
RT1 class I, locus CE4
increases expression
EXP
Corn Oil results in increased expression of RT1-CE4 mRNA
CTD
PMID:22760963
NCBI chr20:3,431,509...3,504,535
G
RT1-CE5
RT1 class I, locus CE5
increases expression
EXP
Corn Oil results in increased expression of RT1-CE5 mRNA
CTD
PMID:22760963
NCBI chr20:3,407,880...3,484,130
G
RT1-N1
RT1 class Ib, locus N1
decreases expression
EXP
Corn Oil results in decreased expression of RT1-N1 mRNA
CTD
PMID:22760963
G
S100a8
S100 calcium binding protein A8
increases expression
EXP
Corn Oil results in increased expression of S100A8 mRNA
CTD
PMID:22760963
NCBI chr 2:178,464,095...178,465,223
Ensembl chr 2:176,167,124...176,167,643
G
S100a9
S100 calcium binding protein A9
increases expression
EXP
Corn Oil results in increased expression of S100A9 mRNA
CTD
PMID:22760963
NCBI chr 2:178,487,941...178,490,622
Ensembl chr 2:176,190,361...176,193,230
G
Scd
stearoyl-CoA desaturase
affects expression
EXP
Corn Oil affects the expression of SCD1 mRNA
CTD
PMID:16360708
NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:243,269,747...243,282,562
G
Scn1b
sodium voltage-gated channel beta subunit 1
affects expression
EXP
Corn Oil affects the expression of SCN1B mRNA
CTD
PMID:16360708
NCBI chr 1:95,481,298...95,491,211
Ensembl chr 1:86,353,917...86,363,739
G
Sds
serine dehydratase
affects expression
EXP
Corn Oil affects the expression of SDS mRNA
CTD
PMID:16360708
NCBI chr12:41,743,796...41,751,108
Ensembl chr12:36,083,229...36,088,203
G
Sfrp2
secreted frizzled-related protein 2
decreases expression
EXP
Corn Oil results in decreased expression of SFRP2 mRNA
CTD
PMID:22760963
NCBI chr 2:171,387,536...171,395,081
Ensembl chr 2:169,089,517...169,097,063
G
Slc25a20
solute carrier family 25 member 20
multiple interactions
ISO
[bisphenol A co-treated with Resveratrol co-treated with Corn Oil] results in increased expression of SLC25A20 mRNA
CTD
PMID:36432690
NCBI chr 8:118,243,573...118,265,027
Ensembl chr 8:109,365,002...109,386,512
G
Slc25a25
solute carrier family 25 member 25
affects expression
EXP
Corn Oil affects the expression of SLC25A25 mRNA
CTD
PMID:16360708
NCBI chr 3:36,106,448...36,139,812
Ensembl chr 3:15,708,703...15,742,216
G
Sod1
superoxide dismutase 1
decreases activity multiple interactions
ISO
Corn Oil results in decreased activity of SOD1 protein [Corn Oil co-treated with Iron, Dietary] results in decreased activity of SOD1 protein; [Corn Oil co-treated with Iron] results in decreased activity of SOD1 protein; Iron promotes the reaction [Corn Oil results in decreased activity of SOD1 protein]; Iron, Dietary promotes the reaction [Corn Oil results in decreased activity of SOD1 protein]
CTD
PMID:17194920
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
Sparc
secreted protein acidic and cysteine rich
increases expression
EXP
Corn Oil results in increased expression of SPARC mRNA
CTD
PMID:22760963
NCBI chr10:40,017,065...40,038,816
Ensembl chr10:39,516,406...39,538,396
G
Sqle
squalene epoxidase
affects expression
EXP
Corn Oil affects the expression of SQLE mRNA
CTD
PMID:16360708
NCBI chr 7:92,758,175...92,773,049
Ensembl chr 7:90,868,011...90,883,618
G
Srebf1
sterol regulatory element binding transcription factor 1
affects expression
EXP
Corn Oil affects the expression of SREBF1 mRNA
CTD
PMID:16360708
NCBI chr10:45,507,152...45,529,164
Ensembl chr10:45,007,637...45,029,650
G
Sstr3
somatostatin receptor 3
decreases expression
EXP
Corn Oil results in decreased expression of SSTR3 mRNA
CTD
PMID:22760963
NCBI chr 7:111,973,049...111,980,250
Ensembl chr 7:110,092,575...110,099,769
G
Sugt1
SGT1 homolog, MIS12 kinetochore complex assembly cochaperone
increases expression
ISO
Corn Oil results in increased expression of SUGT1 mRNA
CTD
PMID:33263755
NCBI chr15:61,400,478...61,441,303
Ensembl chr15:54,990,672...55,069,150
G
Syk
spleen associated tyrosine kinase
increases expression
ISO
Corn Oil results in increased expression of SYK mRNA
CTD
PMID:23409006
NCBI chr17:12,756,493...12,830,927
Ensembl chr17:12,604,619...12,661,410
G
Tac1
tachykinin, precursor 1
decreases expression
EXP
Corn Oil results in decreased expression of TAC1 mRNA
CTD
PMID:22760963
NCBI chr 4:36,645,344...36,653,548
Ensembl chr 4:35,679,704...35,687,178
G
Tat
tyrosine aminotransferase
affects expression
EXP
Corn Oil affects the expression of TAT mRNA
CTD
PMID:16360708
NCBI chr19:54,856,604...54,867,168
Ensembl chr19:37,947,112...37,958,031
G
Tbc1d14
TBC1 domain family, member 14
affects expression
EXP
Corn Oil affects the expression of TBC1D14 mRNA
CTD
PMID:16360708
NCBI chr14:74,172,652...74,272,182
Ensembl chr14:74,172,664...74,272,183
G
Tgfa
transforming growth factor alpha
decreases expression
EXP
Corn Oil results in decreased expression of TGFA mRNA
CTD
PMID:22760963
NCBI chr 4:120,175,549...120,258,342
Ensembl chr 4:118,618,269...118,700,894
G
Ticam1
TIR domain containing adaptor molecule 1
increases expression
ISO
Corn Oil results in increased expression of TICAM1 mRNA
CTD
PMID:33263755
NCBI chr 9:1,189,717...1,197,730
Ensembl chr 9:1,102,366...1,123,147
G
Tjp2
tight junction protein 2
increases expression
ISO
Corn Oil results in increased expression of TJP2 mRNA
CTD
PMID:33263755
NCBI chr 1:231,136,218...231,264,750
Ensembl chr 1:221,709,745...221,838,295
G
Tjp3
tight junction protein 3
increases expression
ISO
Corn Oil results in increased expression of TJP3 mRNA
CTD
PMID:33263755
NCBI chr 7:8,427,650...8,446,279
Ensembl chr 7:8,432,811...8,446,279
G
Tnfrsf1a
TNF receptor superfamily member 1A
increases expression
ISO
Corn Oil results in increased expression of TNFRSF1A mRNA
CTD
PMID:33263755
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:158,150,820...158,163,591
G
Tollip
toll interacting protein
increases expression
ISO
Corn Oil results in increased expression of TOLLIP mRNA
CTD
PMID:33263755
NCBI chr 1:206,391,120...206,413,809
Ensembl chr 1:196,950,771...196,983,625
G
Tpcn2
two pore segment channel 2
affects expression
EXP
Corn Oil affects the expression of TPCN2 mRNA
CTD
PMID:16360708
NCBI chr 1:209,845,827...209,875,561
Ensembl chr 1:200,416,540...200,446,236
G
Tpt1
tumor protein, translationally-controlled 1
increases expression
EXP
Corn Oil results in increased expression of TPT1 mRNA
CTD
PMID:22760963
NCBI chr15:57,562,217...57,568,968
Ensembl chr15:51,146,154...51,159,625
G
Vegfb
vascular endothelial growth factor B
decreases expression
EXP
Corn Oil results in decreased expression of VEGFB mRNA
CTD
PMID:22760963
NCBI chr 1:213,601,570...213,607,254
Ensembl chr 1:204,172,225...204,177,944
G
Vnn1
vanin 1
affects expression
EXP
Corn Oil affects the expression of VNN1 mRNA
CTD
PMID:16360708
NCBI chr 1:23,356,324...23,366,629
Ensembl chr 1:21,537,094...21,547,395
G
Xiap
X-linked inhibitor of apoptosis
decreases expression
ISO
Corn Oil results in decreased expression of XIAP mRNA
CTD
PMID:33263755
NCBI chr X:125,756,107...125,803,979
Ensembl chr X:120,897,907...120,934,700
G
Xpnpep2
X-prolyl aminopeptidase 2
affects expression
EXP
Corn Oil affects the expression of XPNPEP2 mRNA
CTD
PMID:16360708
NCBI chr X:132,165,696...132,194,937
Ensembl chr X:127,287,979...127,317,223
G
Zdhhc23
zinc finger DHHC-type palmitoyltransferase 23
affects expression
EXP
Corn Oil affects the expression of ZDHHC23 mRNA
CTD
PMID:16360708
NCBI chr11:70,224,581...70,240,971
Ensembl chr11:56,718,826...56,734,194
G
Casp3
caspase 3
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of CASP3 protein]
CTD
PMID:22389237
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Crabp2
cellular retinoic acid binding protein 2
multiple interactions
ISO
[Tretinoin co-treated with delta-tocopherol] results in increased expression of CRABP2 mRNA
CTD
PMID:15225641
NCBI chr 2:173,417,004...173,421,352
Ensembl chr 2:173,416,857...173,421,379
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of CYP1A1 mRNA]
CTD
PMID:22389237
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Esr1
estrogen receptor 1
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR1 protein]
CTD
PMID:22389237
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR2 mRNA]
CTD
PMID:22389237
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:94,809,547...94,908,919
G
Gclm
glutamate cysteine ligase, modifier subunit
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GCLM mRNA]
CTD
PMID:22389237
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:210,347,482...210,367,535
G
Gstm1
glutathione S-transferase mu 1
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GSTM1 mRNA]
CTD
PMID:22389237
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:195,649,845...195,655,411
G
Hmox1
heme oxygenase 1
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of HMOX1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of HMOX1 protein]
CTD
PMID:22389237
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NFE2L2 protein]
CTD
PMID:22389237
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NQO1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NQO1 protein]
CTD
PMID:22389237
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Pcna
proliferating cell nuclear antigen
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PCNA protein]
CTD
PMID:22389237
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:119,498,810...119,502,995
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein]
CTD
PMID:22389237
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PTGS2 protein]
CTD
PMID:22389237
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of UGT1A1 mRNA]
CTD
PMID:22389237
NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Abcb1a
ATP binding cassette subfamily B member 1A
increases expression
ISO
tocotrienol, delta results in increased expression of ABCB1
CTD
PMID:15269186
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
G
Abcc1
ATP binding cassette subfamily C member 1
multiple interactions increases expression
ISO
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of ABCC1 mRNA] tocotrienol, delta results in increased expression of ABCC1 mRNA
CTD
PMID:22185406
NCBI chr10:1,022,041...1,162,431
Ensembl chr10:531,812...655,114
G
Abcd2
ATP binding cassette subfamily D member 2
decreases expression
ISO
tocotrienol, delta results in decreased expression of ABCD2 mRNA
CTD
PMID:22185406
NCBI chr 7:124,142,597...124,191,202
Ensembl chr 7:122,263,032...122,311,642
G
Actl6b
actin-like 6B
increases expression
ISO
tocotrienol, delta results in increased expression of ACTL6B mRNA
CTD
PMID:22185406
NCBI chr12:19,124,887...19,141,419
Ensembl chr12:19,124,916...19,141,376
G
Atp2a2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
multiple interactions increases expression
ISO
tocotrienol, delta promotes the reaction [Lipopolysaccharides results in increased expression of ATP2A2 mRNA] tocotrienol, delta results in increased expression of ATP2A2 mRNA
CTD
PMID:22185406
NCBI chr12:39,733,519...39,782,942
Ensembl chr12:34,072,683...34,122,101
G
Ccnd1
cyclin D1
decreases expression
ISO
tocotrienol, delta results in decreased expression of CCND1 protein
CTD
PMID:21453743
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
G
Ccnd2
cyclin D2
multiple interactions increases expression
ISO
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of CCND2 mRNA] tocotrienol, delta results in increased expression of CCND2 mRNA
CTD
PMID:22185406
NCBI chr 4:161,653,048...161,675,422
Ensembl chr 4:159,962,363...159,989,495
G
Cd40
CD40 molecule
multiple interactions increases expression
ISO
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of CD40 mRNA] tocotrienol, delta results in increased expression of CD40 mRNA
CTD
PMID:22185406
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:153,790,449...153,805,534
G
Cd69
Cd69 molecule
multiple interactions increases expression
ISO
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of CD69 mRNA] tocotrienol, delta results in increased expression of CD69 mRNA
CTD
PMID:22185406
NCBI chr 4:164,411,485...164,419,403
Ensembl chr 4:162,725,446...162,733,542
G
Cox7b2
cytochrome c oxidase subunit 7B2
multiple interactions decreases expression
ISO
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in decreased expression of COX7B2 mRNA] tocotrienol, delta results in decreased expression of COX7B2 mRNA
CTD
PMID:22185406
NCBI chr14:37,047,081...37,159,288
Ensembl chr14:36,693,105...36,805,523
G
Crp
C-reactive protein
multiple interactions
ISO
[resveratrol co-treated with pterostilbene co-treated with Quercetin co-treated with tocotrienol, delta co-treated with Niacin] results in decreased expression of CRP protein
CTD
PMID:24319627
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:85,124,977...85,175,178
G
Ctnnb1
catenin beta 1
decreases expression
ISO
tocotrienol, delta results in decreased expression of CTNNB1 protein
CTD
PMID:21453743
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions increases expression
ISO
tocotrienol, delta inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Testosterone]; tocotrienol, delta inhibits the reaction [CYP3A4 protein results in increased oxidation of Lithocholic Acid] tocotrienol, delta results in increased expression of CYP3A4
CTD
PMID:15269186 PMID:31102695
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
multiple interactions affects response to substance
ISO
tocotrienol, delta inhibits the reaction [CYP3A5 protein results in increased hydroxylation of Testosterone]; tocotrienol, delta inhibits the reaction [CYP3A5 protein results in increased oxidation of Lithocholic Acid] CYP3A5 gene polymorphism affects the susceptibility to tocotrienol, delta
CTD
PMID:31102695
NCBI chr12:21,919,955...21,960,160
Ensembl chr12:16,806,207...16,846,422
G
Gimap1
GTPase, IMAP family member 1
multiple interactions decreases expression
ISO
tocotrienol, delta promotes the reaction [Lipopolysaccharides results in decreased expression of GIMAP1 mRNA] tocotrienol, delta results in decreased expression of GIMAP1 mRNA
CTD
PMID:22185406
NCBI chr 4:79,018,473...79,022,360
Ensembl chr 4:77,682,171...77,691,866
G
Icam1
intercellular adhesion molecule 1
decreases expression multiple interactions
ISO
tocotrienol, delta results in decreased expression of ICAM1 mRNA tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 mRNA]
CTD
PMID:22185406
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Ifnb1
interferon beta 1
multiple interactions
ISO
tocotrienol, delta inhibits the reaction [[IFNB1 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide]
CTD
PMID:22185406
NCBI chr 5:108,066,650...108,067,487
Ensembl chr 5:103,020,969...103,021,523
G
Ifng
interferon gamma
multiple interactions
ISO
tocotrienol, delta inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide]
CTD
PMID:22185406
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
G
Ifngr1
interferon gamma receptor 1
decreases expression multiple interactions
ISO
tocotrienol, delta results in decreased expression of IFNGR1 mRNA tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in decreased expression of IFNGR1 mRNA]
CTD
PMID:22185406
NCBI chr 1:16,152,811...16,171,439
Ensembl chr 1:14,333,187...14,351,785
G
Il12b
interleukin 12B
decreases expression multiple interactions
ISO
tocotrienol, delta results in decreased expression of IL12B mRNA tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of IL12B mRNA]
CTD
PMID:22185406
NCBI chr10:29,390,300...29,405,194
Ensembl chr10:28,893,008...28,902,903
G
Il1a
interleukin 1 alpha
increases expression
ISO
tocotrienol, delta results in increased expression of IL1A mRNA
CTD
PMID:22185406
NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
multiple interactions increases expression
ISO
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] tocotrienol, delta results in increased expression of IL1B mRNA
CTD
PMID:22185406
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il1rn
interleukin 1 receptor antagonist
increases expression multiple interactions
ISO
tocotrienol, delta results in increased expression of IL1RN mRNA tocotrienol, delta promotes the reaction [Lipopolysaccharides results in increased expression of IL1RN mRNA]
CTD
PMID:22185406
NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:7,111,550...7,127,445
G
Il6
interleukin 6
increases expression multiple interactions
ISO
tocotrienol, delta results in increased expression of IL6 mRNA tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]
CTD
PMID:22185406
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
decreases expression
ISO
tocotrienol, delta results in decreased expression of JUN protein
CTD
PMID:21453743
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
G
Mmp7
matrix metallopeptidase 7
decreases expression
ISO
tocotrienol, delta results in decreased expression of MMP7 protein
CTD
PMID:21453743
NCBI chr 8:13,133,043...13,140,761
Ensembl chr 8:4,848,186...4,855,902
G
Ncor1
nuclear receptor co-repressor 1
multiple interactions
ISO
tocotrienol, delta inhibits the reaction [NR1I2 protein binds to NCOR1 protein]
CTD
PMID:15269186
NCBI chr10:47,498,852...47,641,612
Ensembl chr10:46,999,536...47,141,032
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
Lipopolysaccharides inhibits the reaction [tocotrienol, delta results in increased expression of NOS2]; tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]
CTD
PMID:21356098 PMID:22185406
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
tocotrienol, delta binds to and results in increased activity of NR1I2 protein; tocotrienol, delta inhibits the reaction [NR1I2 protein binds to NCOR1 protein]
CTD
PMID:15269186
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:62,460,213...62,496,658
G
Phka2
phosphorylase kinase regulatory subunit alpha 2
multiple interactions increases expression
ISO
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in decreased expression of PHKA2 mRNA] tocotrienol, delta results in increased expression of PHKA2 mRNA
CTD
PMID:22185406
NCBI chr X:37,979,629...38,102,656
Ensembl chr X:34,171,323...34,293,466
G
Psmb2
proteasome 20S subunit beta 2
decreases expression
ISO
tocotrienol, delta results in decreased expression of PSMB2 mRNA
CTD
PMID:22185406
NCBI chr 5:144,255,058...144,287,200
Ensembl chr 5:138,970,533...139,021,137
G
Ptbp2
polypyrimidine tract binding protein 2
multiple interactions increases expression
ISO
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in decreased expression of PTBP2 mRNA] tocotrienol, delta results in increased expression of PTBP2 mRNA
CTD
PMID:22185406
NCBI chr 2:210,497,610...210,558,497
Ensembl chr 2:207,812,920...207,873,506
G
Rasgrp1
RAS guanyl releasing protein 1
multiple interactions increases expression
ISO
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of RASGRP1 mRNA] tocotrienol, delta results in increased expression of RASGRP1 mRNA
CTD
PMID:22185406
NCBI chr 3:124,624,039...124,684,079
Ensembl chr 3:104,170,013...104,230,056
G
Rasgrp3
RAS guanyl releasing protein 3
decreases expression multiple interactions
ISO
tocotrienol, delta results in decreased expression of RASGRP3 mRNA tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in decreased expression of RASGRP3 mRNA]
CTD
PMID:22185406
NCBI chr 6:25,647,386...25,745,952
Ensembl chr 6:19,895,390...19,958,578
G
Socs3
suppressor of cytokine signaling 3
multiple interactions decreases expression
ISO
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of SOCS3 mRNA] tocotrienol, delta results in decreased expression of SOCS3 mRNA
CTD
PMID:22185406
NCBI chr10:103,692,579...103,695,975
Ensembl chr10:103,193,537...103,197,787
G
Tnf
tumor necrosis factor
multiple interactions decreases expression
ISO
Lipopolysaccharides inhibits the reaction [tocotrienol, delta results in increased expression of TNF]; tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] tocotrienol, delta results in decreased expression of TNF mRNA
CTD
PMID:21356098 PMID:22185406
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnp1
transition protein 1
multiple interactions decreases expression
ISO
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in decreased expression of TNP1 mRNA] tocotrienol, delta results in decreased expression of TNP1 mRNA
CTD
PMID:22185406
NCBI chr 9:74,594,463...74,595,072
Ensembl chr 9:74,594,466...74,595,274
G
Traf1
TNF receptor-associated factor 1
multiple interactions increases expression
ISO
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of TRAF1 mRNA] tocotrienol, delta results in increased expression of TRAF1 mRNA
CTD
PMID:22185406
NCBI chr 3:38,607,707...38,639,641
Ensembl chr 3:18,222,054...18,241,807
G
Ube2d2
ubiquitin-conjugating enzyme E2D 2
multiple interactions decreases expression
ISO
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in decreased expression of UBE2D2A mRNA] tocotrienol, delta results in decreased expression of UBE2D2A mRNA
CTD
PMID:22185406
NCBI chr18:27,364,325...27,406,322
Ensembl chr18:27,364,303...27,406,181
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases expression
ISO
tocotrienol, delta results in increased expression of UGT1A1
CTD
PMID:15269186
NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Vcam1
vascular cell adhesion molecule 1
multiple interactions decreases expression
ISO
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of VCAM1 mRNA] tocotrienol, delta results in decreased expression of VCAM1 mRNA
CTD
PMID:22185406
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:204,038,114...204,057,958
G
Wnt1
Wnt family member 1
decreases expression
ISO
tocotrienol, delta results in decreased expression of WNT1 protein
CTD
PMID:21453743
NCBI chr 7:131,817,558...131,821,605
Ensembl chr 7:129,938,604...129,942,651
G
Abcc1
ATP binding cassette subfamily C member 1
decreases activity multiple interactions
ISO
Tocopherols results in decreased activity of ABCC1 protein Tocopherols inhibits the reaction [ABCC1 protein affects the export of Etoposide]
CTD
PMID:15617835
NCBI chr10:1,022,041...1,162,431
Ensembl chr10:531,812...655,114
G
Alb
albumin
multiple interactions
EXP
gamma-Tocopherol inhibits the reaction [ALB protein results in increased expression of MUC5AC mRNA]
CTD
PMID:19389874
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
G
App
amyloid beta precursor protein
decreases abundance multiple interactions
EXP
APP protein modified form results in decreased abundance of Tocopherols resveratrol inhibits the reaction [APP protein modified form results in decreased abundance of Tocopherols]
CTD
PMID:25654502
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561
G
Ar
androgen receptor
decreases expression decreases activity
ISO
[Tocopherols results in decreased expression of AR protein] which results in decreased expression of KLK3 protein; Tocopherols results in decreased expression of AR mRNA; Tocopherols results in decreased expression of AR protein Tocopherols results in decreased activity of AR protein
CTD
PMID:12032296 PMID:16302272
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:63,104,771...63,273,925
G
Arf3
ARF GTPase 3
increases expression
ISO
Tocopherols results in increased expression of ARF3 mRNA
CTD
PMID:17654050
NCBI chr 7:131,765,039...131,792,075
Ensembl chr 7:129,886,082...129,912,002
G
Aspm
assembly factor for spindle microtubules
increases expression
ISO
Tocopherols results in increased expression of ASPM mRNA
CTD
PMID:17056531
NCBI chr13:53,625,584...53,674,489
Ensembl chr13:51,074,849...51,123,755
G
Atp1a2
ATPase Na+/K+ transporting subunit alpha 2
increases expression
ISO
Tocopherols results in increased expression of ATP1A2 mRNA
CTD
PMID:17654050
NCBI chr13:87,261,964...87,286,911
Ensembl chr13:84,729,601...84,754,544
G
Atp1b2
ATPase Na+/K+ transporting subunit beta 2
increases expression
ISO
Tocopherols results in increased expression of ATP1B2 mRNA
CTD
PMID:17654050
NCBI chr10:54,817,473...54,823,708
Ensembl chr10:54,318,701...54,324,933
G
Aurka
aurora kinase A
increases expression
ISO
Tocopherols results in increased expression of AURKA mRNA
CTD
PMID:17056531
NCBI chr 3:181,546,742...181,562,890
Ensembl chr 3:161,128,313...161,144,390
G
Bax
BCL2 associated X, apoptosis regulator
increases response to substance multiple interactions increases expression
ISO
BAX protein results in increased susceptibility to Tocopherols [Fluorouracil co-treated with gamma-Tocopherol] results in increased expression of BAX mRNA gamma-Tocopherol results in increased expression of BAX mRNA
CTD
PMID:16001965 PMID:31587439
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
increases expression multiple interactions decreases expression decreases response to substance
ISO
Tocopherols results in increased expression of BCL2 mRNA; Tocopherols results in increased expression of BCL2 protein [Fluorouracil co-treated with gamma-Tocopherol] results in decreased expression of BCL2 mRNA gamma-Tocopherol results in decreased expression of BCL2 mRNA BCL2 protein results in decreased susceptibility to Tocopherols
CTD
PMID:8970189 PMID:16001965 PMID:31587439
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
decreases response to substance
ISO
BCL2L1 protein results in decreased susceptibility to Tocopherols
CTD
PMID:16001965
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Birc5
baculoviral IAP repeat-containing 5
increases expression
ISO
Tocopherols results in increased expression of BIRC5 mRNA
CTD
PMID:17056531
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,073,408...103,081,380
G
Camk2g
calcium/calmodulin-dependent protein kinase II gamma
increases expression
ISO
Tocopherols results in increased expression of CAMK2G mRNA
CTD
PMID:17654050
NCBI chr15:3,553,238...3,612,310
Ensembl chr15:3,504,085...3,563,050
G
Casp3
caspase 3
increases activity multiple interactions
ISO EXP
gamma-Tocopherol results in increased activity of CASP3 protein [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of CASP3 protein] thermozymocidin inhibits the reaction [gamma-Tocopherol results in increased activity of CASP3 protein]
CTD
PMID:15596715 PMID:22389237
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
increases activity
ISO
gamma-Tocopherol results in increased activity of CASP9 protein
CTD
PMID:15596715
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
increases expression
ISO
gamma-Tocopherol results in increased expression of CAT protein
CTD
PMID:19115203
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Ccnb2
cyclin B2
increases expression
ISO
Tocopherols results in increased expression of CCNB2 mRNA
CTD
PMID:17056531
NCBI chr 8:79,968,459...79,981,717
Ensembl chr 8:71,087,595...71,100,874
G
Ccnd1
cyclin D1
decreases expression multiple interactions
ISO
gamma-Tocopherol results in decreased expression of CCND1 mRNA; gamma-Tocopherol results in decreased expression of CCND1 protein; Tocopherols results in decreased expression of CCND1 protein [Fluorouracil co-treated with gamma-Tocopherol] results in decreased expression of CCND1 mRNA
CTD
PMID:12368234 PMID:12504091 PMID:31587439
NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:200,089,002...200,098,602
G
Ccnd3
cyclin D3
decreases expression
ISO
Tocopherols results in decreased expression of CCND3 protein
CTD
PMID:12504091
NCBI chr 9:20,891,696...20,987,199
Ensembl chr 9:13,394,169...13,489,371
G
Ccne1
cyclin E1
decreases expression multiple interactions
ISO
gamma-Tocopherol results in decreased expression of CCNE1 mRNA; gamma-Tocopherol results in decreased expression of CCNE1 protein; Tocopherols results in decreased expression of CCNE1 mRNA; Tocopherols results in decreased expression of CCNE1 protein [Fluorouracil co-treated with gamma-Tocopherol] results in decreased expression of CCNE1 mRNA
CTD
PMID:12368234 PMID:12504091 PMID:31587439
NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:90,781,949...90,791,101
G
Cdc6
cell division cycle 6
increases expression
ISO
Tocopherols results in increased expression of CDC6 mRNA
CTD
PMID:17056531
NCBI chr10:84,360,361...84,374,239
Ensembl chr10:83,864,638...83,878,011
G
Cdk1
cyclin-dependent kinase 1
increases expression
ISO
Tocopherols results in increased expression of CDK1 mRNA
CTD
PMID:17056531
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,266,248...19,281,408
G
Cdk2
cyclin dependent kinase 2
decreases expression
ISO
Tocopherols results in decreased expression of CDK2 protein
CTD
PMID:12504091
NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,129,811...1,137,403
G
Cdk4
cyclin-dependent kinase 4
multiple interactions
ISO
Tocopherols results in decreased expression of and results in decreased activity of CDK4 protein
CTD
PMID:12504091
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:62,883,105...62,942,403
G
Cdk5r1
cyclin-dependent kinase 5 regulatory subunit 1
increases expression
ISO
Tocopherols results in increased expression of CDK5R1 mRNA
CTD
PMID:17654050
NCBI chr10:65,981,692...65,985,831
Ensembl chr10:65,483,941...65,488,456
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
decreases expression
ISO
gamma-Tocopherol results in decreased expression of CDKN1A protein
CTD
PMID:12368234
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
decreases expression
ISO
gamma-Tocopherol results in decreased expression of CDKN1B protein
CTD
PMID:12368234
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:167,760,181...167,764,982
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
decreases expression
ISO
gamma-Tocopherol results in decreased expression of CDKN2A protein
CTD
PMID:12368234
NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:103,984,949...104,003,149
G
Clec4e
C-type lectin domain family 4, member E
increases expression
ISO
Tocopherols results in increased expression of CLEC4E mRNA
CTD
PMID:17056531
NCBI chr 4:158,292,624...158,298,607
Ensembl chr 4:156,607,614...156,612,767
G
Cplx1
complexin 1
increases expression
ISO
Tocopherols results in increased expression of CPLX1 mRNA
CTD
PMID:17654050
NCBI chr14:1,329,073...1,360,781
G
Cplx2
complexin 2
increases expression
ISO
Tocopherols results in increased expression of CPLX2 mRNA
CTD
PMID:17654050
NCBI chr17:10,224,673...10,297,974
Ensembl chr17:10,222,347...10,293,855
G
Crabp2
cellular retinoic acid binding protein 2
multiple interactions
ISO
[Tretinoin co-treated with gamma-Tocopherol] results in increased expression of CRABP2 mRNA
CTD
PMID:15225641
NCBI chr 2:173,417,004...173,421,352
Ensembl chr 2:173,416,857...173,421,379
G
Crp
C-reactive protein
multiple interactions
ISO
[alpha-Tocopherol co-treated with gamma-Tocopherol] results in decreased expression of CRP protein
CTD
PMID:18191645
NCBI chr13:87,694,062...87,695,978
Ensembl chr13:85,124,977...85,175,178
G
Csf1r
colony stimulating factor 1 receptor
increases expression
ISO
Tocopherols results in increased expression of CSF1R mRNA
CTD
PMID:17056531
NCBI chr18:56,834,152...56,860,804
Ensembl chr18:54,546,659...54,590,415
G
Csrp2
cysteine and glycine-rich protein 2
increases expression
ISO
Tocopherols results in increased expression of CSRP2 mRNA
CTD
PMID:17056531
NCBI chr 7:48,235,415...48,254,049
Ensembl chr 7:46,348,686...46,367,745
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of CYP1A1 mRNA]
CTD
PMID:22389237
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Dnajc5
DnaJ heat shock protein family (Hsp40) member C5
increases expression
ISO
Tocopherols results in increased expression of DNAJC5 mRNA
CTD
PMID:17654050
NCBI chr 3:188,999,508...189,033,455
Ensembl chr 3:168,621,969...168,655,935
G
E2f1
E2F transcription factor 1
increases expression
ISO
Tocopherols results in increased expression of E2F1 protein
CTD
PMID:15883045
NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:143,049,478...143,075,361
G
Egr1
early growth response 1
decreases activity
ISO
Tocopherols results in decreased activity of EGR1 protein
CTD
PMID:15878867
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,462,981...26,466,766
G
Esr1
estrogen receptor 1
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR1 protein]
CTD
PMID:22389237
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR2 mRNA]
CTD
PMID:22389237
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:94,809,547...94,908,919
G
Fcer1a
Fc epsilon receptor Ia
increases expression
ISO
Tocopherols results in increased expression of FCER1A mRNA
CTD
PMID:17056531
NCBI chr13:88,218,427...88,224,723
Ensembl chr13:85,686,092...85,692,351
G
Fes
FES proto-oncogene, tyrosine kinase
increases expression
ISO
Tocopherols results in increased expression of FES mRNA
CTD
PMID:17056531
NCBI chr 1:143,746,945...143,756,181
Ensembl chr 1:134,337,698...134,346,934
G
Fgf1
fibroblast growth factor 1
decreases expression
ISO
Tocopherols results in decreased expression of FGF1 mRNA
CTD
PMID:15878867
NCBI chr18:30,937,670...31,023,786
Ensembl chr18:30,686,581...30,772,357
G
Fgf2
fibroblast growth factor 2
decreases expression
ISO
Tocopherols results in decreased expression of FGF2 mRNA
CTD
PMID:15878867
NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:120,236,328...120,291,221
G
Fgfr1
Fibroblast growth factor receptor 1
decreases expression
ISO
Tocopherols results in decreased expression of FGFR1 mRNA
CTD
PMID:15144885
NCBI chr16:73,194,631...73,249,855
Ensembl chr16:66,494,042...66,547,350
G
Fkbp9
FKBP prolyl isomerase 9
increases expression
ISO
Tocopherols results in increased expression of FKBP9 mRNA
CTD
PMID:17056531
NCBI chr 4:86,106,256...86,156,723
Ensembl chr 4:86,106,282...86,156,721
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Tocopherols results in increased expression of FOS mRNA; Tocopherols results in increased expression of FOS protein
CTD
PMID:8970189
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Gclm
glutamate cysteine ligase, modifier subunit
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GCLM mRNA]
CTD
PMID:22389237
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:210,347,482...210,367,535
G
Gria2
glutamate ionotropic receptor AMPA type subunit 2
increases expression
ISO
Tocopherols results in increased expression of GRIA2 mRNA
CTD
PMID:17654050
NCBI chr 2:168,247,490...168,367,616
Ensembl chr 2:165,947,521...166,069,510
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
increases expression
ISO
Tocopherols results in increased expression of GRIN1 mRNA
CTD
PMID:17654050
NCBI chr 3:28,501,836...28,528,754
Ensembl chr 3:8,103,680...8,130,603
G
Gstm1
glutathione S-transferase mu 1
increases expression multiple interactions
ISO EXP
gamma-Tocopherol results in increased expression of GSTM1 mRNA; gamma-Tocopherol results in increased expression of GSTM1 protein [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GSTM1 mRNA]
CTD
PMID:19115203 PMID:22389237
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:195,649,845...195,655,411
G
Gsto1
glutathione S-transferase omega 1
decreases activity
ISO
Tocopherols results in decreased activity of GSTO1 protein
CTD
PMID:16781109
NCBI chr 1:256,662,377...256,672,515
Ensembl chr 1:246,721,221...246,731,468
G
Haspin
histone H3 associated protein kinase
increases expression
ISO
Tocopherols results in increased expression of HASPIN mRNA
CTD
PMID:17056531
NCBI chr10:58,246,244...58,249,031
Ensembl chr10:57,747,573...57,750,512
G
Hmox1
heme oxygenase 1
increases expression multiple interactions
ISO EXP
gamma-Tocopherol results in increased expression of HMOX1 protein [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of HMOX1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of HMOX1 protein]
CTD
PMID:19115203 PMID:22389237
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Tocopherols results in increased expression of JUN mRNA; Tocopherols results in increased expression of JUN protein
CTD
PMID:8970189
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
G
Kif20a
kinesin family member 20A
increases expression
ISO
Tocopherols results in increased expression of KIF20A mRNA
CTD
PMID:17056531
NCBI chr18:26,504,422...26,512,908
Ensembl chr18:26,230,230...26,238,780
G
Kif4a
kinesin family member 4A
increases expression
ISO
Tocopherols results in increased expression of KIF4 mRNA
CTD
PMID:17056531
NCBI chr X:69,761,803...69,864,335
Ensembl chr X:65,721,779...65,824,139
G
Klk1c10
kallikrein 1-related peptidase C10
decreases expression multiple interactions
ISO
[Tocopherols results in decreased expression of AR protein] which results in decreased expression of KLK3 protein; Tocopherols results in decreased expression of KLK3 mRNA; Tocopherols results in decreased expression of KLK3 protein Tocopherols inhibits the reaction [Dihydrotestosterone results in increased expression of KLK3 mRNA]; Tocopherols inhibits the reaction [Dihydrotestosterone results in increased expression of KLK3 protein]
CTD
PMID:12032296 PMID:16302272
NCBI chr 1:103,539,527...103,543,586
Ensembl chr 1:94,402,993...94,407,052
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
decreases response to substance
ISO
MCL1 protein results in decreased susceptibility to Tocopherols
CTD
PMID:16001965
NCBI chr 2:185,884,840...185,912,532
Ensembl chr 2:183,219,220...183,222,303
G
Muc5ac
mucin 5AC, oligomeric mucus/gel-forming
multiple interactions
EXP
gamma-Tocopherol inhibits the reaction [ALB protein results in increased expression of MUC5AC mRNA]
CTD
PMID:19389874
NCBI chr 1:206,293,717...206,326,006
Ensembl chr 1:196,864,336...196,896,475
G
Myc
MYC proto-oncogene, bHLH transcription factor
decreases expression decreases activity
ISO
Tocopherols results in decreased expression of MYC mRNA Tocopherols results in decreased activity of MYC protein
CTD
PMID:8970189
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:93,593,705...93,598,630
G
Napb
NSF attachment protein beta
increases expression
ISO
Tocopherols results in increased expression of NAPB mRNA
CTD
PMID:17654050
NCBI chr 3:156,585,394...156,632,418
Ensembl chr 3:136,133,428...136,179,345
G
Nfe2l2
NFE2 like bZIP transcription factor 2
increases expression multiple interactions
ISO EXP
gamma-Tocopherol results in increased expression of NFE2L2 mRNA; gamma-Tocopherol results in increased expression of NFE2L2 protein [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NFE2L2 protein]
CTD
PMID:19115203 PMID:22389237
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NQO1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NQO1 protein]
CTD
PMID:22389237
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Nsf
N-ethylmaleimide sensitive factor, vesicle fusing ATPase
increases expression
ISO
Tocopherols results in increased expression of NSF mRNA
CTD
PMID:17654050
NCBI chr10:89,227,937...89,357,383
Ensembl chr10:88,727,912...88,857,386
G
Pcna
proliferating cell nuclear antigen
multiple interactions decreases expression
EXP
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PCNA protein] Tocopherols results in decreased expression of PCNA
CTD
PMID:17927505 PMID:22389237
NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:119,498,810...119,502,995
G
Pparg
peroxisome proliferator-activated receptor gamma
increases expression multiple interactions
ISO EXP
gamma-Tocopherol results in increased expression of PPARG mRNA; gamma-Tocopherol results in increased expression of PPARG protein [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein]
CTD
PMID:14521714 PMID:22389237
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Ppp3ca
protein phosphatase 3 catalytic subunit alpha
increases expression
ISO
Tocopherols results in increased expression of PPP3CA mRNA
CTD
PMID:17654050
NCBI chr 2:227,839,058...228,113,560
Ensembl chr 2:225,165,766...225,438,974
G
Prtn3
proteinase 3
increases expression
ISO
Tocopherols results in increased expression of PRTN3 mRNA
CTD
PMID:17056531
NCBI chr 7:10,472,750...10,482,037
Ensembl chr 7:9,822,122...9,831,944
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases activity multiple interactions
ISO EXP
gamma-Tocopherol results in decreased activity of PTGS2 protein [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PTGS2 protein]
CTD
PMID:15225597 PMID:22389237
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Ptpro
protein tyrosine phosphatase, receptor type, O
increases expression
ISO
Tocopherols results in increased expression of PTPRO mRNA
CTD
PMID:17056531
NCBI chr 4:171,895,104...172,105,911
Ensembl chr 4:170,164,431...170,374,771
G
Rab11b
RAB11B, member RAS oncogene family
increases expression
ISO
Tocopherols results in increased expression of RAB11B mRNA
CTD
PMID:17654050
NCBI chr 7:15,223,613...15,236,754
Ensembl chr 7:14,521,368...14,534,593
G
Rab3a
RAB3A, member RAS oncogene family
increases expression
ISO
Tocopherols results in increased expression of RAB3A mRNA
CTD
PMID:17654050
NCBI chr16:18,718,164...18,722,273
Ensembl chr16:18,684,188...18,688,336
G
Rab6b
RAB6B, member RAS oncogene family
increases expression
ISO
Tocopherols results in increased expression of RAB6B mRNA
CTD
PMID:17654050
NCBI chr 8:112,574,223...112,642,911
Ensembl chr 8:103,695,631...103,805,732
G
Rb1
RB transcriptional corepressor 1
decreases phosphorylation
ISO
Tocopherols results in decreased phosphorylation of RB1 protein
CTD
PMID:12504091
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:48,371,296...48,502,302
G
Rrm1
ribonucleotide reductase catalytic subunit M1
increases expression
ISO
Tocopherols results in increased expression of RRM1 mRNA
CTD
PMID:17056531
NCBI chr 1:166,235,904...166,260,206
Ensembl chr 1:156,823,960...156,848,261
G
Rrm2
ribonucleotide reductase regulatory subunit M2
increases expression
ISO
Tocopherols results in increased expression of RRM2 mRNA
CTD
PMID:17056531
NCBI chr 6:47,044,755...47,075,370
Ensembl chr 6:41,340,557...41,346,773
G
Snca
synuclein alpha
increases expression
ISO
Tocopherols results in increased expression of SNCA mRNA
CTD
PMID:17654050
NCBI chr 4:91,026,474...91,127,444
Ensembl chr 4:89,696,420...89,796,262
G
Sncb
synuclein, beta
increases expression
ISO
Tocopherols results in increased expression of SNCB mRNA
CTD
PMID:17654050
NCBI chr17:9,851,825...9,860,143
Ensembl chr17:9,846,802...9,855,012
G
Sod1
superoxide dismutase 1
increases expression
ISO
gamma-Tocopherol results in increased expression of SOD1 protein
CTD
PMID:19115203
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
Stx1a
syntaxin 1A
increases expression
ISO
Tocopherols results in increased expression of STX1A mRNA
CTD
PMID:17654050
NCBI chr12:27,278,517...27,306,547
Ensembl chr12:21,641,969...21,669,930
G
Stxbp1
syntaxin binding protein 1
increases expression
ISO
Tocopherols results in increased expression of STXBP1 mRNA
CTD
PMID:17654050
NCBI chr 3:36,474,428...36,536,120
Ensembl chr 3:16,076,391...16,138,369
G
Sv2a
synaptic vesicle glycoprotein 2a
increases expression
ISO
Tocopherols results in increased expression of SV2A mRNA
CTD
PMID:17654050
NCBI chr 2:183,741,489...183,757,290
Ensembl chr 2:183,741,547...183,756,927
G
Syn1
synapsin I
increases expression
ISO
Tocopherols results in increased expression of SYN1 mRNA
CTD
PMID:17654050
NCBI chr X:3,725,745...3,780,940
Ensembl chr X:1,172,208...1,227,396
G
Syn2
synapsin II
increases expression
ISO
Tocopherols results in increased expression of SYN2 mRNA
CTD
PMID:17654050
NCBI chr 4:149,858,919...150,016,845
Ensembl chr 4:148,186,270...148,344,192
G
Syngr1
synaptogyrin 1
increases expression
ISO
Tocopherols results in increased expression of SYNGR1 mRNA
CTD
PMID:17654050
NCBI chr 7:113,516,246...113,542,918
Ensembl chr 7:111,635,918...111,659,341
G
Syp
synaptophysin
increases expression
ISO
Tocopherols results in increased expression of SYP mRNA
CTD
PMID:17654050
NCBI chr X:17,521,348...17,536,449
Ensembl chr X:14,849,444...14,864,745
G
Syt11
synaptotagmin 11
increases expression
ISO
Tocopherols results in increased expression of SYT11 mRNA
CTD
PMID:17654050
NCBI chr 2:176,503,845...176,530,354
Ensembl chr 2:174,206,191...174,231,964
G
Syt13
synaptotagmin 13
increases expression
ISO
Tocopherols results in increased expression of SYT13 mRNA
CTD
PMID:17654050
NCBI chr 3:99,332,554...99,372,960
Ensembl chr 3:78,877,114...78,917,392
G
Tnf
tumor necrosis factor
multiple interactions
ISO EXP
[alpha-Tocopherol co-treated with gamma-Tocopherol] results in decreased expression of TNF protein Tocopherols inhibits the reaction [TNF protein results in decreased export of Potassium]
CTD
PMID:17337591 PMID:18191645
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip2
TNF alpha induced protein 2
increases expression
ISO
Tocopherols results in increased expression of TNFAIP2 mRNA
CTD
PMID:17056531
NCBI chr 6:130,476,832...130,489,914
Ensembl chr 6:130,476,889...130,489,914
G
Tp53
tumor protein p53
increases activity
ISO
Tocopherols results in increased activity of TP53 protein
CTD
PMID:15883045
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Ttc3
tetratricopeptide repeat domain 3
increases expression
ISO
Tocopherols results in increased expression of TTC3 mRNA
CTD
PMID:17654050
NCBI chr11:47,158,766...47,258,612
Ensembl chr11:33,688,952...33,788,975
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases expression multiple interactions
ISO EXP
gamma-Tocopherol results in increased expression of UGT1A1 mRNA [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of UGT1A1 mRNA]
CTD
PMID:19115203 PMID:22389237
NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:88,713,184...88,808,465
G
Vamp1
vesicle-associated membrane protein 1
increases expression
ISO
Tocopherols results in increased expression of VAMP1 mRNA
CTD
PMID:17654050
NCBI chr 4:159,698,894...159,705,582
Ensembl chr 4:158,012,663...158,019,349
G
Vamp2
vesicle-associated membrane protein 2
increases expression
ISO
Tocopherols results in increased expression of VAMP2 mRNA
CTD
PMID:17654050
NCBI chr10:54,292,423...54,296,657
Ensembl chr10:53,793,923...53,797,809
G
Vdr
vitamin D receptor
increases expression
ISO
Tocopherols results in increased expression of VDR mRNA
CTD
PMID:12032296
NCBI chr 7:130,864,764...130,916,757
Ensembl chr 7:128,987,981...129,037,677
G
Akt1
AKT serine/threonine kinase 1
increases phosphorylation
ISO
Gamma-tocotrienol increases phosphorylation of AKT1 protein in PC-3 prostate gland cancer cells
RGD
PMID:17601486
RGD:408364950
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all